-DOCSTART - (8701013)

Using	VERB	O	O
the	DET	O	O
Quality	NOUN	O	O
Adjusted	VERB	O	O
Life	NOUN	O	O
Year	NOUN	O	O
outcome,	ADJ	O	O
the	DET	O	O
intervention	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
cost	NOUN	O	O
effective	ADJ	O	O
from	ADP	O	O
an	DET	O	O
NHS/PSS	ADV	O	O
perspective.	ADJ	O	O

RESULTS:	NOUN	O	O
No	DET	O	O
statistical	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
implantation	NOUN	O	B-outcome
rate	NOUN	O	O
(42.6%	NOUN	O	O
vs	CCONJ	O	O
39.1%,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
.737,	NUM	O	O
rate	NOUN	O	O
ratio	NOUN	O	O
0.868,	NUM	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI]:	ADP	O	O
0.379-1.986)	ADP	O	O
and	CCONJ	O	O
the	DET	O	O
clinical	ADJ	O	B-outcome
pregnancy	NOUN	O	I-outcome
rate	NOUN	O	O
(23.4%	NUM	O	O
vs	CCONJ	O	O
26.1%,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
.764,	PUNCT	O	O
rate	NOUN	O	O
ratio	NOUN	O	O
1.155,	NOUN	O	O
95%	NOUN	O	O
CI:	NOUN	O	O
0.450-2.966)	NUM	O	O
were	VERB	O	O
detected	VERB	O	O
between	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
treatment	NOUN	O	O
groups.	NOUN	O	O

The	DET	O	O
last	NOUN	O	O
date	NOUN	O	O
of	ADP	O	O
follow-up	NOUN	O	O
was	VERB	O	O
June	NOUN	O	O
12,	NUM	O	O
2018.	NUM	O	O

The	DET	O	O
return	NOUN	O	O
of	ADP	O	O
symmetrical	ADJ	O	B-outcome
pelvic	ADJ	O	I-outcome
floor	NOUN	O	I-outcome
muscles	NOUN	O	I-outcome
(PFM)	PUNCT	O	I-outcome
work	NOUN	O	O
after	ADP	O	O
pelvis	NOUN	O	O
reposition	NOUN	O	O
exercise	NOUN	O	O
was	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group.	VERB	O	O

MATERIALS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
a	DET	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
in	ADP	O	O
which	ADP	O	O
80	NUM	O	O
patients	NOUN	O	O
suffering	VERB	O	O
from	ADP	O	O
cancer	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
two	NUM	O	O
groups	NOUN	O	O
of	ADP	O	O
experimental	ADJ	O	O
and	CCONJ	O	O
control.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Similar	ADJ	O	O
skeletal	ADJ	O	B-outcome
,	PUNCT	O	O
dental	ADJ	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
soft	NOUN	O	B-outcome
tissue	NOUN	O	I-outcome
changes	NOUN	O	O
were	VERB	O	O
obtained	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
after	ADP	O	O
Herbst	NOUN	O	O
therapy.	NOUN	O	O

PMID:	NOUN	O	O
31596411	NUM	O	O

The	DET	O	O
PaCO(2)	ADV	O	B-outcome
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
was	VERB	O	O
(62.0+/-4.7)	PUNCT	O	O
mmHg	NOUN	O	O
,	PUNCT	O	O
which	ADP	O	O
was	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
than	ADP	O	O
group	NOUN	O	O
B	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
operation[(51.9+/-4.2)	NOUN	O	O
mmHg,	NOUN	O	O
t=2.432,	NUM	O	O
P<0.05].	NOUN	O	O
The	DET	O	O
time	NOUN	O	B-outcome
spent	VERB	O	I-outcome
successfully	ADV	O	I-outcome
positioning	VERB	O	I-outcome
the	DET	O	Seperator
insertion	NOUN	O	I-outcome
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
and	CCONJ	O	O
group	NOUN	O	O
B	NOUN	O	O
were	VERB	O	O
(17.6+/-7.5),	NOUN	O	O
(29.8+/-13.6)s,	ADV	O	O
the	DET	O	O
endoscope	NOUN	O	B-outcome
indwelling	VERB	O	I-outcome
duration	NOUN	O	I-outcome
were(0.8+/-0.1),	NUM	O	O
(1.4+/-0.3)min,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
operation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
were(32.3+/-4.3),	NOUN	O	O
(46.8+/-4.8)min,	PUNCT	O	O
there	PRON	O	O
were	VERB	O	O
significantly	ADV	O	O
difference	NOUN	O	O
between	ADP	O	O
group	NOUN	O	O
A	DET	O	O
and	CCONJ	O	O
group	NOUN	O	O
B(t=2.670,	NOUN	O	O
2.214,	ADJ	O	O
2.166,	ADJ	O	O
all	DET	O	O
P<0.05).	NOUN	O	O

Title:	NOUN	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O
of	ADP	O	O
Two	NUM	O	O
Incremental	ADJ	O	O
Milk-Feeding	VERB	O	O
Rates	NOUN	O	O
in	ADP	O	O
Preterm	NOUN	O	O
Infants.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Contrast	NOUN	O	B-outcome
enhancement	NOUN	O	I-outcome
was	VERB	O	O
equivalent	ADJ	O	O
under	ADP	O	O
both	CCONJ	O	O
protocols.	NOUN	O	O

Conical	ADJ	O	O
implant	NOUN	O	O
interfaces,	NOUN	O	O
but	CCONJ	O	O
not	ADV	O	O
flat-to-flat	NOUN	O	O
or	CCONJ	O	O
platform-switched	VERB	O	O
implant	NOUN	O	O
interfaces,	NOUN	O	O
were	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
no	DET	O	O
marginal	ADJ	O	B-outcome
bone	NOUN	O	I-outcome
level	NOUN	O	O
(MBL)	NOUN	O	O
changes	NOUN	O	O
over	ADP	O	O
3	NUM	O	O
years.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Therefore,	NOUN	O	O
our	ADJ	O	O
results	NOUN	O	O
do	VERB	O	O
not	ADV	O	O
support	NOUN	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
antibiotic	ADJ	O	O
treatment	NOUN	O	O
for	ADP	O	O
chronic	ADJ	O	O
low	ADJ	O	O
back	ADP	O	O
pain	NOUN	O	O
and	CCONJ	O	O
Modic	NOUN	O	O
changes.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal-Name:Indian	NOUN	O	O
heart	NOUN	O	O
journal	ADJ	O	O

This	DET	O	O
paper	NOUN	O	O
presents	NOUN	O	O
the	DET	O	O
MIM's	NOUN	O	O
intervention	NOUN	O	O
effect	NOUN	O	O
on	ADP	O	O
self-efficacy	NOUN	O	B-outcome
to	PART	O	O
cope	NOUN	O	O
with	ADP	O	O
stress,	NOUN	O	O
emotional	ADJ	O	O
coping	VERB	O	B-outcome
response,	NOUN	O	O
social	ADJ	O	B-outcome
support	NOUN	O	I-outcome
for	ADP	O	O
stress	NOUN	O	O
management,	NOUN	O	O
stress	NOUN	O	B-outcome
,	PUNCT	O	O
depressive	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
positive	ADJ	O	B-outcome
and	CCONJ	O	Seperator
negative	ADJ	O	B-outcome
affect	NOUN	O	E1-outcome
.	PUNCT	O	O
METHODS:	NOUN	O	O
Participants	NOUN	O	O
(N	PUNCT	O	O
=	SYM	O	O
612)	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
from	ADP	O	O
the	DET	O	O
Special	ADJ	O	O
Supplemental	ADJ	O	O
Nutrition	NOUN	O	O
Program	NOUN	O	O
for	ADP	O	O
Women,	NOUN	O	O
Infants,	NOUN	O	O
and	CCONJ	O	O
Children	NOUN	O	O
in	ADP	O	O
Michigan.	NOUN	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
of	ADP	O	O
oncological	ADJ	O	O
benefits	NOUN	O	O
of	ADP	O	O
deep	ADJ	O	O
neuromuscular	ADJ	O	O
block	VERB	O	O
in	ADP	O	O
obese	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
gastric	ADJ	O	O
cancer	NOUN	O	O
(DEBLOQS_GC	PUNCT	O	O
study):	NUM	O	O
A	DET	O	O
study	NOUN	O	O
protocol	NOUN	O	O
for	ADP	O	O
a	DET	O	O
double-blind,	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
evaluated	VERB	O	O
clinical	ADJ	O	O
and	CCONJ	O	O
radiographic	ADJ	O	O
twelve-month	NOUN	O	O
outcomes	NOUN	O	O
of	ADP	O	O
root	NOUN	O	O
canal	NOUN	O	O
treatments	NOUN	O	O
(CT)	NOUN	O	O
with	ADP	O	O
smear	NOUN	O	O
layer	NOUN	O	O
removal,	ADJ	O	O
performed	VERB	O	O
in	ADP	O	O
primary	ADJ	O	O
teeth,	NOUN	O	O
using	VERB	O	O
two	NUM	O	O
different	ADJ	O	O
root	NOUN	O	O
canal	NOUN	O	O
filling	VERB	O	O
materials.	NOUN	O	O

PC	NOUN	O	O
may	VERB	O	O
help	VERB	O	O
prevent	NOUN	O	O
dangerous	ADJ	O	O
hyperthermia	NOUN	O	O
in	ADP	O	O
athletes.	ADV	O	O

OBJECTIVE:	NOUN	O	O
One	NUM	O	O
of	ADP	O	O
the	DET	O	O
important	ADJ	O	O
aspects	NOUN	O	O
involved	VERB	O	O
in	ADP	O	O
achieving	VERB	O	O
optimal	ADJ	O	O
outcomes	NOUN	O	O
after	ADP	O	O
assisted	VERB	O	O
reproductive	ADJ	O	O
treatment	NOUN	O	O
(ART)	NOUN	O	O
is	VERB	O	O
the	DET	O	O
endometrium.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/15	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

OBJECTIVE:	NOUN	O	O
to	PART	O	O
measure	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
an	DET	O	O
infant	NOUN	O	O
stimulation	NOUN	O	O
therapy	NOUN	O	O
(auditory,	NOUN	O	O
tactile,	NOUN	O	O
visual	ADJ	O	O
and	CCONJ	O	O
vestibular)	NOUN	O	O
on	ADP	O	O
the	DET	O	O
adaptation	NOUN	O	B-outcome
to	PART	O	I-outcome
postnatal	ADJ	O	I-outcome
life	NOUN	O	I-outcome
of	ADP	O	O
the	DET	O	O
mother-child	NOUN	O	O
dyad.	NOUN	O	O

A	DET	O	O
fragility	NOUN	O	B-outcome
fracture	NOUN	O	I-outcome
occurred	VERB	O	O
in	ADP	O	O
190	NUM	O	O
women	NOUN	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
122	NUM	O	O
women	NOUN	O	O
in	ADP	O	O
the	DET	O	O
zoledronate	ADJ	O	O
group	NOUN	O	O
(hazard	PUNCT	O	O
ratio	NOUN	O	O
with	ADP	O	O
zoledronate,	NOUN	O	O
0.63;	NUM	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval,	ADP	O	O
0.50	NUM	O	O
to	PART	O	O
0.79;	NOUN	O	O
P<0.001).	NUM	O	O

OBJECTIVE:	NOUN	O	O
The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
the	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
test	NOUN	O	O
the	DET	O	O
applicability	NOUN	O	B-outcome
of	ADP	O	O
low-dose	NOUN	O	O
MDCT	NOUN	O	O
protocols	NOUN	O	O
for	ADP	O	O
decision-making	VERB	O	O
of	ADP	O	O
sinus	NOUN	O	O
surgeries	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
uncontrolled	VERB	O	O
chronic	ADJ	O	O
rhinosinusitis.	SYM	O	O

The	DET	O	O
study	NOUN	O	O
compares	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
MCP	NOUN	O	O
using	VERB	O	O
the	DET	O	O
AIMhi	NOUN	O	O
Stay	NOUN	O	O
Strong	ADJ	O	O
App	NOUN	O	O
with	ADP	O	O
two	NUM	O	O
control	NOUN	O	O
groups	NOUN	O	O
(control	PUNCT	O	O
app	CCONJ	O	O
intervention	NOUN	O	O
and	CCONJ	O	O
treatment	NOUN	O	O
as	ADP	O	O
usual)	NOUN	O	O
on	ADP	O	O
participant-reported	VERB	O	O
psychological	ADJ	O	B-outcome
distress	NOUN	O	I-outcome
(the	NOUN	O	O
primary	ADJ	O	O
outcome)	PUNCT	O	O
using	VERB	O	O
the	DET	O	O
Kessler	NOUN	O	O
Distress	NOUN	O	O
Scale	NOUN	O	O
(K10)];	NOUN	O	O
depressive	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
using	VERB	O	O
the	DET	O	O
adapted	VERB	O	O
Patient	NOUN	O	O
Health	NOUN	O	B-outcome
Questionnaire	PROPN	O	O
(PHQ-9)];	NOUN	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
using	VERB	O	O
the	DET	O	O
EuroQoL	NOUN	O	O
instrument	NOUN	O	O
(	NOUN	O	O
EQ5D])	NOUN	O	O
and	CCONJ	O	O
adherence	NOUN	O	B-outcome
to	PART	O	O
dialysis	NOUN	O	O
treatment	NOUN	O	O
planning	VERB	O	O
through	ADP	O	O
file	NOUN	O	O
audit.	NOUN	O	O

Contrary	NOUN	O	O
to	PART	O	O
the	DET	O	O
progress	NOUN	O	O
in	ADP	O	O
the	DET	O	O
management	NOUN	O	O
of	ADP	O	O
severe	ADJ	O	O
AP,	NOUN	O	O
the	DET	O	O
MAP	NOUN	O	O
has	VERB	O	O
not	ADV	O	O
presented	VERB	O	O
significant	ADJ	O	O
changes	NOUN	O	O
in	ADP	O	O
recent	ADJ	O	O
years.	NOUN	O	O

Title:	NOUN	O	O
ED50	NOUN	O	O
and	CCONJ	O	O
ED95	NOUN	O	O
of	ADP	O	O
intrathecal	ADJ	O	O
hyperbaric	ADJ	O	O
ropivacaine	NOUN	O	O
for	ADP	O	O
parturients	NOUN	O	O
undergoing	VERB	O	O
cesarean	NOUN	O	O
section	NOUN	O	O
with	ADP	O	O
prophylactic	ADJ	O	O
infusion	NOUN	O	O
of	ADP	O	O
phenylephrine:	NOUN	O	O
A	DET	O	O
Prospective	ADJ	O	O
dose-finding	VERB	O	O
Study.	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
ED95	NOUN	O	O
and	CCONJ	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
intervals	NOUN	O	O
(95%	PUNCT	O	O
CI)	NOUN	O	O
of	ADP	O	O
spinal	ADJ	O	O
hyperbaric	ADJ	O	O
bupivacaine	NOUN	O	O
in	ADP	O	O
group	NOUN	O	O
D	NOUN	O	O
and	CCONJ	O	O
group	NOUN	O	O
C	NOUN	O	O
were	VERB	O	O
7.4	NUM	O	O
mg	NOUN	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
5.6-12.4	NUM	O	O
mg)	NOUN	O	O
and	CCONJ	O	O
11.0	NUM	O	O
mg	NOUN	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
4.4-56.8	NUM	O	O
mg),	NOUN	O	O
respectively.	NOUN	O	O

Here,	NOUN	O	O
we	PRON	O	O
present	ADJ	O	O
the	DET	O	O
impact	NOUN	O	O
of	ADP	O	O
the	DET	O	O
diet	NOUN	O	O
intervention	NOUN	O	O
on	ADP	O	O
cost-effectiveness	NOUN	O	O
and	CCONJ	O	O
explore	ADP	O	O
changes	NOUN	O	O
in	ADP	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QOL)	PUNCT	O	I-outcome
.	PUNCT	O	O
METHODS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
110	NUM	O	O
postpartum	NOUN	O	O
women	NOUN	O	O
with	ADP	O	O
overweight/obesity	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
diet	NOUN	O	O
(D-group)	PUNCT	O	O
or	CCONJ	O	O
control	NOUN	O	O
(C-group).	NOUN	O	O

Medical	ADJ	O	O
sciences	NOUN	O	O

A	DET	O	O
partial	ADJ	O	O
support	NOUN	O	O
of	ADP	O	O
the	DET	O	O
MAT	NOUN	O	O
and	CCONJ	O	O
of	ADP	O	O
ruminations	NOUN	O	O
reduction	NOUN	O	O
to	PART	O	O
the	DET	O	O
MBI's	NOUN	O	O
efficacy	NOUN	O	O
was	VERB	O	O
found.	NOUN	O	O

Title:	NOUN	O	O
Randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
comparing	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
daily	ADJ	O	O
and	CCONJ	O	O
every	DET	O	O
other	ADJ	O	O
day	NOUN	O	O
atorvastatin	NOUN	O	O
therapy	NOUN	O	O
and	CCONJ	O	O
its	ADJ	O	O
correlation	NOUN	O	O
with	ADP	O	O
serum	NOUN	O	O
hydroxymethylglutaryl-CoA	NOUN	O	B-outcome
reductase	NOUN	O	I-outcome
enzyme	NOUN	O	I-outcome
levels	NOUN	O	O
in	ADP	O	O
naive	ADJ	O	O
dyslipidemic	ADJ	O	O
patients.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
Significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
operation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
liquid	ADV	O	B-outcome
input	NOUN	O	I-outcome
and	CCONJ	O	O
blood	NOUN	O	B-outcome
output	NOUN	O	I-outcome
between	ADP	O	O
group	NOUN	O	O
C	NOUN	O	O
and	CCONJ	O	O
group	NOUN	O	O
D(all	PUNCT	O	O
P>0.05).	NOUN	O	O

The	DET	O	O
intake	NOUN	O	O
of	ADP	O	O
CSO	NOUN	O	O
in	ADP	O	O
the	DET	O	O
CSO	NOUN	O	O
group,	NOUN	O	O
but	CCONJ	O	O
not	ADV	O	O
the	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
plasma	NOUN	O	O
ALA	NOUN	O	O
proportions,	NOUN	O	O
correlated	VERB	O	O
inversely	ADV	O	O
with	ADP	O	O
the	DET	O	O
IFNG	NOUN	O	O
mRNA	NOUN	O	B-outcome
expression	NOUN	O	I-outcome
in	ADP	O	O
PBMCs	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
0.08).	NUM	O	O

The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
severe	ADJ	O	B-outcome
disability	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
SBH	NOUN	O	O
treatment	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
routine	ADJ	O	O
treatment	NOUN	O	O
group	NOUN	O	O
[5.6%	NOUN	O	O
(1/18)	PUNCT	O	O
vs.	CCONJ	O	O
44.4%	NUM	O	O
(8/18),	NUM	O	O
P	NOUN	O	O
<	SYM	O	O
0.05].	NUM	O	O
There	PRON	O	O
was	VERB	O	O
1	NUM	O	O
child	NOUN	O	O
death	NOUN	O	B-outcome
in	ADP	O	O
the	DET	O	O
routine	ADJ	O	O
treatment	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
no	DET	O	O
death	NOUN	O	O
in	ADP	O	O
the	DET	O	O
SBH	NOUN	O	O
treatment	NOUN	O	O
group.	VERB	O	O

There	PRON	O	O
is	VERB	O	O
currently	ADV	O	O
no	DET	O	O
standard	ADJ	O	O
therapeutic	ADJ	O	O
regimen	NOUN	O	O
available	ADJ	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
advanced	VERB	O	O
colorectal	ADJ	O	O
cancer	NOUN	O	O
in	ADP	O	O
whom	ADP	O	O
the	DET	O	O
disease	NOUN	O	O
continues	NOUN	O	O
to	PART	O	O
progress	NOUN	O	O
after	ADP	O	O
2	NUM	O	O
or	CCONJ	O	O
more	ADV	O	O
lines	NOUN	O	O
of	ADP	O	O
chemotherapy.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
group	NOUN	O	O
will	VERB	O	O
take	NOUN	O	O
2.5	NUM	O	O
g	NOUN	O	O
of	ADP	O	O
Bosinji	NOUN	O	O
granule	NOUN	O	O
(1.523	PUNCT	O	O
g	NOUN	O	O
of	ADP	O	O
Bosinji	NOUN	O	O
extract)	NOUN	O	O
or	CCONJ	O	O
Loxonin	NOUN	O	O
tablet	NOUN	O	O
(60	PUNCT	O	O
mg	NOUN	O	O
of	ADP	O	O
loxoprofen)	ADV	O	O
3	NUM	O	O
times	NOUN	O	O
a	DET	O	O
day	NOUN	O	O
for	ADP	O	O
6	NUM	O	O
weeks.	NOUN	O	O

At	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
an	DET	O	O
8-week	NOUN	O	O
consumption	NOUN	O	O
period,	NOUN	O	O
all	DET	O	O
subjects	NOUN	O	O
were	VERB	O	O
determined	VERB	O	O
serum	NOUN	O	O
bone	NOUN	O	B-outcome
markers	NOUN	O	O
including	VERB	O	O
calcium	NOUN	O	B-outcome
,	PUNCT	O	O
alkaline	ADJ	O	B-outcome
phosphatase	NOUN	O	I-outcome
,	PUNCT	O	O
osteocalcin	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
beta	NOUN	O	B-outcome
CTX	NOUN	O	I-outcome
.	PUNCT	O	O
In	ADP	O	O
addition,	NOUN	O	O
the	DET	O	O
hematological	ADJ	O	B-outcome
and	CCONJ	O	O
blood	NOUN	O	O
clinical	ADJ	O	B-outcome
chemistry	NOUN	O	I-outcome
changes,	NOUN	O	O
and	CCONJ	O	O
total	ADJ	O	O
phenolic	NOUN	O	B-outcome
content	NOUN	O	O
in	ADP	O	O
the	DET	O	O
serum	NOUN	O	O
were	VERB	O	O
also	ADV	O	O
determined.	NOUN	O	O

Trial	NOUN	O	O
Registration:	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
Identifier:	NOUN	O	O
NCT02241655.	ADP	O	O

Teachers	NOUN	O	O
assigned	VERB	O	O
to	PART	O	O
the	DET	O	O
waitlist	ADJ	O	O
control	NOUN	O	O
condition	NOUN	O	O
will	VERB	O	O
receive	VERB	O	O
an	DET	O	O
alternative	ADJ	O	O
training	VERB	O	O
on	ADP	O	O
how	ADP	O	O
to	PART	O	O
monitor	NOUN	O	O
physical	ADJ	O	O
functional	ADJ	O	O
capacity	NOUN	O	O
in	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
special	ADJ	O	O
needs.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/10	ADV	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/17	ADP	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8908809	NUM	O	O

A	DET	O	O
heat	NOUN	O	B-outcome
stress	NOUN	O	I-outcome
test	NOUN	O	O
(120min,	NOUN	O	O
45%	ADJ	O	O
V	NUM	O	O
O2peak)	NOUN	O	O
before	ADP	O	O
(Pre	NUM	O	O
HA)	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
HA	NOUN	O	O
(Post	PUNCT	O	O
HA)	NOUN	O	O
in	ADP	O	O
similar	ADJ	O	O
hot	ADJ	O	O
conditions	NOUN	O	O
assessed	VERB	O	O
heat	NOUN	O	B-outcome
acclimation	NOUN	O	I-outcome
status.	NOUN	O	O

Both	CCONJ	O	O
groups	NOUN	O	O
showed	VERB	O	O
significant	ADJ	O	O
gains	NOUN	O	O
at	ADP	O	O
the	DET	O	O
Fugl-Meyer	NOUN	O	O
motor	NOUN	O	B-outcome
assessment	NOUN	O	I-outcome
(FMA)	NOUN	O	O
(ST:	NOUN	O	O
5+/-4	NOUN	O	O
points/FT:	NOUN	O	O
6+/-4	NUM	O	O
points;	NOUN	O	O
P=0.04)	NOUN	O	O
and	CCONJ	O	O
Wolf	NOUN	O	O
motor	NOUN	O	B-outcome
function	NOUN	O	I-outcome
test	NOUN	O	O
(ST:	NOUN	O	O
0.4+/-0.3	NOUN	O	O
points/FT:	NOUN	O	O
0.6+/-0.4	NOUN	O	O
points;	NOUN	O	O
P=0.05),	NOUN	O	O
which	ADP	O	O
were	VERB	O	O
comparable	ADJ	O	O
between	ADP	O	O
groups	NOUN	O	O
(P>/=0.47).	PUNCT	O	O

METHODS:	NOUN	O	O
One	NUM	O	O
hundred	NUM	O	O
and	CCONJ	O	O
three	NUM	O	O
high	ADJ	O	O
school	NOUN	O	O
athletes	NOUN	O	O
completed	VERB	O	O
the	DET	O	O
study	NOUN	O	O
(M	NUM	O	O
age	NOUN	O	O
=	SYM	O	O
15.3,	NOUN	O	O
SD	NOUN	O	O
=	SYM	O	O
1.2;	NUM	O	O
70.9%	NUM	O	O
male;	NOUN	O	O
37.9%	NUM	O	O
Afr.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/09	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal-Name:Indian	NOUN	O	O
heart	NOUN	O	O
journal	ADJ	O	O

Recovery	NOUN	O	B-outcome
conditions	NOUN	O	I-outcome
,	PUNCT	O	O
postoperative	ADJ	O	O
agitation	NOUN	O	B-outcome
were	VERB	O	O
also	ADV	O	O
recorded.	NOUN	O	O

Depression	NOUN	O	B-outcome
and	CCONJ	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
variability	NOUN	O	I-outcome
were	VERB	O	O
measured	VERB	O	O
using	VERB	O	O
the	DET	O	O
GDS	NOUN	O	O
and	CCONJ	O	O
digital	ADJ	O	O
electrocardiogram	NOUN	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
the	DET	O	O
24-week	NUM	O	O
intervention.	NOUN	O	O

On	ADP	O	O
each	DET	O	O
visit	NOUN	O	O
the	DET	O	O
participants	NOUN	O	O
consumed	VERB	O	O
either	CCONJ	O	O
a	DET	O	O
CA	NOUN	O	O
+	SYM	O	O
C	NOUN	O	O
(100	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
CA	NOUN	O	O
and	CCONJ	O	O
100	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
C)	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
(dextrose)	NUM	O	O
capsule.	NUM	O	O

BACKGROUND:	NOUN	O	O
Alveolar	ADJ	O	O
osteitis	NOUN	O	O
is	VERB	O	O
a	DET	O	O
frequent	ADJ	O	O
postoperative	ADJ	O	O
complication	NOUN	O	O
of	ADP	O	O
third	ADJ	O	O
molar	ADJ	O	O
surgery.	VERB	O	O

INTERPRETATION:	CCONJ	O	O
Compared	VERB	O	O
with	ADP	O	O
ICSI,	NOUN	O	O
PICSI	NOUN	O	O
does	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
improve	VERB	O	O
term	NOUN	O	O
livebirth	ADJ	O	B-outcome
rates.	NOUN	O	O

DISCUSSION:	NOUN	O	O
This	DET	O	O
trial	NOUN	O	O
will	VERB	O	O
assess	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
selenium	NOUN	O	O
supplementation	NOUN	O	O
on	ADP	O	O
pregnancy	NOUN	O	B-outcome
outcome	NOUN	O	I-outcome
and	CCONJ	O	O
HIV	NOUN	O	B-outcome
disease	NOUN	O	I-outcome
progression	NOUN	O	I-outcome
among	ADP	O	O
HIV-infected	VERB	O	O
pregnant	ADJ	O	O
women	NOUN	O	O
in	ADP	O	O
Lagos.	NOUN	O	O

The	DET	O	O
success	NOUN	O	O
rates	NOUN	O	O
of	ADP	O	O
hemostasis	NOUN	O	B-outcome
for	ADP	O	O
3	NUM	O	O
minutes	NOUN	O	O
and	CCONJ	O	O
5	NUM	O	O
minutes,	NOUN	O	O
the	DET	O	O
time	NOUN	O	B-outcome
of	ADP	O	I-outcome
operation	NOUN	O	I-outcome
,	PUNCT	O	O
the	DET	O	O
amount	NOUN	O	O
of	ADP	O	O
intraoperative	ADJ	O	O
bleeding	VERB	O	B-outcome
,	PUNCT	O	O
the	DET	O	O
volume	NOUN	O	O
of	ADP	O	O
autogenously	ADV	O	O
blood	NOUN	O	B-outcome
transfusion	NOUN	O	I-outcome
,	PUNCT	O	O
the	DET	O	O
amount	NOUN	O	O
of	ADP	O	O
blood	NOUN	O	B-outcome
during	ADP	O	O
hemostasis,	NOUN	O	O
the	DET	O	O
amount	NOUN	O	O
of	ADP	O	O
blood	NOUN	O	B-outcome
transfusion	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
BP	NOUN	O	B-outcome
,	PUNCT	O	O
red	ADJ	O	B-outcome
blood	NOUN	O	I-outcome
cell	NOUN	O	I-outcome
count	NOUN	O	I-outcome
(RBC)	NOUN	O	I-outcome
,	PUNCT	O	O
haematocrit	NOUN	O	B-outcome
(HCT)	PUNCT	O	I-outcome
,	PUNCT	O	O
haemoglobin	NOUN	O	B-outcome
(HB)	ADV	O	I-outcome
of	ADP	O	O
preoperative,	ADJ	O	O
2	NUM	O	O
to	PART	O	O
3	NUM	O	O
days,	NOUN	O	O
and	CCONJ	O	O
5	NUM	O	O
to	PART	O	O
7	NUM	O	O
days	NOUN	O	O
following	VERB	O	O
operation	NOUN	O	O
were	VERB	O	O
recorded	VERB	O	O
to	PART	O	O
compare.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/16	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
results	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
demonstrated	VERB	O	O
that	ADP	O	O
NES	NOUN	O	O
may	VERB	O	O
help	VERB	O	O
to	PART	O	O
relieve	NOUN	O	O
CINV	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
AGC.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
the	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
observe	NOUN	O	O
the	DET	O	O
feasibility	NOUN	O	B-outcome
and	CCONJ	O	O
effect	NOUN	O	O
of	ADP	O	O
cornea	NOUN	O	O
slice	NOUN	O	O
acquired	VERB	O	O
from	ADP	O	O
femtosecond	NOUN	O	O
laser	NOUN	O	O
surgery,	NOUN	O	O
small	ADJ	O	O
incision	NOUN	O	O
lenticule	NOUN	O	O
extraction	NOUN	O	O
(SMILE)	NUM	O	O
as	ADP	O	O
patch	NOUN	O	O
graft	NOUN	O	O
for	ADP	O	O
the	DET	O	O
prevention	NOUN	O	O
of	ADP	O	O
drainage	NOUN	O	B-outcome
tube	NOUN	O	I-outcome
exposure	NOUN	O	I-outcome
and	CCONJ	O	O
to	PART	O	O
compare	NOUN	O	O
with	ADP	O	O
the	DET	O	O
sclera.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9435674	NUM	O	O

Metabolomics	NOUN	O	O
was	VERB	O	O
employed	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
cellular	ADJ	O	B-outcome
metabolism	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
DKD	NOUN	O	O
patients	NOUN	O	O
had	VERB	O	O
decreased	VERB	O	O
mtDNA	ADJ	O	B-outcome
copy	NOUN	O	I-outcome
numbers	NOUN	O	O
and	CCONJ	O	O
increased	VERB	O	O
mtDNA	ADJ	O	B-outcome
damage	NOUN	O	I-outcome
compared	VERB	O	O
to	PART	O	O
DCs.	NOUN	O	O

Patient	NOUN	O	O
satisfaction	NOUN	O	B-outcome
at	ADP	O	O
24	NUM	O	O
h	NOUN	O	O
postoperatively	ADV	O	O
was	VERB	O	O
filed	VERB	O	O
on	ADP	O	O
a	DET	O	O
11-point	NOUN	O	O
numeric	ADJ	O	O
rating	VERB	O	O
scale	NOUN	O	O
(SFS24;	PUNCT	O	O
0=fully	ADV	O	O
unsatisfied;	NOUN	O	O
10=fully	ADV	O	O
satisfied).	NUM	O	O

Lastly,	NOUN	O	O
EMLA	NOUN	O	O
lowered	VERB	O	O
overall	ADJ	O	B-outcome
pain	NOUN	O	I-outcome
score	NOUN	O	O
at	ADP	O	O
the	DET	O	O
time	NOUN	O	O
of	ADP	O	O
first	ADV	O	O
analgesic	ADP	O	O
request	NOUN	O	O
in	ADP	O	O
ward	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
control	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.02).	PUNCT	O	O

The	DET	O	O
menstrual	ADJ	O	O
disturbances	NOUN	O	O
as	ADP	O	O
a	DET	O	O
health	NOUN	O	O
problem	ADP	O	O
among	ADP	O	O
young	ADJ	O	O
girls	NOUN	O	O
affect	NOUN	O	O
not	ADV	O	O
only	ADV	O	O
reproductive,	NOUN	O	O
but	CCONJ	O	O
also	ADV	O	O
psychical	ADJ	O	O
health	NOUN	O	O
and	CCONJ	O	O
quality	NOUN	O	O
of	ADP	O	O
life.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
evaluated	VERB	O	O
40	NUM	O	O
patients	NOUN	O	O
aged	VERB	O	O
>/=18	NOUN	O	O
years	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
elective	ADJ	O	O
muscle	NOUN	O	O
sparing	VERB	O	O
thoracotomies.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
This	DET	O	O
study's	ADP	O	O
findings	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
an	DET	O	O
educational	ADJ	O	O
video	ADJ	O	O
can	VERB	O	O
be	VERB	O	O
as	ADP	O	O
beneficial	ADJ	O	O
as	ADP	O	O
expert	NOUN	O	O
proctoring,	NOUN	O	O
which	ADP	O	O
implies	NOUN	O	O
that	ADP	O	O
the	DET	O	O
development	NOUN	O	O
of	ADP	O	O
a	DET	O	O
standardized	VERB	O	O
educational	ADJ	O	O
video	ADJ	O	O
would	VERB	O	O
be	VERB	O	O
worthwhile.	VERB	O	O

Journal-Name:Hematology	NOUN	O	O
(Amsterdam,	NOUN	O	O
Netherlands)	ADJ	O	O

Title:	NOUN	O	O
Taping	VERB	O	O
to	PART	O	O
Improve	NOUN	O	O
Scapular	ADJ	O	B-outcome
Dyskinesis	NOUN	O	I-outcome
,	PUNCT	O	O
Scapular	ADJ	O	B-outcome
Upward	NOUN	O	I-outcome
Rotation	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
Pectoralis	NOUN	O	B-outcome
Minor	ADJ	O	I-outcome
Length	NOUN	O	I-outcome
in	ADP	O	O
Overhead	ADP	O	O
Athletes.	NOUN	O	O

Before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
anthropometric	ADP	O	B-outcome
parameters,	NOUN	O	O
serum	NOUN	O	O
lipid	NOUN	O	B-outcome
profile,	NOUN	O	O
serum	NOUN	O	O
concentrations	NOUN	O	O
of	ADP	O	O
alanine	NOUN	O	B-outcome
aminotransferase	NOUN	O	I-outcome
,	PUNCT	O	O
aspartate	NOUN	O	B-outcome
aminotransferase	NOUN	O	I-outcome
,	PUNCT	O	O
insulin	NOUN	O	B-outcome
,	PUNCT	O	O
glucose	NOUN	O	B-outcome
,	PUNCT	O	O
insulin-like	ADJ	O	B-outcome
growth	NOUN	O	I-outcome
factor-1	NOUN	O	I-outcome
,	PUNCT	O	O
HOMA-IR	ADV	O	B-outcome
(homeostatic	PUNCT	O	O
model	NOUN	O	O
assessment),	NOUN	O	O
and	CCONJ	O	O
visceral	ADJ	O	B-outcome
adiposity	NOUN	O	I-outcome
index	NOUN	O	O
(VAI),	SYM	O	O
and	CCONJ	O	O
their	ADJ	O	O
changes	NOUN	O	O
were	VERB	O	O
registered.	NOUN	O	O

Comparison	NOUN	O	O
of	ADP	O	O
the	DET	O	O
mean	NOUN	O	O
differences	NOUN	O	O
at	ADP	O	O
the	DET	O	O
beginning	VERB	O	O
and	CCONJ	O	O
two	NUM	O	O
months	NOUN	O	O
after	ADP	O	O
the	DET	O	O
study	NOUN	O	O
in	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
the	DET	O	O
scores	NOUN	O	O
related	VERB	O	O
to	PART	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QOL)	PUNCT	O	I-outcome
dimensions	NOUN	O	O
in	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
greater	ADJ	O	O
than	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(p</=0.05).	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
The	DET	O	O
study	NOUN	O	O
is	VERB	O	O
registered	VERB	O	O
at	ADP	O	O
EudraCT	NOUN	O	O
(2016-003017-10,	NOUN	O	O
date	NOUN	O	O
of	ADP	O	O
registration:	NOUN	O	O
22	NUM	O	O
July	NOUN	O	O
2016)	NUM	O	O
and	CCONJ	O	O
(	PUNCT	O	O
NCT02868385	NOUN	O	O
,	PUNCT	O	O
date	NOUN	O	O
of	ADP	O	O
registration:	NOUN	O	O
16	NUM	O	O
August	NOUN	O	O
2016).	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
shoulder	NOUN	O	O
and	CCONJ	O	O
elbow	NOUN	O	O
surgery	NOUN	O	O

OBJECTIVE:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
means	NOUN	O	O
to	PART	O	O
determine	NOUN	O	O
whether	ADP	O	O
Mg	NOUN	O	O
supplementation	NOUN	O	O
improves	NOUN	O	O
glycemic	ADJ	O	B-outcome
control	NOUN	O	I-outcome
indicators	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
T2D.	NOUN	O	O
METHODS:	NOUN	O	O
After	ADP	O	O
one	NUM	O	O
week	NOUN	O	O
of	ADP	O	O
the	DET	O	O
dietary	ADJ	O	O
stabilization	NOUN	O	O
phase,	NOUN	O	O
42	NUM	O	O
T2D	NOUN	O	O
patients	NOUN	O	O
were	VERB	O	O
stratified	VERB	O	O
according	ADJ	O	O
to	PART	O	O
sex,	NOUN	O	O
age,	NOUN	O	O
fasting	VERB	O	O
blood	NOUN	O	O
sugar	NOUN	O	O
(FBS)	PUNCT	O	O
and	CCONJ	O	O
Mg	NOUN	O	O
levels	NOUN	O	O
and	CCONJ	O	O
then	ADV	O	O
randomly	ADV	O	O
allocated	VERB	O	O
into	ADP	O	O
two	NUM	O	O
groups.	NOUN	O	O

Participants	NOUN	O	O
were	VERB	O	O
critically	ADV	O	O
ill	ADJ	O	O
patients	NOUN	O	O
who	ADP	O	O
regained	VERB	O	O
mental	ADJ	O	O
capacity	NOUN	O	O
following	VERB	O	O
receipt	NOUN	O	O
of	ADP	O	O
level	NOUN	O	O
3	NUM	O	O
(intensive)	PUNCT	O	O
care.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
and	CCONJ	O	O
secondary	ADJ	O	O
endpoints,	NOUN	O	O
excluding	VERB	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QoL)	NOUN	O	I-outcome
,	PUNCT	O	O
have	VERB	O	O
been	VERB	O	O
published.	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned,	NOUN	O	O
in	ADP	O	O
a	DET	O	O
2:1	ADP	O	O
ratio,	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
a	DET	O	O
single	ADJ	O	O
300-mg	NUM	O	O
dose	NOUN	O	O
of	ADP	O	O
tafenoquine	NOUN	O	O
or	CCONJ	O	O
15	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
primaquine	NOUN	O	O
once	ADP	O	O
daily	ADJ	O	O
for	ADP	O	O
14	NUM	O	O
days	NOUN	O	O
(administered	PUNCT	O	O
under	ADP	O	O
supervision);	NOUN	O	O
all	DET	O	O
patients	NOUN	O	O
received	VERB	O	O
a	DET	O	O
3-day	NOUN	O	O
course	NOUN	O	O
of	ADP	O	O
chloroquine	NOUN	O	O
and	CCONJ	O	O
were	VERB	O	O
followed	VERB	O	O
for	ADP	O	O
180	NUM	O	O
days.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
current	ADJ	O	O
exploratory	ADJ	O	O
analysis,	NOUN	O	O
these	DET	O	O
ardms	NOUN	O	O
were	VERB	O	O
categorized	VERB	O	O
into	ADP	O	O
the	DET	O	O
moderate	ADJ	O	O
hypofractionated	VERB	O	O
(MHF)	PUNCT	O	O
group	NOUN	O	O
(52	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
Arms	NOUN	O	O
1-3)	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
extreme	NOUN	O	O
hypofractionated	VERB	O	O
(EHF)	NOUN	O	O
group	NOUN	O	O
(30	NOUN	O	O
patients	NOUN	O	O
in	ADP	O	O
Arms	NOUN	O	O
4-5).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Intravenous	ADJ	O	O
boluses	NOUN	O	O
of	ADP	O	O
50	NUM	O	O
mug	NUM	O	O
were	VERB	O	O
administered	VERB	O	O
for	ADP	O	O
breakthrough	NOUN	O	O
pain.	NOUN	O	O

Hence,	NOUN	O	O
the	DET	O	O
primary	ADJ	O	O
objective	ADP	O	O
was	VERB	O	O
to	PART	O	O
study	NOUN	O	O
the	DET	O	O
hypothesis	NOUN	O	O
that	ADP	O	O
methohexital	ADJ	O	O
confers	NOUN	O	O
a	DET	O	O
better	ADJ	O	O
hemodynamic	ADJ	O	B-outcome
profile	NOUN	O	O
than	ADP	O	O
propofol	NOUN	O	O
for	ADP	O	O
anesthetic	ADJ	O	O
induction,	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
receiving	VERB	O	O
AAB.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Highly	ADV	O	B-outcome
sensitive	ADJ	O	I-outcome
troponin	NOUN	O	I-outcome
(HS-Tp)	NOUN	O	I-outcome
as	ADP	O	O
a	DET	O	O
biomarker	NOUN	O	O
of	ADP	O	O
irreversible	ADJ	O	O
damage	NOUN	O	O
to	PART	O	O
the	DET	O	O
myocardium	NOUN	O	O
was	VERB	O	O
evaluated	VERB	O	O
before	ADP	O	O
PCI	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
PCI	NOUN	O	O
in	ADP	O	O
24	NUM	O	O
hours.	DET	O	O

Incremental	ADJ	O	O
cost-effectiveness	NOUN	O	O
ratios	NOUN	O	O
were	VERB	O	O
calculated,	NOUN	O	O
with	ADP	O	O
uncertainty	NOUN	O	O
around	ADP	O	O
the	DET	O	O
values	NOUN	O	O
estimated	VERB	O	O
using	VERB	O	O
bootstrapping.	NOUN	O	O

Clear	ADJ	O	O
recommendations	NOUN	O	O
regarding	VERB	O	O
the	DET	O	O
dosage	NOUN	O	O
should	VERB	O	O
be	VERB	O	O
established.	NOUN	O	O

The	DET	O	O
objective	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
right	ADJ	O	B-outcome
heart	NOUN	O	I-outcome
size	NOUN	O	I-outcome
and	CCONJ	O	Seperator
function	NOUN	O	S2-outcome
assessed	VERB	O	O
by	ADP	O	O
echocardiography	NOUN	O	O
during	ADP	O	O
long	ADV	O	O
term	NOUN	O	O
treatment	NOUN	O	O
with	ADP	O	O
riociguat.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal-Name:Einstein	NOUN	O	O
(Sao	ADV	O	O
Paulo,	NOUN	O	O
Brazil)	NOUN	O	O

2)	NOUN	O	O
Simulated	VERB	O	O
scuba	ADJ	O	O
results	NOUN	O	O
in	ADP	O	O
vitro:	ADP	O	O
under	ADP	O	O
VCV	NOUN	O	O
mode,	NOUN	O	O
exhaled	VERB	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
monitored	VERB	O	O
by	ADP	O	O
respirator	NOUN	O	O
and	CCONJ	O	O
tidal	DET	O	B-outcome
volume	NOUN	O	I-outcome
showed	VERB	O	O
by	ADP	O	O
simulated	VERB	O	O
scuba	ADJ	O	O
in	ADP	O	O
different	ADJ	O	O
preset	NOUN	O	O
VT	NOUN	O	O
groups	NOUN	O	O
were	VERB	O	O
continuously	ADV	O	O
increased	VERB	O	O
with	ADP	O	O
the	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
oxygen	NOUN	O	O
atomization	NOUN	O	O
flow,	NOUN	O	O
while	ADP	O	O
inspiratory	ADJ	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
monitored	VERB	O	O
by	ADP	O	O
ventilator	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
changed.	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
pragmatic,	NOUN	O	O
randomized,	NOUN	O	O
controlled,	NOUN	O	O
parallel-group	NOUN	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
will	VERB	O	O
compare	NOUN	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
the	DET	O	O
motivational	ADJ	O	O
interviewing	VERB	O	O
to	PART	O	O
an	DET	O	O
educational	ADJ	O	O
intervention,	ADP	O	O
including	VERB	O	O
the	DET	O	O
distribution	NOUN	O	O
of	ADP	O	O
an	DET	O	O
information	NOUN	O	O
flyer	NOUN	O	O
as	ADP	O	O
standard	ADJ	O	O
of	ADP	O	O
care	NOUN	O	O
on	ADP	O	O
vaccination	NOUN	O	O
coverage	NOUN	O	O
in	ADP	O	O
four	NUM	O	O
maternity	NOUN	O	O
wards	NOUN	O	O
across	ADP	O	O
the	DET	O	O
Province	NOUN	O	O
of	ADP	O	O
Quebec	NOUN	O	O
(PromovaQ).	NUM	O	O

Modified	VERB	O	O
classical	ADJ	O	O
pilates	NOUN	O	O
exercises	NOUN	O	O
were	VERB	O	O
performed	VERB	O	O
by	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
three	NUM	O	O
times	NOUN	O	O
a	DET	O	O
week	NOUN	O	O
over	ADP	O	O
a	DET	O	O
12-week	NOUN	O	O
period.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/20	ADJ	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

CONCLUSION:	NOUN	O	O
RIPC	NOUN	O	O
does	VERB	O	O
not	ADV	O	O
result	VERB	O	O
in	ADP	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
of	ADP	O	O
contrast	NOUN	O	B-outcome
induced	VERB	O	I-outcome
nephropathy	NOUN	O	I-outcome
.	PUNCT	O	O
However	ADV	O	O
RIPC	NOUN	O	O
helps	ADJ	O	O
in	ADP	O	O
the	DET	O	O
prevention	NOUN	O	O
of	ADP	O	O
post	ADV	O	O
procedural	ADJ	O	O
worsening	VERB	O	O
in	ADP	O	O
eGFR	NOUN	O	B-outcome
and	CCONJ	O	O
serum	NOUN	O	O
creatinine	NOUN	O	B-outcome
even	ADV	O	O
up	ADP	O	O
to	PART	O	O
6	NUM	O	O
weeks.	NOUN	O	O

Effectiveness	NOUN	O	O
of	ADP	O	O
a	DET	O	O
national	ADJ	O	O
quality	NOUN	O	O
improvement	NOUN	O	O
programme	NOUN	O	O
to	PART	O	O
improve	VERB	O	O
survival	NOUN	O	O
after	ADP	O	O
emergency	NOUN	O	O
abdominal	ADJ	O	O
surgery	NOUN	O	O
(EPOCH):	NOUN	O	O
a	DET	O	O
stepped-wedge	NOUN	O	O
cluster-randomised	VERB	O	O
trial.	NOUN	O	O

Title:	NOUN	O	O
Vitamin	NOUN	O	O
D	NOUN	O	O
and	CCONJ	O	O
probiotic	ADJ	O	O
co-supplementation	NOUN	O	O
affects	NOUN	O	O
mental	ADJ	O	B-outcome
health	NOUN	O	I-outcome
,	PUNCT	O	O
hormonal	ADJ	O	B-outcome
,	PUNCT	O	O
inflammatory	ADJ	O	B-outcome
and	CCONJ	O	O
oxidative	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
parameters	NOUN	O	O
in	ADP	O	O
women	NOUN	O	O
with	ADP	O	O
polycystic	ADJ	O	O
ovary	NOUN	O	O
syndrome.	NOUN	O	O

Thus,	NOUN	O	O
reasons	NOUN	O	O
for	ADP	O	O
engaging	VERB	O	O
in	ADP	O	O
weight	NOUN	O	O
loss	NOUN	O	O
interventions	NOUN	O	O
needs	NOUN	O	O
exploring,	NOUN	O	O
in	ADP	O	O
order	NOUN	O	O
to	PART	O	O
engage	NOUN	O	O
more	ADV	O	O
workplaces	NOUN	O	O
in	ADP	O	O
weight	NOUN	O	O
loss	NOUN	O	O
interventions.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

RESULTS:	NOUN	O	O
There	PRON	O	O
were	VERB	O	O
significant	ADJ	O	O
increases	NOUN	O	O
in	ADP	O	O
the	DET	O	O
scores	NOUN	O	O
of	ADP	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QOL)	PUNCT	O	I-outcome
dimensions	NOUN	O	O
in	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
after	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
(p</=0.05).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/17	ADP	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Level	NOUN	O	O
of	ADP	O	O
evidence	NOUN	O	O
II-2.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
compare	NOUN	O	O
the	DET	O	O
chest	NOUN	O	O
tube	NOUN	O	O
drainage	NOUN	O	O
by	ADP	O	O
the	DET	O	O
same	ADJ	O	O
thoracotomy	NOUN	O	O
intercostal	ADJ	O	O
space	NOUN	O	O
with	ADP	O	O
the	DET	O	O
traditional	ADJ	O	O
approach	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
muscle-sparing	VERB	O	O
thoracotomy.	NOUN	O	O

BACKGROUND:	NOUN	O	O
A	DET	O	O
high-fidelity	NOUN	O	O
task	NOUN	O	O
simulator	NOUN	O	O
for	ADP	O	O
cricothyroidotomy	NOUN	O	O
was	VERB	O	O
created	VERB	O	O
using	VERB	O	O
data	NOUN	O	O
from	ADP	O	O
a	DET	O	O
3-dimensional	ADJ	O	O
(3D)	NOUN	O	O
computed	VERB	O	O
tomography	NOUN	O	O
scan	NOUN	O	O
using	VERB	O	O
a	DET	O	O
3D	NOUN	O	O
printer.	NOUN	O	O

The	DET	O	O
visual	ADJ	O	O
analogue	NOUN	O	O
scale	NOUN	O	O
(VAS)	PUNCT	O	O
of	ADP	O	O
taste	NOUN	O	B-outcome
disturbance	NOUN	O	I-outcome
symptoms	NOUN	O	I-outcome
and	CCONJ	O	O
the	DET	O	O
gustatory	ADJ	O	B-outcome
tests	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
before	ADP	O	O
and	CCONJ	O	O
8	NUM	O	O
weeks	NOUN	O	O
after	ADP	O	O
treatment	NOUN	O	O
with	ADP	O	O
esomeprazole,	NOUN	O	O
a	DET	O	O
PPI	NOUN	O	O
(20	PUNCT	O	O
patients,	NOUN	O	O
aged	VERB	O	O
50.0	NUM	O	O
+/-	SYM	O	O
1.7	NUM	O	O
years)	NOUN	O	O
or	CCONJ	O	O
famotidine,	NOUN	O	O
a	DET	O	O
H2	NOUN	O	O
blocker	NOUN	O	O
(20	PUNCT	O	O
patients,	NOUN	O	O
aged	VERB	O	O
47.1	NUM	O	O
+/-	SYM	O	O
1.8	NUM	O	O
years).	NOUN	O	O

The	DET	O	O
final	ADJ	O	O
follow-up	NOUN	O	O
visit	NOUN	O	O
was	VERB	O	O
April	NOUN	O	O
2017.	NUM	O	O

The	DET	O	O
scores	NOUN	O	O
of	ADP	O	O
unintentional	ADJ	O	O
injury	NOUN	O	O
risk	NOUN	O	B-outcome
behavior	NOUN	O	I-outcome
for	ADP	O	O
children	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
at	ADP	O	O
3	NUM	O	O
and	CCONJ	O	O
6	NUM	O	O
months	NOUN	O	O
after	ADP	O	O
intervention	NOUN	O	O
were	VERB	O	O
14.42+/-5.67	NUM	O	O
and	CCONJ	O	O
14.14+/-8.95,	NOUN	O	O
respectively,	NOUN	O	O
lower	ADJ	O	O
than	ADP	O	O
those	DET	O	O
before	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
(16.85+/-8.48)	ADV	O	O
and	CCONJ	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(P=0.001).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Eradication	NOUN	O	B-outcome
failures	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
factors	NOUN	O	O
including	VERB	O	O
gender,	NOUN	O	O
age,	NOUN	O	O
body	NOUN	O	O
mass	NOUN	O	O
index,	NOUN	O	O
smoking,	NOUN	O	O
alcohol	NOUN	O	O
consumption,	NOUN	O	O
educational	ADJ	O	O
level,	NOUN	O	O
and	CCONJ	O	O
urban-rural	ADJ	O	O
distribution	NOUN	O	O
in	ADP	O	O
this	DET	O	O
observation	NOUN	O	O
(P	NUM	O	O
>	SYM	O	O
.05).Despite	NUM	O	O
increasing	VERB	O	O
drug	NOUN	O	B-outcome
resistance	NOUN	O	I-outcome
to	PART	O	O
CLA,	ADJ	O	O
Hp	NOUN	O	B-outcome
eradication	NOUN	O	I-outcome
rates	NOUN	O	O
in	ADP	O	O
FZD	NOUN	O	O
and	CCONJ	O	O
CLA	NOUN	O	O
groups	NOUN	O	O
have	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
at	ADP	O	O
present;	NOUN	O	O
as	ADP	O	O
FZD-based	VERB	O	O
quadruple	ADJ	O	O
therapy	NOUN	O	O
is	VERB	O	O
more	ADV	O	O
cost-effective,	NOUN	O	O
we	PRON	O	O
recommend	NOUN	O	O
this	DET	O	O
regimen	NOUN	O	O
be	VERB	O	O
a	DET	O	O
first-line	NOUN	O	O
choice	NOUN	O	O
for	ADP	O	O
Hp	NOUN	O	O
eradication.	ADV	O	O

No	DET	O	O
other	ADJ	O	O
complications	NOUN	O	B-outcome
,	PUNCT	O	O
such	ADJ	O	O
as	ADP	O	O
infection	NOUN	O	B-outcome
or	CCONJ	O	O
deep	ADJ	O	B-outcome
vein	NOUN	O	I-outcome
thrombosis	NOUN	O	I-outcome
,	PUNCT	O	O
occurred	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
groups.	NOUN	O	O

Title:	NOUN	O	O
Hippotherapy	NOUN	O	O
in	ADP	O	O
Rehabilitation	NOUN	O	O
Care	NOUN	O	O
for	ADP	O	O
Children	NOUN	O	O
With	ADP	O	O
Neurological	ADJ	O	O
Impairments	NOUN	O	O
and	CCONJ	O	O
Developmental	ADJ	O	O
Delays:	NOUN	O	O
A	DET	O	O
Case	NOUN	O	O
Series.	NOUN	O	O

PMID:	NOUN	O	O
31613346	NUM	O	O

METHODS:	NOUN	O	O
Cross-sectional	ADJ	O	O
analyses	NOUN	O	O
of	ADP	O	O
the	DET	O	O
PREDIMED-Plus	NOUN	O	O
trial.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Clinicaltrials.gov	NOUN	O	O
,	PUNCT	O	O
NCT03236961,	NOUN	O	O
retrospectively	ADV	O	O
registered	VERB	O	O
on	ADP	O	O
the	DET	O	O
2nd	ADJ	O	O
of	ADP	O	O
August	NOUN	O	O
2017.	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/29	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Methods	NOUN	O	O
Sixty	NUM	O	O
older	ADJ	O	O
individuals	NOUN	O	O
with	ADP	O	O
depression	NOUN	O	O
score	NOUN	O	O
of	ADP	O	O
10	NUM	O	O
or	CCONJ	O	O
above	ADP	O	O
(the	NOUN	O	O
Geriatric	NOUN	O	O
Depression	NOUN	O	O
Scale,	NOUN	O	O
GDS])	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
into	ADP	O	O
two	NUM	O	O
groups:	NOUN	O	O
TC	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
30)	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
30).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/05	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Conclusions	NOUN	O	O
and	CCONJ	O	O
Relevance:	NOUN	O	O
Among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
MI,	NOUN	O	O
provision	NOUN	O	O
of	ADP	O	O
vouchers	NOUN	O	O
to	PART	O	O
offset	NOUN	O	O
medication	NOUN	O	O
co-payments	NOUN	O	O
for	ADP	O	O
P2Y12	NOUN	O	O
inhibitors,	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
no	DET	O	O
vouchers,	NOUN	O	O
resulted	VERB	O	O
in	ADP	O	O
a	DET	O	O
3.3%	NOUN	O	O
absolute	ADJ	O	O
increase	NOUN	O	O
in	ADP	O	O
patient-reported	VERB	O	O
persistence	NOUN	O	B-outcome
with	ADP	O	O
P2Y12	NOUN	O	O
inhibitors	NOUN	O	O
and	CCONJ	O	O
no	DET	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
in	ADP	O	O
1-year	NOUN	O	O
major	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
cardiovascular	ADJ	O	I-outcome
events	NOUN	O	I-outcome
(MACE)	PUNCT	O	I-outcome
outcomes.	ADJ	O	O

Palo	NOUN	O	O
Alto,	NOUN	O	O
CA,	NOUN	O	O
USA.	NOUN	O	O

Children	NOUN	O	O
were	VERB	O	O
filmed	VERB	O	O
playing	VERB	O	O
pre-,	NOUN	O	O
mid-,	NOUN	O	O
and	CCONJ	O	O
postintervention,	NOUN	O	O
using	VERB	O	O
the	DET	O	O
Test	NOUN	O	O
of	ADP	O	O
Playfulness	ADV	O	B-outcome
(ToP)	ADV	O	O
to	PART	O	O
assess	NOUN	O	O
playfulness	ADV	O	B-outcome
.	PUNCT	O	O
The	DET	O	O
PICIHBI	NOUN	O	O
comprised	VERB	O	O
of	ADP	O	O
10	NUM	O	O
monthly	ADV	O	O
sessions	NOUN	O	O
facilitated	VERB	O	O
by	ADP	O	O
an	DET	O	O
occupational	ADJ	O	O
therapist,	NOUN	O	O
involving	VERB	O	O
group	NOUN	O	O
discussions	NOUN	O	O
with	ADP	O	O
caregivers	NOUN	O	O
and	CCONJ	O	O
periods	NOUN	O	O
of	ADP	O	O
experiential	ADJ	O	O
play.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101225531	NUM	O	O

METHODS:	NOUN	O	O
Forty-four	NUM	O	O
children	NOUN	O	O
(27	PUNCT	O	O
girls	NOUN	O	O
and	CCONJ	O	O
17	NUM	O	O
boys)	NOUN	O	O
between	ADP	O	O
13	NUM	O	O
and	CCONJ	O	O
17	NUM	O	O
years	NOUN	O	O
of	ADP	O	O
age	NOUN	O	O
with	ADP	O	O
unilateral	ADJ	O	O
recurrent	ADP	O	O
patellar	ADJ	O	O
dislocation	NOUN	O	O
underwent	VERB	O	O
medial	ADJ	O	O
patellofemoral	ADJ	O	O
ligament	NOUN	O	O
(MPFL)	NOUN	O	O
reconstruction.	NOUN	O	O

The	DET	O	O
population	NOUN	O	O
studied	VERB	O	O
had	VERB	O	O
a	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
of	ADP	O	O
60.6	NUM	O	O
years.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
success	NOUN	O	B-outcome
rate	NOUN	O	O
or	CCONJ	O	O
procedure	NOUN	O	B-outcome
time	NOUN	O	I-outcome
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
groups	NOUN	O	O
(success	ADV	O	O
rate:	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.24,	ADP	O	O
procedure	NOUN	O	O
time:	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.34).	ADP	O	O

Further	ADV	O	O
additional	ADJ	O	O
benefits	NOUN	O	O
are	VERB	O	O
better	ADJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QoL)	NOUN	O	I-outcome
and	CCONJ	O	O
shorter	ADJ	O	O
immunosuppressive	ADJ	O	B-outcome
treatment	NOUN	O	I-outcome
compared	VERB	O	O
with	ADP	O	O
standard	ADJ	O	O
GVHD	NOUN	O	O
prophylaxis	NOUN	O	O
without	ADP	O	O
ATLG.	NOUN	O	O

PURPOSE:	NOUN	O	O
While	ADP	O	O
some	DET	O	O
micro-organisms,	NOUN	O	O
such	ADJ	O	O
as	ADP	O	O
Staphylococcus	NOUN	O	O
aureus,	NOUN	O	O
are	VERB	O	O
clearly	ADV	O	O
implicated	VERB	O	O
in	ADP	O	O
causing	VERB	O	O
tissue	NOUN	O	O
damage	NOUN	O	O
in	ADP	O	O
diabetic	ADJ	O	O
foot	NOUN	O	O
ulcers	NOUN	O	O
(DFUs),	NOUN	O	O
our	ADJ	O	O
knowledge	NOUN	O	O
of	ADP	O	O
the	DET	O	O
contribution	NOUN	O	O
of	ADP	O	O
the	DET	O	O
entire	ADJ	O	O
microbiome	NOUN	O	O
to	PART	O	O
clinical	ADJ	O	O
outcomes	NOUN	O	O
is	VERB	O	O
limited.	NOUN	O	O

Journal-Name:JAMA	NOUN	O	O

Materials	NOUN	O	O
and	CCONJ	O	O
Methods:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
240	NUM	O	O
(129	NUM	O	O
females	NOUN	O	O
and	CCONJ	O	O
111	NUM	O	O
male)	NOUN	O	O
aged	VERB	O	O
18	NUM	O	O
-	PUNCT	O	O
65	NUM	O	O
years	NOUN	O	O
were	VERB	O	O
referred	VERB	O	O
and	CCONJ	O	O
integrated	VERB	O	O
in	ADP	O	O
this	DET	O	O
clinical	ADJ	O	O
trial,	NOUN	O	O
All	DET	O	O
patients	NOUN	O	O
presented	VERB	O	O
with	ADP	O	O
a	DET	O	O
vital	ADJ	O	O
maxillary	ADJ	O	O
or	CCONJ	O	O
mandibular	ADJ	O	O
molar,	ADV	O	O
premolar	ADJ	O	O
or	CCONJ	O	O
front	NOUN	O	O
teeth	NOUN	O	O
designated	VERB	O	O
for	ADP	O	O
conventional	ADJ	O	O
root	NOUN	O	O
canal	NOUN	O	O
treatment	NOUN	O	O
for	ADP	O	O
prosthetic	ADJ	O	O
reasons	NOUN	O	O
detected	VERB	O	O
with	ADP	O	O
only	ADV	O	O
vital	ADJ	O	O
pulps.	NOUN	O	O

The	DET	O	O
purpose	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
analgesic	ADP	O	B-outcome
benefits	NOUN	O	O
and	CCONJ	O	O
physiotherapy	NOUN	O	B-outcome
(PT)	NOUN	O	I-outcome
outcomes	NOUN	O	O
of	ADP	O	O
single-shot	NOUN	O	O
ACB	NOUN	O	O
to	PART	O	O
two	NUM	O	O
different	ADJ	O	O
regimens	NOUN	O	O
of	ADP	O	O
infusion	NOUN	O	O
of	ADP	O	O
the	DET	O	O
continuous	ADJ	O	O
ACB,	NUM	O	O
24-hour	NOUN	O	O
and	CCONJ	O	O
48-hour	NOUN	O	O
infusion.	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
strong	ADJ	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
favorable	ADJ	O	O
benefit-risk	NOUN	O	O
profile	NOUN	O	O
of	ADP	O	O
DMF	NOUN	O	O
extends	NOUN	O	O
to	PART	O	O
Japanese,	NOUN	O	O
and	CCONJ	O	O
more	ADV	O	O
broadly,	NOUN	O	O
East	ADV	O	O
Asian	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
RRMS.	NOUN	O	O

Participants	NOUN	O	O
were	VERB	O	O
divided	VERB	O	O
into	ADP	O	O
groups	NOUN	O	O
that	ADP	O	O
received	VERB	O	O
16	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
either	CCONJ	O	O
usual	ADJ	O	O
care	NOUN	O	O
or	CCONJ	O	O
exercise	NOUN	O	O
intervention.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/03/20	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

At	ADP	O	O
late	ADJ	O	O
follow-up	NOUN	O	O
(24	NOUN	O	O
to	PART	O	O
32	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
initiation	NOUN	O	O
of	ADP	O	O
therapy),	NOUN	O	O
fewer	ADJ	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
plazomicin	NOUN	O	O
group	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
meropenem	NOUN	O	O
group	NOUN	O	O
had	VERB	O	O
microbiologic	ADJ	O	B-outcome
recurrence	NOUN	O	I-outcome
(3.7%	PUNCT	O	O
vs.	CCONJ	O	O
8.1%)	NUM	O	O
or	CCONJ	O	O
clinical	ADJ	O	B-outcome
relapse	NOUN	O	I-outcome
(1.6%	NOUN	O	O
vs.	CCONJ	O	O
7.1%).	NOUN	O	O

Title:	NOUN	O	O
Gua	NOUN	O	O
Sha	NOUN	O	O
therapy	NOUN	O	O
for	ADP	O	O
chronic	ADJ	O	O
low	ADJ	O	O
back	ADP	O	O
pain:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Title:	NOUN	O	O
Contrast	NOUN	O	O
Material	ADJ	O	O
Injection	NOUN	O	O
Protocol	NOUN	O	O
With	ADP	O	O
the	DET	O	O
Dose	NOUN	O	O
Determined	VERB	O	O
According	ADJ	O	O
to	PART	O	O
Lean	ADJ	O	O
Body	NOUN	O	O
Weight	NOUN	O	O
at	ADP	O	O
Hepatic	ADJ	O	O
Dynamic	ADJ	O	O
Computed	VERB	O	O
Tomography:	ADP	O	O
Comparison	NOUN	O	O
Among	ADP	O	O
Patients	NOUN	O	O
With	ADP	O	O
Different	ADJ	O	O
Body	NOUN	O	O
Mass	NOUN	O	O
Indices.	NOUN	O	O

Visual	ADJ	O	O
impairment	NOUN	O	O
is	VERB	O	O
common	ADJ	O	O
among	ADP	O	O
rural	ADJ	O	O
Chinese	NOUN	O	O
children,	NOUN	O	O
but	CCONJ	O	O
fewer	ADJ	O	O
than	ADP	O	O
a	DET	O	O
quarter	NOUN	O	O
of	ADP	O	O
children	NOUN	O	O
who	ADP	O	O
need	NOUN	O	O
glasses	NOUN	O	O
actually	ADV	O	O
own	ADJ	O	O
and	CCONJ	O	O
use	NOUN	O	O
them.	NOUN	O	O

For	ADP	O	O
the	DET	O	O
secondary	ADJ	O	O
endpoint,	VERB	O	O
from	ADP	O	O
baseline	NOUN	O	O
to	PART	O	O
week	NOUN	O	O
24,	NUM	O	O
the	DET	O	O
total	ADJ	O	O
number	NOUN	O	O
of	ADP	O	O
new	ADJ	O	O
gadolinium-enhancing	VERB	O	B-outcome
(Gd(+))	NUM	O	I-outcome
lesions	NOUN	O	I-outcome
was	VERB	O	O
reduced	VERB	O	O
by	ADP	O	O
75%	NUM	O	O
and	CCONJ	O	O
the	DET	O	O
mean	NOUN	O	O
number	NOUN	O	O
of	ADP	O	O
new/newly	ADV	O	O
enlarging	VERB	O	O
T2	NOUN	O	B-outcome
hyperintense	NOUN	O	I-outcome
lesions	NOUN	O	I-outcome
was	VERB	O	O
reduced	VERB	O	O
by	ADP	O	O
63%	NOUN	O	O
(both	NOUN	O	O
p	NOUN	O	O
<	SYM	O	O
0.0001).	NUM	O	O

A	DET	O	O
mixed	VERB	O	O
analysis	NOUN	O	O
of	ADP	O	O
variance	NOUN	O	O
(ANOVA)	NUM	O	O
with	ADP	O	O
repeated	VERB	O	O
measures	NOUN	O	O
showed	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
effects	NOUN	O	O
for	ADP	O	O
self-reported	VERB	O	O
pain	NOUN	O	B-outcome
perception.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Persistent	ADJ	O	O
post-surgical	ADJ	O	O
pain	NOUN	O	O
and	CCONJ	O	O
associated	VERB	O	O
disability	NOUN	O	O
are	VERB	O	O
common	ADJ	O	O
after	ADP	O	O
a	DET	O	O
traumatic	ADJ	O	O
fracture	NOUN	O	O
repair.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

The	DET	O	O
surgical	ADJ	O	B-outcome
findings	NOUN	O	I-outcome
and	CCONJ	O	O
success	NOUN	O	B-outcome
rate	NOUN	O	O
in	ADP	O	O
two	NUM	O	O
subgroups	NOUN	O	O
were	VERB	O	O
compared.	NOUN	O	O

Results:	NOUN	O	O
Operative	ADJ	O	B-outcome
time	NOUN	O	I-outcome
of	ADP	O	O
the	DET	O	O
TAP	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
parecoxib	NOUN	O	O
+	SYM	O	O
TAP	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
longer	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
of	ADP	O	O
the	DET	O	O
parecoxib	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
control	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
trial	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
at	ADP	O	O
seven	NUM	O	O
hospitals	NOUN	O	O
or	CCONJ	O	O
clinics	NOUN	O	O
in	ADP	O	O
Peru,	ADP	O	O
Brazil,	NOUN	O	O
Colombia,	NOUN	O	O
Vietnam,	NOUN	O	O
and	CCONJ	O	O
Thailand	NOUN	O	O
and	CCONJ	O	O
involved	VERB	O	O
patients	NOUN	O	O
with	ADP	O	O
normal	ADJ	O	O
glucose-6-phosphate	NOUN	O	O
dehydrogenase	NOUN	O	O
(G6PD)	PUNCT	O	O
enzyme	NOUN	O	O
activity	NOUN	O	O
and	CCONJ	O	O
female	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
moderate	ADJ	O	O
G6PD	NOUN	O	O
enzyme	NOUN	O	O
deficiency;	NOUN	O	O
all	DET	O	O
patients	NOUN	O	O
had	VERB	O	O
confirmed	VERB	O	O
P.	NOUN	O	O
vivax	NOUN	O	O
parasitemia.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Findings	NOUN	O	O
suggest	VERB	O	O
that	ADP	O	O
restricting	VERB	O	O
elite	ADP	O	O
sport	ADJ	O	O
sponsorship	NOUN	O	O
to	PART	O	O
healthier	ADJ	O	O
food	NOUN	O	O
brands	NOUN	O	O
that	ADP	O	O
meet	NOUN	O	O
set	NOUN	O	O
nutritional	ADJ	O	O
criteria	NOUN	O	O
could	VERB	O	O
help	VERB	O	O
promote	VERB	O	O
healthier	ADJ	O	O
eating	VERB	O	O
among	ADP	O	O
young	ADJ	O	O
adults.	NOUN	O	O

BACKGROUND:	NOUN	O	O
The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
analysis	NOUN	O	O
was	VERB	O	O
to	PART	O	O
ascertain	NOUN	O	O
the	DET	O	O
type	NOUN	O	O
of	ADP	O	O
relationship	NOUN	O	O
between	ADP	O	O
fish	NOUN	O	O
and	CCONJ	O	O
seafood	NOUN	O	O
consumption,	NOUN	O	O
omega-3	NOUN	O	O
polyunsaturated	VERB	O	O
fatty	ADJ	O	O
acids	NOUN	O	O
(omega-3	NUM	O	O
PUFA)	NOUN	O	O
intake,	NOUN	O	O
and	CCONJ	O	O
depression	NOUN	O	B-outcome
prevalence.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/23	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Pain	NOUN	O	B-outcome
score	NOUN	O	O
in	ADP	O	O
the	DET	O	O
paracetamol	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
dexmedetomidine	NOUN	O	O
group	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.04);	NOUN	O	O
nevertheless,	NOUN	O	O
there	PRON	O	O
were	VERB	O	O
no	DET	O	O
group	NOUN	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
mean	NOUN	O	O
scores	NOUN	O	O
of	ADP	O	O
pain	NOUN	O	B-outcome
during	ADP	O	O
these	DET	O	O
hours	NOUN	O	O
(P	NUM	O	O
>	SYM	O	O
.05).	NUM	O	O

Intranasal	ADJ	O	O
DEX	NOUN	O	O
2	NUM	O	O
mug/kg	NOUN	O	O
is	VERB	O	O
an	DET	O	O
effective	ADJ	O	O
and	CCONJ	O	O
safe	ADJ	O	O
alternative	ADJ	O	O
for	ADP	O	O
premedication	NOUN	O	O
in	ADP	O	O
children.	NOUN	O	O

Assuming	VERB	O	O
null	ADJ	O	O
hypothesis,	NOUN	O	O
80%	NOUN	O	O
power	NOUN	O	O
and	CCONJ	O	O
5%	NOUN	O	O
alpha	NOUN	O	O
error,	NOUN	O	O
to	PART	O	O
detect	VERB	O	O
a	DET	O	O
10%	ADP	O	O
difference,	NOUN	O	O
adjusting	VERB	O	O
for	ADP	O	O
10%	ADP	O	O
loss	NOUN	O	O
of	ADP	O	O
follow	VERB	O	O
up,	NOUN	O	O
sample	NOUN	O	O
size	NOUN	O	O
was	VERB	O	O
204.	NUM	O	O

METHODS:	NOUN	O	O
The	DET	O	O
central	ADJ	O	B-outcome
corneal	ADJ	O	I-outcome
endothelium	NOUN	O	I-outcome
was	VERB	O	O
evaluated	VERB	O	O
by	ADP	O	O
serial	ADJ	O	O
specular	ADJ	O	O
microscopy	NOUN	O	O
at	ADP	O	O
0	NUM	O	O
to	PART	O	O
24	NUM	O	O
months.	NOUN	O	O

All	DET	O	O
included	VERB	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
a	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
43)	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
sham	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
43).	NUM	O	O

Journal-Name:Medicine	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

The	DET	O	O
subjects,	NOUN	O	O
who	ADP	O	O
had	VERB	O	O
inclusion	NOUN	O	O
criteria,	NOUN	O	O
were	VERB	O	O
selected	VERB	O	O
through	ADP	O	O
convenience	NOUN	O	O
sampling	VERB	O	O
based	VERB	O	O
on	ADP	O	O
inclusion	NOUN	O	O
criteria	NOUN	O	O
and	CCONJ	O	O
randomly	ADV	O	O
allocated	VERB	O	O
into	ADP	O	O
three	NUM	O	O
groups.	NOUN	O	O

In	ADP	O	O
addition,	NOUN	O	O
no	DET	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
related	VERB	O	O
to	PART	O	O
the	DET	O	O
treatment	NOUN	O	O
were	VERB	O	O
recorded	VERB	O	O
in	ADP	O	O
either	CCONJ	O	O
group.	VERB	O	O

Approximately	ADV	O	O
6%	NOUN	O	O
of	ADP	O	O
galcanezumab-treated	VERB	O	O
patients	NOUN	O	O
maintained	VERB	O	O
>/=75%	NUM	O	O
response	NOUN	O	B-outcome
all	DET	O	O
6	NUM	O	O
months	NOUN	O	O
versus	CCONJ	O	O
2%	NUM	O	O
of	ADP	O	O
placebo-treated	VERB	O	O
patients.	NOUN	O	O

During	ADP	O	O
the	DET	O	O
study	NOUN	O	O
period	NOUN	O	O
(0-12	NOUN	O	O
months)	NOUN	O	O
mean	NOUN	O	O
total	ADJ	O	O
costs	NOUN	O	B-outcome
were	VERB	O	O
lowest	ADV	O	O
in	ADP	O	O
the	DET	O	O
Combined-arm	NUM	O	O
(euro476	ADV	O	O
vs.	CCONJ	O	O
euro1062-euro1992,	NOUN	O	O
p	NOUN	O	O
<	SYM	O	O
0.001)	NUM	O	O
as	ADP	O	O
were	VERB	O	O
the	DET	O	O
mean	NOUN	O	O
number	NOUN	O	O
of	ADP	O	O
sickness	NOUN	O	B-outcome
absence	NOUN	O	I-outcome
days	NOUN	O	O
(0.15	PUNCT	O	O
vs.	CCONJ	O	O
2.29-4.17,	NUM	O	O
p	NOUN	O	O
=	SYM	O	O
0.025).	NUM	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
adults	NOUN	O	O
attending	VERB	O	O
U.K.	ADJ	O	O
National	ADJ	O	O
Health	NOUN	O	O
Service	NOUN	O	O
stop-smoking	VERB	O	O
services	NOUN	O	O
to	PART	O	O
either	CCONJ	O	O
nicotine-replacement	ADJ	O	O
products	NOUN	O	O
of	ADP	O	O
their	ADJ	O	O
choice,	NOUN	O	O
including	VERB	O	O
product	NOUN	O	O
combinations,	NOUN	O	O
provided	ADJ	O	O
for	ADP	O	O
up	ADP	O	O
to	PART	O	O
3	NUM	O	O
months,	NOUN	O	O
or	CCONJ	O	O
an	DET	O	O
e-cigarette	NOUN	O	O
starter	NOUN	O	O
pack	NOUN	O	O
(a	PUNCT	O	O
second-generation	NOUN	O	O
refillable	ADJ	O	O
e-cigarette	NOUN	O	O
with	ADP	O	O
one	NUM	O	O
bottle	NOUN	O	O
of	ADP	O	O
nicotine	NOUN	O	O
e-liquid	NOUN	O	O
[18	NUM	O	O
mg	NOUN	O	O
per	ADP	O	O
milliliter]),	NOUN	O	O
with	ADP	O	O
a	DET	O	O
recommendation	NOUN	O	O
to	PART	O	O
purchase	NOUN	O	O
further	ADV	O	O
e-liquids	NOUN	O	O
of	ADP	O	O
the	DET	O	O
flavor	NOUN	O	O
and	CCONJ	O	O
strength	NOUN	O	O
of	ADP	O	O
their	ADJ	O	O
choice.	NOUN	O	O

Participants	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
SCTG+CAF+EMD	NOUN	O	O
application	NOUN	O	O
were	VERB	O	O
identified	VERB	O	O
as	ADP	O	O
the	DET	O	O
test	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
19)	NOUN	O	O
and	CCONJ	O	O
those	DET	O	O
who	ADP	O	O
underwent	VERB	O	O
SCTG+CAF	NUM	O	O
as	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
19).	ADJ	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

However,	ADV	O	O
its	ADJ	O	O
effectiveness	NOUN	O	O
is	VERB	O	O
controversial.	NOUN	O	O

We	PRON	O	O
found	VERB	O	O
significant	ADJ	O	O
positive	ADJ	O	O
correlations	NOUN	O	O
of	ADP	O	O
Delta	NOUN	O	O
insulin-like	ADJ	O	B-outcome
growth	NOUN	O	I-outcome
factor-1	NOUN	O	I-outcome
with	ADP	O	O
initial	ADJ	O	O
and	CCONJ	O	O
Delta	NOUN	O	O
values	NOUN	O	O
of:	NOUN	O	O
HOMA-IR	ADV	O	B-outcome
,	PUNCT	O	O
triglyceride/high-density	NOUN	O	B-outcome
cholesterol	NOUN	O	I-outcome
ratio	NOUN	O	I-outcome
,	PUNCT	O	O
visceral	ADJ	O	B-outcome
adiposity	NOUN	O	I-outcome
index	NOUN	O	O
(VAI).	NOUN	O	O

Achaogen,	VERB	O	O
South	NOUN	O	O
San	NOUN	O	O
Francisco,	ADV	O	O
CA.	NOUN	O	O

Results:	NOUN	O	O
The	DET	O	O
age,	NOUN	O	O
sex	NOUN	O	O
ratio,	NOUN	O	O
body	NOUN	O	O
mass	NOUN	O	O
index	NOUN	O	O
(BMI)	PUNCT	O	O
and	CCONJ	O	O
ASA	NOUN	O	O
grading	VERB	O	O
ratio	NOUN	O	O
in	ADP	O	O
two	NUM	O	O
groups	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
different(all	CCONJ	O	O
P>0.05).	NOUN	O	O

METHODS:	NOUN	O	O
This	DET	O	O
pilot	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
compared	VERB	O	O
BZSF	NOUN	O	O
as	ADP	O	O
an	DET	O	O
adjunctive	ADJ	O	O
therapy	NOUN	O	O
to	PART	O	O
ceftriaxone	NOUN	O	O
with	ADP	O	O
ceftriaxone	NOUN	O	O
alone	ADJ	O	O
for	ADP	O	O
Chinese	NOUN	O	O
female	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
uncomplicated	VERB	O	O
gonorrhea.	NOUN	O	O

All	DET	O	O
three	NUM	O	O
indicators	NOUN	O	O
of	ADP	O	O
CHW	NOUN	O	O
functioning	VERB	O	O
(as	PUNCT	O	O
measured	VERB	O	O
by	ADP	O	O
reports	NOUN	O	O
submitted	VERB	O	O
from	ADP	O	O
CHWs)	NOUN	O	O
improved	VERB	O	O
more	ADV	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
area	NOUN	O	O
relative	ADJ	O	O
to	PART	O	O
the	DET	O	O
comparison	NOUN	O	O
area,	NOUN	O	O
with	ADP	O	O
2	NUM	O	O
out	ADP	O	O
of	ADP	O	O
3	NUM	O	O
measures	NOUN	O	O
of	ADP	O	O
improvement	NOUN	O	O
reaching	VERB	O	O
statistical	ADJ	O	O
significance.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/07	ADV	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Dietary	ADJ	O	O
carbohydrate	NOUN	O	O
reduction	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
suggested	VERB	O	O
as	ADP	O	O
non-pharmacological	ADJ	O	O
therapy	NOUN	O	O
for	ADP	O	O
T2DM,	NOUN	O	O
but	CCONJ	O	O
the	DET	O	O
acute	ADJ	O	O
effects	NOUN	O	O
on	ADP	O	O
non-esterified	VERB	O	B-outcome
fatty	ADJ	O	I-outcome
acid	NOUN	O	I-outcome
(NEFA)	NUM	O	I-outcome
and	CCONJ	O	O
triglyceride	NOUN	O	B-outcome
(TG)	NOUN	O	I-outcome
during	ADP	O	O
subsequent	ADJ	O	O
meals	NOUN	O	O
remain	VERB	O	O
to	PART	O	O
be	VERB	O	O
investigated.	NOUN	O	O

However,	ADV	O	O
consistent	ADJ	O	O
with	ADP	O	O
previous	ADJ	O	O
research,	NOUN	O	O
we	PRON	O	O
present	ADJ	O	O
further	ADV	O	O
evidence	NOUN	O	O
of	ADP	O	O
a	DET	O	O
role	NOUN	O	O
for	ADP	O	O
active	ADJ	O	B-outcome
B12	NOUN	O	I-outcome
,	PUNCT	O	O
HcY	NOUN	O	B-outcome
and	CCONJ	O	O
folate	NOUN	O	B-outcome
in	ADP	O	O
supporting	VERB	O	O
cognitive	ADJ	O	B-outcome
improvement	NOUN	O	O
in	ADP	O	O
adults	NOUN	O	O
with	ADP	O	O
low	ADJ	O	O
B	NOUN	O	O
vitamin	NOUN	O	O
status.	NOUN	O	O

Title:	NOUN	O	O
Role	NOUN	O	O
of	ADP	O	O
Lactobacillus	NOUN	O	O
rhamnosus	NOUN	O	O
(FloraActive)	NOUN	O	O
19070-2	NUM	O	O
and	CCONJ	O	O
Lactobacillus	NOUN	O	O
reuteri	NOUN	O	O
(FloraActive)	NOUN	O	O
12246	NUM	O	O
in	ADP	O	O
Infant	NOUN	O	O
Colic:	NOUN	O	O
A	DET	O	O
Randomized	VERB	O	O
Dietary	ADJ	O	O
Study.	NOUN	O	O

This	DET	O	O
trial	NOUN	O	O
began	VERB	O	O
in	ADP	O	O
January	NOUN	O	O
2013	NUM	O	O
and	CCONJ	O	O
was	VERB	O	O
registered	VERB	O	O
with	ADP	O	O
the	DET	O	O
UMIN	NOUN	O	O
Clinical	ADJ	O	O
Trials	NOUN	O	O
Registry	NOUN	O	O
(UMIN000009634).	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101281800	NUM	O	O

316	NUM	O	O
(29%)	NUM	O	O
of	ADP	O	O
1093	NUM	O	O
infants	NOUN	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
acquired	VERB	O	O
a	DET	O	O
late-onset	NOUN	O	O
infection	NOUN	O	B-outcome
versus	CCONJ	O	O
334	NUM	O	O
(31%)	NUM	O	O
of	ADP	O	O
1089	NUM	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

Baseline	NOUN	O	O
characteristics	NOUN	O	O
were	VERB	O	O
comparable	ADJ	O	O
between	ADP	O	O
both	CCONJ	O	O
groups.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
concluded	VERB	O	O
that	ADP	O	O
if	ADP	O	O
targeting	VERB	O	O
the	DET	O	O
increasing	VERB	O	O
worldwide	ADJ	O	O
obesity	NOUN	O	O
problem	ADP	O	O
through	ADP	O	O
workplace	ADJ	O	O
initiated	VERB	O	O
weight	NOUN	O	O
loss	NOUN	O	O
programs,	NOUN	O	O
the	DET	O	O
sales	NOUN	O	O
pitch	NOUN	O	O
to	PART	O	O
managements	NOUN	O	O
and	CCONJ	O	O
employers	NOUN	O	O
have	VERB	O	O
to	PART	O	O
be	VERB	O	O
tailored	VERB	O	O
in	ADP	O	O
order	NOUN	O	O
to	PART	O	O
increase	NOUN	O	O
the	DET	O	O
participation	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
motivation	NOUN	O	O
for	ADP	O	O
the	DET	O	O
initiative.	PUNCT	O	O

In	ADP	O	O
conclusion,	NOUN	O	O
intraduodenal	ADJ	O	O
infusion	NOUN	O	O
of	ADP	O	O
L-valine,	ADJ	O	O
at	ADP	O	O
loads	NOUN	O	O
that	ADP	O	O
are	VERB	O	O
moderately	ADV	O	O
(3.3	NOUN	O	O
g)	NOUN	O	O
or	CCONJ	O	O
substantially	ADV	O	O
(9.9	PUNCT	O	O
g)	NOUN	O	O
above	ADP	O	O
World	NOUN	O	O
Health	NOUN	O	O
Organization	NOUN	O	O
valine	NOUN	O	O
requirement	NOUN	O	O
recommendations,	NOUN	O	O
does	VERB	O	O
not	ADV	O	O
appear	VERB	O	O
to	PART	O	O
have	VERB	O	O
energy	NOUN	O	B-outcome
intake	NOUN	O	I-outcome
-	PUNCT	O	O
or	CCONJ	O	O
blood	NOUN	O	B-outcome
glucose	NOUN	O	I-outcome
-lowering	VERB	O	O
effects.	NOUN	O	O

OBJECTIVES:	NOUN	O	O
To	PART	O	O
study	NOUN	O	O
if	ADP	O	O
four	NUM	O	O
cycles	NOUN	O	O
of	ADP	O	O
remote	ADV	O	O
ischemic	ADJ	O	O
preconditioning	VERB	O	O
(RIPC)	NUM	O	O
could	VERB	O	O
offer	VERB	O	O
protection	NOUN	O	O
against	ADP	O	O
contrast	NOUN	O	B-outcome
induced	VERB	O	I-outcome
nephropathy	NOUN	O	I-outcome
(CIN)	NOUN	O	I-outcome
and	CCONJ	O	O
post	ADV	O	O
procedural	ADJ	O	O
renal	ADJ	O	B-outcome
dysfunction	NOUN	O	I-outcome
in	ADP	O	O
high	ADJ	O	O
risk	NOUN	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
percutaneous	ADJ	O	O
coronary	ADJ	O	O
intervention	NOUN	O	O
(PCI).	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

A	DET	O	O
prenatal	ADJ	O	O
diet	NOUN	O	O
affects	NOUN	O	O
materno-foetal	ADJ	O	O
outcomes.	ADJ	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/20	ADJ	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101234168	NUM	O	O

DESIGN:	NOUN	O	O
A	DET	O	O
parallel-group	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

However,	ADV	O	O
blood	NOUN	O	O
loss	NOUN	O	O
and	CCONJ	O	O
fibrinolytic	ADJ	O	O
activity,	ADP	O	O
accounting	VERB	O	O
for	ADP	O	O
a	DET	O	O
poor	ADJ	O	O
prognosis	NOUN	O	O
following	VERB	O	O
TKA	NOUN	O	O
operation,	NOUN	O	O
were	VERB	O	O
relieved	VERB	O	O
by	ADP	O	O
fibrinolytic	ADJ	O	O
inhibitor	NOUN	O	O
tranexamic	ADJ	O	O
acid	NOUN	O	O
(TXA).	NOUN	O	O

108	NUM	O	O
(27%)	NUM	O	O
of	ADP	O	O
394	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
ixazomib	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
51	NUM	O	O
(20%)	NOUN	O	O
of	ADP	O	O
259	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
experienced	VERB	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
.	PUNCT	O	O
During	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
period,	NOUN	O	O
one	NUM	O	O
patient	NOUN	O	O
died	VERB	O	B-outcome
in	ADP	O	O
the	DET	O	O
ixazomib	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
none	NUM	O	O
died	VERB	O	B-outcome
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group.	VERB	O	O

Participants	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
in	ADP	O	O
a	DET	O	O
1:1	ADJ	O	O
ratio	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
either	CCONJ	O	O
800	NUM	O	O
mug	NUM	O	O
of	ADP	O	O
misoprostol	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
sublingually	ADV	O	O
if	ADP	O	O
PPH	NOUN	O	O
was	VERB	O	O
diagnosed,	VERB	O	O
having	VERB	O	O
previously	ADV	O	O
received	VERB	O	O
a	DET	O	O
prophylactic	ADJ	O	O
oral	ADJ	O	O
dose	NOUN	O	O
of	ADP	O	O
600	NUM	O	O
mug	NUM	O	O
misoprostol.	NOUN	O	O

RESULTS:	NOUN	O	O
the	DET	O	O
adaptive	ADJ	O	B-outcome
capacity	NOUN	O	I-outcome
was	VERB	O	O
measured	VERB	O	O
in	ADP	O	O
two	NUM	O	O
modes.	NOUN	O	O

The	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
43)	NOUN	O	O
was	VERB	O	O
only	ADV	O	O
received	VERB	O	O
HRT.	NOUN	O	O

Title:	NOUN	O	O
Performance	NOUN	O	O
of	ADP	O	O
Litholyme	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
Sodasorb	ADV	O	O
carbon	NOUN	O	O
dioxide	NOUN	O	O
absorbents	NOUN	O	O
in	ADP	O	O
a	DET	O	O
standard	ADJ	O	O
clinical	ADJ	O	O
setting.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101599229	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/16	NOUN	O	O
06:00'	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

CONCLUSION:	NOUN	O	O
Longitudinal	ADJ	O	O
profiling	VERB	O	O
is	VERB	O	O
an	DET	O	O
essential	ADJ	O	O
tool	NOUN	O	O
for	ADP	O	O
improving	VERB	O	O
our	ADJ	O	O
understanding	VERB	O	O
of	ADP	O	O
the	DET	O	O
microbiology	NOUN	O	O
of	ADP	O	O
chronic	ADJ	O	O
wounds,	ADV	O	O
as	ADP	O	O
community	NOUN	O	O
dynamics	NOUN	O	O
associated	VERB	O	O
with	ADP	O	O
clinical	ADJ	O	O
events	NOUN	O	O
can	VERB	O	O
only	ADV	O	O
be	VERB	O	O
identified	VERB	O	O
by	ADP	O	O
examining	VERB	O	O
changes	NOUN	O	O
over	ADP	O	O
multiple	ADJ	O	O
time	NOUN	O	O
points.	NOUN	O	O

The	DET	O	O
median	ADJ	O	O
opioid	NOUN	O	B-outcome
use	NOUN	O	I-outcome
in	ADP	O	O
24	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
operation	NOUN	O	O
in	ADP	O	O
the	DET	O	O
paracetamol	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
lower	ADJ	O	O
when	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
dexmedetomidine	NOUN	O	O
group,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
mean	NOUN	O	O
duration	NOUN	O	B-outcome
of	ADP	O	I-outcome
analgesia	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
paracetamol	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
higher	ADJ	O	O
when	ADP	O	O
comparing	VERB	O	O
with	ADP	O	O
dexmedetomidine	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

DISCUSSION:	NOUN	O	O
This	DET	O	O
trial	NOUN	O	O
is	VERB	O	O
designed	VERB	O	O
to	PART	O	O
confirm	NOUN	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
Simvastatin	NOUN	O	O
to	PART	O	O
protect	VERB	O	O
healthy	ADJ	O	O
and	CCONJ	O	O
steatotic	ADJ	O	O
livers	NOUN	O	O
undergoing	VERB	O	O
cold	NOUN	O	O
storage	NOUN	O	O
and	CCONJ	O	O
warm	ADP	O	O
reperfusion	NOUN	O	O
before	ADP	O	O
transplantation	NOUN	O	O
and	CCONJ	O	O
to	PART	O	O
evaluate	VERB	O	O
if	ADP	O	O
the	DET	O	O
addition	NOUN	O	O
of	ADP	O	O
Simvastatin	NOUN	O	O
translates	NOUN	O	O
into	ADP	O	O
improved	VERB	O	O
graft	NOUN	O	B-outcome
outcomes.	ADJ	O	O

The	DET	O	O
future	NOUN	O	O
researches	NOUN	O	O
with	ADP	O	O
longer	ADJ	O	O
pursuing	VERB	O	O
period's	NOUN	O	O
efficacy	NOUN	O	O
continuation	NOUN	O	O
are	VERB	O	O
suggested.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
experimental	ADJ	O	O
human	NOUN	O	O
laboratory	NOUN	O	O
study,	NOUN	O	O
participants	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
128)	NOUN	O	O
were	VERB	O	O
randomised	VERB	O	O
to	PART	O	O
a	DET	O	O
self-affirmation	NOUN	O	O
or	CCONJ	O	O
control	NOUN	O	O
group.	VERB	O	O

Crossover	NOUN	O	O
to	PART	O	O
the	DET	O	O
sorafenib	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
permitted	VERB	O	O
for	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group	NOUN	O	O
who	ADP	O	O
had	VERB	O	O
disease	NOUN	O	O
progression.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

INTERPRETATION:	CCONJ	O	O
Front-line	NOUN	O	O
treatment	NOUN	O	O
with	ADP	O	O
A+CHP	ADV	O	O
is	VERB	O	O
superior	ADJ	O	O
to	PART	O	O
CHOP	VERB	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
CD30-positive	ADJ	O	O
peripheral	ADJ	O	O
T-cell	NOUN	O	O
lymphomas	NOUN	O	O
as	ADP	O	O
shown	VERB	O	O
by	ADP	O	O
a	DET	O	O
significant	ADJ	O	O
improvement	NOUN	O	O
in	ADP	O	O
progression-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
and	CCONJ	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
with	ADP	O	O
a	DET	O	O
manageable	ADJ	O	O
safety	NOUN	O	O
profile.	NOUN	O	O

Randomization	NOUN	O	O
began	VERB	O	O
on	ADP	O	O
November	NOUN	O	O
8,	NOUN	O	O
2010.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968562	NUM	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Patients	NOUN	O	O
were	VERB	O	O
tested	VERB	O	O
4	NUM	O	O
weeks	NOUN	O	O
post-treatment	NOUN	O	O
to	PART	O	O
confirm	NOUN	O	O
eradication.	ADV	O	O

Journal-Name:Medicine	NOUN	O	O

Little	ADJ	O	O
is	VERB	O	O
known	VERB	O	O
regarding	VERB	O	O
the	DET	O	O
optimal	ADJ	O	O
method	NOUN	O	O
of	ADP	O	O
instruction	NOUN	O	O
for	ADP	O	O
this	DET	O	O
critical	ADJ	O	O
skill.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
Fully	ADV	O	O
Automated	VERB	O	O
Method	NOUN	O	O
for	ADP	O	O
the	DET	O	O
Determination	NOUN	O	O
of	ADP	O	O
Serum	NOUN	O	O
Belatacept	NOUN	O	O
and	CCONJ	O	O
Its	ADJ	O	O
Application	NOUN	O	O
in	ADP	O	O
a	DET	O	O
Pharmacokinetic	ADJ	O	O
Investigation	NOUN	O	O
in	ADP	O	O
Renal	ADJ	O	O
Transplant	NOUN	O	O
Recipients.	NOUN	O	O

Journal-Name:Zhonghua	NOUN	O	O
liu	NOUN	O	O
xing	VERB	O	O
bing	VERB	O	O
xue	NOUN	O	O
za	ADP	O	O
zhi	NUM	O	O
=	SYM	O	O
Zhonghua	NOUN	O	O
liuxingbingxue	NOUN	O	O
zazhi	NOUN	O	O

BACKGROUND:	NOUN	O	O
Observational	ADJ	O	O
data	NOUN	O	O
have	VERB	O	O
shown	VERB	O	O
that	ADP	O	O
slow	ADJ	O	O
advancement	ADJ	O	O
of	ADP	O	O
enteral	ADJ	O	O
feeding	VERB	O	O
volumes	NOUN	O	O
in	ADP	O	O
preterm	NOUN	O	O
infants	NOUN	O	O
is	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
reduced	VERB	O	O
risk	NOUN	O	O
of	ADP	O	O
necrotizing	VERB	O	O
enterocolitis	NOUN	O	O
but	CCONJ	O	O
an	DET	O	O
increased	VERB	O	O
risk	NOUN	O	O
of	ADP	O	O
late-onset	NOUN	O	O
sepsis.	NOUN	O	O

The	DET	O	O
haemoglobin	NOUN	O	B-outcome
and	CCONJ	O	O
hematocrit	NOUN	O	B-outcome
were	VERB	O	O
recorded;	NOUN	O	O
the	DET	O	O
total	ADJ	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
and	CCONJ	O	O
intraoperative	ADJ	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
were	VERB	O	O
calculated.	NOUN	O	O

However,	ADV	O	O
there	PRON	O	O
was	VERB	O	O
a	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
improvement	NOUN	O	O
in	ADP	O	O
child	NOUN	O	O
and	CCONJ	O	O
parent	NOUN	O	O
reported	VERB	O	O
pain	NOUN	O	B-outcome
,	PUNCT	O	O
coordination	NOUN	O	B-outcome
and	CCONJ	O	O
grip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
in	ADP	O	O
both	CCONJ	O	O
groups.	NOUN	O	O

Systolic	ADJ	O	B-outcome
(SBP)	PUNCT	O	I-outcome
and	NUM	O	X
mean	NOUN	O	X
(MBP)	PUNCT	O	X
blood	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
cardiac	ADJ	O	B-outcome
index	NOUN	O	O
(CI)	NOUN	O	O
were	VERB	O	O
related	VERB	O	O
to	PART	O	O
time	NOUN	O	O
after	ADP	O	O
polynomial	ADJ	O	O
transformation,	NOUN	O	O
and	CCONJ	O	O
showed	VERB	O	O
an	DET	O	O
increase	NOUN	O	O
after	ADP	O	O
intubation	NOUN	O	O
in	ADP	O	O
Group	NOUN	O	O
SM	NOUN	O	O
but	CCONJ	O	O
a	DET	O	O
decrease	NOUN	O	O
in	ADP	O	O
Group	NOUN	O	O
S	NOUN	O	O
(Ptime2*group<0.0001).	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
number	NOUN	O	O
of	ADP	O	O
task	NOUN	O	B-outcome
repetitions	NOUN	O	I-outcome
required	VERB	O	O
to	PART	O	O
reach	NOUN	O	O
the	DET	O	O
learning	VERB	O	O
curve	NOUN	O	O
plateau	NOUN	O	O
was	VERB	O	O
45,	NUM	O	O
42,	NUM	O	O
and	CCONJ	O	O
37	NUM	O	O
repetitions	NOUN	O	O
in	ADP	O	O
groups	NOUN	O	O
I,	ADJ	O	O
II,	NOUN	O	O
and	CCONJ	O	O
III,	NOUN	O	O
which	ADP	O	O
means	NOUN	O	O
that	ADP	O	O
there	PRON	O	O
was	VERB	O	O
continuous	ADJ	O	O
improvement	NOUN	O	O
in	ADP	O	O
performing	VERB	O	B-outcome
the	DET	O	Seperator
task	NOUN	O	I-outcome
after	ADP	O	O
40	NUM	O	O
repetitions	NOUN	O	O
only	ADV	O	O
in	ADP	O	O
groups	NOUN	O	O
I	NUM	O	O
and	CCONJ	O	O
II.	NUM	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
prospective,	NOUN	O	O
controlled	VERB	O	O
study,	NOUN	O	O
60	NUM	O	O
age-related	VERB	O	O
cataract	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
mild	ADJ	O	O
Meibomian	NOUN	O	O
gland	NOUN	O	O
dysfunction	NOUN	O	O
(MGD)	ADV	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
treatment	NOUN	O	O
with	ADP	O	O
an	DET	O	O
ocular	ADJ	O	O
bandage	NOUN	O	O
contact	NOUN	O	O
lens	NOUN	O	O
(BCL)	PUNCT	O	O
(n	NOUN	O	O
=	SYM	O	O
30)	NOUN	O	O
or	CCONJ	O	O
to	PART	O	O
an	DET	O	O
untreated	VERB	O	O
control	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
30)	NOUN	O	O
after	ADP	O	O
phacoemulsification	NOUN	O	O
and	CCONJ	O	O
intraocular	ADJ	O	O
lens	NOUN	O	O
implantation.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
adds	NOUN	O	O
to	PART	O	O
a	DET	O	O
growing	VERB	O	O
body	NOUN	O	O
of	ADP	O	O
research	NOUN	O	O
showing	VERB	O	O
that	ADP	O	O
TC	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
effective	ADJ	O	O
in	ADP	O	O
treating	VERB	O	O
depression	NOUN	O	O
of	ADP	O	O
the	DET	O	O
elderly.	NOUN	O	O

At	ADP	O	O
10	NUM	O	O
minutes	NOUN	O	O
after	ADP	O	O
the	DET	O	O
beginning	VERB	O	O
of	ADP	O	O
atomization,	NOUN	O	O
the	DET	O	O
inspiratory	ADJ	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
monitored	VERB	O	O
by	ADP	O	O
ventilator	NOUN	O	O
in	ADP	O	O
different	ADJ	O	O
preset	NOUN	O	O
suction	NOUN	O	O
pressure	NOUN	O	O
groups	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
than	ADP	O	O
tidal	DET	O	B-outcome
volume	NOUN	O	I-outcome
showed	VERB	O	O
by	ADP	O	O
simulated	VERB	O	O
water	NOUN	O	O
lung	NOUN	O	O
(mL:	PUNCT	O	O
917.33+/-4.51	NOUN	O	O
vs.	CCONJ	O	O
1	NUM	O	O
103.33+/-5.77	NOUN	O	O
at	ADP	O	O
20	NUM	O	O
cmH2O	NOUN	O	O
of	ADP	O	O
preset	NOUN	O	O
suction	NOUN	O	O
pressure	NOUN	O	O
and	CCONJ	O	O
9	NUM	O	O
L/min	NOUN	O	O
of	ADP	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow,	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
0.05),	NUM	O	O
and	CCONJ	O	O
exhaled	VERB	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
than	ADP	O	O
tidal	DET	O	B-outcome
volume	NOUN	O	I-outcome
showed	VERB	O	O
by	ADP	O	O
simulated	VERB	O	O
water	NOUN	O	O
lung	NOUN	O	O
(mL:	PUNCT	O	O
1	NUM	O	O
433.33+/-4.73	NOUN	O	O
vs.	CCONJ	O	O
1	NUM	O	O
103.33+/-5.77	NOUN	O	O
at	ADP	O	O
20	NUM	O	O
cmH2O	NOUN	O	O
of	ADP	O	O
preset	NOUN	O	O
suction	NOUN	O	O
pressure	NOUN	O	O
and	CCONJ	O	O
9	NUM	O	O
L/min	NOUN	O	O
of	ADP	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow,	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Background:	NOUN	O	O
Foot	NOUN	O	O
and	CCONJ	O	O
ankle	NOUN	O	O
characteristics	NOUN	O	O
and	CCONJ	O	O
dynamic	ADJ	O	O
knee	NOUN	O	O
valgus	NOUN	O	O
differ	VERB	O	O
in	ADP	O	O
people	NOUN	O	O
with	ADP	O	O
and	CCONJ	O	O
without	ADP	O	O
patellofemoral	ADJ	O	O
(PF)	NOUN	O	O
pain.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Title:	NOUN	O	O
Rectus	ADJ	O	O
Sheath	NOUN	O	O
Block	NOUN	O	O
(RSB)	NOUN	O	O
Analgesia	NOUN	O	O
Could	VERB	O	O
Enhance	NOUN	O	O
Significantly	ADV	O	O
the	DET	O	O
Patient	NOUN	O	O
Satisfaction	NOUN	O	B-outcome
Following	VERB	O	O
Midline	NOUN	O	O
Laparotomy	NOUN	O	O
in	ADP	O	O
Benign	ADV	O	O
Disease	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
Cancer:	NOUN	O	O
A	DET	O	O
Prospective	ADJ	O	O
Study	NOUN	O	O
With	ADP	O	O
Special	ADJ	O	O
Reference	NOUN	O	O
to	PART	O	O
Nitrosative	ADJ	O	O
Stress	NOUN	O	O
Marker	NOUN	O	O
Nitrotyrosine	NOUN	O	B-outcome
(NT)	NOUN	O	I-outcome
Plasma	NOUN	O	O
Concentrations.	NOUN	O	O

Methods:	NOUN	O	O
Post	ADV	O	O
hoc	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
two	NUM	O	O
multicenter,	NOUN	O	O
randomized,	NOUN	O	O
double-blind,	NOUN	O	O
vehicle-controlled	VERB	O	O
Phase	NOUN	O	O
3	NUM	O	O
studies	NOUN	O	O
in	ADP	O	O
moderate	ADJ	O	O
or	CCONJ	O	O
severe	ADJ	O	O
acne.	NOUN	O	O

These	DET	O	O
findings	NOUN	O	O
may	VERB	O	O
caution	NOUN	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
erythromycin	NOUN	O	O
as	ADP	O	O
empirical	ADJ	O	O
therapy	NOUN	O	O
in	ADP	O	O
these	DET	O	O
patients.	NOUN	O	O

Asthma	NOUN	O	O
and	CCONJ	O	O
body	NOUN	O	O
posture	ADJ	O	O
abnormalities	NOUN	O	O
in	ADP	O	O
children	NOUN	O	O
and	CCONJ	O	O
young	ADJ	O	O
people	NOUN	O	O
are	VERB	O	O
major	ADJ	O	O
epidemiological	ADJ	O	O
problems	NOUN	O	O
worldwide.	VERB	O	O

Journal-Name:Nutrients	NOUN	O	O

Other	ADJ	O	O
dentoalveolar	ADJ	O	B-outcome
changes	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
were	VERB	O	O
intrusion	NOUN	O	B-outcome
of	ADP	O	I-outcome
the	DET	O	Seperator
maxillary	ADJ	O	I-outcome
first	ADV	O	I-outcome
molars	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
extrusion	NOUN	O	B-outcome
of	ADP	O	I-outcome
the	DET	O	Seperator
mandibular	ADJ	O	I-outcome
first	ADV	O	I-outcome
molars	NOUN	O	I-outcome
and	CCONJ	O	Seperator
maxillary	ADJ	O	I-outcome
incisors	NOUN	O	S3-outcome
.	PUNCT	O	O
The	DET	O	O
mentolabial	ADJ	O	B-outcome
sulcus	NOUN	O	I-outcome
was	VERB	O	O
flattened,	NOUN	O	O
soft	NOUN	O	B-outcome
tissue	NOUN	O	I-outcome
convexity	NOUN	O	I-outcome
was	VERB	O	O
reduced,	VERB	O	O
and	CCONJ	O	O
forward	ADV	O	O
movement	NOUN	O	B-outcome
of	ADP	O	I-outcome
mandibular	ADJ	O	I-outcome
soft	NOUN	O	I-outcome
tissues	NOUN	O	I-outcome
was	VERB	O	O
seen	VERB	O	O
after	ADP	O	O
Herbst	NOUN	O	O
therapy.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Energy	NOUN	O	B-outcome
intake	NOUN	O	I-outcome
from	ADP	O	O
a	DET	O	O
buffet-meal	NOUN	O	O
immediately	ADV	O	O
after	ADP	O	O
the	DET	O	O
infusions	NOUN	O	O
was	VERB	O	O
quantified.	NOUN	O	O

Implants,	NOUN	O	O
titanium	NOUN	O	O
abutments,	NOUN	O	O
and	CCONJ	O	O
provisional	ADJ	O	O
crowns	VERB	O	O
were	VERB	O	O
placed	VERB	O	O
in	ADP	O	O
healed	VERB	O	O
ridges	NOUN	O	O
5	NUM	O	O
months	NOUN	O	O
following	VERB	O	O
preservation	NOUN	O	O
after	ADP	O	O
tooth	NOUN	O	O
extraction	NOUN	O	O
with	ADP	O	O
recombinant	ADJ	O	O
human	NOUN	O	O
bone	NOUN	O	O
morphogenetic	ADJ	O	O
protein-2	NOUN	O	O
(rhBMP-2).	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Antropyloroduodenal	ADJ	O	B-outcome
pressures	NOUN	O	I-outcome
,	PUNCT	O	O
plasma	NOUN	O	O
cholecystokinin	NOUN	O	B-outcome
,	PUNCT	O	O
blood	NOUN	O	B-outcome
glucose	NOUN	O	I-outcome
,	PUNCT	O	O
appetite	NOUN	O	B-outcome
perceptions	NOUN	O	I-outcome
and	CCONJ	O	O
gastrointestinal	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
were	VERB	O	O
measured	VERB	O	O
during	ADP	O	O
90-min	NOUN	O	O
intraduodenal	ADJ	O	O
infusions	NOUN	O	O
of	ADP	O	O
L-valine	NOUN	O	O
at	ADP	O	O
0.15	NUM	O	O
kcal/min	NOUN	O	O
(total:	NOUN	O	O
3.3	NUM	O	O
g)	NOUN	O	O
or	CCONJ	O	O
0.45	NUM	O	O
kcal/min	NOUN	O	O
(total:	NOUN	O	O
9.9	NUM	O	O
g),	NOUN	O	O
or	CCONJ	O	O
0.9%	NOUN	O	O
saline	NOUN	O	O
(control).	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Amongst	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
surgical	ADJ	O	O
repair	NOUN	O	O
of	ADP	O	O
open	ADJ	O	O
extremity	NOUN	O	O
fractures,	ADP	O	O
high	ADJ	O	O
SPOC	NOUN	O	O
questionnaire	NOUN	O	O
scores	NOUN	O	O
at	ADP	O	O
6	NUM	O	O
weeks	NOUN	O	O
post-surgery	NOUN	O	O
were	VERB	O	O
predictive	ADJ	O	O
of	ADP	O	O
persistent	ADJ	O	B-outcome
pain	NOUN	O	I-outcome
,	PUNCT	O	O
reduced	VERB	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
pain	NOUN	O	B-outcome
interference	NOUN	O	I-outcome
at	ADP	O	O
1	NUM	O	O
yr.	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101225531	NUM	O	O

White	ADP	O	O
sweet	ADJ	O	O
potato	NOUN	O	O
(WSP;	PUNCT	O	O
Ipomoea	NOUN	O	O
batatas	NOUN	O	O
L.),	NOUN	O	O
used	VERB	O	O
in	ADP	O	O
traditional	ADJ	O	O
medicine	NOUN	O	O
in	ADP	O	O
Brazil,	NOUN	O	O
Japan,	NOUN	O	O
and	CCONJ	O	O
Taiwan,	DET	O	O
is	VERB	O	O
a	DET	O	O
healthy	ADJ	O	O
carbohydrate	NOUN	O	O
source.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101215359	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
16210490R	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/29	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

During	ADP	O	O
induction	NOUN	O	O
chemotherapy,	NOUN	O	O
the	DET	O	O
incidence	NOUN	O	O
rates	NOUN	O	O
of	ADP	O	O
leukocytopenia	NOUN	O	B-outcome
(43.3%	PUNCT	O	O
vs.	CCONJ	O	O
80%,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
0.003),	NUM	O	O
thrombocytopenia	NOUN	O	B-outcome
(26.7%	NUM	O	O
vs.	CCONJ	O	O
56.7%,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
0.018),	NUM	O	O
and	CCONJ	O	O
nausea/vomiting	VERB	O	B-outcome
(40%	PUNCT	O	O
vs.	CCONJ	O	O
66.7%,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
0.038)	NUM	O	O
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
the	DET	O	O
CC	NOUN	O	O
group	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
RC	NOUN	O	O
group.	VERB	O	O

Plasma	NOUN	O	O
vitamins	NOUN	O	B-outcome
and	CCONJ	O	O
phytonutrients	NOUN	O	B-outcome
were	VERB	O	O
significantly	ADV	O	O
correlated	VERB	O	O
with	ADP	O	O
ROS	NOUN	O	O
scavenging	VERB	O	O
and	CCONJ	O	O
DNA	NOUN	O	O
damage.	NOUN	O	O

Total	ADJ	O	O
180	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
Group	NOUN	O	O
A	DET	O	O
in	ADP	O	O
which	ADP	O	O
patients	NOUN	O	O
received	VERB	O	O
0.2%	NOUN	O	O
bio-adhesive	ADJ	O	O
chlorhexidine	NOUN	O	O
gel	NOUN	O	O
and	CCONJ	O	O
Group	NOUN	O	O
B	NOUN	O	O
where	ADP	O	O
patients	NOUN	O	O
received	VERB	O	O
placebo	NOUN	O	O
gel	NOUN	O	O
in	ADP	O	O
the	DET	O	O
extraction	NOUN	O	O
socket	NOUN	O	O
after	ADP	O	O
removal	NOUN	O	O
of	ADP	O	O
mandibular	ADJ	O	O
third	ADJ	O	O
molar.	NOUN	O	O

CONCLUSION:	NOUN	O	O
We	PRON	O	O
propose	NOUN	O	O
that	ADP	O	O
CSO	NOUN	O	O
intake	NOUN	O	O
may	VERB	O	O
partly	ADV	O	O
exert	NOUN	O	O
its	ADJ	O	O
benefits	NOUN	O	O
through	ADP	O	O
immuno-inflammatory	ADJ	O	O
molecular	ADJ	O	O
regulation	NOUN	O	O
in	ADP	O	O
PBMCs,	NOUN	O	O
while	ADP	O	O
modulation	NOUN	O	O
of	ADP	O	O
ICAM1	NOUN	O	O
expression,	NOUN	O	O
an	DET	O	O
endothelial/vascular-related	VERB	O	O
gene,	ADJ	O	O
may	VERB	O	O
be	VERB	O	O
more	ADV	O	O
dependent	ADJ	O	O
on	ADP	O	O
the	DET	O	O
type	NOUN	O	O
of	ADP	O	O
fish	NOUN	O	O
consumed.	NOUN	O	O

RESULTS:	NOUN	O	O
After	ADP	O	O
6-week	NOUN	O	O
treatment	NOUN	O	O
and	CCONJ	O	O
2-week	NOUN	O	O
follow-up,	ADP	O	O
although	ADP	O	O
ET	NOUN	O	O
plus	CCONJ	O	O
montelukast	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
show	VERB	O	O
better	ADJ	O	O
effectiveness	NOUN	O	O
in	ADP	O	O
improving	VERB	O	O
lung	NOUN	O	B-outcome
function	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
evaluated	VERB	O	O
by	ADP	O	O
the	DET	O	O
forced	VERB	O	B-outcome
expiratory	ADJ	O	I-outcome
volume	NOUN	O	I-outcome
in	ADP	O	Seperator
1	NUM	O	I-outcome
second	ADJ	O	I-outcome
(FEV1)	NOUN	O	I-outcome
(P	NUM	O	O
>	SYM	O	O
.05)	NOUN	O	O
and	CCONJ	O	O
FEV1/FVC	NOUN	O	B-outcome
(P	NUM	O	O
>	SYM	O	O
.05)	NOUN	O	O
than	ADP	O	O
montelukast	NOUN	O	O
alone,	NOUN	O	O
significant	ADJ	O	O
relief	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
(P	NUM	O	O
<	SYM	O	O
.01),	PUNCT	O	O
and	CCONJ	O	O
improvement	NOUN	O	O
in	ADP	O	O
Quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
Life	NOUN	O	I-outcome
(P	NUM	O	O
<	SYM	O	O
.01)	PUNCT	O	O
have	VERB	O	O
achieved.	NOUN	O	O

The	DET	O	O
average	NOUN	O	O
available	ADJ	O	O
energy	NOUN	O	O
(calorie)	NOUN	O	O
content	NOUN	O	O
of	ADP	O	O
a	DET	O	O
28	NUM	O	O
g	NOUN	O	O
serving	VERB	O	O
of	ADP	O	O
cashew	NOUN	O	O
nuts	NOUN	O	O
was	VERB	O	O
137	NUM	O	O
kcal	NOUN	O	O
(+/-3.4	NUM	O	O
kcal	NOUN	O	O
SEM)	NOUN	O	O
and	CCONJ	O	O
ranged	VERB	O	O
from	ADP	O	O
105	NUM	O	O
to	PART	O	O
151	NUM	O	O
kcal.	NOUN	O	O

The	DET	O	O
patients	NOUN	O	O
with	ADP	O	O
exercise	NOUN	O	O
habit	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
31)	NOUN	O	O
showed	VERB	O	O
lower	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
pain	NOUN	O	B-outcome
than	ADP	O	O
patients	NOUN	O	O
without	ADP	O	O
exercise	NOUN	O	O
habit	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
26)	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.002,	ADP	O	O
P	NOUN	O	O
=	SYM	O	O
.005,	PUNCT	O	O
and	CCONJ	O	O
P	NOUN	O	O
=	SYM	O	O
.037	NUM	O	O
in	ADP	O	O
overall,	NOUN	O	B-outcome
abdominal,	ADJ	O	B-outcome
and	CCONJ	O	Seperator
shoulder	NOUN	O	B-outcome
pain	NOUN	O	E1-outcome
,	PUNCT	O	O
respectively).	NOUN	O	O

This	DET	O	O
trial	NOUN	O	O
is	VERB	O	O
registered	VERB	O	O
with	ADP	O	O
ClinicalTrials.gov,	NOUN	O	O
number	NOUN	O	O
NCT01777152.	NOUN	O	O

The	DET	O	O
secondary	ADJ	O	O
outcomes	NOUN	O	O
consisted	VERB	O	O
of	ADP	O	O
shoulder	NOUN	O	B-outcome
disorder	ADP	O	I-outcome
,	PUNCT	O	O
measured	VERB	O	O
by	ADP	O	O
the	DET	O	O
score	NOUN	O	O
of	ADP	O	O
shoulder	NOUN	O	B-outcome
pain	NOUN	O	I-outcome
and	CCONJ	O	O
disability	NOUN	O	B-outcome
index	NOUN	O	O
(SPADI)];	NOUN	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
,	PUNCT	O	O
assessed	VERB	O	O
by	ADP	O	O
the	DET	O	O
Short	NOUN	O	O
Form-36	NOUN	O	O
questionnaire	NOUN	O	O
(SF-36)];	NOUN	O	O
and	CCONJ	O	O
any	DET	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
(AEs)	NOUN	O	I-outcome
during	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
period.	NOUN	O	O

Trial	NOUN	O	O
Registration:	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
Identifier:	NOUN	O	O
NCT01656278.	NOUN	O	O

This	DET	O	O
trial	NOUN	O	O
was	VERB	O	O
registered	VERB	O	O
with	ADP	O	O
ClinicalTrials.gov,	NOUN	O	O
number	NOUN	O	O
NCT02413372.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8102988	NUM	O	O

Pain	NOUN	O	B-outcome
scores	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
use	NOUN	O	B-outcome
of	ADP	O	I-outcome
rescue	NOUN	O	I-outcome
analgesics	NOUN	O	I-outcome
were	VERB	O	O
not	ADV	O	O
significantly	ADV	O	O
different	ADJ	O	O
between	ADP	O	O
2	NUM	O	O
groups.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/12	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

We	PRON	O	O
enrolled	VERB	O	O
522	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
microscopically	ADV	O	O
confirmed	VERB	O	O
P.	NOUN	O	O
vivax	NOUN	O	O
infection	NOUN	O	O
(>100	NOUN	O	O
to	PART	O	O
<100,000	NUM	O	O
parasites	NOUN	O	O
per	ADP	O	O
microliter)	NOUN	O	O
and	CCONJ	O	O
normal	ADJ	O	O
glucose-6-phosphate	NOUN	O	O
dehydrogenase	NOUN	O	O
(G6PD)	PUNCT	O	O
activity	NOUN	O	O
(with	PUNCT	O	O
normal	ADJ	O	O
activity	NOUN	O	O
defined	VERB	O	O
as	ADP	O	O
>/=70%	NUM	O	O
of	ADP	O	O
the	DET	O	O
median	ADJ	O	O
value	NOUN	O	O
determined	VERB	O	O
at	ADP	O	O
each	DET	O	O
trial	NOUN	O	O
site	NOUN	O	O
among	ADP	O	O
36	NUM	O	O
healthy	ADJ	O	O
male	NOUN	O	O
volunteers	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
otherwise	NOUN	O	O
not	ADV	O	O
involved	VERB	O	O
in	ADP	O	O
the	DET	O	O
trial).	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/17	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

We	PRON	O	O
studied	VERB	O	O
whether	ADP	O	O
a	DET	O	O
DHA	NOUN	O	O
supply	NOUN	O	O
modified	VERB	O	O
plasma	NOUN	O	O
docosahexaenoic	VERB	O	B-outcome
acid	NOUN	O	I-outcome
(DHA)	NOUN	O	I-outcome
and	CCONJ	O	O
neurological	ADJ	O	B-outcome
and	CCONJ	O	Seperator
intellectual	ADJ	O	B-outcome
functioning	VERB	O	E1-outcome
in	ADP	O	O
PKU.	NOUN	O	O

ETHNOPHARMACOLOGICAL	ADJ	O	O
RELEVANCE:	NOUN	O	O
Polygala	NOUN	O	O
tenuifolia	NOUN	O	O
Willdenow	NOUN	O	O
root	NOUN	O	O
extract	NOUN	O	O
(BT-11)	NOUN	O	O
has	VERB	O	O
beneficial	ADJ	O	O
effects	NOUN	O	O
on	ADP	O	O
central	ADJ	O	O
nervous	ADJ	O	O
system	NOUN	O	O
disorders	NOUN	O	O
in	ADP	O	O
human.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0374675	NUM	O	O

Maternal	ADJ	O	B-outcome
outcomes	NOUN	O	O
and	CCONJ	O	O
other	ADJ	O	O
obstetric	ADP	O	B-outcome
interventions	NOUN	O	I-outcome
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
between	ADP	O	O
the	DET	O	O
strategies.	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

The	DET	O	O
interventions	NOUN	O	O
were	VERB	O	O
conducted	VERB	O	O
by	ADP	O	O
means	NOUN	O	O
of	ADP	O	O
home	NOUN	O	O
visits	NOUN	O	O
over	ADP	O	O
6	NUM	O	O
months.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/02	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

During	ADP	O	O
the	DET	O	O
trial	NOUN	O	O
there	PRON	O	O
were	VERB	O	O
16	NUM	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
for	ADP	O	O
infants	NOUN	O	O
in	ADP	O	O
the	DET	O	O
lactoferrin	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
10	NUM	O	O
for	ADP	O	O
infants	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

At	ADP	O	O
6	NUM	O	O
min,	NOUN	O	O
hemostasis	NOUN	O	B-outcome
was	VERB	O	O
achieved	NOUN	O	O
in	ADP	O	O
93.0%	NOUN	O	O
(238/256)	NOUN	O	O
of	ADP	O	O
the	DET	O	O
HP	NOUN	O	O
group	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
77.3%	NUM	O	O
(102/132)	NOUN	O	O
of	ADP	O	O
the	DET	O	O
G	NOUN	O	O
+	SYM	O	O
T	NOUN	O	O
group	NOUN	O	O
(non-inferiority	NUM	O	O
P	NOUN	O	O
<	SYM	O	O
0.0001,	NUM	O	O
superiority	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
0.0001).	NUM	O	O

The	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
PZQ	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
evaluated	VERB	O	O
in	ADP	O	O
stool	NOUN	O	O
samples	NOUN	O	O
using	VERB	O	O
the	DET	O	O
KK	NOUN	O	O
technique	NOUN	O	O
and	CCONJ	O	O
real-time	NOUN	O	O
PCR	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
in	ADP	O	O
urine	NOUN	O	O
using	VERB	O	O
the	DET	O	O
point-of-care	NOUN	O	O
circulating	VERB	O	O
cathodic	ADJ	O	O
antigen	NOUN	O	O
test	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
up-converting	VERB	O	O
phosphor,	NOUN	O	O
lateral	ADJ	O	O
flow,	NOUN	O	O
circulating	VERB	O	O
anodic	NOUN	O	O
antigen	NOUN	O	O
assay.	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

BACKGROUND:	NOUN	O	O
We	PRON	O	O
examined	VERB	O	O
whether	ADP	O	O
enhancing	VERB	O	O
self-affirmation	NOUN	O	O
among	ADP	O	O
a	DET	O	O
population	NOUN	O	O
of	ADP	O	O
drinkers,	NOUN	O	O
prior	ADJ	O	O
to	PART	O	O
viewing	VERB	O	O
threatening	VERB	O	O
alcohol	NOUN	O	O
pictorial	ADJ	O	O
health	NOUN	O	O
warning	VERB	O	O
labels,	NOUN	O	O
would	VERB	O	O
reduce	VERB	O	O
defensive	ADJ	O	B-outcome
reactions	NOUN	O	I-outcome
and	CCONJ	O	O
promote	VERB	O	O
reactions	NOUN	O	B-outcome
related	VERB	O	O
to	PART	O	O
behaviour	NOUN	O	O
change.	NOUN	O	O

For	ADP	O	O
observed	VERB	O	O
pain	NOUN	O	B-outcome
,	PUNCT	O	O
ANOVA	NOUN	O	O
results	NOUN	O	O
did	VERB	O	O
show	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
interaction	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
.05)	NOUN	O	O
between	ADP	O	O
group	NOUN	O	O
and	CCONJ	O	O
study	NOUN	O	O
interval.	NOUN	O	O

The	DET	O	O
sterol	NOUN	O	B-outcome
regulatory	ADJ	O	I-outcome
element-binding	VERB	O	I-outcome
protein-1	NOUN	O	I-outcome
(SREBP1)	NUM	O	I-outcome
expression	NOUN	O	I-outcome
in	ADP	O	O
endometrial	ADJ	O	O
tissues	NOUN	O	O
was	VERB	O	O
detected	VERB	O	O
by	ADP	O	O
qRT-PCR.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
in	ADP	O	O
a	DET	O	O
double-blind,	NOUN	O	O
randomized	VERB	O	O
crossover	NOUN	O	O
fashion	NOUN	O	O
consisting	VERB	O	O
of	ADP	O	O
two	NUM	O	O
exhaustive	ADJ	O	O
exercise	NOUN	O	O
protocols.	NOUN	O	O

Electromyographic	ADJ	O	B-outcome
amplitude	ADJ	O	I-outcome
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
between	ADP	O	O
limbs	NOUN	O	O
or	CCONJ	O	O
groups	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
the	DET	O	O
intervention.	NOUN	O	O

Compared	VERB	O	O
to	PART	O	O
controls,	NOUN	O	O
subcutaneous	ADJ	O	B-outcome
and	CCONJ	O	Seperator
intra-abdominal	ADJ	O	B-outcome
fat	NOUN	O	E1-outcome
reduced	VERB	O	O
significantly	ADV	O	O
with	ADP	O	O
both	CCONJ	O	O
diet	NOUN	O	O
(-	NOUN	O	O
12.5%	NUM	O	O
and	CCONJ	O	O
-	PUNCT	O	O
12.0%)	NOUN	O	O
and	CCONJ	O	O
exercise	NOUN	O	O
plus	CCONJ	O	O
diet	NOUN	O	O
(-	NOUN	O	O
16.0%	NUM	O	O
and	CCONJ	O	O
-	PUNCT	O	O
14.6%).	NUM	O	O

FINDINGS:	ADJ	O	O
Between	ADP	O	O
Feb	NOUN	O	O
1,	NOUN	O	O
2014,	NUM	O	O
and	CCONJ	O	O
Aug	NOUN	O	O
31,	NUM	O	O
2016,	NUM	O	O
2772	NUM	O	O
couples	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
receive	VERB	O	O
PICSI	NOUN	O	O
(n=1387)	NUM	O	O
or	CCONJ	O	O
ICSI	NOUN	O	O
(n=1385),	PUNCT	O	O
of	ADP	O	O
whom	ADP	O	O
2752	NUM	O	O
(1381	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
PICSI	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
1371	NUM	O	O
in	ADP	O	O
the	DET	O	O
ICSI	NOUN	O	O
group)	ADJ	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
analysis.	NOUN	O	O

In	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
episodic	NOUN	O	O
migraine,	ADJ	O	O
>/=50%	ADV	O	O
response	NOUN	O	O
was	VERB	O	O
maintained	VERB	O	O
in	ADP	O	O
41.5	NUM	O	O
and	CCONJ	O	O
41.1%	NOUN	O	O
of	ADP	O	O
galcanezumab-treated	VERB	O	O
patients	NOUN	O	O
(120	NUM	O	O
mg	NOUN	O	O
and	CCONJ	O	O
240	NUM	O	O
mg,	NOUN	O	O
respectively)	NOUN	O	O
for	ADP	O	O
>/=3	NOUN	O	O
consecutive	ADJ	O	O
months	NOUN	O	O
(until	NOUN	O	O
patient's	NOUN	O	O
endpoint)	NOUN	O	O
and	CCONJ	O	O
19.0	NUM	O	O
and	CCONJ	O	O
20.5%,	NUM	O	O
respectively,	NOUN	O	O
for	ADP	O	O
6	NUM	O	O
consecutive	ADJ	O	O
months	NOUN	O	O
and	CCONJ	O	O
was	VERB	O	O
significantly	ADV	O	O
greater	ADJ	O	O
than	ADP	O	O
the	DET	O	O
21.4	NUM	O	O
and	CCONJ	O	O
8.0%	NOUN	O	O
of	ADP	O	O
placebo-treated	VERB	O	O
patients	NOUN	O	O
at	ADP	O	O
>/=3	NOUN	O	O
and	CCONJ	O	O
6	NUM	O	O
months	NOUN	O	O
consecutively	ADV	O	O
(P	NUM	O	O
<	SYM	O	O
0.001).	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Main	ADJ	O	O
Outcomes	NOUN	O	O
and	CCONJ	O	O
Measures:	NOUN	O	O
Independent	ADJ	O	O
coprimary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
patient-reported	VERB	O	O
persistence	NOUN	O	B-outcome
with	ADP	O	O
P2Y12	NOUN	O	O
inhibitor	NOUN	O	O
(defined	NUM	O	O
as	ADP	O	O
continued	NOUN	O	O
treatment	NOUN	O	O
without	ADP	O	O
gap	NOUN	O	O
in	ADP	O	O
use	NOUN	O	O
>/=30	NOUN	O	O
days)	NOUN	O	O
and	CCONJ	O	O
major	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
cardiovascular	ADJ	O	I-outcome
events	NOUN	O	I-outcome
(MACE)	PUNCT	O	I-outcome
(	PUNCT	O	O
death	NOUN	O	B-outcome
,	PUNCT	O	O
recurrent	ADP	O	B-outcome
MI	NOUN	O	I-outcome
,	PUNCT	O	O
or	CCONJ	O	O
stroke	NOUN	O	B-outcome
)	PUNCT	O	O
at	ADP	O	O
1	NUM	O	O
year	NOUN	O	O
among	ADP	O	O
patients	NOUN	O	O
discharged	VERB	O	O
with	ADP	O	O
a	DET	O	O
prescription	NOUN	O	O
for	ADP	O	O
clopidogrel	NOUN	O	O
or	CCONJ	O	O
ticagrelor.	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101213819	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Department	NOUN	O	O
of	ADP	O	O
Pharmacy	NOUN	O	O
Practice,	NOUN	O	O
Sri	NOUN	O	O
Adichunchanagiri	NOUN	O	O
College	NOUN	O	O
of	ADP	O	O
Pharmacy,	NOUN	O	O
B.	NOUN	O	O
G.	NOUN	O	O
Nagara,	NOUN	O	O
Karnataka,	NOUN	O	O
India.	NOUN	O	O

RESULTS:	NOUN	O	O
After	ADP	O	O
treatment,	NOUN	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Gua	NOUN	O	O
Sha	NOUN	O	O
group	NOUN	O	O
reported	VERB	O	O
lower	ADJ	O	O
pain	NOUN	O	B-outcome
intensity	NOUN	O	I-outcome
(p<0.001)	PUNCT	O	O
and	CCONJ	O	O
better	ADJ	O	O
overall	ADJ	O	O
health	NOUN	O	B-outcome
status	NOUN	O	O
(p=0.002)	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
waitlist	ADJ	O	O
group.	VERB	O	O

In	ADP	O	O
logistic	ADJ	O	O
regression	NOUN	O	O
models,	NOUN	O	O
treatment	NOUN	O	O
group	NOUN	O	O
membership	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
spectacle	NOUN	O	B-outcome
ownership	NOUN	O	I-outcome
(Odds	NOUN	O	O
Ratio	NOUN	O	O
[OR]	NOUN	O	O
=	SYM	O	O
11.9,	VERB	O	O
p	NOUN	O	O
<	SYM	O	O
0.001)	NUM	O	O
and	CCONJ	O	O
wearing	VERB	O	B-outcome
behavior	NOUN	O	I-outcome
(OR	NOUN	O	O
=	SYM	O	O
7.2,	NOUN	O	O
p	NOUN	O	O
<	SYM	O	O
0.001).	NUM	O	O

Journal-Name:Lancet	NOUN	O	O
(London,	PUNCT	O	O
England)	NOUN	O	O

Electromyographic	ADJ	O	B-outcome
amplitude	ADJ	O	I-outcome
and	CCONJ	O	Seperator
median	NOUN	O	X
frequency	NOUN	O	S1-outcome
did	VERB	O	O
not	ADV	O	O
differ	VERB	O	O
between	ADP	O	O
limbs	NOUN	O	O
at	ADP	O	O
the	DET	O	O
start	NOUN	O	O
of	ADP	O	O
the	DET	O	O
intervention.	NOUN	O	O

The	DET	O	O
EMID	NOUN	O	O
study	NOUN	O	O
is	VERB	O	O
a	DET	O	O
randomized	VERB	O	O
and	CCONJ	O	O
controlled	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
with	ADP	O	O
two	NUM	O	O
parallel	ADJ	O	O
groups	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
12-month	NOUN	O	O
follow-up	NOUN	O	O
period.	NOUN	O	O

RESULTS:	NOUN	O	O
A	DET	O	O
2	NUM	O	O
(group)	PUNCT	O	O
x	SYM	O	O
2	NUM	O	O
(time)	PUNCT	O	O
repeated	VERB	O	O
measures	NOUN	O	O
ANOVA	NOUN	O	O
showed	VERB	O	O
there	PRON	O	O
was	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
main	ADJ	O	O
effect	NOUN	O	O
on	ADP	O	O
time	NOUN	O	O
for	ADP	O	O
increase	NOUN	O	O
in	ADP	O	O
the	DET	O	O
composite	NOUN	O	O
strength	NOUN	O	B-outcome
score	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
.002,	ADP	O	O
engp2	NOUN	O	O
=	SYM	O	O
.18).	NUM	O	O

Hops,	NOUN	O	O
the	DET	O	O
immature	ADJ	O	O
inflorescences	NOUN	O	O
of	ADP	O	O
the	DET	O	O
female	NOUN	O	O
hop	NOUN	O	O
plant	NOUN	O	O
(Humulus	NOUN	O	O
lupulus	NOUN	O	O
L.)	ADP	O	O
are	VERB	O	O
one	NUM	O	O
of	ADP	O	O
the	DET	O	O
main	ADJ	O	O
components	NOUN	O	O
of	ADP	O	O
beer	NOUN	O	O
and	CCONJ	O	O
provides	NOUN	O	O
flavor	NOUN	O	O
and	CCONJ	O	O
bitterness.	NOUN	O	O

Journal-Name:Complementary	ADJ	O	O
therapies	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
practice	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Clinical	ADJ	O	O
Trial,	NOUN	O	O
Phase	NOUN	O	O
III	NUM	O	O

No	DET	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
occurred.	NOUN	O	O

Journal-Name:JAMA	NOUN	O	O

Journal-Name:	NOUN	O	O
Lin	NOUN	O	O
chuang	NOUN	O	O
er	NOUN	O	O
bi	ADP	O	O
yan	NOUN	O	O
hou	VERB	O	O
tou	NOUN	O	O
jing	VERB	O	O
wai	CCONJ	O	O
ke	NOUN	O	O
za	ADP	O	O
zhi	NUM	O	O
=	SYM	O	O
Journal	ADJ	O	O
of	ADP	O	O
clinical	ADJ	O	O
otorhinolaryngology,	NOUN	O	O
head,	ADJ	O	O
and	CCONJ	O	O
neck	NOUN	O	O
surgery	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

The	DET	O	O
7-year	NOUN	O	O
biochemical	ADJ	O	B-outcome
failure-free	ADJ	O	I-outcome
survival	NOUN	O	I-outcome
(BCFFS)	NUM	O	I-outcome
of	ADP	O	O
the	DET	O	O
MHF	NOUN	O	O
and	CCONJ	O	O
EHF	NOUN	O	O
groups	NOUN	O	O
were	VERB	O	O
90.5	NUM	O	O
and	CCONJ	O	O
57.1%	NUM	O	O
in	ADP	O	O
the	DET	O	O
low-risk	NOUN	O	O
group	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.154);	NOUN	O	O
83.5	NUM	O	O
and	CCONJ	O	O
42.9%	NUM	O	O
in	ADP	O	O
the	DET	O	O
intermediate	ADJ	O	O
risk	NOUN	O	O
group	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.018);	NUM	O	O
and	CCONJ	O	O
41.7	NUM	O	O
and	CCONJ	O	O
40.0%	NUM	O	O
in	ADP	O	O
the	DET	O	O
high	ADJ	O	O
risk	NOUN	O	O
group	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.786),	NUM	O	O
respectively.	NOUN	O	O

At	ADP	O	O
Month	NOUN	O	O
6,	NOUN	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
groups	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.85)	NUM	O	O
with	ADP	O	O
regard	NOUN	O	O
to	PART	O	O
analgesics	NOUN	O	B-outcome
and	CCONJ	O	O
social	ADJ	O	B-outcome
impact.	NOUN	O	O

Meanwhile,	NOUN	O	O
active	ADJ	O	B-outcome
flexional	ADJ	O	I-outcome
angle	NOUN	O	I-outcome
and	CCONJ	O	O
passive	ADJ	O	B-outcome
flexional	ADJ	O	I-outcome
angle	NOUN	O	I-outcome
in	ADP	O	O
preoperative	ADJ	O	O
analgesia	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
larger	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
postoperative	ADJ	O	O
analgesia	NOUN	O	O
group	NOUN	O	O
at	ADP	O	O
72	NUM	O	O
hours	NOUN	O	O
post	ADV	O	O
operation.	ADV	O	O

Title:	NOUN	O	O
Baltimore	NOUN	O	O
CONNECT:	NOUN	O	O
A	DET	O	O
Randomized	VERB	O	O
Trial	NOUN	O	O
to	PART	O	O
Build	NOUN	O	O
Partnership	NOUN	O	O
Between	ADP	O	O
Community	NOUN	O	O
Organizations	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
Local	ADJ	O	O
Health	NOUN	O	O
System.	NOUN	O	O

Both	CCONJ	O	O
PPI	NOUN	O	O
and	CCONJ	O	O
H2	NOUN	O	O
blocker	NOUN	O	O
could	VERB	O	O
inhibit	NOUN	O	O
acid	NOUN	O	B-outcome
reflux	NOUN	O	I-outcome
.	PUNCT	O	O
LPR	NOUN	O	O
was	VERB	O	O
diagnosed	VERB	O	O
with	ADP	O	O
reflux	NOUN	O	O
finding	VERB	O	O
score	NOUN	O	O
and	CCONJ	O	O
reflux	NOUN	O	O
symptom	NOUN	O	O
index.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101249598	NUM	O	O

This	DET	O	O
was	VERB	O	O
a	DET	O	O
post	ADV	O	O
hoc	NOUN	O	O
investigation	NOUN	O	O
of	ADP	O	O
serum	NOUN	O	O
noggin	NOUN	O	B-outcome
levels	NOUN	O	O
among	ADP	O	O
TDT	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
osteoporosis	NOUN	O	O
who	ADP	O	O
participated	VERB	O	O
in	ADP	O	O
a	DET	O	O
randomized,	NOUN	O	O
placebo-control,	NOUN	O	O
phase	NOUN	O	O
2b	NOUN	O	O
study.	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0374675	NUM	O	O

Journal-Name:Medicine	NOUN	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
lacrimal	ADJ	O	O
duct	NOUN	O	O
probing	VERB	O	O
combined	VERB	O	O
with	ADP	O	O
tobramycin/dexamethasone	NOUN	O	O
eye	NOUN	O	O
drops	NOUN	O	O
or	CCONJ	O	O
ointment	NOUN	O	O
on	ADP	O	O
persistent	ADJ	O	O
CNLDO	NOUN	O	O
in	ADP	O	O
children	NOUN	O	O
older	ADJ	O	O
than	ADP	O	O
1-year-old.	ADV	O	O

Yi	NOUN	O	O
xue	NOUN	O	O
ban	NOUN	O	O
=	SYM	O	O
Journal	ADJ	O	O
of	ADP	O	O
Peking	VERB	O	O
University.	NOUN	O	O

Extracorporeal	PUNCT	O	O
magnetic	ADJ	O	O
innervation	NOUN	O	O
(ExMI)	NUM	O	O
is	VERB	O	O
a	DET	O	O
relatively	ADV	O	O
new	ADJ	O	O
conservative	ADJ	O	O
treatment	NOUN	O	O
method	NOUN	O	O
for	ADP	O	O
UI.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101126433	NUM	O	O

CONCLUSIONS:	NOUN	O	O
Omadacycline	NOUN	O	O
was	VERB	O	O
noninferior	ADJ	O	O
to	PART	O	O
linezolid	NOUN	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
acute	ADJ	O	O
bacterial	ADJ	O	O
skin	NOUN	O	O
and	CCONJ	O	O
skin-structure	NOUN	O	O
infections	NOUN	O	O
and	CCONJ	O	O
had	VERB	O	O
a	DET	O	O
similar	ADJ	O	O
safety	NOUN	O	O
profile.	NOUN	O	O
(	PUNCT	O	O

The	DET	O	O
mean	NOUN	O	O
increase	NOUN	O	O
in	ADP	O	O
peak	NOUN	O	B-outcome
oxygen	NOUN	O	I-outcome
uptake	NOUN	O	I-outcome
,	PUNCT	O	O
relative	ADJ	O	O
to	PART	O	O
control,	NOUN	O	O
was	VERB	O	O
greater	ADJ	O	O
following	VERB	O	O
HIIT	NOUN	O	O
than	ADP	O	O
MICT	NOUN	O	O
(2.4	NOUN	O	O
vs.	CCONJ	O	O
0.7	NUM	O	O
mL/kg/min).	NOUN	O	O

In	ADP	O	O
terms	NOUN	O	O
of	ADP	O	O
adverse	ADJ	O	B-outcome
reactions	NOUN	O	I-outcome
,	PUNCT	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
bone	NOUN	O	B-outcome
marrow	NOUN	O	I-outcome
suppression	NOUN	O	I-outcome
,	PUNCT	O	O
gastrointestinal	ADJ	O	B-outcome
reaction	NOUN	O	I-outcome
and	CCONJ	O	O
low-protein	NOUN	O	B-outcome
reaction	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
group	NOUN	O	O
A	DET	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
group	NOUN	O	O
BP<0.05.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
intraoperative	ADJ	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
,	PUNCT	O	O
total	ADJ	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
,	PUNCT	O	O
hemoglobin	NOUN	O	B-outcome
and	CCONJ	O	O
hematocrit	NOUN	O	B-outcome
before	ADP	O	O
operation	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
1	NUM	O	O
and	CCONJ	O	O
3	NUM	O	O
days	NOUN	O	O
after	ADP	O	O
operation,	NOUN	O	O
and	CCONJ	O	O
C-reactive	ADJ	O	B-outcome
protein	NOUN	O	I-outcome
and	CCONJ	O	O
erythrocyte	NOUN	O	B-outcome
sedimentation	NOUN	O	I-outcome
rate	NOUN	O	I-outcome
before	ADP	O	O
operation	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
1,	NOUN	O	O
3,	NOUN	O	O
and	CCONJ	O	O
14	NUM	O	O
days	NOUN	O	O
between	ADP	O	O
2	NUM	O	O
groups	NOUN	O	O
(	PUNCT	O	O
P>0.05).	NOUN	O	O

Global	NOUN	O	B-outcome
health	NOUN	O	I-outcome
status	NOUN	O	O
showed	VERB	O	O
a	DET	O	O
more	ADV	O	O
favourable	ADJ	O	O
time	NOUN	O	O
course	NOUN	O	O
in	ADP	O	O
the	DET	O	O
ATLG	NOUN	O	O
group	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
non-ATLG	NOUN	O	O
group	NOUN	O	O
(p=0.02;	NOUN	O	O
treatment	NOUN	O	O
by	ADP	O	O
visit	NOUN	O	O
interaction).	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Mean	NOUN	O	O
steps/day	NOUN	O	B-outcome
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
vs	CCONJ	O	O
control	NOUN	O	O
group	NOUN	O	O
(adjusted	PUNCT	O	O
mean	NOUN	O	O
difference	NOUN	O	O
=	SYM	O	O
-	PUNCT	O	O
336,	NOUN	O	O
95%	NOUN	O	O
CI:	NOUN	O	O
-612	NUM	O	O
to	PART	O	O
-	PUNCT	O	O
60,	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.02)	NUM	O	O
at	ADP	O	O
6	NUM	O	O
months.	NOUN	O	O

Methods:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
52	NUM	O	O
women	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
analysis:	NOUN	O	O
28	NUM	O	O
participants	NOUN	O	O
were	VERB	O	O
allocated	VERB	O	O
to	PART	O	O
the	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
(EG)	NOUN	O	O
and	CCONJ	O	O
24	NUM	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(CG).	NUM	O	O

RESULTS:	NOUN	O	O
Improved	VERB	O	O
physical	ADJ	O	B-outcome
fitness	ADP	O	I-outcome
was	VERB	O	O
demonstrated	VERB	O	O
in	ADP	O	O
the	DET	O	O
exercise	NOUN	O	O
group	NOUN	O	O
by	ADP	O	O
increases	NOUN	O	O
in	ADP	O	O
median	ADJ	O	O
estimated	VERB	O	O
VO2max	NOUN	O	O
(Baseline:	PUNCT	O	O
43.41mls/kg/min;	PUNCT	O	O
post-intervention:	NOUN	O	O
46.01mls/kg/min;	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.03).	NUM	O	O

SUBJECTS/METHODS:	NOUN	O	O
Samples	NOUN	O	O
from	ADP	O	O
72	NUM	O	O
participants	NOUN	O	O
randomized	VERB	O	O
to	PART	O	O
one	NUM	O	O
of	ADP	O	O
the	DET	O	O
following	VERB	O	O
12-week	NOUN	O	O
intervention	NOUN	O	O
groups,	NOUN	O	O
FF	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
19),	NUM	O	O
LF	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
19),	NUM	O	O
CSO	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
17)	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
17),	NUM	O	O
were	VERB	O	O
available	ADJ	O	O
for	ADP	O	O
the	DET	O	O
PBMC	NOUN	O	O
study.	NOUN	O	O

A	DET	O	O
sample	NOUN	O	O
of	ADP	O	O
210	NUM	O	O
pregnant	ADJ	O	O
women	NOUN	O	O
within	ADP	O	O
gestational	ADJ	O	O
ages	NOUN	O	O
of	ADP	O	O
16-24	NUM	O	O
wk	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
at	ADP	O	O
antenatal	ADJ	O	O
clinics	NOUN	O	O
and	CCONJ	O	O
equally	ADV	O	O
randomized	VERB	O	O
to	PART	O	O
either	CCONJ	O	O
a	DET	O	O
two-dose	NOUN	O	O
SP	NOUN	O	O
or	CCONJ	O	O
three-dose	NOUN	O	O
SP	NOUN	O	O
group.	VERB	O	O

MATERIALS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
Participants	NOUN	O	O
requiring	VERB	O	O
replacement	NOUN	O	O
of	ADP	O	O
single	ADJ	O	O
maxillary	ADJ	O	O
anterior	ADJ	O	O
and	CCONJ	O	O
first	ADV	O	O
premolar	ADJ	O	O
teeth	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
and	CCONJ	O	O
treated	VERB	O	O
under	ADP	O	O
an	DET	O	O
institutional	ADJ	O	O
review	NOUN	O	O
board	ADP	O	O
(IRB)-approved	PUNCT	O	O
protocol.	NOUN	O	O

However,	ADV	O	O
Kruskal	NOUN	O	O
Wallis	NOUN	O	O
test	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
show	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
relationship	NOUN	O	O
between	ADP	O	O
the	DET	O	O
three	NUM	O	O
positions	NOUN	O	O
under	ADP	O	O
study	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
mean	NOUN	O	O
gastric	ADJ	O	B-outcome
residual	ADJ	O	I-outcome
volume	NOUN	O	I-outcome
.	PUNCT	O	O
CONCLUSION:	NOUN	O	O
Prone	NOUN	O	O
position	NOUN	O	O
was	VERB	O	O
featured	VERB	O	O
with	ADP	O	O
the	DET	O	O
lowest	ADV	O	O
gastric	ADJ	O	B-outcome
residual	ADJ	O	I-outcome
volume	NOUN	O	I-outcome
and	CCONJ	O	O
highest	ADP	O	O
possibility	NOUN	O	O
of	ADP	O	O
absorbing	VERB	O	B-outcome
nutrient	NOUN	O	I-outcome
.	PUNCT	O	O
Still,	NOUN	O	O
given	VERB	O	O
the	DET	O	O
fact	NOUN	O	O
that	ADP	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
was	VERB	O	O
found	VERB	O	O
in	ADP	O	O
the	DET	O	O
three	NUM	O	O
groups,	NOUN	O	O
further	ADV	O	O
and	CCONJ	O	O
deeper	NOUN	O	O
studies	NOUN	O	O
are	VERB	O	O
needed.	NOUN	O	O

Rectal	ADJ	O	B-outcome
temperature	NOUN	O	I-outcome
,	PUNCT	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
,	PUNCT	O	O
thermal	ADJ	O	B-outcome
sensation	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
ratings	NOUN	O	O
of	ADP	O	O
perceived	VERB	O	B-outcome
exertion	NOUN	O	I-outcome
were	VERB	O	O
measured	VERB	O	O
at	ADP	O	O
various	ADJ	O	O
times	NOUN	O	O
before,	NOUN	O	O
during,	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
exercise.	NOUN	O	O

CONCLUSIONS/SIGNIFICANCE:	NOUN	O	O
The	DET	O	O
extended	VERB	O	O
treatment	NOUN	O	O
strategy	NOUN	O	O
with	ADP	O	O
the	DET	O	O
combination	NOUN	O	O
regimen	NOUN	O	O
showed	VERB	O	O
the	DET	O	O
highest	ADP	O	O
documented	VERB	O	O
efficacy	NOUN	O	O
in	ADP	O	O
HIV-VL	NOUN	O	O
patients;	NOUN	O	O
these	DET	O	O
results	NOUN	O	O
support	NOUN	O	O
a	DET	O	O
recommendation	NOUN	O	O
of	ADP	O	O
this	DET	O	O
regimen	NOUN	O	O
as	ADP	O	O
first-line	NOUN	O	O
treatment	NOUN	O	O
strategy	NOUN	O	O
for	ADP	O	O
HIV-VL	NOUN	O	O
patients	NOUN	O	O
in	ADP	O	O
eastern	NOUN	O	O
Africa.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Treatment	NOUN	O	B-outcome
failure	NOUN	O	I-outcome
occurred	VERB	O	O
in	ADP	O	O
74	NUM	O	O
of	ADP	O	O
506	NUM	O	O
participants	NOUN	O	O
(14.6%)	ADV	O	O
in	ADP	O	O
the	DET	O	O
intravenous	ADJ	O	O
group	NOUN	O	O
and	CCONJ	O	O
67	NUM	O	O
of	ADP	O	O
509	NUM	O	O
participants	NOUN	O	O
(13.2%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
oral	ADJ	O	O
group.	VERB	O	O

Furthermore,	NOUN	O	O
trends	NOUN	O	O
for	ADP	O	O
sex	NOUN	O	O
differences	NOUN	O	O
were	VERB	O	O
discovered	VERB	O	O
in	ADP	O	O
urinary,	ADJ	O	O
but	CCONJ	O	O
not	ADV	O	O
salivary,	ADJ	O	O
hydration	NOUN	O	B-outcome
markers,	NOUN	O	O
with	ADP	O	O
discrepancies	NOUN	O	O
in	ADP	O	O
kinetics	NOUN	O	O
between	ADP	O	O
fluid	NOUN	O	O
compartments	NOUN	O	O
both	CCONJ	O	O
warranting	VERB	O	O
further	ADV	O	O
study.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
This	DET	O	O
trial	NOUN	O	O
is	VERB	O	O
registered	VERB	O	O
on	ADP	O	O
ClinicalTrials.gov	NOUN	O	O
(identifier:	NOUN	O	O
NCT01838668	NOUN	O	O
),	NUM	O	O
April	NOUN	O	O
20,	NUM	O	O
2013	NUM	O	O
(retrospectively	ADV	O	O
registered).	ADP	O	O

4)	NOUN	O	O
Conclusion:	NOUN	O	O
The	DET	O	O
effects	NOUN	O	O
found	VERB	O	O
in	ADP	O	O
the	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
agree	ADJ	O	O
with	ADP	O	O
antihypertensive	ADJ	O	O
and	CCONJ	O	O
antioxidant	NOUN	O	O
effects	NOUN	O	O
previously	ADV	O	O
reported	VERB	O	O
for	ADP	O	O
Spirulina	NOUN	O	O
maxima.	NOUN	O	O

CONCLUSIONS::	NOUN	O	O
We	PRON	O	O
suggest	VERB	O	O
that	ADP	O	O
after	ADP	O	O
reposition	NOUN	O	O
exercises,	NOUN	O	O
the	DET	O	O
pelvis	NOUN	O	O
was	VERB	O	O
more	ADV	O	O
symmetrically	ADV	O	O
aligned	VERB	O	O
in	ADP	O	O
relation	NOUN	O	O
to	PART	O	O
body	NOUN	O	O
axis;	NOUN	O	O
therefore,	NOUN	O	O
the	DET	O	O
muscles	NOUN	O	O
of	ADP	O	O
the	DET	O	O
pelvic	ADJ	O	O
floor	NOUN	O	O
have	VERB	O	O
functional	ADJ	O	O
length	NOUN	O	O
and	CCONJ	O	O
did	VERB	O	O
not	ADV	O	O
shorten	NOUN	O	O
or	CCONJ	O	O
lengthen	ADV	O	O
due	ADJ	O	O
to	PART	O	O
pelvis	NOUN	O	O
rotation.	NOUN	O	O

Title:	NOUN	O	O
Rehydrating	VERB	O	B-outcome
efficacy	NOUN	O	O
of	ADP	O	O
maple	NOUN	O	O
water	NOUN	O	O
after	ADP	O	O
exercise-induced	VERB	O	O
dehydration.	ADV	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/10/29	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

At	ADP	O	O
D58,	NOUN	O	O
the	DET	O	O
adjusted	VERB	O	O
efficacy	NOUN	O	O
was	VERB	O	O
55%	NOUN	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
32-78%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
monotherapy	NOUN	O	O
arm,	ADJ	O	O
and	CCONJ	O	O
88%	VERB	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
79-98%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
combination	NOUN	O	O
arm.	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
impact	NOUN	O	O
of	ADP	O	O
unhealthy	NOUN	O	O
food	NOUN	O	O
sponsorship	NOUN	O	O
vs.	CCONJ	O	O
pro-health	ADJ	O	O
sponsorship	NOUN	O	O
models	NOUN	O	O
on	ADP	O	O
young	ADJ	O	O
adults'	NOUN	O	O
food	NOUN	O	B-outcome
preferences	NOUN	O	I-outcome
:	PUNCT	O	O
a	DET	O	O
randomised	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Following	VERB	O	O
a	DET	O	O
16-week	NOUN	O	O
washout	ADV	O	O
phase,	NOUN	O	O
they	PRON	O	O
consumed	VERB	O	O
the	DET	O	O
alternative	ADJ	O	O
supplement.	NOUN	O	O

However,	ADV	O	O
it	PRON	O	O
was	VERB	O	O
confirmed	VERB	O	O
that	ADP	O	O
they	PRON	O	O
were	VERB	O	O
not	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
the	DET	O	O
test	NOUN	O	O
product.	NOUN	O	O

Greater	ADJ	O	O
proclination	NOUN	O	B-outcome
and	CCONJ	O	Seperator
more	NOUN	O	X
protrusion	NOUN	O	B-outcome
of	ADP	O	I-outcome
mandibular	ADJ	O	I-outcome
incisors	NOUN	O	E3-outcome
were	VERB	O	O
found	VERB	O	O
in	ADP	O	O
the	DET	O	O
IA	NOUN	O	O
group.	VERB	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101273480	NUM	O	O

Journal-Name:Nutrients	NOUN	O	O

We	PRON	O	O
found	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
overall	ADJ	O	O
experience,	NOUN	O	O
helpfulness	ADV	O	O
of	ADP	O	O
the	DET	O	O
meeting,	ADP	O	O
or	CCONJ	O	O
stress	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
the	DET	O	O
meeting	VERB	O	O
between	ADP	O	O
those	DET	O	O
who	ADP	O	O
met	VERB	O	O
via	ADP	O	O
videoconference	NOUN	O	O
vs.	CCONJ	O	O
in-person	NOUN	O	O
(p=0.9909;	NUM	O	O
p=0.8420;	NOUN	O	O
p=0.2352,	NOUN	O	O
respectively).	NOUN	O	O

2.1%	NOUN	O	O
reported	VERB	O	O
thinking	VERB	O	O
they	PRON	O	O
would	VERB	O	O
be	VERB	O	O
better	ADJ	O	O
off	ADP	O	O
dead	ADP	O	O
or	CCONJ	O	O
of	ADP	O	O
hurting	VERB	O	O
themselves	PRON	O	O
in	ADP	O	O
some	DET	O	O
way	NOUN	O	O
in	ADP	O	O
the	DET	O	O
past	NOUN	O	O
2	NUM	O	O
weeks.	NOUN	O	O

Title:	NOUN	O	O
Corneal	ADJ	O	B-outcome
Endothelial	ADJ	O	I-outcome
Cell	NOUN	O	I-outcome
Density	NOUN	O	I-outcome
and	CCONJ	O	Seperator
Morphology	NOUN	O	S3-outcome
After	ADP	O	O
Phacoemulsification	NOUN	O	O
in	ADP	O	O
Patients	NOUN	O	O
With	ADP	O	O
Primary	ADJ	O	O
Open-Angle	NOUN	O	O
Glaucoma	NOUN	O	O
and	CCONJ	O	O
Cataracts:	NOUN	O	O
2-Year	NUM	O	O
Results	NOUN	O	O
of	ADP	O	O
a	DET	O	O
Randomized	VERB	O	O
Multicenter	NOUN	O	O
Trial.	NOUN	O	O

Significant	ADJ	O	O
differences	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
observed	VERB	O	O
in	ADP	O	O
the	DET	O	O
remaining	VERB	O	O
Makoto	NOUN	O	O
tests.	NOUN	O	O

Our	ADJ	O	O
results	NOUN	O	O
support	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
vitamin	NOUN	O	O
D3	NOUN	O	O
given	VERB	O	O
monthly	ADV	O	O
both	CCONJ	O	O
for	ADP	O	O
correcting	VERB	O	O
hypovitaminosis	NOUN	O	B-outcome
and	CCONJ	O	O
for	ADP	O	O
maintaining	VERB	O	O
vitamin	NOUN	O	O
D	NOUN	O	O
levels.	NOUN	O	O

BACKGROUND:	NOUN	O	O
This	DET	O	O
pilot	NOUN	O	O
study	NOUN	O	O
aimed	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
feasible	ADJ	O	O
effectiveness	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
Bazhengsan	NOUN	O	O
formula	NOUN	O	O
(BZSF)	NUM	O	O
as	ADP	O	O
an	DET	O	O
adjunctive	ADJ	O	O
therapy	NOUN	O	O
to	PART	O	O
ceftriaxone	NOUN	O	O
for	ADP	O	O
female	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
uncomplicated	VERB	O	O
gonorrhea.	NOUN	O	O

Follow-up	NOUN	O	O
was	VERB	O	O
completed	VERB	O	O
December	NOUN	O	O
2017.	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/14	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

At	ADP	O	O
T3,	NOUN	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
still	ADV	O	O
reported	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
self-efficacy	NOUN	O	B-outcome
to	PART	O	O
cope	NOUN	O	O
with	ADP	O	O
stress	NOUN	O	O
(d	NOUN	O	O
=	SYM	O	O
0.32)	NUM	O	O
and	CCONJ	O	O
better	ADJ	O	O
emotional	ADJ	O	O
coping	VERB	O	B-outcome
response	NOUN	O	O
(d	NOUN	O	O
=	SYM	O	O
0.34)	NUM	O	O
than	ADP	O	O
the	DET	O	O
comparison	NOUN	O	O
group	NOUN	O	O
but	CCONJ	O	O
did	VERB	O	O
not	ADV	O	O
report	NOUN	O	O
significantly	ADV	O	O
higher	ADJ	O	O
social	ADJ	O	B-outcome
support	NOUN	O	I-outcome
for	ADP	O	O
stress	NOUN	O	O
management,	NOUN	O	O
stress	NOUN	O	B-outcome
,	PUNCT	O	O
depressive	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
positive	ADJ	O	B-outcome
and	CCONJ	O	Seperator
negative	ADJ	O	B-outcome
affect	NOUN	O	E1-outcome
.	PUNCT	O	O
CONCLUSIONS:	NOUN	O	O
To	PART	O	O
help	VERB	O	O
young,	NOUN	O	O
low-income	NOUN	O	O
women	NOUN	O	O
with	ADP	O	O
overweight	NUM	O	O
or	CCONJ	O	O
obesity	NOUN	O	O
manage	NOUN	O	O
stress,	NOUN	O	O
researchers	NOUN	O	O
and	CCONJ	O	O
program	NOUN	O	O
planners	NOUN	O	O
may	VERB	O	O
consider	NOUN	O	O
focusing	VERB	O	O
on	ADP	O	O
building	VERB	O	O
self-efficacy	NOUN	O	B-outcome
to	PART	O	O
cope	NOUN	O	O
with	ADP	O	O
stress.	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
determine	NOUN	O	O
whether	ADP	O	O
a	DET	O	O
therapeutic	ADJ	O	O
strategy	NOUN	O	O
involving	VERB	O	O
low-dose	NOUN	O	O
intracoronary	ADJ	O	O
fibrinolytic	ADJ	O	O
therapy	NOUN	O	O
with	ADP	O	O
alteplase	NOUN	O	O
infused	VERB	O	O
early	ADJ	O	O
after	ADP	O	O
coronary	ADJ	O	O
reperfusion	NOUN	O	O
will	VERB	O	O
reduce	VERB	O	O
microvascular	ADJ	O	B-outcome
obstruction	NOUN	O	I-outcome
.	PUNCT	O	O
Design,	NOUN	O	O
Setting,	ADV	O	O
and	CCONJ	O	O
Participants:	NOUN	O	O
Between	ADP	O	O
March	NOUN	O	O
17,	NUM	O	O
2016,	NUM	O	O
and	CCONJ	O	O
December	NOUN	O	O
21,	NUM	O	O
2017,	NUM	O	O
440	NUM	O	O
patients	NOUN	O	O
presenting	VERB	O	O
at	ADP	O	O
11	NUM	O	O
hospitals	NOUN	O	O
in	ADP	O	O
the	DET	O	O
United	VERB	O	O
Kingdom	NOUN	O	O
within	ADP	O	O
6	NUM	O	O
hours	NOUN	O	O
of	ADP	O	O
STEMI	NOUN	O	O
due	ADJ	O	O
to	PART	O	O
a	DET	O	O
proximal-mid-vessel	NOUN	O	O
occlusion	NOUN	O	O
of	ADP	O	O
a	DET	O	O
major	ADJ	O	O
coronary	ADJ	O	O
artery	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
in	ADP	O	O
a	DET	O	O
1:1:1	ADJ	O	O
dose-ranging	VERB	O	O
trial	NOUN	O	O
design.	NOUN	O	O

Simulation	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
shown	VERB	O	O
in	ADP	O	O
similar	ADJ	O	O
settings	NOUN	O	O
to	PART	O	O
enhance	NOUN	O	O
performance	NOUN	O	O
and	CCONJ	O	O
knowledge.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101476450	NUM	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101479826	NUM	O	O

The	DET	O	O
differences	NOUN	O	O
of	ADP	O	O
morbidity	NOUN	O	B-outcome
,	PUNCT	O	O
pulmonary	ADJ	O	B-outcome
function	NOUN	O	I-outcome
,	PUNCT	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
were	VERB	O	O
compared	VERB	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

Eighteen	NUM	O	O
healthy	ADJ	O	O
adults	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
in	ADP	O	O
a	DET	O	O
randomized,	NOUN	O	O
crossover	NOUN	O	O
study	NOUN	O	O
with	ADP	O	O
two	NUM	O	O
treatment	NOUN	O	O
periods.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/28	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Outcome	NOUN	O	O
measures	NOUN	O	O
used	VERB	O	O
were	VERB	O	O
Barthel	PROPN	O	O
index	NOUN	O	O
(BI)],	NOUN	O	O
modified	VERB	O	O
Ashworth	NOUN	O	O
scale],	NUM	O	O
manual	ADJ	O	O
muscle	NOUN	O	O
testing,	NOUN	O	O
and	CCONJ	O	O
goniometry	NOUN	O	O
for	ADP	O	O
range	NOUN	O	B-outcome
of	ADP	O	I-outcome
motion	NOUN	O	I-outcome
(ROM)	NOUN	O	I-outcome
assessment.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101479826	NUM	O	O

All	DET	O	O
analyses	NOUN	O	O
were	VERB	O	O
performed	VERB	O	O
with	ADP	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
proportional-hazards	NOUN	O	O
models	NOUN	O	O
in	ADP	O	O
the	DET	O	O
per-protocol	NOUN	O	O
population	NOUN	O	O
(all	PUNCT	O	O
participants	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
randomization,	NOUN	O	O
met	VERB	O	O
the	DET	O	O
inclusion	NOUN	O	O
criteria,	NOUN	O	O
and	CCONJ	O	O
survived	VERB	O	O
beyond	ADP	O	O
the	DET	O	O
recruitment	NOUN	O	O
hospitalization)	NOUN	O	O
and	CCONJ	O	O
as-treated	VERB	O	O
population	NOUN	O	O
(participants	NOUN	O	O
stratified	VERB	O	O
according	ADJ	O	O
to	PART	O	O
adherence).	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
FPPA	NOUN	O	O
(knee	NUM	O	O
valgus	NOUN	O	O
angle)	NOUN	O	O
between	ADP	O	O
groups	NOUN	O	O
(15,	PUNCT	O	O
0.63-377.99).	NUM	O	O

Likely	ADV	O	O
due	ADJ	O	O
to	PART	O	O
greater	ADJ	O	O
beverage	ADP	O	O
osmolality	NOUN	O	O
(81	PUNCT	O	O
+/-	SYM	O	O
1.4	NUM	O	O
vs.	CCONJ	O	O
11	NUM	O	O
+/-	SYM	O	O
0.7	NUM	O	O
mOsmol/kg),	NOUN	O	O
thirst	ADV	O	B-outcome
sensation	NOUN	O	I-outcome
remained	VERB	O	O
12%	NUM	O	O
higher	ADJ	O	O
with	ADP	O	O
MW	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05).	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
statistical	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
adverse	ADJ	O	B-outcome
reactions	NOUN	O	I-outcome
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

The	DET	O	O
patient	NOUN	O	O
satisfaction	NOUN	O	B-outcome
scores	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
in	ADP	O	O
the	DET	O	O
sedation	NOUN	O	O
group	NOUN	O	O
(Z=2.07,	PUNCT	O	O
P	NOUN	O	O
&lt;	NOUN	O	O
0.05).	NOUN	O	O

In	ADP	O	O
acute,	NOUN	O	O
the	DET	O	O
maximum	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
resveratrol	NOUN	O	B-outcome
(RSV)	PUNCT	O	I-outcome
were	VERB	O	O
detected	VERB	O	O
both	CCONJ	O	O
in	ADP	O	O
serum	NOUN	O	O
and	CCONJ	O	O
whole	ADJ	O	O
blood	NOUN	O	O
60	NUM	O	O
min	NOUN	O	O
after	ADP	O	O
the	DET	O	O
administration	NOUN	O	O
of	ADP	O	O
Taurisolo((R));	NOUN	O	O
in	ADP	O	O
chronic,	NOUN	O	O
a	DET	O	O
significant	ADJ	O	O
increase	NOUN	O	O
of	ADP	O	O
resveratrol	NOUN	O	B-outcome
(RSV)	PUNCT	O	I-outcome
was	VERB	O	O
detected	VERB	O	O
in	ADP	O	O
serum	NOUN	O	O
after	ADP	O	O
the	DET	O	O
4-week	NOUN	O	O
treatment.	NOUN	O	O

Methods:	NOUN	O	O
Participants	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
30)	NOUN	O	O
came	NOUN	O	O
to	PART	O	O
the	DET	O	O
lab	NOUN	O	O
on	ADP	O	O
three	NUM	O	O
consecutive	ADJ	O	O
days	NOUN	O	O
after	ADP	O	O
being	VERB	O	O
overnight	ADV	O	O
smoking	VERB	O	O
abstinent.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Title:	NOUN	O	O
Menthol	NOUN	O	O
chewing	VERB	O	O
gum	NOUN	O	O
on	ADP	O	O
preoperative	ADJ	O	O
thirst	ADV	O	B-outcome
management:	NOUN	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/26	VERB	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Patients	NOUN	O	O
with	ADP	O	O
clinically	ADV	O	O
diagnosed	VERB	O	O
osteoarthritis	NOUN	O	O
of	ADP	O	O
knee	NOUN	O	O
were	VERB	O	O
injected	VERB	O	O
either	CCONJ	O	O
Triamcinolone	NOUN	O	O
or	CCONJ	O	O
Placebo	NOUN	O	O
after	ADP	O	O
recording	VERB	O	O
the	DET	O	O
baseline	NOUN	O	O
scores	NOUN	O	O
of	ADP	O	O
the	DET	O	O
knee	NOUN	O	O
by	ADP	O	O
Knee	NOUN	O	O
injury	NOUN	O	O
and	CCONJ	O	O
Osteoarthritis	NOUN	O	O
Outcome	NOUN	O	O
Score	NOUN	O	O
(KOOS)	PUNCT	O	O
-	PUNCT	O	O
Physical	ADJ	O	O
Function	NOUN	O	O
Short	NOUN	O	O
form	NOUN	O	O
(KOOS-PS),	NUM	O	O
the	DET	O	O
Western	NOUN	O	O
Ontario	NOUN	O	O
and	CCONJ	O	O
McMaster	NOUN	O	O
Universities	NOUN	O	O
Osteoarthritis	NOUN	O	O
Index	NOUN	O	O
(WOMAC)	NUM	O	O
and	CCONJ	O	O
Visual	ADJ	O	O
Analogue	NOUN	O	O
Scale	NOUN	O	O
(VAS).	NOUN	O	O

Vaping	VERB	O	O
did	VERB	O	O
not	ADV	O	O
affect	NOUN	O	O
exhaled	VERB	O	B-outcome
CO	NOUN	O	I-outcome
.	PUNCT	O	O
Cigarette	NOUN	O	B-outcome
craving	VERB	O	I-outcome
reduced	VERB	O	O
significantly	ADV	O	O
after	ADP	O	O
product	NOUN	O	O
use,	NOUN	O	O
with	ADP	O	O
the	DET	O	O
decline	NOUN	O	O
being	VERB	O	O
stronger	ADJ	O	O
for	ADP	O	O
smoking	VERB	O	O
than	ADP	O	O
for	ADP	O	O
e-cigarettes	NOUN	O	O
or	CCONJ	O	O
IQOS(TM).	NOUN	O	O

CONCLUSION:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
demonstrated	VERB	O	O
the	DET	O	O
potential	ADJ	O	O
benefits	NOUN	O	O
and	CCONJ	O	O
high	ADJ	O	O
clinical	ADJ	O	O
relevance	NOUN	O	O
of	ADP	O	O
exercise	NOUN	O	O
programs	NOUN	O	O
to	PART	O	O
improve	VERB	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
in	ADP	O	O
older	ADJ	O	O
breast	NOUN	O	O
cancer	NOUN	O	O
survivors	NOUN	O	O
undergoing	VERB	O	O
aromatase	NOUN	O	O
inhibitor	NOUN	O	O
therapy.	NOUN	O	O

Department	NOUN	O	O
of	ADP	O	O
Pharmacy	NOUN	O	O
Practice,	NOUN	O	O
Sri	NOUN	O	O
Adichunchanagiri	NOUN	O	O
College	NOUN	O	O
of	ADP	O	O
Pharmacy,	NOUN	O	O
B.	NOUN	O	O
G.	NOUN	O	O
Nagara,	NOUN	O	O
Karnataka,	NOUN	O	O
India	PROPN	O	O
-	PUNCT	O	O
rajesh.venkyresearch01@gmail.com.	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
intravenous	ADJ	O	O
(IV)	NUM	O	O
acetaminophen	ADV	O	O
(paracetamol)	NUM	O	O
vs	CCONJ	O	O
placebo	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
IV	NUM	O	O
propofol	NOUN	O	O
vs	CCONJ	O	O
dexmedetomidine	NOUN	O	O
on	ADP	O	O
postoperative	ADJ	O	O
delirium	NOUN	O	B-outcome
among	ADP	O	O
older	ADJ	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
cardiac	ADJ	O	O
surgery.	VERB	O	O

Journal-Name:Medicine	NOUN	O	O

Osteoporosis	NOUN	O	O
is	VERB	O	O
a	DET	O	O
common	ADJ	O	O
complication	NOUN	O	O
of	ADP	O	O
transfusion	NOUN	O	O
dependent	ADJ	O	O
beta-thalassemia	NOUN	O	O
(TDT)	NOUN	O	O
and	CCONJ	O	O
denosumab	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
recently	ADV	O	O
emerged	VERB	O	O
as	ADP	O	O
a	DET	O	O
promising	VERB	O	O
therapeutic	ADJ	O	O
option.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101215702	NUM	O	O

Title:	NOUN	O	O
"We	NOUN	O	O
find	ADP	O	O
what	DET	O	O
we	PRON	O	O
look	PUNCT	O	O
for,	NOUN	O	O
and	CCONJ	O	O
we	PRON	O	O
look	PUNCT	O	O
for	ADP	O	O
what	DET	O	O
we	PRON	O	O
know":	NOUN	O	O
factors	NOUN	O	O
interacting	VERB	O	O
with	ADP	O	O
a	DET	O	O
mental	ADJ	O	O
health	NOUN	O	O
training	VERB	O	O
program	NOUN	O	O
to	PART	O	O
influence	NOUN	O	O
its	ADJ	O	O
expected	VERB	O	O
outcomes	NOUN	O	O
in	ADP	O	O
Tunisia.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

All	DET	O	O
biomarkers	NOUN	O	O
of	ADP	O	O
metabolic	ADJ	O	B-outcome
recovery	NOUN	O	I-outcome
were	VERB	O	O
equivalent	ADJ	O	O
when	ADP	O	O
evaluating	VERB	O	O
R1	NOUN	O	O
v	NUM	O	O
R2.	NOUN	O	O

Stratified	VERB	O	O
by	ADP	O	O
country,	NOUN	O	O
patients	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
1:1	ADJ	O	O
to	PART	O	O
receive	VERB	O	O
DMF	NOUN	O	O
240	NUM	O	O
mg	NOUN	O	O
twice	ADV	O	O
daily	ADJ	O	O
or	CCONJ	O	O
placebo.	NOUN	O	O

Qualitative	ADJ	O	O
data	NOUN	O	O
was	VERB	O	O
analyzed	VERB	O	O
using	VERB	O	O
thematic	ADJ	O	O
analysis.	NOUN	O	O

CLINICAL	ADJ	O	O
SIGNIFICANCE:	NOUN	O	O
Curcumin	NOUN	O	O
gel	NOUN	O	O
as	ADP	O	O
an	DET	O	O
adjunct	ADP	O	O
to	PART	O	O
SRP	NOUN	O	O
showed	VERB	O	O
a	DET	O	O
marked	VERB	O	O
improvement	NOUN	O	O
in	ADP	O	O
restoring	VERB	O	O
gingival	ADJ	O	B-outcome
health	NOUN	O	I-outcome
by	ADP	O	O
an	DET	O	O
improvement	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
parameters.	NOUN	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
a	DET	O	O
short-term	NOUN	O	O
low	ADJ	O	O
fermentable	ADJ	O	O
oligiosaccharide,	NOUN	O	O
disaccharide,	NOUN	O	O
monosaccharide	NOUN	O	O
and	CCONJ	O	O
polyol	NOUN	O	O
(FODMAP)	PUNCT	O	O
diet	NOUN	O	O
on	ADP	O	O
exercise-related	VERB	O	O
gastrointestinal	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
.	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

BACKGROUND:	NOUN	O	O
Although	ADP	O	O
conventional	ADJ	O	O
60	NUM	O	O
mg	NOUN	O	O
of	ADP	O	O
prasugrel	NOUN	O	O
allows	NOUN	O	O
for	ADP	O	O
rapid	ADJ	O	O
and	CCONJ	O	O
potent	ADJ	O	O
platelet	NOUN	O	O
inhibition	NOUN	O	O
within	ADP	O	O
30	NUM	O	O
min	NOUN	O	O
after	ADP	O	O
loading	VERB	O	O
dose,	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
lower	ADJ	O	O
doses	NOUN	O	O
of	ADP	O	O
prasugrel	NOUN	O	O
in	ADP	O	O
Indian	NOUN	O	O
patients	NOUN	O	O
has	VERB	O	O
not	ADV	O	O
yet	ADV	O	O
been	VERB	O	O
investigated.	NOUN	O	O

Journal-Name:Zhong	ADJ	O	O
nan	VERB	O	O
da	NOUN	O	O
xue	NOUN	O	O
xue	NOUN	O	O
bao.	ADP	O	O

Whether	ADP	O	O
positive-pressure	NOUN	O	O
ventilation	NOUN	O	O
with	ADP	O	O
a	DET	O	O
bag-mask	ADJ	O	O
device	NOUN	O	O
(bag-mask	NUM	O	O
ventilation)	NOUN	O	O
during	ADP	O	O
tracheal	ADJ	O	O
intubation	NOUN	O	O
of	ADP	O	O
critically	ADV	O	O
ill	ADJ	O	O
adults	NOUN	O	O
prevents	NOUN	O	O
hypoxemia	NOUN	O	O
without	ADP	O	O
increasing	VERB	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
aspiration	NOUN	O	O
remains	NOUN	O	O
controversial.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
assess	NOUN	O	O
whether	ADP	O	O
EEG-guided	VERB	O	O
anesthetic	ADJ	O	O
administration	NOUN	O	O
decreases	NOUN	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
delirium	NOUN	O	B-outcome
.	PUNCT	O	O
Design,	NOUN	O	O
Setting,	ADV	O	O
and	CCONJ	O	O
Participants:	NOUN	O	O
Randomized	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
of	ADP	O	O
1232	NUM	O	O
adults	NOUN	O	O
aged	VERB	O	O
60	NUM	O	O
years	NOUN	O	O
and	CCONJ	O	O
older	ADJ	O	O
undergoing	VERB	O	O
major	ADJ	O	O
surgery	NOUN	O	O
and	CCONJ	O	O
receiving	VERB	O	O
general	ADJ	O	O
anesthesia	NOUN	O	O
at	ADP	O	O
Barnes-Jewish	NOUN	O	O
Hospital	NOUN	O	O
in	ADP	O	O
St	NOUN	O	O
Louis.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7501160	NUM	O	O

RESULTS:	NOUN	O	O
All	DET	O	O
mandibular	ADJ	O	B-outcome
skeletal	ADJ	O	I-outcome
dimensions	NOUN	O	O
increased,	NOUN	O	O
and	CCONJ	O	O
improvements	NOUN	O	O
of	ADP	O	O
the	DET	O	O
sagittal	ADJ	O	B-outcome
maxillomandibular	ADJ	O	I-outcome
parameters	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
groups.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Most	DET	O	O
subjects	NOUN	O	O
were	VERB	O	O
vitD(3)	NOUN	O	O
deficient	ADJ	O	O
at	ADP	O	O
enrolment,	NOUN	O	O
but	CCONJ	O	O
a	DET	O	O
gradual	ADJ	O	O
and	CCONJ	O	O
significant	ADJ	O	O
improvement	NOUN	O	O
of	ADP	O	O
vitD(3)	NOUN	O	B-outcome
status	NOUN	O	O
was	VERB	O	O
demonstrated	VERB	O	O
in	ADP	O	O
the	DET	O	O
vitD(3)	NOUN	O	O
+	SYM	O	O
PBA	NOUN	O	O
group	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
placebo	NOUN	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.0001)	NUM	O	O
from	ADP	O	O
week	NOUN	O	O
0	NUM	O	O
to	PART	O	O
16	NUM	O	O
(median	PUNCT	O	O
37.5	NUM	O	O
versus	CCONJ	O	O
115.5	NUM	O	O
nmol/L).	NOUN	O	O

In	ADP	O	O
the	DET	O	O
current	ADJ	O	O
clinical	ADJ	O	O
trial,	NOUN	O	O
we	PRON	O	O
examined	VERB	O	O
the	DET	O	O
antioxidant	NOUN	O	B-outcome
and	CCONJ	O	O
DNA	NOUN	O	B-outcome
protection	NOUN	O	I-outcome
capacity	NOUN	O	O
of	ADP	O	O
a	DET	O	O
plant-based,	NOUN	O	O
multi-vitamin/mineral,	NOUN	O	O
and	CCONJ	O	O
phytonutrient	NOUN	O	O
(PMP)	NOUN	O	O
supplementation	NOUN	O	O
in	ADP	O	O
healthy	ADJ	O	O
adults	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
habitually	ADV	O	O
low	ADJ	O	O
in	ADP	O	O
the	DET	O	O
consumption	NOUN	O	O
of	ADP	O	O
fruits	NOUN	O	O
and	CCONJ	O	O
vegetables.	PUNCT	O	O

BACKGROUND:	NOUN	O	O
Registered	VERB	O	O
healthcare	NOUN	O	O
workers	NOUN	O	O
worldwide	ADJ	O	O
have	VERB	O	O
a	DET	O	O
high	ADJ	O	O
prevalence	NOUN	O	O
of	ADP	O	O
work-related	VERB	O	O
musculoskeletal	ADJ	O	O
disorders,	NOUN	O	O
particularly	ADV	O	O
of	ADP	O	O
the	DET	O	O
back.	NOUN	O	O

Conclusion:	NOUN	O	O
Supraglottic	ADJ	O	O
tracheal	ADJ	O	O
tube	NOUN	O	O
ventilation	NOUN	O	O
for	ADP	O	O
painless	NOUN	O	O
fiberbronchoscopy	NOUN	O	O
is	VERB	O	O
a	DET	O	O
safe	ADJ	O	O
and	CCONJ	O	O
effective	ADJ	O	O
procedure.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

At	ADP	O	O
baseline,	NOUN	O	O
mean	NOUN	O	O
(SD)	NOUN	O	O
duration	NOUN	O	O
of	ADP	O	O
cry	NOUN	O	B-outcome
and	CCONJ	O	Seperator
fuss	NOUN	O	B-outcome
time	NOUN	O	E1-outcome
was	VERB	O	O
comparable	ADJ	O	O
in	ADP	O	O
the	DET	O	O
probiotic	ADJ	O	O
and	CCONJ	O	O
control	NOUN	O	O
groups:	NOUN	O	O
305	NUM	O	O
(81)	NOUN	O	O
vs.	CCONJ	O	O
315	NUM	O	O
(90)	PUNCT	O	O
min.,	NUM	O	O

Journal-Name:Oncology	NOUN	O	O
reports	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
use	NOUN	O	O
of	ADP	O	O
ETView	NOUN	O	O
endotracheal	ADJ	O	O
tube	NOUN	O	O
for	ADP	O	O
surveillance	NOUN	O	O
after	ADP	O	O
tube	NOUN	O	O
positioning	VERB	O	O
in	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
lobectomy,	NOUN	O	O
randomized	VERB	O	O
trial.	NOUN	O	O

To	PART	O	O
this	DET	O	O
end,	NOUN	O	O
we	PRON	O	O
tested	VERB	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
two	NUM	O	O
commercially-available	ADJ	O	O
drinks	NOUN	O	O
on	ADP	O	O
strength	NOUN	O	O
in	ADP	O	O
a	DET	O	O
field-based	VERB	O	O
setting	VERB	O	O
with	ADP	O	O
both	CCONJ	O	O
male	NOUN	O	O
and	CCONJ	O	O
female	NOUN	O	O
high	ADJ	O	O
school	NOUN	O	O
athletes	NOUN	O	O
completing	VERB	O	O
a	DET	O	O
summer	NOUN	O	O
training	VERB	O	O
program.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
609	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
complicated	VERB	O	O
urinary	ADJ	O	O
tract	NOUN	O	O
infections	NOUN	O	O
(UTIs),	PUNCT	O	O
including	VERB	O	O
acute	ADJ	O	O
pyelonephritis,	NOUN	O	O
in	ADP	O	O
a	DET	O	O
1:1	ADJ	O	O
ratio	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
intravenous	ADJ	O	O
plazomicin	NOUN	O	O
(15	PUNCT	O	O
mg	NOUN	O	O
per	ADP	O	O
kilogram	NOUN	O	O
of	ADP	O	O
body	NOUN	O	O
weight	NOUN	O	O
once	ADP	O	O
daily)	CCONJ	O	O
or	CCONJ	O	O
meropenem	NOUN	O	O
(1	NOUN	O	O
g	NOUN	O	O
every	DET	O	O
8	NUM	O	O
hours),	NOUN	O	O
with	ADP	O	O
optional	ADJ	O	O
oral	ADJ	O	O
step-down	VERB	O	O
therapy	NOUN	O	O
after	ADP	O	O
at	ADP	O	O
least	ADV	O	O
4	NUM	O	O
days	NOUN	O	O
of	ADP	O	O
intravenous	ADJ	O	O
therapy,	NOUN	O	O
for	ADP	O	O
a	DET	O	O
total	ADJ	O	O
of	ADP	O	O
7	NUM	O	O
to	PART	O	O
10	NUM	O	O
days	NOUN	O	O
of	ADP	O	O
therapy.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7501160	NUM	O	O

The	DET	O	O
ETView	NOUN	O	O
single	ADJ	O	O
lumen	NOUN	O	O
endotracheal	ADJ	O	O
tube	NOUN	O	O
had	VERB	O	O
fewer	ADJ	O	O
associated	VERB	O	O
complications	NOUN	O	B-outcome
and	CCONJ	O	O
is	VERB	O	O
superior	ADJ	O	O
to	PART	O	O
the	DET	O	O
2	NUM	O	O
double-lumen	NOUN	O	O
tubes.	NOUN	O	O

DISCUSSION:	NOUN	O	O
Halitosis	NOUN	O	O
treatment	NOUN	O	O
is	VERB	O	O
a	DET	O	O
topic	ADJ	O	O
that	ADP	O	O
still	ADV	O	O
needs	NOUN	O	O
attention.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0374675	NUM	O	O

This	DET	O	O
tendency	NOUN	O	O
of	ADP	O	O
the	DET	O	O
improvement	NOUN	O	O
was	VERB	O	O
maintained,	NOUN	O	O
in	ADP	O	O
favour	NOUN	O	O
of	ADP	O	O
the	DET	O	O
IG,	NOUN	O	O
at	ADP	O	O
the	DET	O	O
12-month	NOUN	O	O
follow-up	NOUN	O	O
visit.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
a	DET	O	O
significant	ADJ	O	O
interaction	NOUN	O	O
of	ADP	O	O
composite	NOUN	O	O
strength	NOUN	O	B-outcome
score	NOUN	O	O
between	ADP	O	O
groups,	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
.04,	PUNCT	O	O
engp2	NOUN	O	O
=	SYM	O	O
.08).	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985213R	NOUN	O	O

They	PRON	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
either	CCONJ	O	O
neoadjuvant	ADJ	O	O
chemotherapy	NOUN	O	O
or	CCONJ	O	O
upfront	ADP	O	O
surgery.	VERB	O	O

REGISTRATION:	NOUN	O	O
This	DET	O	O
trial	NOUN	O	O
was	VERB	O	O
registered	VERB	O	O
at	ADP	O	O
ClinicalTrials.govNCT01925924.	NOUN	O	O

Secondary	ADJ	O	O
endpoints	NOUN	O	O
include	VERB	O	O
symptomatic	ADJ	O	B-outcome
malaria	NOUN	O	I-outcome
,	PUNCT	O	O
Polymerase	NOUN	O	O
Chain	NOUN	O	O
Reaction	NOUN	O	O
(PCR)-detectable	ADJ	O	O
Plasmodium	NOUN	O	B-outcome
spp	NOUN	O	I-outcome
Infections	NOUN	O	I-outcome
,	PUNCT	O	O
molecular	ADJ	O	O
markers	NOUN	O	O
of	ADP	O	O
drug	NOUN	O	B-outcome
resistance	NOUN	O	I-outcome
and	CCONJ	O	O
antibodies	NOUN	O	B-outcome
specific	ADJ	O	I-outcome
for	ADP	O	Seperator
Plasmodium	NOUN	O	I-outcome
spp	NOUN	O	I-outcome
Parasites	NOUN	O	I-outcome
.	PUNCT	O	O
DISCUSSION:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
approved	VERB	O	O
by	ADP	O	O
relevant	ADJ	O	O
institutional	ADJ	O	O
ethics	NOUN	O	O
committees	NOUN	O	O
in	ADP	O	O
Myanmar	ADJ	O	O
and	CCONJ	O	O
Australia.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

BACKGROUND:	NOUN	O	O
Mothers	NOUN	O	O
of	ADP	O	O
preterm	NOUN	O	O
infants	NOUN	O	O
often	ADV	O	O
have	VERB	O	O
symptoms	NOUN	O	O
of	ADP	O	O
anxiety	NOUN	O	O
and	CCONJ	O	O
depression,	NOUN	O	O
recognized	VERB	O	O
as	ADP	O	O
risk	NOUN	O	O
factors	NOUN	O	O
for	ADP	O	O
the	DET	O	O
development	NOUN	O	O
of	ADP	O	O
cardiovascular	ADJ	O	O
diseases	NOUN	O	O
and	CCONJ	O	O
associated	VERB	O	O
with	ADP	O	O
low	ADJ	O	O
rates	NOUN	O	O
of	ADP	O	O
heart	NOUN	O	O
rate	NOUN	O	O
variability	NOUN	O	O
(HRV).	NOUN	O	O

Participants	NOUN	O	O
recovered	VERB	O	O
in	ADP	O	O
a	DET	O	O
similar	ADJ	O	O
time-dependent	ADJ	O	O
manner	NOUN	O	O
in	ADP	O	O
all	DET	O	O
markers	NOUN	O	O
of	ADP	O	O
metabolism	NOUN	O	B-outcome
following	VERB	O	O
the	DET	O	O
PLA	NOUN	O	O
and	CCONJ	O	O
CA	NOUN	O	O
+	SYM	O	O
C	NOUN	O	O
trials.	NOUN	O	O

Results:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
240	NUM	O	O
of	ADP	O	O
279	NUM	O	O
patients	NOUN	O	O
(129	NUM	O	O
females	NOUN	O	O
and	CCONJ	O	O
111	NUM	O	O
male)	NOUN	O	O
aged	VERB	O	O
18	NUM	O	O
-	PUNCT	O	O
65	NUM	O	O
years	NOUN	O	O
were	VERB	O	O
referred	VERB	O	O
and	CCONJ	O	O
integrated	VERB	O	O
in	ADP	O	O
this	DET	O	O
clinical	ADJ	O	O
trial,	NOUN	O	O
whereas	ADP	O	O
29	NUM	O	O
were	VERB	O	O
rejected	VERB	O	O
as	ADP	O	O
not	ADV	O	O
completing	VERB	O	O
the	DET	O	O
requirements	NOUN	O	O
needed.	NOUN	O	O

PATIENT	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
We	PRON	O	O
propose	NOUN	O	O
a	DET	O	O
prospective,	NOUN	O	O
double-blinded,	NOUN	O	O
randomized	VERB	O	O
phase	NOUN	O	O
2	NUM	O	O
study	NOUN	O	O
of	ADP	O	O
2	NUM	O	O
parallel	ADJ	O	O
groups	NOUN	O	O
of	ADP	O	O
eligible	ADJ	O	O
adult	NOUN	O	O
patients.	NOUN	O	O

Methods:	NOUN	O	O
A	DET	O	O
feasibility	NOUN	O	O
randomized	VERB	O	O
control	NOUN	O	O
trial	NOUN	O	O
allowed	VERB	O	O
for	ADP	O	O
comparison	NOUN	O	O
of	ADP	O	O
PICIHBI	NOUN	O	O
and	CCONJ	O	O
conventional	ADJ	O	O
one-on-one	NUM	O	O
occupational	ADJ	O	O
therapy	NOUN	O	O
interventions.	NOUN	O	O

Study	NOUN	O	O
1	NUM	O	O
tested	VERB	O	O
8-week	NOUN	O	O
group-based	VERB	O	O
Monitor	NOUN	O	O
+	SYM	O	O
Accept	ADV	O	O
and	CCONJ	O	O
Monitor	NOUN	O	O
Only	ADV	O	O
interventions	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
a	DET	O	O
no	DET	O	O
treatment	NOUN	O	O
control	NOUN	O	O
group.	VERB	O	O

Title:	NOUN	O	O
Effect	NOUN	O	O
of	ADP	O	O
the	DET	O	O
soft-tissue	NOUN	O	O
techniques	NOUN	O	O
in	ADP	O	O
the	DET	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
Crohn's	NOUN	O	O
disease:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Tai	NOUN	O	O
Chi	NOUN	O	O
as	ADP	O	O
a	DET	O	O
mild	ADJ	O	O
to	PART	O	O
moderate	ADJ	O	O
mind-body	NOUN	O	O
exercise	NOUN	O	O
is	VERB	O	O
suitable	ADJ	O	O
for	ADP	O	O
older	ADJ	O	O
individuals	NOUN	O	O
who	ADP	O	O
suffer	NOUN	O	O
from	ADP	O	O
depression.	NOUN	O	O

CONCLUSION:	NOUN	O	O
While	ADP	O	O
methohexital	ADJ	O	O
was	VERB	O	O
shown	VERB	O	O
to	PART	O	O
confer	VERB	O	O
greater	ADJ	O	O
hemodynamic	ADJ	O	B-outcome
stability	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
taking	VERB	O	O
ACEi/ARB,	NOUN	O	O
the	DET	O	O
measured	VERB	O	O
hormone	NOUN	O	B-outcome
levels	NOUN	O	O
could	VERB	O	O
not	ADV	O	O
explain	NOUN	O	O
the	DET	O	O
mechanism	NOUN	O	O
for	ADP	O	O
this	DET	O	O
effect.	NOUN	O	O

RESULTS:	NOUN	O	O
In	ADP	O	O
the	DET	O	O
modified	VERB	O	O
intention-to-treat	NOUN	O	O
population,	NOUN	O	O
omadacycline	NOUN	O	O
(316	NUM	O	O
patients)	NOUN	O	O
was	VERB	O	O
noninferior	ADJ	O	O
to	PART	O	O
linezolid	NOUN	O	O
(311	NOUN	O	O
patients)	NOUN	O	O
with	ADP	O	O
respect	NOUN	O	O
to	PART	O	O
early	ADJ	O	O
clinical	ADJ	O	O
response	NOUN	O	O
(rate	NOUN	O	O
of	ADP	O	O
response,	NOUN	O	O
84.8%	NUM	O	O
and	CCONJ	O	O
85.5%,	NUM	O	O
respectively;	NOUN	O	O
difference,	NOUN	O	O
-0.7	NOUN	O	O
percentage	NOUN	O	O
points;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
-6.3	CCONJ	O	O
to	PART	O	O
4.9).	NOUN	O	O

Therefore,	NOUN	O	O
we	PRON	O	O
conducted	VERB	O	O
this	DET	O	O
study	NOUN	O	O
to	PART	O	O
determine	NOUN	O	O
the	DET	O	O
95%	NOUN	O	O
effective	ADJ	O	O
dose	NOUN	O	B-outcome
(ED95)	PUNCT	O	O
of	ADP	O	O
intrathecal	ADJ	O	O
hyperbaric	ADJ	O	O
ropivacaine	NOUN	O	O
for	ADP	O	O
cesarean	NOUN	O	O
section	NOUN	O	O
in	ADP	O	O
parturients	NOUN	O	O
receiving	VERB	O	O
prophylactic	ADJ	O	O
infusion	NOUN	O	O
of	ADP	O	O
phenylephrine	NOUN	O	O
to	PART	O	O
prevent	NOUN	O	O
spinal-induced	VERB	O	O
hypotension.	NOUN	O	O

The	DET	O	O
view	NOUN	O	O
from	ADP	O	O
the	DET	O	O
tip	NOUN	O	O
appears	NOUN	O	O
continuously	ADV	O	O
on	ADP	O	O
a	DET	O	O
portable	ADJ	O	O
monitor	NOUN	O	O
in	ADP	O	O
the	DET	O	O
anesthesia	NOUN	O	O
area.	NOUN	O	O

Journal-Name:Therapeutic	ADJ	O	O
drug	NOUN	O	O
monitoring	VERB	O	O

BACKGROUND	NOUN	O	O
AND	CCONJ	O	O
PURPOSE:	NOUN	O	O
There	PRON	O	O
is	VERB	O	O
a	DET	O	O
need	NOUN	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
pilates	NOUN	O	O
exercises	NOUN	O	O
on	ADP	O	O
the	DET	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(QOL)	PUNCT	O	I-outcome
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
kidney	NOUN	O	O
diseases	NOUN	O	O
(CKD).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/14	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/05	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Bilateral	ADJ	O	O
strength	NOUN	O	O
training	VERB	O	O
did	VERB	O	O
not	ADV	O	O
correct	ADJ	O	O
the	DET	O	O
unilateral	ADJ	O	O
strength	NOUN	O	B-outcome
deficit	ADP	O	I-outcome
observed	VERB	O	O
in	ADP	O	O
this	DET	O	O
group	NOUN	O	O
of	ADP	O	O
survivors	NOUN	O	O
of	ADP	O	O
breast	NOUN	O	O
cancer.	NOUN	O	O

RESULTS:	NOUN	O	O
Overall,	NOUN	O	O
834	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
minor	ADJ	O	O
stroke	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
this	DET	O	O
subgroup,	NOUN	O	O
553	NUM	O	O
SAI	NOUN	O	O
(381	PUNCT	O	O
lacunar	NOUN	O	O
infarction,	ADP	O	O
172	NUM	O	O
non-lacunar	NOUN	O	O
infarction)	NOUN	O	O
and	CCONJ	O	O
281	NUM	O	O
MAIs.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/04	ADP	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Complication	NOUN	O	B-outcome
rates	NOUN	O	O
in	ADP	O	O
all	DET	O	O
strategy	NOUN	O	O
groups	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group;	ADJ	O	O
however,	ADV	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
was	VERB	O	O
found	VERB	O	O
among	ADP	O	O
the	DET	O	O
strategy	NOUN	O	O
groups.	NOUN	O	O

Resting	VERB	O	O
blood	NOUN	O	O
samples	NOUN	O	O
were	VERB	O	O
collected	VERB	O	O
prior	ADJ	O	O
to	PART	O	O
and	CCONJ	O	O
on	ADP	O	O
completion	NOUN	O	O
of	ADP	O	O
each	DET	O	O
diet	NOUN	O	O
to	PART	O	O
determine	NOUN	O	O
plasma	NOUN	O	O
intestinal	ADJ	O	B-outcome
fatty	ADJ	O	I-outcome
acid	NOUN	O	I-outcome
binding	VERB	O	I-outcome
protein	NOUN	O	I-outcome
(I-FABP)	ADV	O	I-outcome
as	ADP	O	O
a	DET	O	O
marker	NOUN	O	O
of	ADP	O	O
acute	ADJ	O	B-outcome
GI	NOUN	O	I-outcome
injury	NOUN	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
Overall	ADV	O	O
Irritable	ADJ	O	B-outcome
Bowel	NOUN	O	I-outcome
Syndrome-Severity	NOUN	O	I-outcome
Scoring	VERB	O	O
System	NOUN	O	O
(IBS-SSS)	PUNCT	O	O
score	NOUN	O	O
significantly	ADV	O	O
reduced	VERB	O	O
in	ADP	O	O
the	DET	O	O
LOWFODMAP	NOUN	O	O
condition	NOUN	O	O
from	ADP	O	O
81.1	NUM	O	O
+/-	SYM	O	O
16.4	NUM	O	O
to	PART	O	O
31.3	NUM	O	O
+/-	SYM	O	O
9.2	NUM	O	O
(arbitrary	PUNCT	O	O
units;	ADJ	O	O
P	NOUN	O	O
=	SYM	O	O
0.004).	NUM	O	O

Title:	NOUN	O	O
Using	VERB	O	O
the	DET	O	O
Borg	ADJ	O	O
rating	VERB	O	O
of	ADP	O	O
perceived	VERB	O	B-outcome
exertion	NOUN	O	I-outcome
scale	NOUN	O	O
to	PART	O	O
grade	NOUN	O	O
the	DET	O	O
intensity	NOUN	O	B-outcome
of	ADP	O	O
a	DET	O	O
functional	ADJ	O	O
training	VERB	O	O
program	NOUN	O	O
of	ADP	O	O
the	DET	O	O
affected	VERB	O	O
upper	ADJ	O	O
limb	NOUN	O	O
after	ADP	O	O
a	DET	O	O
stroke:	NOUN	O	O
a	DET	O	O
feasibility	NOUN	O	O
study.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
ophthalmology	NOUN	O	O

FUNDING:	NOUN	O	O
Seattle	ADJ	O	O
Genetics	NOUN	O	O
Inc,	NOUN	O	O
Millennium	NOUN	O	O
Pharmaceuticals	NOUN	O	O
Inc,	NOUN	O	O
a	DET	O	O
wholly	ADV	O	O
owned	VERB	O	O
subsidiary	NOUN	O	O
of	ADP	O	O
Takeda	NOUN	O	O
Pharmacuetical	NOUN	O	O
Company	DET	O	O
Limited,	VERB	O	O
and	CCONJ	O	O
National	ADJ	O	O
Institutes	NOUN	O	O
of	ADP	O	O
Health	NOUN	O	O
National	ADJ	O	O
Cancer	NOUN	O	O
Institute	NOUN	O	O
Cancer	NOUN	O	O
Center.	NOUN	O	O

A	DET	O	O
noninferiority	NOUN	O	O
margin	ADP	O	O
of	ADP	O	O
10	NUM	O	O
percentage	NOUN	O	O
points	NOUN	O	O
was	VERB	O	O
used.	NOUN	O	O

Efficacy	NOUN	O	O
was	VERB	O	O
evaluated	VERB	O	O
again	ADV	O	O
at	ADP	O	O
day	NOUN	O	O
58,	NUM	O	O
after	ADP	O	O
completion	NOUN	O	O
of	ADP	O	O
treatment.	NOUN	O	O

Journal-Name:International	ADJ	O	O
journal	ADJ	O	O
of	ADP	O	O
environmental	ADJ	O	O
research	NOUN	O	O
and	CCONJ	O	O
public	ADJ	O	O
health	NOUN	O	O

TPI	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
TPIs	NOUN	O	O
with	ADP	O	O
2	NUM	O	O
mL	NOUN	O	O
of	ADP	O	O
0.2%	NOUN	O	O
ropivacaine,	ADJ	O	O
and	CCONJ	O	O
EMLA	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
an	DET	O	O
occlusive	ADJ	O	O
dressing	VERB	O	O
with	ADP	O	O
EMLA	NOUN	O	O
cream	NOUN	O	O
2	NUM	O	O
g	NOUN	O	O
on	ADP	O	O
both	CCONJ	O	O
shoulders.	NOUN	O	O

METHODS:	NOUN	O	O
We	PRON	O	O
conducted	VERB	O	O
a	DET	O	O
case	NOUN	O	O
study	NOUN	O	O
with	ADP	O	O
a	DET	O	O
purposeful	ADJ	O	O
sample	NOUN	O	O
of	ADP	O	O
18	NUM	O	O
trained	VERB	O	O
PCPs.	NOUN	O	O

The	DET	O	O
most	DET	O	O
common	ADJ	O	O
adverse	ADJ	O	B-outcome
event	NOUN	O	I-outcome
was	VERB	O	O
mucocutaneous	ADJ	O	B-outcome
bleeding	VERB	O	I-outcome
,	PUNCT	O	O
which	ADP	O	O
was	VERB	O	O
reported	VERB	O	O
in	ADP	O	O
65%	NUM	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
caplacizumab	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
48%	ADP	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/29	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Anticoagulants	NOUN	O	O
are	VERB	O	O
effective	ADJ	O	O
as	ADP	O	O
venous	ADJ	O	O
thromboprophylaxis,	NOUN	O	O
but	CCONJ	O	O
with	ADP	O	O
an	DET	O	O
increased	VERB	O	O
risk	NOUN	O	O
of	ADP	O	O
bleeding.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/01	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

After	ADP	O	O
4	NUM	O	O
weeks,	NOUN	O	O
the	DET	O	O
levels	NOUN	O	O
of	ADP	O	O
Trimethylamine	NOUN	O	B-outcome
N-oxide	NOUN	O	I-outcome
(TMAO)	NOUN	O	I-outcome
were	VERB	O	O
significantly	ADV	O	O
decreased	VERB	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
placebo	NOUN	O	O
(63.6%	NOUN	O	O
vs.	CCONJ	O	O
0.54%,	NUM	O	O
respectively,	NOUN	O	O
P	NOUN	O	O
<	SYM	O	O
0.0001).	NUM	O	O

The	DET	O	O
potential	ADJ	O	O
role	NOUN	O	O
of	ADP	O	O
the	DET	O	O
clinical	ADJ	O	O
assessment	NOUN	O	O
of	ADP	O	O
peripheral	ADJ	O	O
perfusion	NOUN	O	O
as	ADP	O	O
a	DET	O	O
target	NOUN	O	O
during	ADP	O	O
resuscitation	NOUN	O	O
in	ADP	O	O
early	ADJ	O	O
septic	ADJ	O	O
shock	NOUN	O	O
has	VERB	O	O
not	ADV	O	O
been	VERB	O	O
established.	NOUN	O	O

Pulpectomy	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
on	ADP	O	O
27	NUM	O	O
primary	ADJ	O	O
teeth	NOUN	O	O
with	ADP	O	O
necrosis	NOUN	O	O
or	CCONJ	O	O
irreversible	ADJ	O	O
pulpitis,	NOUN	O	O
caused	VERB	O	O
by	ADP	O	O
dental	ADJ	O	O
caries	NOUN	O	O
or	CCONJ	O	O
trauma,	NOUN	O	O
in	ADP	O	O
23	NUM	O	O
children	NOUN	O	O
(2-7	NOUN	O	O
years	NOUN	O	O
old).	PUNCT	O	O

Funded	VERB	O	O
by	ADP	O	O
Ablynx;	NOUN	O	O
HERCULES	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
number,	ADV	O	O
NCT02553317	ADJ	O	O
.).	NOUN	O	O

3)	NOUN	O	O
Compared	VERB	O	O
with	ADP	O	O
combination	NOUN	O	O
group,	NOUN	O	O
improvement	NOUN	O	O
of	ADP	O	O
sleep	NOUN	O	B-outcome
onset	NOUN	O	I-outcome
latency	NOUN	O	I-outcome
(SOL)	NOUN	O	I-outcome
and	CCONJ	O	O
sleep	NOUN	O	B-outcome
efficiency	NOUN	O	I-outcome
(SE)	NOUN	O	I-outcome
in	ADP	O	O
CBT-i	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
superior	ADJ	O	O
(both	NOUN	O	O
P=0.01).	NOUN	O	O

The	DET	O	O
median	ADJ	O	O
intervention	NOUN	O	O
period	NOUN	O	O
was	VERB	O	O
3.34	NUM	O	O
years.	NOUN	O	O

RESULTS:	NOUN	O	O
Sixty-five	ADJ	O	O
patients	NOUN	O	O
completed	VERB	O	O
the	DET	O	O
study,	NOUN	O	O
including	VERB	O	O
33	NUM	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
32	NUM	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
group.	VERB	O	O

For	ADP	O	O
all	DET	O	O
analyses	NOUN	O	O
a	DET	O	O
level	NOUN	O	O
of	ADP	O	O
significance	NOUN	O	O
of	ADP	O	O
95%	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.05)	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
considered.	NOUN	O	O

The	DET	O	O
Delta	NOUN	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
and	CCONJ	O	O
Delta	NOUN	O	O
cardiac	ADJ	O	B-outcome
output	NOUN	O	O
values	NOUN	O	O
were	VERB	O	O
lower	ADJ	O	O
in	ADP	O	O
the	DET	O	O
Group	NOUN	O	O
R	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.02	NUM	O	O
and	CCONJ	O	O
P	NOUN	O	O
=	SYM	O	O
.04,	PUNCT	O	O
respectively).	NOUN	O	O

Because	ADP	O	O
of	ADP	O	O
the	DET	O	O
time	NOUN	O	O
spent	VERB	O	O
at	ADP	O	O
the	DET	O	O
workplace,	ADP	O	O
workplaces	NOUN	O	O
can	VERB	O	O
be	VERB	O	O
optimal	ADJ	O	O
arenas	NOUN	O	O
for	ADP	O	O
weight	NOUN	O	O
loss	NOUN	O	O
programs	NOUN	O	O
and	CCONJ	O	O
these	DET	O	O
programs	NOUN	O	O
have	VERB	O	O
been	VERB	O	O
effective	ADJ	O	O
to	PART	O	O
decrease	NOUN	O	O
body	NOUN	O	O
weight.	NOUN	O	O

This	DET	O	O
could	VERB	O	O
fill	NOUN	O	O
the	DET	O	O
gap	NOUN	O	O
between	ADP	O	O
devices	NOUN	O	O
that	ADP	O	O
fully	ADV	O	O
compensate	NOUN	O	O
for	ADP	O	O
walking	VERB	O	O
and	CCONJ	O	O
those	DET	O	O
which	ADP	O	O
allow	ADP	O	O
patients	NOUN	O	O
to	PART	O	O
maintain	NOUN	O	O
residual	ADJ	O	O
mobility.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
an	DET	O	O
exploratory	ADJ	O	O
analysis	NOUN	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
secondary	ADJ	O	O
end-point	NOUN	O	O
of	ADP	O	O
biochemical	ADJ	O	B-outcome
failure-free	ADJ	O	I-outcome
survival	NOUN	O	I-outcome
(BCFFS)	NUM	O	I-outcome
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
long-term	NOUN	O	O
follow-up.	PUNCT	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Clinicaltrials.gov	NOUN	O	O
Identifier:	NOUN	O	O
NCT03173339.	NOUN	O	O

The	DET	O	O
purpose	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
assess	NOUN	O	O
the	DET	O	O
prevalence	NOUN	O	O
and	CCONJ	O	O
correlates	NOUN	O	O
of	ADP	O	O
different	ADJ	O	O
indicators	NOUN	O	O
of	ADP	O	O
psychological	ADJ	O	O
distress	NOUN	O	O
among	ADP	O	O
13-14	NUM	O	O
year	NOUN	O	O
old	ADJ	O	O
low	ADJ	O	O
caste	NOUN	O	O
girls	NOUN	O	O
in	ADP	O	O
rural,	ADJ	O	O
south	NOUN	O	O
India.	NOUN	O	O

Title:	NOUN	O	O
How	ADP	O	O
mindfulness	ADV	O	O
training	VERB	O	O
promotes	NOUN	O	O
positive	ADJ	O	B-outcome
emotions	NOUN	O	I-outcome
:	PUNCT	O	O
Dismantling	VERB	O	O
acceptance	NOUN	O	O
skills	NOUN	O	O
training	VERB	O	O
in	ADP	O	O
two	NUM	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trials.	NOUN	O	O

The	DET	O	O
curative	ADJ	O	O
effect	NOUN	O	O
was	VERB	O	O
compared	VERB	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
treatment,	NOUN	O	O
including	VERB	O	O
ulcer	NOUN	O	B-outcome
surface	NOUN	O	I-outcome
pain	NOUN	O	I-outcome
(VAS	PUNCT	O	O
score),	NOUN	O	O
time	NOUN	O	B-outcome
of	ADP	O	I-outcome
ulcer	NOUN	O	I-outcome
healing	VERB	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
the	DET	O	O
changes	NOUN	O	O
of	ADP	O	O
T	NOUN	O	B-outcome
cell	NOUN	O	I-outcome
subsets	NOUN	O	I-outcome
(	PUNCT	O	O
CD3(+)	NOUN	O	B-outcome
,	PUNCT	O	O
CD4(+)	NOUN	O	B-outcome
,	PUNCT	O	O
CD8(+)	NOUN	O	B-outcome
and	CCONJ	O	O
CD4(+)/CD8(+)	NOUN	O	B-outcome
)	PUNCT	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
treatment	NOUN	O	O
were	VERB	O	O
compared	VERB	O	O
by	ADP	O	O
SPSS	ADV	O	O
22	NUM	O	O
software	NOUN	O	O
package.	ADJ	O	O

All	DET	O	O
outcomes	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
at	ADP	O	O
baseline,	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
6-week	NOUN	O	O
treatment	NOUN	O	O
and	CCONJ	O	O
2-week	NOUN	O	O
follow-up	NOUN	O	O
after	ADP	O	O
the	DET	O	O
treatment.	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
a	DET	O	O
multicenter,	NOUN	O	O
double-blind,	NOUN	O	O
placebo-controlled,	NOUN	O	O
delayed-start	NOUN	O	O
trial,	NOUN	O	O
we	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
patients	NOUN	O	O
with	ADP	O	O
early	ADJ	O	O
Parkinson's	NOUN	O	O
disease	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
levodopa	NOUN	O	O
(100	NUM	O	O
mg	NOUN	O	O
three	NUM	O	O
times	NOUN	O	O
per	ADP	O	O
day)	NOUN	O	O
in	ADP	O	O
combination	NOUN	O	O
with	ADP	O	O
carbidopa	NOUN	O	O
(25	NOUN	O	O
mg	NOUN	O	O
three	NUM	O	O
times	NOUN	O	O
per	ADP	O	O
day)	NOUN	O	O
for	ADP	O	O
80	NUM	O	O
weeks	NOUN	O	O
(early-start	NOUN	O	O
group)	ADJ	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
for	ADP	O	O
40	NUM	O	O
weeks	NOUN	O	O
followed	VERB	O	O
by	ADP	O	O
levodopa	NOUN	O	O
in	ADP	O	O
combination	NOUN	O	O
with	ADP	O	O
carbidopa	NOUN	O	O
for	ADP	O	O
40	NUM	O	O
weeks	NOUN	O	O
(delayed-start	NOUN	O	O
group).	NOUN	O	O

PATIENTS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
A	DET	O	O
multicentre,	NOUN	O	O
prospective,	NOUN	O	O
randomized,	NOUN	O	O
double-blind,	NOUN	O	O
placebo-controlled	VERB	O	O
trial	NOUN	O	O
was	VERB	O	O
undertaken	VERB	O	O
involving	VERB	O	O
229	NUM	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
primary	ADJ	O	O
cementless	NOUN	O	O
THA	NOUN	O	O
using	VERB	O	O
a	DET	O	O
posterior	ADJ	O	O
approach,	NOUN	O	O
whose	ADP	O	O
extended	VERB	O	O
rivaroxaban	ADJ	O	O
thromboprophylaxis	NOUN	O	O
started	VERB	O	O
on	ADP	O	O
the	DET	O	O
day	NOUN	O	O
of	ADP	O	O
surgery.	VERB	O	O

Journal-Name:JAMA	NOUN	O	O

Conclusions:	NOUN	O	O
Our	ADJ	O	O
study	NOUN	O	O
demonstrates	NOUN	O	O
that	ADP	O	O
NCH	NOUN	O	O
gel	NOUN	O	O
appears	NOUN	O	O
to	PART	O	O
be	VERB	O	O
able	ADJ	O	O
to	PART	O	O
reduce	VERB	O	O
the	DET	O	O
formation	NOUN	O	O
of	ADP	O	O
intrauterine	ADJ	O	B-outcome
adhesions	NOUN	O	I-outcome
in	ADP	O	O
women	NOUN	O	O
who	ADP	O	O
undergo	NOUN	O	O
curettage	NOUN	O	O
in	ADP	O	O
the	DET	O	O
second	ADJ	O	O
trimester,	ADV	O	O
although	ADP	O	O
larger	ADJ	O	O
controlled,	NOUN	O	O
randomized,	NOUN	O	O
multicenter	NOUN	O	O
studies	NOUN	O	O
are	VERB	O	O
needed	VERB	O	O
to	PART	O	O
confirm	NOUN	O	O
these	DET	O	O
results.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Many	ADJ	O	O
men	NOUN	O	O
have	VERB	O	O
limited	VERB	O	O
knowledge	NOUN	O	O
about	ADV	O	O
reproductive	ADJ	O	O
health	NOUN	O	O
and	CCONJ	O	O
fertility.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Ecabet	NOUN	O	O
sodium	NOUN	O	O
had	VERB	O	O
a	DET	O	O
preventive	ADJ	O	O
effect	NOUN	O	O
on	ADP	O	O
low-dose	NOUN	O	O
aspirin-induced	VERB	O	O
small	ADJ	O	O
intestinal	ADJ	O	O
mucosal	ADJ	O	O
injury	NOUN	O	O
in	ADP	O	O
the	DET	O	O
upper	ADJ	O	O
part	NOUN	O	O
of	ADP	O	O
the	DET	O	O
small	ADJ	O	O
intestine.	NOUN	O	O

General	NOUN	O	O
fertility	NOUN	O	B-outcome
awareness	ADV	O	I-outcome
increased	VERB	O	O
from	ADP	O	O
a	DET	O	O
mean	NOUN	O	O
score	NOUN	O	O
of	ADP	O	O
4.6	NUM	O	O
to	PART	O	O
5.5	NUM	O	O
out	ADP	O	O
of	ADP	O	O
12	NUM	O	O
(P	NUM	O	O
=	SYM	O	O
0.004)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
IG.	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
findings	NOUN	O	O
demonstrated	VERB	O	O
that	ADP	O	O
both	CCONJ	O	O
regimens	NOUN	O	O
of	ADP	O	O
drugs	NOUN	O	O
can	VERB	O	O
control	NOUN	O	O
the	DET	O	O
hemodynamic	ADJ	O	B-outcome
status	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
during	ADP	O	O
laparoscopic	ADJ	O	O
cholecystectomy,	NOUN	O	O
which	ADP	O	O
provides	NOUN	O	O
effective	ADJ	O	O
postoperative	ADJ	O	O
analgesia	NOUN	O	O
for	ADP	O	O
pain	NOUN	O	B-outcome
management.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Statistical	ADJ	O	O
analyses	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
conducted	VERB	O	O
under	ADP	O	O
the	DET	O	O
intention-to-treat	NOUN	O	O
principle.	NOUN	O	O

Although	ADP	O	O
the	DET	O	O
concentration	NOUN	O	B-outcome
of	ADP	O	I-outcome
fentanyl	NOUN	O	I-outcome
was	VERB	O	O
higher	ADJ	O	O
than	ADP	O	O
those	DET	O	O
of	ADP	O	O
previous	ADJ	O	O
researches,	NOUN	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
respiratory	ADJ	O	B-outcome
depression	NOUN	O	I-outcome
.	PUNCT	O	O
But,	NOUN	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
advantage	NOUN	O	O
of	ADP	O	O
reducing	VERB	O	O
pain	NOUN	O	B-outcome
score	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
use	NOUN	O	B-outcome
of	ADP	O	I-outcome
rescue	NOUN	O	I-outcome
analgesics	NOUN	O	I-outcome
.	PUNCT	O	O
CLINICAL	ADJ	O	O
TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
(available	ADP	O	O
at:	NOUN	O	O
http://cris.nih.go.kr,	NOUN	O	O
KCT0002221).	NOUN	O	O

METHODS:	NOUN	O	O
WISDOM	NOUN	O	O
was	VERB	O	O
a	DET	O	O
multinational,	ADJ	O	O
randomized,	NOUN	O	O
double-blind,	NOUN	O	O
active-controlled,	NOUN	O	O
52-week	NOUN	O	O
study	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
severe-to-very	NOUN	O	O
severe	ADJ	O	O
COPD.	NOUN	O	O

Fourteen	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
the	DET	O	O
placebo-dexmedetomidine	NOUN	O	O
and	CCONJ	O	O
acetaminophen-propofol	NOUN	O	O
groups	NOUN	O	O
(46%	NUM	O	O
and	CCONJ	O	O
45%)	NOUN	O	O
and	CCONJ	O	O
7	NUM	O	O
in	ADP	O	O
the	DET	O	O
acetaminophen-dexmedetomidine	NOUN	O	O
and	CCONJ	O	O
placebo-propofol	NOUN	O	O
groups	NOUN	O	O
(24%	NUM	O	O
and	CCONJ	O	O
23%)	NUM	O	O
had	VERB	O	O
hypotension	NOUN	O	B-outcome
.	PUNCT	O	O
Conclusions	NOUN	O	O
and	CCONJ	O	O
Relevance:	NOUN	O	O
Among	ADP	O	O
older	ADJ	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
cardiac	ADJ	O	O
surgery,	NOUN	O	O
postoperative	ADJ	O	O
scheduled	VERB	O	O
IV	NUM	O	O
acetaminophen,	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
IV	NUM	O	O
propofol	NOUN	O	O
or	CCONJ	O	O
dexmedetomidine,	ADP	O	O
reduced	VERB	O	O
in-hospital	NOUN	O	O
delirium	NOUN	O	B-outcome
vs	CCONJ	O	O
placebo.	NOUN	O	O

CONCLUSION:	NOUN	O	O
Intrathecal	ADJ	O	O
5	NUM	O	O
mug	NUM	O	O
Dex	NOUN	O	O
enhances	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
spinal	ADJ	O	O
bupivacaine	NOUN	O	O
by	ADP	O	O
24%	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
cesarean	NOUN	O	O
section	NOUN	O	O
with	ADP	O	O
spinal	ADJ	O	O
anesthesia.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7511141	NUM	O	O

The	DET	O	O
studyPeden	NOUN	O	O
CJ,	NOUN	O	O
Stephens	NOUN	O	O
T,	NOUN	O	O
Martin	NOUN	O	O
G	NOUN	O	O
et	NOUN	O	O
al.	NOUN	O	O

Data	NOUN	O	O
was	VERB	O	O
analyzed	VERB	O	O
by	ADP	O	O
repeated	VERB	O	O
measures	NOUN	O	O
analysis	NOUN	O	O
of	ADP	O	O
variance	NOUN	O	O
(rANOVA)	NOUN	O	O
and	CCONJ	O	O
chi-squared	NOUN	O	O
test	NOUN	O	O
(chi	PUNCT	O	O
test).	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
This	DET	O	O
double	ADV	O	O
blinded,	NOUN	O	O
randomized,	NOUN	O	O
and	CCONJ	O	O
placebo-controlled	VERB	O	O
trial	NOUN	O	O
demonstrated	VERB	O	O
that	ADP	O	O
the	DET	O	O
single	ADJ	O	O
use	NOUN	O	O
of	ADP	O	O
20	NUM	O	O
mg	NOUN	O	O
nifedipine	NOUN	O	O
given	VERB	O	O
30	NUM	O	O
minutes	NOUN	O	O
before	ADP	O	O
embryo	NOUN	O	O
transfer	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
improve	VERB	O	O
the	DET	O	O
implantation	NOUN	O	B-outcome
rate	NOUN	O	O
or	CCONJ	O	O
the	DET	O	O
clinical	ADJ	O	B-outcome
pregnancy	NOUN	O	I-outcome
rate	NOUN	O	O
of	ADP	O	O
the	DET	O	O
infertility	NOUN	O	O
treatment.	NOUN	O	O

Analyses	NOUN	O	O
were	VERB	O	O
done	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
the	DET	O	O
intention-to-treat	NOUN	O	O
principle.	NOUN	O	O

The	DET	O	O
registration	NOUN	O	O
can	VERB	O	O
be	VERB	O	O
found	VERB	O	O
at	ADP	O	O
the	DET	O	O
following	VERB	O	O
URL:	NOUN	O	O
https://clinicaltrials.gov/ct2/show/NCT01838668.	NOUN	O	O

METHODS:	NOUN	O	O
Sixty-seven	NUM	O	O
stable	ADJ	O	O
COPD	NOUN	O	O
patients	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
and	CCONJ	O	O
assigned	VERB	O	O
to	PART	O	O
the	DET	O	O
experiment	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
36)	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
31).	ADP	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Using	VERB	O	O
this	DET	O	O
approach,	NOUN	O	O
repellent	NOUN	O	O
(N,N-diethyl-benzamide	NOUN	O	O
-	PUNCT	O	O
12%	NUM	O	O
w/w,	NOUN	O	O
cream)	NOUN	O	O
is	VERB	O	O
distributed	VERB	O	O
by	ADP	O	O
VHVs	NOUN	O	O
in	ADP	O	O
villages	NOUN	O	O
sequentially	ADV	O	O
throughout	ADV	O	O
the	DET	O	O
malaria	NOUN	O	O
transmission	NOUN	O	O
season.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Exercise-related	VERB	O	O
GI	NOUN	O	O
issues	NOUN	O	O
are	VERB	O	O
a	DET	O	O
common	ADJ	O	O
cause	ADP	O	O
of	ADP	O	O
underperformance,	NOUN	O	O
with	ADP	O	O
current	ADJ	O	O
evidence	NOUN	O	O
focusing	VERB	O	O
on	ADP	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
FODMAP	ADV	O	O
approaches	NOUN	O	O
with	ADP	O	O
recreationally	ADV	O	O
competitive	ADJ	O	O
or	CCONJ	O	O
highly	ADV	O	O
trained	VERB	O	O
athletes.	ADV	O	O

Journal-Name:Aerospace	NOUN	O	O
medicine	NOUN	O	O
and	CCONJ	O	O
human	NOUN	O	O
performance	NOUN	O	O

CONCLUSION:	NOUN	O	O
This	DET	O	O
is	VERB	O	O
the	DET	O	O
first	ADV	O	O
randomised	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
to	PART	O	O
compare	NOUN	O	O
a	DET	O	O
structured	VERB	O	O
multidisciplinary,	NOUN	O	O
multisite	NOUN	O	O
intervention	NOUN	O	O
with	ADP	O	O
standard	ADJ	O	O
care	NOUN	O	O
in	ADP	O	O
symptomatic	ADJ	O	O
childhood	NOUN	O	O
hypermobility.	NUM	O	O

Band	NOUN	O	O
ligation	NOUN	O	O
is	VERB	O	O
the	DET	O	O
main	ADJ	O	O
therapeutic	ADJ	O	O
option,	NOUN	O	O
but	CCONJ	O	O
it	PRON	O	O
may	VERB	O	O
be	VERB	O	O
technically	ADV	O	O
difficult	ADJ	O	O
to	PART	O	O
perform	NOUN	O	O
in	ADP	O	O
active	ADJ	O	O
bleeders.	NOUN	O	O

CONTEXT:	NOUN	O	O
Deviations	NOUN	O	O
in	ADP	O	O
scapular	ADJ	O	O
motions	NOUN	O	O
and	CCONJ	O	O
subsequent	ADJ	O	O
alterations	NOUN	O	O
in	ADP	O	O
associated	VERB	O	O
soft	NOUN	O	O
tissues	NOUN	O	O
are	VERB	O	O
thought	VERB	O	O
to	PART	O	O
contribute	NOUN	O	O
to	PART	O	O
overuse	ADP	O	O
shoulder	NOUN	O	O
injuries	NOUN	O	O
in	ADP	O	O
overhead	ADP	O	O
athletes.	ADV	O	O

The	DET	O	O
trained	VERB	O	O
nodal	NOUN	O	O
teachers	NOUN	O	O
reported	VERB	O	O
children	NOUN	O	O
with	ADP	O	O
symptoms	NOUN	O	O
of	ADP	O	O
acute	ADJ	O	O
pharyngitis	NOUN	O	O
and	CCONJ	O	O
or	CCONJ	O	O
RF/RHD	NOUN	O	O
in	ADP	O	O
intervention	NOUN	O	O
arm	NOUN	O	O
and	CCONJ	O	O
children	NOUN	O	O
taken	VERB	O	O
to	PART	O	O
hospitals	NOUN	O	O
by	ADP	O	O
parents	NOUN	O	O
for	ADP	O	O
symptoms	NOUN	O	O
of	ADP	O	O
acute	ADJ	O	O
pharyngitis	NOUN	O	O
and	CCONJ	O	O
or	CCONJ	O	O
RF/RHD	NOUN	O	O
under	ADP	O	O
control	NOUN	O	O
arm	NOUN	O	O
through	ADP	O	O
mobile	ADJ	O	O
phone	NOUN	O	O
to	PART	O	O
coordinating	VERB	O	O
centre.	NOUN	O	O

The	DET	O	O
linear	ADJ	O	O
mixed	VERB	O	O
model	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
for	ADP	O	O
data	NOUN	O	O
analysis,	NOUN	O	O
in	ADP	O	O
which	ADP	O	O
a	DET	O	O
5%	NOUN	O	O
significance	NOUN	O	O
level	NOUN	O	O
was	VERB	O	O
adopted.	NOUN	O	O

CONCLUSION:	NOUN	O	O
There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
outcomes	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
trial	NOUN	O	O
arms.	ADJ	O	O

No	DET	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
related	VERB	O	O
to	PART	O	O
test	NOUN	O	O
beverage	ADP	O	O
ingestion	NOUN	O	O
were	VERB	O	O
observed.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION	NOUN	O	O
NUMBER:	NOUN	O	O
NCT03386149	NOUN	O	O
(clinicaltrials.gov)	NOUN	O	O
and	CCONJ	O	O
KCT0002848	NOUN	O	O
(Clinical	ADJ	O	O
Research	NOUN	O	O
Information	NOUN	O	O
Service	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Republic	ADJ	O	O
of	ADP	O	O
Korea).	NOUN	O	O

RESULTS:	NOUN	O	O
There	PRON	O	O
were	VERB	O	O
in	ADP	O	O
total	ADJ	O	O
80	NUM	O	O
reported	VERB	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
during	ADP	O	O
the	DET	O	O
follow-up;	ADP	O	O
50	NUM	O	O
in	ADP	O	O
placebo	NOUN	O	O
and	CCONJ	O	O
30	NUM	O	O
in	ADP	O	O
krill	NOUN	O	O
powder	NOUN	O	O
group.	VERB	O	O

Title:	NOUN	O	O
Exercise	NOUN	O	O
training	VERB	O	O
as	ADP	O	O
an	DET	O	O
adjunctive	ADJ	O	O
therapy	NOUN	O	O
to	PART	O	O
montelukast	NOUN	O	O
in	ADP	O	O
children	NOUN	O	O
with	ADP	O	O
mild	ADJ	O	O
asthma:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

MATERIALS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial,	NOUN	O	O
83	NUM	O	O
women	NOUN	O	O
with	ADP	O	O
poor	ADJ	O	O
endometrial	ADJ	O	O
response	NOUN	O	O
to	PART	O	O
standard	ADJ	O	O
hormone	NOUN	O	O
replacement	NOUN	O	O
therapy	NOUN	O	O
(HRT)	ADV	O	O
(endometrium	PUNCT	O	O
thickness	NOUN	O	O
<	SYM	O	O
7	NUM	O	O
mm)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
13th	ADJ	O	O
day	NOUN	O	O
of	ADP	O	O
the	DET	O	O
cycle	NOUN	O	O
in	ADP	O	O
a	DET	O	O
frozen-thawed	VERB	O	O
embryo	NOUN	O	O
transfer	NOUN	O	O
(FET)	PUNCT	O	O
were	VERB	O	O
entered	VERB	O	O
in	ADP	O	O
two	NUM	O	O
groups.	NOUN	O	O

The	DET	O	O
Taurisolo((R))	NOUN	O	O
polyphenol	NOUN	O	O
content	NOUN	O	O
was	VERB	O	O
evaluated	VERB	O	O
by	ADP	O	O
a	DET	O	O
High	ADJ	O	O
Performance	NOUN	O	O
Liquid	NOUN	O	O
Chromatography-diode-array	NOUN	O	O
detector	NOUN	O	O
(HPLC-DAD)	NOUN	O	O
method,	NOUN	O	O
and	CCONJ	O	O
RSV	NOUN	O	O
was	VERB	O	O
monitored	VERB	O	O
as	ADP	O	O
an	DET	O	O
indicative	ADJ	O	O
marker.	NOUN	O	O

Results:	NOUN	O	O
(1)Compared	PUNCT	O	O
with	ADP	O	O
the	DET	O	O
results	NOUN	O	O
at	ADP	O	O
baseline,	NOUN	O	O
the	DET	O	O
total	ADJ	O	O
scores	NOUN	O	O
of	ADP	O	O
Pittsburgh	NOUN	O	O
sleep	NOUN	O	B-outcome
quality	NOUN	O	I-outcome
index	NOUN	O	O
(PSQI)],	NOUN	O	O
Beck	NOUN	O	O
depression	NOUN	O	B-outcome
index	NOUN	O	O
(BDI)	NOUN	O	O
,	PUNCT	O	O
Beck	NOUN	O	O
anxiety	NOUN	O	B-outcome
inventory	ADJ	O	O
(BAI)	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
significantly	ADV	O	O
decreased	VERB	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
treatment:	NOUN	O	O
CBT-i	NOUN	O	O
group,	NOUN	O	O
PSQI	NOUN	O	O
(4.7+/-2.5)	NUM	O	O
vs.	CCONJ	O	O
(12.9+/-3.5);	NOUN	O	O
BDI	NOUN	O	O
(3.2+/-4.4)	NOUN	O	O
vs.	CCONJ	O	O
(9.7+/-6.4);	NOUN	O	O
BAI	NOUN	O	O
(4.2+/-5.6)	NOUN	O	O
vs.	CCONJ	O	O
(10.7+/-8.1);	PUNCT	O	O
and	CCONJ	O	O
combination	NOUN	O	O
group,	NOUN	O	O
PSQI	NOUN	O	O
(5.8+/-2.8)	NUM	O	O
vs.	CCONJ	O	O
(13.9+/-3.1);	NOUN	O	O
BDI	NOUN	O	O
(4.5+/-4.8)	PUNCT	O	O
vs.	CCONJ	O	O
(13.8+/-8.7);	PUNCT	O	O
BAI	NOUN	O	O
(4.4+/-4.0)	NOUN	O	O
vs.	CCONJ	O	O
(14.1+/-6.3)	PUNCT	O	O
(all	PUNCT	O	O
P<0.01).	NOUN	O	O
(	PUNCT	O	O

The	DET	O	O
mean	NOUN	O	O
value	NOUN	O	O
of	ADP	O	O
137	NUM	O	O
kcal/serving	VERB	O	O
is	VERB	O	O
16%	NUM	O	O
lower	ADJ	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.0001)	NUM	O	O
than	ADP	O	O
what	DET	O	O
is	VERB	O	O
typically	ADV	O	O
found	VERB	O	O
on	ADP	O	O
food	NOUN	O	O
labels.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101230586	NUM	O	O

Over	ADP	O	O
the	DET	O	O
36-month	NOUN	O	O
period,	NOUN	O	O
there	PRON	O	O
were	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
changes	NOUN	O	O
in	ADP	O	O
the	DET	O	O
location	NOUN	O	B-outcome
of	ADP	O	I-outcome
mesial	ADJ	O	I-outcome
or	CCONJ	O	Seperator
distal	ADJ	O	I-outcome
papilla	NOUN	O	I-outcome
in	ADP	O	O
any	DET	O	O
group.	VERB	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/19	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Several	ADJ	O	O
studies	NOUN	O	O
demonstrated	VERB	O	O
that	ADP	O	O
polyphenols	NOUN	O	O
are	VERB	O	O
able	ADJ	O	O
to	PART	O	O
inhibit	NOUN	O	O
the	DET	O	O
growth	NOUN	O	O
of	ADP	O	O
TMA-producing	VERB	O	O
bacterial	ADJ	O	O
strains,	NOUN	O	O
and	CCONJ	O	O
resveratrol	NOUN	O	O
(RSV)	PUNCT	O	O
reduced	VERB	O	O
TMAO	NOUN	O	O
levels	NOUN	O	O
in	ADP	O	O
mice.	NOUN	O	O

Incidence	NOUN	O	O
of	ADP	O	O
treatment-related	VERB	O	B-outcome
AEs	NOUN	O	I-outcome
with	ADP	O	O
tretinoin	NOUN	O	O
0.05%	NUM	O	O
lotion	NOUN	O	O
was	VERB	O	O
lower	ADJ	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
overall	ADJ	O	O
study	NOUN	O	O
population;	NOUN	O	O
the	DET	O	O
most	DET	O	O
frequently	ADV	O	O
were	VERB	O	O
application	NOUN	O	O
site	NOUN	O	O
pain	NOUN	O	B-outcome
(2.0%),	NOUN	O	O
dryness	ADV	O	B-outcome
(1.4%),	NOUN	O	O
and	CCONJ	O	O
erythema	NOUN	O	B-outcome
(1.2%).	PUNCT	O	O

DISCUSSION:	NOUN	O	O
The	DET	O	O
evidence	NOUN	O	O
provided	ADJ	O	O
will	VERB	O	O
inform	NOUN	O	O
program	NOUN	O	O
investment	ADJ	O	O
and	CCONJ	O	O
design,	NOUN	O	O
and	CCONJ	O	O
contribute	NOUN	O	O
to	PART	O	O
the	DET	O	O
literature	NOUN	O	O
on	ADP	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
menstrual	ADJ	O	O
health-based	VERB	O	O
interventions	NOUN	O	O
on	ADP	O	O
girls'	NOUN	O	O
agency	NOUN	O	B-outcome
,	PUNCT	O	O
safety	NOUN	O	O
and	CCONJ	O	O
life	NOUN	O	B-outcome
outcomes.	ADJ	O	O

Title:	NOUN	O	O
Single-Dose	NOUN	O	O
Tafenoquine	NOUN	O	O
to	PART	O	O
Prevent	NOUN	O	O
Relapse	NOUN	O	B-outcome
of	ADP	O	O
Plasmodium	NOUN	O	O
vivax	NOUN	O	O
Malaria.	NOUN	O	O

Title:	NOUN	O	O
The	DET	O	O
Effects	NOUN	O	O
of	ADP	O	O
Oral	ADJ	O	O
Magnesium	NOUN	O	O
Supplementation	NOUN	O	O
on	ADP	O	O
Glycemic	ADJ	O	B-outcome
Response	NOUN	O	I-outcome
among	ADP	O	O
Type	NOUN	O	O
2	NUM	O	O
Diabetes	NOUN	O	O
Patients.	NOUN	O	O

Title:	NOUN	O	O
Prevalence	NOUN	O	O
and	CCONJ	O	O
correlates	NOUN	O	O
of	ADP	O	O
psychological	ADJ	O	O
distress	NOUN	O	O
among	ADP	O	O
13-14	NUM	O	O
year	NOUN	O	O
old	ADJ	O	O
adolescent	NOUN	O	O
girls	NOUN	O	O
in	ADP	O	O
North	NOUN	O	O
Karnataka,	NOUN	O	O
South	NOUN	O	O
India:	NOUN	O	O
a	DET	O	O
cross-sectional	ADJ	O	O
study.	NOUN	O	O

Final	ADJ	O	O
irrigation	NOUN	O	O
was	VERB	O	O
done	NOUN	O	O
with	ADP	O	O
cold	NOUN	O	O
(4	NOUN	O	O
degrees	NOUN	O	O
C,	NOUN	O	O
2.5	NUM	O	O
degrees	NOUN	O	O
C,	NOUN	O	O
and	CCONJ	O	O
room	NOUN	O	O
temperature)	NOUN	O	O
17%	NUM	O	O
EDTA	NOUN	O	O
and	CCONJ	O	O
10	NUM	O	O
mL	NOUN	O	O
of	ADP	O	O
cold	NOUN	O	O
saline	NOUN	O	O
solution.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
study	NOUN	O	O
on	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
low	ADJ	O	O
back	ADP	O	O
pain	NOUN	O	O
and	CCONJ	O	O
Modic	NOUN	O	O
changes	NOUN	O	O
at	ADP	O	O
the	DET	O	O
level	NOUN	O	O
of	ADP	O	O
a	DET	O	O
previous	ADJ	O	O
disc	NOUN	O	O
herniation,	NOUN	O	O
three	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
treatment	NOUN	O	O
with	ADP	O	O
amoxicillin	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
provide	VERB	O	O
a	DET	O	O
clinically	ADV	O	O
important	ADJ	O	O
benefit	NUM	O	O
compared	VERB	O	O
with	ADP	O	O
placebo.	NOUN	O	O

Title:	NOUN	O	O
Can	VERB	O	O
autologous	ADJ	O	O
platelet	NOUN	O	O
rich	ADJ	O	O
plasma	NOUN	O	O
expand	NOUN	O	O
endometrial	ADJ	O	B-outcome
thickness	NOUN	O	I-outcome
and	CCONJ	O	O
improve	VERB	O	O
pregnancy	NOUN	O	B-outcome
rate	NOUN	O	O
during	ADP	O	O
frozen-thawed	VERB	O	O
embryo	NOUN	O	O
transfer	NOUN	O	O
cycle?	VERB	O	O

Major	ADP	O	B-outcome
adverse	ADJ	O	I-outcome
cardiac	ADJ	O	I-outcome
events	NOUN	O	I-outcome
(	PUNCT	O	O
cardiac	ADJ	O	B-outcome
death	NOUN	O	I-outcome
,	PUNCT	O	O
nonfatal	ADJ	O	B-outcome
MI	NOUN	O	I-outcome
,	PUNCT	O	O
unplanned	VERB	O	B-outcome
hospitalization	NOUN	O	I-outcome
for	ADP	O	Seperator
heart	NOUN	O	I-outcome
failure	NOUN	O	I-outcome
)	PUNCT	O	O
occurred	VERB	O	O
in	ADP	O	O
15	NUM	O	O
patients	NOUN	O	O
(10.1%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group,	NOUN	O	O
18	NUM	O	O
(12.9%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
10-mg	NOUN	O	O
alteplase	NOUN	O	O
group,	NOUN	O	O
and	CCONJ	O	O
12	NUM	O	O
(8.2%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
20-mg	NOUN	O	O
alteplase	NOUN	O	O
group.	VERB	O	O

Title:	NOUN	O	O
beta-Eudesmol,	NOUN	O	O
an	DET	O	O
Oxygenized	VERB	O	O
Sesquiterpene,	NOUN	O	O
Reduces	NOUN	O	O
the	DET	O	O
Increase	NOUN	O	O
in	ADP	O	O
Saliva	ADJ	O	O
3-Methoxy-4-Hydroxyphenylglycol	NOUN	O	B-outcome
After	ADP	O	O
the	DET	O	O
"Trier	ADP	O	O
Social	ADJ	O	O
Stress	NOUN	O	O
Test"	NOUN	O	O
in	ADP	O	O
Healthy	NOUN	O	O
Humans:	NOUN	O	O
A	DET	O	O
Randomized,	NOUN	O	O
Double-Blind,	NOUN	O	O
Placebo-Controlled	VERB	O	O
Cross-Over	NOUN	O	O
Study.	NOUN	O	O

The	DET	O	O
intervention	NOUN	O	O
was	VERB	O	O
scheduled	VERB	O	O
to	PART	O	O
occur	VERB	O	O
early	ADJ	O	O
during	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
PCI	NOUN	O	O
procedure,	NOUN	O	O
after	ADP	O	O
reperfusion	NOUN	O	O
of	ADP	O	O
the	DET	O	O
infarct-related	VERB	O	O
coronary	ADJ	O	O
artery	NOUN	O	O
and	CCONJ	O	O
before	ADP	O	O
stent	NOUN	O	O
implant.	ADJ	O	O

Title:	NOUN	O	O
Oral	ADJ	O	O
versus	CCONJ	O	O
Intravenous	ADJ	O	O
Antibiotics	NOUN	O	O
for	ADP	O	O
Bone	NOUN	O	O
and	CCONJ	O	O
Joint	NOUN	O	O
Infection.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
MRI-guided	VERB	O	O
group,	NOUN	O	O
the	DET	O	O
treatment	NOUN	O	O
goal	NOUN	O	O
was	VERB	O	O
absence	NOUN	O	B-outcome
of	ADP	O	I-outcome
MRI	NOUN	O	I-outcome
bone	NOUN	O	I-outcome
marrow	NOUN	O	I-outcome
edema	NOUN	O	I-outcome
combined	VERB	O	I-outcome
with	ADP	O	Seperator
clinical	ADJ	O	I-outcome
remission	NOUN	O	I-outcome
,	PUNCT	O	O
defined	VERB	O	O
as	ADP	O	O
DAS28-CRP	NOUN	O	O
of	ADP	O	O
3.2	NUM	O	O
or	CCONJ	O	O
less	ADV	O	O
and	CCONJ	O	O
no	DET	O	O
swollen	NOUN	O	O
joints.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/10/16	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

In	ADP	O	O
experimental	ADJ	O	O
group	NOUN	O	O
one,	NOUN	O	O
a	DET	O	O
15-minute	NOUN	O	O
trial	NOUN	O	O
of	ADP	O	O
pelvis	NOUN	O	O
reposition	NOUN	O	O
exercise	NOUN	O	O
was	VERB	O	O
carried	VERB	O	O
out.	NOUN	O	O
[	PUNCT	O	O

Retrospectively	ADV	O	O
registered	VERB	O	O
12	NUM	O	O
March	NOUN	O	O
2018.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Interventions:	NOUN	O	O
Participants	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
an	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
that	ADP	O	O
encouraged	VERB	O	O
an	DET	O	O
energy-reduced	VERB	O	O
Mediterranean	NOUN	O	O
diet,	ADV	O	O
promoted	VERB	O	O
physical	ADJ	O	O
activity,	ADP	O	O
and	CCONJ	O	O
provided	ADJ	O	O
behavioral	ADJ	O	O
support	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
3406)	NOUN	O	O
or	CCONJ	O	O
to	PART	O	O
a	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
that	ADP	O	O
encouraged	VERB	O	O
an	DET	O	O
energy-unrestricted	VERB	O	O
Mediterranean	NOUN	O	O
diet	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
3468).	NOUN	O	O

Title:	NOUN	O	O
Denosumab	NOUN	O	O
effects	NOUN	O	O
on	ADP	O	O
serum	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
the	DET	O	O
bone	NOUN	O	O
morphogenetic	ADJ	O	O
proteins	NOUN	O	O
antagonist	NOUN	O	O
noggin	NOUN	O	B-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
transfusion-dependent	ADJ	O	O
thalassemia	ADP	O	O
and	CCONJ	O	O
osteoporosis.	NOUN	O	O

Conclusion:	NOUN	O	O
Compared	VERB	O	O
with	ADP	O	O
conventional	ADJ	O	O
chemotherapy,	NOUN	O	O
induction	NOUN	O	O
chrono-chemotherapy	NOUN	O	O
seemed	VERB	O	O
to	PART	O	O
reduce	VERB	O	O
chemotherapy-related	VERB	O	O
toxicities	NOUN	O	B-outcome
and	CCONJ	O	O
improve	VERB	O	O
average	NOUN	O	O
local	ADJ	O	O
relapse	NOUN	O	O
time	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
treated	VERB	O	O
with	ADP	O	O
combined	VERB	O	O
chemoradiotherapy	NOUN	O	O
for	ADP	O	O
NPC.	NOUN	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
the	DET	O	O
present	ADJ	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
preoperative	ADJ	O	O
celecoxib	NOUN	O	O
administration	NOUN	O	O
in	ADP	O	O
alleviating	VERB	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
in	ADP	O	O
knee	NOUN	O	O
osteoarthritis	NOUN	O	O
(OA)	NOUN	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
total	ADJ	O	O
knee	NOUN	O	O
arthroplasty	NOUN	O	O
(TKA).A	NOUN	O	O
total	ADJ	O	O
of	ADP	O	O
226	NUM	O	O
knee	NOUN	O	O
OA	NOUN	O	O
patients	NOUN	O	O
underwent	VERB	O	O
TKA	NOUN	O	O
were	VERB	O	O
consecutively	ADV	O	O
recruited	VERB	O	O
and	CCONJ	O	O
randomized	VERB	O	O
into	ADP	O	O
preoperative	ADJ	O	O
analgesia	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
postoperative	ADJ	O	O
analgesia	NOUN	O	O
group	NOUN	O	O
as	ADP	O	O
1:1	ADJ	O	O
ratio.	NOUN	O	O

Moreover,	NOUN	O	O
results	NOUN	O	O
prove	NOUN	O	O
that	ADP	O	O
participants	NOUN	O	O
positively	ADV	O	O
respond	VERB	O	B-outcome
to	PART	O	O
health-related	VERB	O	O
information,	NOUN	O	O
whereas	ADP	O	O
information	NOUN	O	O
on	ADP	O	O
bitterness-taste	NOUN	O	O
generates	NOUN	O	O
lower	ADJ	O	O
preferences	NOUN	O	B-outcome
.	PUNCT	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Title:	NOUN	O	O
Music-instruction	NOUN	O	O
intervention	NOUN	O	O
for	ADP	O	O
treatment	NOUN	O	O
of	ADP	O	O
post-traumatic	ADJ	O	O
stress	NOUN	O	O
disorder:	NOUN	O	O
a	DET	O	O
randomized	VERB	O	O
pilot	NOUN	O	O
study.	NOUN	O	O

At	ADP	O	O
4-weeks	NOUN	O	O
post-baseline	NOUN	O	O
there	PRON	O	O
were	VERB	O	O
significant	ADJ	O	O
increases	NOUN	O	O
in	ADP	O	O
identified	VERB	O	B-outcome
regulation	NOUN	O	I-outcome
,	PUNCT	O	O
integrated	VERB	O	B-outcome
regulation	NOUN	O	I-outcome
,	PUNCT	O	O
intrinsic	ADJ	O	B-outcome
motivation	NOUN	O	I-outcome
,	PUNCT	O	O
social	ADJ	O	B-outcome
norms	NOUN	O	I-outcome
and	CCONJ	O	O
intentions	NOUN	O	B-outcome
in	ADP	O	O
intervention	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
control	NOUN	O	O
participants.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8205248	NUM	O	O

Title:	NOUN	O	O
Decolonization	NOUN	O	O
to	PART	O	O
Reduce	NOUN	O	O
Postdischarge	NOUN	O	O
Infection	NOUN	O	B-outcome
Risk	NOUN	O	O
among	ADP	O	O
MRSA	NOUN	O	O
Carriers.	NOUN	O	O

We	PRON	O	O
compared	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
a	DET	O	O
modified	VERB	O	O
FOLFIRINOX	NOUN	O	O
regimen	NOUN	O	O
with	ADP	O	O
gemcitabine	NOUN	O	O
as	ADP	O	O
adjuvant	NOUN	O	O
therapy	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
resected	VERB	O	O
pancreatic	ADJ	O	O
cancer.	NOUN	O	O

Journal-Name:Complementary	ADJ	O	O
therapies	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
practice	NOUN	O	O

Our	ADJ	O	O
results	NOUN	O	O
suggest	VERB	O	O
that	ADP	O	O
a	DET	O	O
HIIT	NOUN	O	O
training	VERB	O	O
program	NOUN	O	O
with	ADP	O	O
TRX	NOUN	O	O
have	VERB	O	O
benefits	NOUN	O	O
in	ADP	O	O
BMI	NOUN	O	B-outcome
,	PUNCT	O	O
handgrip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
,	PUNCT	O	O
gait	NOUN	O	B-outcome
speed	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
in	ADP	O	O
older	ADJ	O	O
adults.	NOUN	O	O

Although	ADP	O	O
none	NUM	O	O
of	ADP	O	O
our	ADJ	O	O
patient	NOUN	O	O
had	VERB	O	O
significant	ADJ	O	O
elevation	NOUN	O	O
of	ADP	O	O
CPK	NOUN	O	B-outcome
.	PUNCT	O	O
CONCLUSION:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
concluded	VERB	O	O
that	ADP	O	O
both	CCONJ	O	O
doses	NOUN	O	O
of	ADP	O	O
atorvastatin	NOUN	O	O
(40	NOUN	O	O
&	CCONJ	O	O
80mg)	NUM	O	O
are	VERB	O	O
equally	ADV	O	O
efficacious	ADJ	O	O
in	ADP	O	O
improving	VERB	O	O
dyslipidemia	NOUN	O	B-outcome
but	CCONJ	O	O
higher	ADJ	O	O
dose	NOUN	O	O
leads	NOUN	O	O
to	PART	O	O
more	ADV	O	O
incidence	NOUN	O	O
of	ADP	O	O
myalgia	NOUN	O	B-outcome
.	PUNCT	O	O

Hispanic	ADJ	O	O
subjects	NOUN	O	O
(aged	PUNCT	O	O
11	NUM	O	O
to	PART	O	O
50	NUM	O	O
years,	NOUN	O	O
N=766)	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
(1:1)	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
tretinoin	NOUN	O	O
0.05%	NUM	O	O
lotion	NOUN	O	O
or	CCONJ	O	O
vehicle,	NOUN	O	O
once-daily	ADV	O	O
for	ADP	O	O
12	NUM	O	O
weeks.	NOUN	O	O

This	DET	O	O
study	NOUN	O	O
was	VERB	O	O
an	DET	O	O
eight-week,	NOUN	O	O
double-blind,	NOUN	O	O
randomized,	NOUN	O	O
parallel-arm,	NOUN	O	O
and	CCONJ	O	O
placebo-controlled	VERB	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/06	ADJ	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

In	ADP	O	O
part	NOUN	O	O
C,	NOUN	O	O
patients	NOUN	O	O
who	ADP	O	O
had	VERB	O	O
recurrent	ADP	O	O
attacks	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
receive	VERB	O	O
injections	NOUN	O	O
of	ADP	O	O
one	NUM	O	O
of	ADP	O	O
two	NUM	O	O
doses	NOUN	O	O
of	ADP	O	O
givosiran	NOUN	O	O
(2.5	PUNCT	O	O
or	CCONJ	O	O
5.0	NUM	O	O
mg	NOUN	O	O
per	ADP	O	O
kilogram)	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
once	ADP	O	O
monthly	ADV	O	O
(total	ADJ	O	O
of	ADP	O	O
four	NUM	O	O
injections)	NOUN	O	O
or	CCONJ	O	O
once	ADP	O	O
quarterly	ADV	O	O
(total	ADJ	O	O
of	ADP	O	O
two	NUM	O	O
injections)	NOUN	O	O
during	ADP	O	O
a	DET	O	O
12-week	NOUN	O	O
period,	NOUN	O	O
starting	VERB	O	O
on	ADP	O	O
day	NOUN	O	O
0.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Blood	NOUN	O	B-outcome
lactate	VERB	O	I-outcome
([La-]b	PUNCT	O	O
mmol.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
gastroenterology	NOUN	O	O

Achaogen,	VERB	O	O
South	NOUN	O	O
San	NOUN	O	O
Francisco,	ADV	O	O
CA.	NOUN	O	O

The	DET	O	O
goal	NOUN	O	O
of	ADP	O	O
the	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
results	NOUN	O	O
of	ADP	O	O
medial	ADJ	O	O
patellofemoral	ADJ	O	O
ligament	NOUN	O	O
reconstruction	NOUN	O	O
in	ADP	O	O
children.	NOUN	O	O

MATERIALS	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
This	DET	O	O
is	VERB	O	O
a	DET	O	O
double-blind,	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
multicenter	NOUN	O	O
prospective	ADJ	O	O
trial.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

METHODS:	NOUN	O	O
Prospective	ADJ	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trial	NOUN	O	O
including	VERB	O	O
21	NUM	O	O
mothers	NOUN	O	O
of	ADP	O	O
preterms	NOUN	O	O
admitted	VERB	O	O
to	PART	O	O
the	DET	O	O
Neonatal	ADJ	O	O
Intensive	ADJ	O	O
Care	NOUN	O	O
Unit	NOUN	O	O
of	ADP	O	O
a	DET	O	O
tertiary	ADJ	O	O
hospital,	ADJ	O	O
recruited	VERB	O	O
from	ADP	O	O
August	NOUN	O	O
2015	NUM	O	O
to	PART	O	O
September	NOUN	O	O
2017,	NUM	O	O
and	CCONJ	O	O
divided	VERB	O	O
into	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
(CG;	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
11)	NOUN	O	O
and	CCONJ	O	O
music	ADJ	O	O
therapy	NOUN	O	O
group	NOUN	O	O
(MTG;	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
10).	NOUN	O	O

Purpose:	NOUN	O	O
The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
toxicities	NOUN	O	B-outcome
of	ADP	O	O
induction	NOUN	O	O
chronomodulated	VERB	O	O
chemotherapy	NOUN	O	O
in	ADP	O	O
comparison	NOUN	O	O
with	ADP	O	O
conventional	ADJ	O	O
induction	NOUN	O	O
chemotherapy	NOUN	O	O
for	ADP	O	O
nasopharyngeal	ADJ	O	O
carcinoma	NOUN	O	O
(NPC).	NOUN	O	O

RESULTS:	NOUN	O	O
After	ADP	O	O
treatment,	NOUN	O	O
patients	NOUN	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
achieved	NOUN	O	O
promising	VERB	O	O
effectiveness.	NOUN	O	O

Daily	ADJ	O	O
drainage	NOUN	O	B-outcome
and	CCONJ	O	O
all	DET	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
after	ADP	O	O
operation	NOUN	O	O
were	VERB	O	O
also	ADV	O	O
compared.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
measurement	NOUN	O	O
was	VERB	O	O
the	DET	O	O
headache	NOUN	O	B-outcome
intensity	NOUN	O	I-outcome
.	PUNCT	O	O
Secondary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
frequency	NOUN	O	O
and	CCONJ	O	O
duration	NOUN	O	B-outcome
of	ADP	O	I-outcome
headache	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
,	PUNCT	O	O
assessed	VERB	O	O
by	ADP	O	O
the	DET	O	O
Short	NOUN	O	O
Form-36.	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
Pilot	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O
of	ADP	O	O
Transcutaneous	ADJ	O	O
Electrical	ADJ	O	O
Nerve	NOUN	O	O
Stimulation	NOUN	O	O
for	ADP	O	O
Patients	NOUN	O	O
With	ADP	O	O
Acute	ADJ	O	O
Tinnitus.	NOUN	O	O

The	DET	O	O
study	NOUN	O	O
involves	NOUN	O	O
140	NUM	O	O
public	ADJ	O	O
primary	ADJ	O	O
schools	NOUN	O	O
in	ADP	O	O
three	NUM	O	O
rural	ADJ	O	O
sub-counties	NOUN	O	O
(Magarini,	NOUN	O	O
Kaloleni	NOUN	O	O
and	CCONJ	O	O
Ganze)	NOUN	O	O
of	ADP	O	O
Kilifi	ADV	O	O
County	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Coastal	ADJ	O	O
area	NOUN	O	O
of	ADP	O	O
Kenya.	NOUN	O	O

Journal-Name:Indian	NOUN	O	O
heart	NOUN	O	O
journal	ADJ	O	O

DISCUSSION:	NOUN	O	O
To	PART	O	O
our	ADJ	O	O
knowledge,	NOUN	O	O
APPAC	NOUN	O	O
II	NUM	O	O
trial	NOUN	O	O
is	VERB	O	O
the	DET	O	O
first	ADV	O	O
randomised	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
comparing	VERB	O	O
per	ADP	O	O
oral	ADJ	O	O
antibiotic	ADJ	O	O
monotherapy	NOUN	O	O
with	ADP	O	O
intravenous	ADJ	O	O
antibiotic	ADJ	O	O
therapy	NOUN	O	O
continued	NOUN	O	O
by	ADP	O	O
per	ADP	O	O
oral	ADJ	O	O
antibiotics	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
uncomplicated	VERB	O	O
acute	ADJ	O	O
appendicitis.	NOUN	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
results	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
revealed	VERB	O	O
that	ADP	O	O
oral	ADJ	O	O
Mg	NOUN	O	O
supplementation	NOUN	O	O
reduces	NOUN	O	O
insulin	NOUN	O	B-outcome
resistance	NOUN	O	I-outcome
and	CCONJ	O	O
improves	NOUN	O	O
the	DET	O	O
glycemic	ADJ	O	B-outcome
control	NOUN	O	I-outcome
indicators	NOUN	O	O
among	ADP	O	O
T2D	NOUN	O	O
patients.	NOUN	O	O

METHODS:	NOUN	O	O
The	DET	O	O
BabyGel	NOUN	O	O
pilot	NOUN	O	O
was	VERB	O	O
a	DET	O	O
cluster	NOUN	O	O
randomised	VERB	O	O
trial	NOUN	O	O
that	ADP	O	O
assessed	VERB	O	O
the	DET	O	O
post-partum	NOUN	O	O
use	NOUN	O	O
of	ADP	O	O
alcohol-based	VERB	O	O
hand	NOUN	O	O
rub	NOUN	O	O
(ABHR)	NUM	O	O
to	PART	O	O
prevent	NOUN	O	O
neonatal	ADJ	O	B-outcome
infections	NOUN	O	I-outcome
in	ADP	O	O
Mbale,	ADV	O	O
Uganda.	NOUN	O	O

Interventions:	NOUN	O	O
Hospitals	NOUN	O	O
randomized	VERB	O	O
to	PART	O	O
the	DET	O	O
intervention	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
131	NUM	O	O
[6436	NOUN	O	O
patients])	NUM	O	O
provided	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
co-payment	NOUN	O	O
vouchers	NOUN	O	O
for	ADP	O	O
clopidogrel	NOUN	O	O
or	CCONJ	O	O
ticagrelor	ADV	O	O
for	ADP	O	O
1	NUM	O	O
year	NOUN	O	O
(median	PUNCT	O	O
voucher	ADV	O	O
value	NOUN	O	O
for	ADP	O	O
a	DET	O	O
30-day	NOUN	O	O
supply,	NOUN	O	O
$137	NOUN	O	O
[25th-75th	SYM	O	O
percentile,	NOUN	O	O
$20-$339]).	NOUN	O	O

In	ADP	O	O
the	DET	O	O
low-dose	NOUN	O	O
remifentanil	NOUN	O	O
(LR)	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
46),	NOUN	O	O
remifentanil	NOUN	O	O
was	VERB	O	O
infused	VERB	O	O
at	ADP	O	O
a	DET	O	O
rate	NOUN	O	O
of	ADP	O	O
0.05	NUM	O	O
mug/kg/min.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
the	DET	O	O
bracket	NOUN	O	O
adhesives	NOUN	O	O
in	ADP	O	O
the	DET	O	O
numbers	NOUN	O	O
with	ADP	O	O
at	ADP	O	O
least	ADV	O	O
1	NUM	O	O
new	ADJ	O	O
demineralized	VERB	O	B-outcome
lesion	NOUN	O	I-outcome
(risk	NOUN	O	O
ratio,1.25;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval,	ADP	O	O
0.74-2.13;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.403)	NUM	O	O
or	CCONJ	O	O
first-time	NOUN	O	O
bracket	NOUN	O	O
failure	NOUN	O	O
(risk	NOUN	O	O
ratio,0.88;	ADV	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval,	ADP	O	O
0.67-1.16;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.35).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Journal-Name:Brazilian	ADP	O	O
oral	ADJ	O	O
research	NOUN	O	O

Title:	NOUN	O	O
Efficacy	NOUN	O	O
of	ADP	O	O
different	ADJ	O	O
interaction	NOUN	O	O
devices	NOUN	O	O
using	VERB	O	O
non-immersive	ADJ	O	O
virtual	ADJ	O	O
tasks	NOUN	O	O
in	ADP	O	O
individuals	NOUN	O	O
with	ADP	O	O
Amyotrophic	ADJ	O	O
Lateral	ADJ	O	O
Sclerosis:	NOUN	O	O
a	DET	O	O
cross-sectional	ADJ	O	O
randomized	VERB	O	O
trial.	NOUN	O	O

Pain	NOUN	O	B-outcome
,	PUNCT	O	O
global	ADJ	O	B-outcome
quality	NOUN	O	I-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
(GQoL)	NOUN	O	I-outcome
and	CCONJ	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
specific	ADJ	O	O
for	ADP	O	O
CD	NOUN	O	O
(QoLCD)	NOUN	O	O
were	VERB	O	O
assessed	VERB	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
the	DET	O	O
intervention.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
of	ADP	O	O
neuromuscular	ADJ	O	O
electrical	ADJ	O	O
stimulation	NOUN	O	O
for	ADP	O	O
chronic	ADJ	O	O
urinary	ADJ	O	O
retention	NOUN	O	O
following	VERB	O	O
traumatic	ADJ	O	O
brain	NOUN	O	O
injury.	NOUN	O	O

Background	NOUN	O	O
&	CCONJ	O	O
objectives:	NOUN	O	O
:	PUNCT	O	O
Three	NUM	O	O
doses	NOUN	O	O
of	ADP	O	O
intermittent	ADJ	O	O
preventive	ADJ	O	O
treatment	NOUN	O	O
with	ADP	O	O
sulphadoxine-pyrimethamine	NOUN	O	O
(IPTp-SP)	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
adopted	VERB	O	O
as	ADP	O	O
the	DET	O	O
new	ADJ	O	O
recommendation	NOUN	O	O
for	ADP	O	O
prevention	NOUN	O	O
of	ADP	O	O
malaria	NOUN	O	B-outcome
in	ADP	O	O
pregnancy.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/20	ADJ	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Journal-Name:JAMA	NOUN	O	O

BACKGROUND:	NOUN	O	O
Delayed-release	NOUN	O	O
dimethyl	NOUN	O	O
fumarate	NOUN	O	O
(DMF)	PUNCT	O	O
has	VERB	O	O
demonstrated	VERB	O	O
efficacy	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
favorable	ADJ	O	O
benefit-risk	NOUN	O	O
profile	NOUN	O	O
in	ADP	O	O
phase	NOUN	O	O
2	NUM	O	O
and	CCONJ	O	O
3	NUM	O	O
studies	NOUN	O	O
that	ADP	O	O
enrolled	VERB	O	O
predominantly	ADV	O	O
white	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
relapsing-remitting	VERB	O	O
multiple	ADJ	O	O
sclerosis	NOUN	O	O
(RRMS).	NOUN	O	O

Key	NOUN	O	O
exclusion	NOUN	O	O
criteria	NOUN	O	O
included	VERB	O	O
diagnosis	NOUN	O	O
of	ADP	O	O
neuromyelitis	NOUN	O	O
optica	ADV	O	O
spectrum	NOUN	O	O
disorder.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
adverse	ADJ	O	B-outcome
effects	NOUN	O	I-outcome
.	PUNCT	O	O
CONCLUSIONS:	NOUN	O	O
There	PRON	O	O
is	VERB	O	O
no	DET	O	O
evidence	NOUN	O	O
that	ADP	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
resin	NOUN	O	O
modified	VERB	O	O
glass	NOUN	O	O
ionomer	NOUN	O	O
cement	NOUN	O	O
over	ADP	O	O
light-cured	VERB	O	O
composite	NOUN	O	O
for	ADP	O	O
bonding	VERB	O	O
brackets	NOUN	O	O
reduces	NOUN	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
new	ADJ	O	O
demineralized	VERB	O	B-outcome
lesions	NOUN	O	I-outcome
or	CCONJ	O	O
bond	NOUN	O	B-outcome
failures	NOUN	O	I-outcome
.	PUNCT	O	O
There	PRON	O	O
might	VERB	O	O
be	VERB	O	O
other	ADJ	O	O
reasons	NOUN	O	O
for	ADP	O	O
using	VERB	O	O
resin	NOUN	O	O
modified	VERB	O	O
glass	NOUN	O	O
ionomer	NOUN	O	O
cement.	NOUN	O	O

The	DET	O	O
median	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
morphine	NOUN	O	B-outcome
consumption	NOUN	O	I-outcome
between	ADP	O	O
the	DET	O	O
PCM	NOUN	O	O
+	SYM	O	O
IBU	NOUN	O	O
group	NOUN	O	O
vs	CCONJ	O	O
PCM	NOUN	O	O
alone	ADJ	O	O
was	VERB	O	O
16	NUM	O	O
mg	NOUN	O	O
(99.6%	PUNCT	O	O
CI,	NOUN	O	O
6.5	NUM	O	O
to	PART	O	O
24;	NUM	O	O
P	NOUN	O	O
<	SYM	O	O
.001);	NOUN	O	O
for	ADP	O	O
the	DET	O	O
PCM-alone	NOUN	O	O
group	NOUN	O	O
vs	CCONJ	O	O
HS-PCM	NOUN	O	O
+	SYM	O	O
IBU,	NOUN	O	O
8	NUM	O	O
mg	NOUN	O	O
(99.6%	PUNCT	O	O
CI,	NOUN	O	O
-1	NUM	O	O
to	PART	O	O
14;	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
.001);	NOUN	O	O
and	CCONJ	O	O
for	ADP	O	O
the	DET	O	O
PCM	NOUN	O	O
+	SYM	O	O
IBU	NOUN	O	O
group	NOUN	O	O
vs	CCONJ	O	O
IBU	NOUN	O	O
alone,	NOUN	O	O
6	NUM	O	O
mg	NOUN	O	O
(99.6%	PUNCT	O	O
CI,	NOUN	O	O
-2	NUM	O	O
to	PART	O	O
16;	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
.002).	PUNCT	O	O

BACKGROUND:	NOUN	O	O
E-cigarettes	NOUN	O	O
are	VERB	O	O
commonly	ADV	O	O
used	VERB	O	O
in	ADP	O	O
attempts	NOUN	O	O
to	PART	O	O
stop	NOUN	O	O
smoking,	NOUN	O	O
but	CCONJ	O	O
evidence	NOUN	O	O
is	VERB	O	O
limited	VERB	O	O
regarding	VERB	O	O
their	ADJ	O	O
effectiveness	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
that	ADP	O	O
of	ADP	O	O
nicotine	NOUN	O	O
products	NOUN	O	O
approved	VERB	O	O
as	ADP	O	O
smoking-cessation	NOUN	O	O
treatments.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968567	NUM	O	O

The	DET	O	O
clinical	ADJ	O	O
and	CCONJ	O	O
radiographic	ADJ	O	O
twelve-month	NOUN	O	O
outcomes	NOUN	O	O
indicated	VERB	O	O
successful	ADJ	O	B-outcome
treatment	NOUN	O	I-outcome
,	PUNCT	O	O
independently	ADV	O	O
of	ADP	O	O
the	DET	O	O
root	NOUN	O	O
filling	VERB	O	O
material	ADJ	O	O
used.	NOUN	O	O

No	DET	O	O
protocol-related	VERB	O	O
serious	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
reactions	NOUN	O	I-outcome
were	VERB	O	O
confirmed.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
HP	NOUN	O	O
had	VERB	O	O
superior	ADJ	O	O
rates	NOUN	O	O
of	ADP	O	O
hemostasis	NOUN	O	B-outcome
,	PUNCT	O	O
shorter	ADJ	O	O
preparation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
a	DET	O	O
similar	ADJ	O	O
safety	NOUN	O	O
profile	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
G	NOUN	O	O
+	SYM	O	O
T	NOUN	O	O
in	ADP	O	O
this	DET	O	O
prospective,	NOUN	O	O
randomized	VERB	O	O
trial	NOUN	O	O
using	VERB	O	O
quantitative	ADJ	O	O
bleeding	VERB	O	B-outcome
severity	NOUN	O	I-outcome
criteria.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9113221	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

The	DET	O	O
measures	NOUN	O	O
represent	NOUN	O	O
the	DET	O	O
exposure	NOUN	O	O
in	ADP	O	O
a	DET	O	O
normal	ADJ	O	O
workload	ADP	O	O
schedule	NOUN	O	O
of	ADP	O	O
ninety	NOUN	O	O
randomly	ADV	O	O
selected	VERB	O	O
workers	NOUN	O	O
over	ADP	O	O
a	DET	O	O
3-month	NOUN	O	O
period,	NOUN	O	O
extrapolated	VERB	O	O
to	PART	O	O
1	NUM	O	O
year.	NOUN	O	O

Under	ADP	O	O
PCV	NOUN	O	O
mode,	NOUN	O	O
with	ADP	O	O
the	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow,	NOUN	O	O
inspiratory	ADJ	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
monitored	VERB	O	O
by	ADP	O	O
ventilator	NOUN	O	O
in	ADP	O	O
different	ADJ	O	O
preset	NOUN	O	O
suction	NOUN	O	O
pressure	NOUN	O	O
groups	NOUN	O	O
was	VERB	O	O
decreased	VERB	O	O
gradually,	NOUN	O	O
and	CCONJ	O	O
exhaled	VERB	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
was	VERB	O	O
increased	VERB	O	O
gradually,	NOUN	O	O
but	CCONJ	O	O
peak	NOUN	O	B-outcome
airway	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
monitored	VERB	O	O
by	ADP	O	O
ventilator	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
changed	VERB	O	O
significantly.	CCONJ	O	O

Improvement	NOUN	O	O
in	ADP	O	O
body	NOUN	O	B-outcome
composition	NOUN	O	I-outcome
was	VERB	O	O
achieved	NOUN	O	O
by	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
13)	DET	O	O
with	ADP	O	O
a	DET	O	O
median	ADJ	O	O
decrease	NOUN	O	O
of	ADP	O	O
2.1%	NOUN	O	O
body	NOUN	O	O
fat	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
a	DET	O	O
non-exercising	VERB	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
7)	NOUN	O	O
(0.1%	NOUN	O	O
increase;	NOUN	O	O
p	NOUN	O	O
=	SYM	O	O
0.022).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
multicentre,	NOUN	O	O
randomised,	NOUN	O	O
double-blind,	NOUN	O	O
placebo-controlled,	NOUN	O	O
parallel-group,	NOUN	O	O
phase	NOUN	O	O
2a	NOUN	O	O
study,	NOUN	O	O
we	PRON	O	O
recruited	VERB	O	O
adults	NOUN	O	O
(aged	PUNCT	O	O
21-75	NUM	O	O
years)	NOUN	O	O
with	ADP	O	O
a	DET	O	O
body-mass	NOUN	O	O
index	NOUN	O	O
of	ADP	O	O
at	ADP	O	O
least	ADV	O	O
25	NUM	O	O
kg/m(2),	NOUN	O	O
biopsy-confirmed	VERB	O	O
non-alcoholic	ADJ	O	O
steatohepatitis	NOUN	O	O
(fibrosis	PUNCT	O	O
stage	NOUN	O	O
1-3),	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
hepatic	ADJ	O	O
fat	NOUN	O	O
fraction	NOUN	O	O
of	ADP	O	O
at	ADP	O	O
least	ADV	O	O
10%	ADP	O	O
when	ADP	O	O
assessed	VERB	O	O
by	ADP	O	O
magnetic	ADJ	O	O
resonance	NOUN	O	O
imaging-proton	NOUN	O	O
density	NOUN	O	O
fat	NOUN	O	O
fraction.	NUM	O	O

RESULTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
1773	NUM	O	O
adult	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
episodic	NOUN	O	O
migraine	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
444	NUM	O	O
for	ADP	O	O
galcanezumab	NOUN	O	O
120	NUM	O	O
mg;	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
435	NUM	O	O
for	ADP	O	O
galcanezumab	NOUN	O	O
240	NUM	O	O
mg;	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
894	NUM	O	O
for	ADP	O	O
placebo	NOUN	O	O
for	ADP	O	O
2	NUM	O	O
studies	NOUN	O	O
pooled)	NOUN	O	O
and	CCONJ	O	O
1113	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
migraine	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
278	NUM	O	O
for	ADP	O	O
galcanezumab	NOUN	O	O
120	NUM	O	O
mg;	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
277	NUM	O	O
for	ADP	O	O
galcanezumab	NOUN	O	O
240	NUM	O	O
mg;	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
558	NUM	O	O
for	ADP	O	O
placebo)	NOUN	O	O
were	VERB	O	O
evaluated.	NOUN	O	O

The	DET	O	O
G1	NOUN	O	O
presented	VERB	O	O
higher	ADJ	O	O
values	NOUN	O	O
of	ADP	O	O
CRP	NOUN	O	B-outcome
in	ADP	O	O
relation	NOUN	O	O
to	PART	O	O
the	DET	O	O
G2	NOUN	O	O
significantly	ADV	O	O
(p	PUNCT	O	O
?	PUNCT	O	O

The	DET	O	O
objective	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
immediate	ADJ	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
2	NUM	O	O
counterforce	NOUN	O	O
orthoses	NOUN	O	O
in	ADP	O	O
improving	VERB	O	O
the	DET	O	O
sensorimotor	NOUN	O	B-outcome
abilities	NOUN	O	O
of	ADP	O	O
the	DET	O	O
hand	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
lateral	ADJ	O	O
elbow	NOUN	O	O
tendinopathy.	NOUN	O	O

Captured	PUNCT	O	O
drug	NOUN	O	O
was	VERB	O	O
quantified	VERB	O	O
using	VERB	O	O
Eu-labeled	VERB	O	O
protein	NOUN	O	O
A	DET	O	O
and	CCONJ	O	O
time-resolved	VERB	O	O
fluorescence.	NOUN	O	O

Main	ADJ	O	B-outcome
curve	NOUN	O	I-outcome
correction	NOUN	O	I-outcome
success	NOUN	O	O
rate	NOUN	O	O
was	VERB	O	O
in	ADP	O	O
association	NOUN	O	O
with	ADP	O	O
patients'	NOUN	O	O
age	NOUN	O	O
and	CCONJ	O	O
type	NOUN	O	O
of	ADP	O	O
rod	NOUN	O	O
(P-value=0.054,	PUNCT	O	O
r=-1.863	NOUN	O	O
and	CCONJ	O	O
P-value=0.001,	NOUN	O	O
r=8.865	NOUN	O	O
respectively).	NOUN	O	O

METHODS:	NOUN	O	O
Sixty-two	NUM	O	O
10-	NUM	O	O
to	PART	O	O
14-year-old	ADJ	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
either	CCONJ	O	O
full-time	NOUN	O	O
(FT,	PUNCT	O	O
22	NUM	O	O
hours	NOUN	O	O
daily)	CCONJ	O	O
or	CCONJ	O	O
part-time	NOUN	O	O
(PT,	NOUN	O	O
12	NUM	O	O
hours	NOUN	O	O
daily)	CCONJ	O	O
wear	ADJ	O	O
of	ADP	O	O
a	DET	O	O
modified	VERB	O	O
Twin-block	NOUN	O	O
appliance.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
complementary	ADJ	O	O
and	CCONJ	O	O
alternative	ADJ	O	O
medicine	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article,	ADJ	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial,	NOUN	O	O

Title:	NOUN	O	O
[Effects	NOUN	O	O
of	ADP	O	O
propofol	NOUN	O	O
sedation	NOUN	O	O
on	ADP	O	O
psychological	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
in	ADP	O	O
surgical	ADJ	O	O
patients	NOUN	O	O
under	ADP	O	O
epidural].	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

Title:	NOUN	O	O
Plazomicin	NOUN	O	O
for	ADP	O	O
Infections	NOUN	O	O
Caused	VERB	O	O
by	ADP	O	O
Carbapenem-Resistant	NOUN	O	O
Enterobacteriaceae.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

METHOD:	NOUN	O	O
an	DET	O	O
experimental	ADJ	O	O
and	CCONJ	O	O
blind	PUNCT	O	O
study	NOUN	O	O
composed	VERB	O	O
of	ADP	O	O
120	NUM	O	O
dyads	NOUN	O	O
of	ADP	O	O
first-time	NOUN	O	O
mothers	NOUN	O	O
and	CCONJ	O	O
full-term	NOUN	O	O
newborns,	NOUN	O	O
who	ADP	O	O
practiced	VERB	O	O
breastfeeding.	NOUN	O	O

Title:	NOUN	O	O
Effectiveness	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Nutritional	ADJ	O	O
App	NOUN	O	O
"MyNutriCart"	NOUN	O	O
on	ADP	O	O
Food	NOUN	O	B-outcome
Choices	NOUN	O	I-outcome
Related	VERB	O	O
to	PART	O	O
Purchase	NOUN	O	B-outcome
and	CCONJ	O	Seperator
Dietary	ADJ	O	B-outcome
Behavior	NOUN	O	E1-outcome
:	PUNCT	O	O
A	DET	O	O
Pilot	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial.	NOUN	O	O

HR's	NOUN	O	O
for	ADP	O	O
levofloxacin	NOUN	O	O
and	CCONJ	O	O
moxifloxacin,	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
beta-lactam	NOUN	O	O
monotherapy,	ADJ	O	O
on	ADP	O	O
any	DET	O	O
cardiac	ADJ	O	B-outcome
event	NOUN	O	I-outcome
were	VERB	O	O
0.40	NUM	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
0.18;0.87)and	NUM	O	O
0.56	NUM	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
0.36;0.87),	NUM	O	O
respectively.	NOUN	O	O

Journal-Name:	NOUN	O	O
Revista	NOUN	O	O
da	NOUN	O	O
Associacao	NOUN	O	O
Medica	NOUN	O	O
Brasileira	NOUN	O	O
(1992)	PUNCT	O	O

Intensive	ADJ	O	O
BP	NOUN	O	O
control	NOUN	O	O
significantly	ADV	O	O
reduced	VERB	O	O
the	DET	O	O
risk	NOUN	O	O
of	ADP	O	O
mild	ADJ	O	O
cognitive	ADJ	O	B-outcome
impairment	NOUN	O	I-outcome
(14.6	ADV	O	O
vs	CCONJ	O	O
18.3	NUM	O	O
cases	NOUN	O	O
per	ADP	O	O
1000	NUM	O	O
person-years;	NOUN	O	O
HR,	NOUN	O	O
0.81;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.69-0.95)	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
combined	VERB	O	O
rate	NOUN	O	O
of	ADP	O	O
mild	ADJ	O	O
cognitive	ADJ	O	B-outcome
impairment	NOUN	O	I-outcome
or	CCONJ	O	Seperator
probable	ADJ	O	I-outcome
dementia	NOUN	O	I-outcome
(20.2	NUM	O	O
vs	CCONJ	O	O
24.1	NUM	O	O
cases	NOUN	O	O
per	ADP	O	O
1000	NUM	O	O
person-years;	NOUN	O	O
HR,	NOUN	O	O
0.85;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.74-0.97).	NUM	O	O

This	DET	O	O
trial	NOUN	O	O
is	VERB	O	O
registered	VERB	O	O
with	ADP	O	O
ClinicalTrials.gov,	NOUN	O	O
number	NOUN	O	O
NCT02181413,	NOUN	O	O
and	CCONJ	O	O
follow-up	NOUN	O	O
is	VERB	O	O
ongoing.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

No	DET	O	O
trial-dependent	ADJ	O	O
differences	NOUN	O	O
were	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
the	DET	O	O
Recovery	NOUN	O	O
period.	NOUN	O	O

Title:	NOUN	O	O
Are	VERB	O	O
(All)	PUNCT	O	O
Consumers	NOUN	O	O
Averse	NOUN	O	B-outcome
to	PART	O	I-outcome
Bitter	NOUN	O	I-outcome
Taste	NOUN	O	I-outcome
?	PUNCT	O	O

RESULTS:	NOUN	O	O
From	ADP	O	O
October	ADJ	O	O
2009	NUM	O	O
through	ADP	O	O
April	NOUN	O	O
2012,	NUM	O	O
we	PRON	O	O
randomly	ADV	O	O
assigned	VERB	O	O
103	NUM	O	O
patients	NOUN	O	O
to	PART	O	O
the	DET	O	O
hybrid-procedure	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
104	NUM	O	O
to	PART	O	O
the	DET	O	O
open-procedure	NOUN	O	O
group.	VERB	O	O

Journal-Name:	NOUN	O	O
The	DET	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

Title:	NOUN	O	O
Does	VERB	O	O
Doctor	NOUN	O	O
Race	NOUN	O	O
Affect	NOUN	O	O
the	DET	O	O
Health	NOUN	O	O
of	ADP	O	O
Black	NOUN	O	O
Men?	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
no	DET	O	O
significantly	ADV	O	O
difference	NOUN	O	O
of	ADP	O	O
the	DET	O	O
numbers	NOUN	O	O
of	ADP	O	O
bucking	VERB	O	B-outcome
or	CCONJ	O	O
body	NOUN	O	B-outcome
moving	VERB	O	I-outcome
,	PUNCT	O	O
the	DET	O	O
satisfaction	NOUN	O	B-outcome
of	ADP	O	O
operators	NOUN	O	O
and	CCONJ	O	O
patients,	NOUN	O	O
and	CCONJ	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
(all	PUNCT	O	O
P>0.05).	NOUN	O	O

Between-group	ADJ	O	O
differences	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
significant.	NOUN	O	O

The	DET	O	O
results	NOUN	O	O
of	ADP	O	O
this	DET	O	O
trial	NOUN	O	O
could	VERB	O	O
support	NOUN	O	O
decision-making	VERB	O	O
by	ADP	O	O
clinicians	NOUN	O	O
regarding	VERB	O	O
aPDT	NOUN	O	O
using	VERB	O	O
aPDT	NOUN	O	O
for	ADP	O	O
treating	VERB	O	O
halitosis.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

Conclusion:	NOUN	O	O
Compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
posterolateral	ADJ	O	O
approach,	NOUN	O	O
the	DET	O	O
SuperPATH	NOUN	O	O
approach	NOUN	O	O
can	VERB	O	O
reduce	VERB	O	O
muscle	NOUN	O	B-outcome
damage	NOUN	O	I-outcome
,	PUNCT	O	O
relieve	NOUN	O	O
early	ADJ	O	O
pain	NOUN	O	B-outcome
,	PUNCT	O	O
promote	VERB	O	O
recovery	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
obtain	VERB	O	O
the	DET	O	O
similar	ADJ	O	O
short-term	NOUN	O	O
effectiveness.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/16	NOUN	O	O
06:00'	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/21	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Title:	NOUN	O	O
Comparing	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
between	ADP	O	O
continuous	ADJ	O	O
infusion	NOUN	O	O
and	CCONJ	O	O
intermittent	ADJ	O	O
bolus	NOUN	O	O
of	ADP	O	O
rocuronium	NOUN	O	O
for	ADP	O	O
intraoperative	ADJ	O	O
neurophysiologic	ADJ	O	O
monitoring	VERB	O	O
of	ADP	O	O
neurointervention	NOUN	O	O
under	ADP	O	O
general	ADJ	O	O
anesthesia.	NOUN	O	O

Unhealthy	NOUN	O	O
food	NOUN	O	O
sponsorship	NOUN	O	O
also	ADV	O	O
led	VERB	O	O
to	PART	O	O
greater	ADJ	O	O
perceived	VERB	O	O
event-sponsor	NOUN	O	B-outcome
fit	NOUN	O	I-outcome
and	CCONJ	O	Seperator
transfer	NOUN	O	B-outcome
of	ADP	O	I-outcome
perceptions	NOUN	O	E1-outcome
of	ADP	O	O
the	DET	O	O
sporting	VERB	O	O
event	NOUN	O	O
to	PART	O	O
the	DET	O	O
unhealthy	NOUN	O	O
food	NOUN	O	O
sponsor	ADP	O	O
brands,	NOUN	O	O
relative	ADJ	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

BACKGROUND:	NOUN	O	O
To	PART	O	O
compare	NOUN	O	O
the	DET	O	O
superiority	NOUN	O	O
of	ADP	O	O
teaching	VERB	O	O
methods	NOUN	O	O
for	ADP	O	O
acquiring	VERB	O	O
a	DET	O	O
proficient	ADP	O	O
level	NOUN	O	O
of	ADP	O	O
surgical	ADJ	O	O
skill	ADV	O	B-outcome
in	ADP	O	O
a	DET	O	O
robotic	ADJ	O	O
surgery-naive	ADJ	O	O
individual	ADJ	O	O
using	VERB	O	O
a	DET	O	O
robotic	ADJ	O	O
virtual	ADJ	O	O
reality	NOUN	O	O
simulator.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/05	NOUN	O	O
06:00	ADP	O	O
[pubmed]	PUNCT	O	O

The	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
additional	ADJ	O	O
individual	ADJ	O	O
pre-discharge	NOUN	O	O
pharmacotherapeutic	ADJ	O	O
education	NOUN	O	O
about	ADV	O	O
the	DET	O	O
discharge	NOUN	O	O
prescriptions.	NOUN	O	O

Physical	ADJ	O	B-outcome
activity-related	VERB	O	I-outcome
fear	ADJ	O	I-outcome
was	VERB	O	O
reduced	VERB	O	O
only	ADV	O	O
in	ADP	O	O
the	DET	O	O
Exercise-arm	NUM	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.008).	NUM	O	O

Linear	ADJ	O	O
regressions	NOUN	O	O
examined	VERB	O	O
between-groups	NOUN	O	O
relationships	NOUN	O	O
for	ADP	O	O
foot	NOUN	O	O
and	CCONJ	O	O
ankle	NOUN	O	O
characteristics	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
FPPA.	NOUN	O	O

Title:	NOUN	O	O
Evaluation	NOUN	O	O
of	ADP	O	O
a	DET	O	O
Single	NOUN	O	O
Dose	NOUN	O	O
of	ADP	O	O
Azithromycin	NOUN	O	O
for	ADP	O	O
Trachoma	NOUN	O	O
in	ADP	O	O
Low-Prevalence	NOUN	O	O
Communities.	NOUN	O	O

Journal-Name:Zhonghua	NOUN	O	O
wei	NUM	O	O
zhong	PUNCT	O	O
bing	VERB	O	O
ji	ADP	O	O
jiu	NOUN	O	O
yi	ADP	O	O
xue	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
efficacy	NOUN	O	O
endpoint	NOUN	O	O
was	VERB	O	O
measured	VERB	O	O
by	ADP	O	O
the	DET	O	O
Tinnitus	NOUN	O	B-outcome
Severity	NOUN	O	I-outcome
Scale	NOUN	O	O
(TSS)	PUNCT	O	O
and	CCONJ	O	O
Tinnitus	NOUN	O	B-outcome
Questionnaire	PROPN	O	O
(TQ)	NOUN	O	O
sum	NOUN	O	O
score.	NOUN	O	O

To	PART	O	O
date,	VERB	O	O
no	DET	O	O
published	VERB	O	O
study	NOUN	O	O
has	VERB	O	O
examined	VERB	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
an	DET	O	O
active,	ADJ	O	O
music-instruction	NOUN	O	O
intervention	NOUN	O	O
as	ADP	O	O
a	DET	O	O
complementary	ADJ	O	O
strategy	NOUN	O	O
to	PART	O	O
improve	VERB	O	O
the	DET	O	O
psychological	ADJ	O	O
well-being	VERB	O	O
of	ADP	O	O
veterans	NOUN	O	O
with	ADP	O	O
PTSD.	NOUN	O	O

In	ADP	O	O
third	ADJ	O	O
postoperative	ADJ	O	O
day,	ADP	O	O
mean	NOUN	O	O
was	VERB	O	O
3.18	NUM	O	O
for	ADP	O	O
the	DET	O	O
first	ADV	O	O
group	NOUN	O	O
and	CCONJ	O	O
3.11	NUM	O	O
for	ADP	O	O
the	DET	O	O
traditional	ADJ	O	O
group	NOUN	O	O
(p=0.937).	PUNCT	O	O

Baltimore	NOUN	O	O
Community-based	VERB	O	O
Organizations	NOUN	O	O
Neighborhood	NOUN	O	O
Network:	ADJ	O	O
Enhancing	VERB	O	O
Capacity	NOUN	O	O
Together	ADV	O	O
(CONNECT)	PUNCT	O	O
was	VERB	O	O
a	DET	O	O
randomized,	NOUN	O	O
controlled	VERB	O	O
trial	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
the	DET	O	O
core	NOUN	O	O
tenets	NOUN	O	O
of	ADP	O	O
the	DET	O	O
World	NOUN	O	O
Health	NOUN	O	O
Organization's	NOUN	O	O
(WHO)	NOUN	O	O
African	ADV	O	O
Partnerships	NOUN	O	O
for	ADP	O	O
Patient	NOUN	O	O
Safety	NOUN	O	O
Community	NOUN	O	O
Engagement	NOUN	O	O
(ACE)	NOUN	O	O
approach.	NOUN	O	O

Registered	VERB	O	O
1	NUM	O	O
February	ADJ	O	O
2013.	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/07	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Title:	NOUN	O	O
Effectiveness	NOUN	O	O
and	CCONJ	O	O
cost-effectiveness	NOUN	O	O
of	ADP	O	O
neuromuscular	ADJ	O	O
exercise	NOUN	O	O
and	CCONJ	O	O
back	ADP	O	O
care	NOUN	O	O
counseling	VERB	O	O
in	ADP	O	O
female	NOUN	O	O
healthcare	NOUN	O	O
workers	NOUN	O	O
with	ADP	O	O
recurrent	ADP	O	O
non-specific	ADJ	O	O
low	ADJ	O	O
back	ADP	O	O
pain:	NOUN	O	O
a	DET	O	O
blinded	VERB	O	O
four-arm	NOUN	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

Compared	VERB	O	O
to	PART	O	O
controls,	NOUN	O	O
elite	ADP	O	O
football	NOUN	O	O
players	NOUN	O	O
showed	VERB	O	O
lower	ADJ	O	O
antioxidant	NOUN	O	B-outcome
power	NOUN	O	I-outcome
and	CCONJ	O	O
higher	ADJ	O	O
oxidative	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
paralleled	VERB	O	O
by	ADP	O	O
an	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
muscle	NOUN	O	B-outcome
damage	NOUN	O	I-outcome
markers.	NOUN	O	O

There	PRON	O	O
were	VERB	O	O
30	NUM	O	O
statistically	ADV	O	O
significant	ADJ	O	O
metabolite	NOUN	O	B-outcome
differences	NOUN	O	O
in	ADP	O	O
the	DET	O	O
stool	NOUN	O	O
of	ADP	O	O
participants	NOUN	O	O
that	ADP	O	O
consumed	VERB	O	O
navy	ADJ	O	O
bean	NOUN	O	O
at	ADP	O	O
day	NOUN	O	O
28	NUM	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
participants'	NOUN	O	O
baseline	NOUN	O	O
(p	PUNCT	O	O
</=	NOUN	O	O
0.05)	NUM	O	O
and	CCONJ	O	O
26	NUM	O	O
significantly	ADV	O	O
different	ADJ	O	O
metabolites	NOUN	O	B-outcome
when	ADP	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/10	ADV	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
9420934	NUM	O	O

BACKGROUND:	NOUN	O	O
Studies	NOUN	O	O
have	VERB	O	O
reported	VERB	O	O
that	ADP	O	O
the	DET	O	O
ED50	NOUN	O	O
of	ADP	O	O
intrathecal	ADJ	O	O
ropivacaine	NOUN	O	O
was	VERB	O	O
increased	VERB	O	O
when	ADP	O	O
using	VERB	O	O
prophylactic	ADJ	O	O
infusion	NOUN	O	O
of	ADP	O	O
phenylephrine	NOUN	O	O
to	PART	O	O
prevent	NOUN	O	O
spinal-induced	VERB	O	O
hypotension.	NOUN	O	O

A	DET	O	O
common	ADJ	O	O
approach	NOUN	O	O
to	PART	O	O
deliver	ADP	O	O
malaria	NOUN	O	O
services	NOUN	O	O
is	VERB	O	O
to	PART	O	O
assign	ADV	O	O
Village	NOUN	O	O
Health	NOUN	O	O
Volunteers	NOUN	O	O
(VHVs)	PUNCT	O	O
to	PART	O	O
villages,	NOUN	O	O
particularly	ADV	O	O
where	ADP	O	O
limited	VERB	O	O
or	CCONJ	O	O
no	DET	O	O
services	NOUN	O	O
exist.	ADJ	O	O

Results:	NOUN	O	O
The	DET	O	O
authors	NOUN	O	O
compared	VERB	O	O
the	DET	O	O
EG	NOUN	O	O
results	NOUN	O	O
at	ADP	O	O
the	DET	O	O
initial	ADJ	O	O
and	CCONJ	O	O
final	ADJ	O	O
assessments	NOUN	O	O
and	CCONJ	O	O
found	VERB	O	O
a	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
improvement	NOUN	O	O
in	ADP	O	O
severity	NOUN	O	O
of	ADP	O	O
urinary	ADJ	O	B-outcome
incontinence	NOUN	O	I-outcome
(P=0.001)	ADV	O	O
and	CCONJ	O	O
depression	NOUN	O	B-outcome
severity	NOUN	O	O
(P=0.006),	NUM	O	O
and	CCONJ	O	O
a	DET	O	O
decrease	NOUN	O	O
in	ADP	O	O
myostatin	NOUN	O	B-outcome
concentration	NOUN	O	O
(P</=0.001).	NUM	O	O

Journal-Name:Ophthalmic	ADJ	O	O
epidemiology	NOUN	O	O

Objective:	NOUN	O	O
To	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
cognitive-behavioral	ADJ	O	O
therapy	NOUN	O	O
for	ADP	O	O
insomnia	NOUN	O	O
(CBT-i)	NOUN	O	O
or	CCONJ	O	O
combination	NOUN	O	O
with	ADP	O	O
tapered	VERB	O	O
hypnotic	ADJ	O	O
agents.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
between	ADP	O	O
groups	NOUN	O	O
in	ADP	O	O
the	DET	O	O
median	ADJ	O	O
cumulative	ADJ	O	O
time	NOUN	O	O
with	ADP	O	O
mean	NOUN	O	O
arterial	ADJ	O	O
pressure	NOUN	O	O
below	ADP	O	O
60	NUM	O	O
mm	NOUN	O	O
Hg	NOUN	O	O
(7	NOUN	O	O
vs	CCONJ	O	O
7	NUM	O	O
minutes;	NOUN	O	O
difference,	NOUN	O	O
0.0	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-1.7	NOUN	O	O
to	PART	O	O
1.7]).	ADJ	O	O

METHODS:	NOUN	O	O
This	DET	O	O
is	VERB	O	O
a	DET	O	O
3-arm,	NUM	O	O
waitlist,	NOUN	O	O
single-blind	NOUN	O	O
randomised	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
testing	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Stay	NOUN	O	O
Strong	ADJ	O	O
App	NOUN	O	O
in	ADP	O	O
improving	VERB	O	O
psychological	ADJ	O	B-outcome
distress	NOUN	O	I-outcome
,	PUNCT	O	O
depressive	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
,	PUNCT	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
and	CCONJ	O	O
treatment	NOUN	O	B-outcome
adherence	NOUN	O	I-outcome
among	ADP	O	O
Indigenous	ADJ	O	O
clients	NOUN	O	O
undergoing	VERB	O	O
haemodialysis	NOUN	O	O
for	ADP	O	O
ESKD	NOUN	O	O
in	ADP	O	O
Alice	NOUN	O	O
Springs	NOUN	O	O
and	CCONJ	O	O
Darwin	ADP	O	O
with	ADP	O	O
follow	VERB	O	O
up	ADP	O	O
over	ADP	O	O
two	NUM	O	O
periods	NOUN	O	O
of	ADP	O	O
3	NUM	O	O
months	NOUN	O	O
(total	ADJ	O	O
of	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
observation).	PUNCT	O	O

After	ADP	O	O
12	NUM	O	O
months,	NOUN	O	O
the	DET	O	O
Combined-arm	NUM	O	O
showed	VERB	O	O
reduced	VERB	O	O
intensity	NOUN	O	B-outcome
of	ADP	O	I-outcome
low	ADJ	O	I-outcome
back	ADP	O	I-outcome
pain	NOUN	O	I-outcome
(p	PUNCT	O	O
=	SYM	O	O
0.006;	NOUN	O	O
effect	NOUN	O	O
size	NOUN	O	O
0.70,	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
0.23	NUM	O	O
to	PART	O	O
1.17)	NUM	O	O
and	CCONJ	O	O
pain	NOUN	O	B-outcome
interfering	VERB	O	I-outcome
with	ADP	O	Seperator
work	NOUN	O	I-outcome
(p	PUNCT	O	O
=	SYM	O	O
0.011)	NUM	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
Control-arm.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
pilot	NOUN	O	O
test	NOUN	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
"MyNutriCart",	NOUN	O	O
a	DET	O	O
smartphone	NOUN	O	O
application	NOUN	O	O
(app)	NUM	O	O
that	ADP	O	O
generates	NOUN	O	O
healthy	ADJ	O	O
grocery	NOUN	O	O
lists,	NOUN	O	O
on	ADP	O	O
diet	NOUN	O	B-outcome
and	CCONJ	O	O
weight	NOUN	O	B-outcome
.	PUNCT	O	O
METHODS:	NOUN	O	O
A	DET	O	O
pilot	NOUN	O	O
randomized	VERB	O	O
trial	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
to	PART	O	O
test	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
using	VERB	O	O
the	DET	O	O
"MyNutriCart"	NOUN	O	O
app	CCONJ	O	O
compared	VERB	O	O
to	PART	O	O
one	NUM	O	O
face-to-face	NUM	O	O
counseling	VERB	O	O
session	NOUN	O	O
(Traditional	ADJ	O	O
group)	ADJ	O	O
in	ADP	O	O
Hispanic	ADJ	O	O
overweight	NUM	O	O
and	CCONJ	O	O
obese	NOUN	O	O
adults.	NOUN	O	O

Wound	NOUN	O	B-outcome
complications	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
first	ADV	O	O
30	NUM	O	O
days	NOUN	O	O
and	CCONJ	O	O
incisional	ADJ	O	B-outcome
hernia	NOUN	O	I-outcome
rates	NOUN	O	O
were	VERB	O	O
assessed.	NOUN	O	O

Both	CCONJ	O	O
techniques	NOUN	O	O
created	VERB	O	O
the	DET	O	O
same	ADJ	O	O
level	NOUN	O	O
of	ADP	O	O
epithelial	ADJ	O	B-outcome
thickness	NOUN	O	I-outcome
increase	NOUN	O	O
and	CCONJ	O	O
variation,	NOUN	O	O
with	ADP	O	O
a	DET	O	O
significantly	ADV	O	O
higher	ADJ	O	O
mid-peripheral	ADJ	O	B-outcome
epithelial	ADJ	O	I-outcome
thickness	NOUN	O	I-outcome
increase.	NOUN	O	O

Topical	ADJ	O	O
repellents	NOUN	O	O
are	VERB	O	O
an	DET	O	O
intervention	NOUN	O	O
that	ADP	O	O
can	VERB	O	O
be	VERB	O	O
used	VERB	O	O
to	PART	O	O
target	NOUN	O	O
residual	ADJ	O	O
malaria	NOUN	O	O
transmission	NOUN	O	O
not	ADV	O	O
covered	VERB	O	O
by	ADP	O	O
long	ADV	O	O
lasting	VERB	O	O
insecticide	NOUN	O	O
nets	NOUN	O	O
and	CCONJ	O	O
indoor	NOUN	O	O
residual	ADJ	O	O
spraying.	ADV	O	O

Objective:	NOUN	O	O
To	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
dexmedetomidine	NOUN	O	O
on	ADP	O	O
perioperative	ADJ	O	O
stress	NOUN	O	B-outcome
and	CCONJ	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
radical	NOUN	O	O
resection	NOUN	O	O
of	ADP	O	O
esophageal	ADJ	O	O
cancer	NOUN	O	O
under	ADP	O	O
combined	VERB	O	O
thoracoscope	NOUN	O	O
and	CCONJ	O	O
laparoscope.	NOUN	O	O

The	DET	O	O
blood	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
sICAM-1	NOUN	O	B-outcome
,	PUNCT	O	O
sVCAM-1	NOUN	O	B-outcome
,	PUNCT	O	O
endothelin-1	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
sE-selectin	NOUN	O	B-outcome
were	VERB	O	O
quantified;	NOUN	O	O
the	DET	O	O
activities	NOUN	O	O
of	ADP	O	O
catalase	NOUN	O	B-outcome
,	PUNCT	O	O
superoxide	NOUN	O	B-outcome
dismutase	NOUN	O	I-outcome
,	PUNCT	O	O
glutathione	NOUN	O	B-outcome
peroxidase	NOUN	O	I-outcome
,	PUNCT	O	O
glutathione	NOUN	O	B-outcome
reductase	NOUN	O	I-outcome
and	CCONJ	O	O
concentrations	NOUN	O	O
of	ADP	O	O
reduced	VERB	O	O
glutathione	NOUN	O	B-outcome
,	PUNCT	O	O
oxidized	VERB	O	B-outcome
glutathione	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
thiobarbituric	ADJ	O	B-outcome
acid	NOUN	O	I-outcome
reactive	ADJ	O	O
substances,	NOUN	O	O
were	VERB	O	O
also	ADV	O	O
quantified	VERB	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
period.	NOUN	O	O
(	PUNCT	O	O

The	DET	O	O
total	ADJ	O	B-outcome
sleep	NOUN	O	I-outcome
time	NOUN	O	I-outcome
and	CCONJ	O	O
arousal	ADJ	O	B-outcome
time	NOUN	O	I-outcome
were	VERB	O	O
obtained	VERB	O	O
by	ADP	O	O
bispectral	ADJ	O	O
index	NOUN	O	O
(BIS)	PUNCT	O	O
monitoring	VERB	O	O
from	ADP	O	O
20:	NOUN	O	O
00	NUM	O	O
(the	NOUN	O	O
first	ADV	O	O
day)	NOUN	O	O
to	PART	O	O
6:	ADP	O	O
00	NUM	O	O
(the	NOUN	O	O
second	ADJ	O	O
day).	NOUN	O	O

The	DET	O	O
secondary	ADJ	O	O
objective	ADP	O	O
was	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
postinduction	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
serum	NOUN	O	O
neurohormones	NOUN	O	B-outcome
in	ADP	O	O
an	DET	O	O
attempt	NOUN	O	O
to	PART	O	O
explain	NOUN	O	O
the	DET	O	O
mechanisms	NOUN	O	O
involved.	NOUN	O	O

Importance:	NOUN	O	O
Abnormal	ADJ	O	O
peripheral	ADJ	O	O
perfusion	NOUN	O	O
after	ADP	O	O
septic	ADJ	O	O
shock	NOUN	O	O
resuscitation	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
organ	NOUN	O	O
dysfunction	NOUN	O	O
and	CCONJ	O	O
mortality.	NOUN	O	O

Journal-Name:Zhonghua	NOUN	O	O
lao	NOUN	O	O
dong	ADJ	O	O
wei	NUM	O	O
sheng	NOUN	O	O
zhi	NUM	O	O
ye	ADP	O	O
bing	VERB	O	O
za	ADP	O	O
zhi	NUM	O	O
=	SYM	O	O
Zhonghua	NOUN	O	O
laodong	ADV	O	O
weisheng	NOUN	O	O
zhiyebing	VERB	O	O
zazhi	NOUN	O	O
=	SYM	O	O
Chinese	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
industrial	ADJ	O	O
hygiene	NOUN	O	O
and	CCONJ	O	O
occupational	ADJ	O	O
diseases	NOUN	O	O

Secondary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
from	ADP	O	O
start	NOUN	O	O
of	ADP	O	O
the	DET	O	O
propofol	NOUN	O	O
infusion	NOUN	O	O
time	NOUN	O	B-outcome
to	PART	O	I-outcome
loss	NOUN	O	I-outcome
of	ADP	O	I-outcome
consciousness	NOUN	O	I-outcome
(LOC)	NOUN	O	I-outcome
,	PUNCT	O	O
rocuronium	NOUN	O	B-outcome
onset	NOUN	O	I-outcome
time	NOUN	O	I-outcome
,	PUNCT	O	O
time	NOUN	O	B-outcome
to	PART	O	I-outcome
Bispectral	ADJ	O	I-outcome
index	NOUN	O	I-outcome
(BIS)	PUNCT	O	I-outcome
60	NUM	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
hemodynamic	ADJ	O	B-outcome
variables.	NUM	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
fentanyl	NOUN	O	O
level	NOUN	O	O
peaked	VERB	O	O
1	NUM	O	O
h	NOUN	O	O
after	ADP	O	O
operation	NOUN	O	O
in	ADP	O	O
the	DET	O	O
TFP	NOUN	O	O
group	NOUN	O	O
(3.27	NOUN	O	O
+/-	SYM	O	O
0.34	NUM	O	O
ng/mL)	NOUN	O	O
and	CCONJ	O	O
24	NUM	O	O
h	NOUN	O	O
postoperatively	ADV	O	O
in	ADP	O	O
the	DET	O	O
IV	NUM	O	O
group	NOUN	O	O
(2.9	NUM	O	O
+/-	SYM	O	O
0.42	NUM	O	O
ng/mL).	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Both	CCONJ	O	O
LASIK	NOUN	O	O
and	CCONJ	O	O
SMILE	NOUN	O	O
resulted	VERB	O	O
in	ADP	O	O
significant	ADJ	O	O
epithelial	ADJ	O	B-outcome
thickening	VERB	O	I-outcome
.	PUNCT	O	O
This	DET	O	O
response	NOUN	O	O
seemed	VERB	O	O
to	PART	O	O
be	VERB	O	O
surprisingly	ADV	O	O
quite	ADV	O	O
similar	ADJ	O	O
between	ADP	O	O
the	DET	O	O
2	NUM	O	O
different	ADJ	O	O
techniques.	NUM	O	O

Two	NUM	O	O
clinical	ADJ	O	O
trials	NOUN	O	O
have	VERB	O	O
examined	VERB	O	O
this	DET	O	O
strategy	NOUN	O	O
and	CCONJ	O	O
reported	VERB	O	O
controversial	ADJ	O	O
results.	NOUN	O	O

For	ADP	O	O
the	DET	O	O
comparison	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Ocular	ADJ	O	B-outcome
Surface	NOUN	O	I-outcome
Disease	NOUN	O	I-outcome
Index	NOUN	O	O
(OSDI)],	NOUN	O	O
subjective	ADJ	O	O
evaluation	NOUN	O	O
scores,	NOUN	O	O
tear	NUM	O	B-outcome
breakup	ADP	O	I-outcome
time	NOUN	O	I-outcome
(TBUT)	PUNCT	O	I-outcome
and	CCONJ	O	O
fluorescein	NOUN	O	B-outcome
staining	VERB	O	I-outcome
,	PUNCT	O	O
statistically	ADV	O	O
significant	ADJ	O	O
improvements	NOUN	O	O
were	VERB	O	O
noted	VERB	O	O
in	ADP	O	O
the	DET	O	O
BCL	NOUN	O	O
group,	NOUN	O	O
especially	ADV	O	O
on	ADP	O	O
days	NOUN	O	O
7	NUM	O	O
and	CCONJ	O	O
14	NUM	O	O
(P	NUM	O	O
<	SYM	O	O
0.001,	NUM	O	O
P	NOUN	O	O
<	SYM	O	O
0.001;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.031,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
0.009;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
0.021,	PUNCT	O	O
P	NOUN	O	O
=	SYM	O	O
0.028;	NOUN	O	O
and	CCONJ	O	O
P	NOUN	O	O
=	SYM	O	O
0.03,	NUM	O	O
P	NOUN	O	O
=	SYM	O	O
0.032,	NUM	O	O
respectively).	NOUN	O	O

RESULTS:	NOUN	O	O
HSS,	ADJ	O	O
KSS,	ADJ	O	O
NASS	NOUN	O	O
scores,	NOUN	O	O
and	CCONJ	O	O
ROM	NOUN	O	O
were	VERB	O	O
elevated	VERB	O	O
after	ADP	O	O
patients	NOUN	O	O
receiving	VERB	O	O
TKA.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101160020	NUM	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
the	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
if	ADP	O	O
Reproductive	ADJ	O	O
Life	NOUN	O	O
Plan	NOUN	O	O
(RLP)-based	VERB	O	O
counselling	VERB	O	O
during	ADP	O	O
a	DET	O	O
sexual	ADJ	O	O
health	NOUN	O	O
visit	NOUN	O	O
could	VERB	O	O
increase	NOUN	O	O
men's	NOUN	O	O
fertility	NOUN	O	B-outcome
awareness	ADV	O	I-outcome
.	PUNCT	O	O
MATERIAL	NOUN	O	O
AND	CCONJ	O	O
METHODS:	NOUN	O	O
The	DET	O	O
study	NOUN	O	O
was	VERB	O	O
a	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
including	VERB	O	O
201	NUM	O	O
men	NOUN	O	O
aged	VERB	O	O
18-50	NUM	O	O
who	ADP	O	O
visited	VERB	O	O
either	CCONJ	O	O
of	ADP	O	O
two	NUM	O	O
participating	VERB	O	O
sexual	ADJ	O	O
health	NOUN	O	O
clinics	NOUN	O	O
in	ADP	O	O
Sweden	NOUN	O	O
for	ADP	O	O
sexually	ADV	O	O
transmitted	VERB	O	O
infection	NOUN	O	O
testing	VERB	O	O
during	ADP	O	O
2014-2016.	NOUN	O	O

The	DET	O	O
aim	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
exploit	NOUN	O	O
the	DET	O	O
effect	NOUN	O	O
of	ADP	O	O
cocoa	NOUN	O	O
polyphenols	NOUN	O	O
on	ADP	O	O
oxidative	ADJ	O	B-outcome
stress	NOUN	O	I-outcome
and	CCONJ	O	O
muscular	ADJ	O	B-outcome
injuries	NOUN	O	I-outcome
induced	VERB	O	O
by	ADP	O	O
intensive	ADJ	O	O
physical	ADJ	O	O
exercise	NOUN	O	O
in	ADP	O	O
elite	ADP	O	O
football	NOUN	O	O
players.	NOUN	O	O

On	ADP	O	O
intention-to-treat	NOUN	O	O
analysis,	NOUN	O	O
Hp	NOUN	O	B-outcome
eradication	NOUN	O	I-outcome
rates	NOUN	O	O
in	ADP	O	O
FZD	NOUN	O	O
and	CCONJ	O	O
CLA	NOUN	O	O
groups	NOUN	O	O
were	VERB	O	O
90.22%	NOUN	O	O
and	CCONJ	O	O
86.02%	NUM	O	O
(P	NUM	O	O
=	SYM	O	O
.378);	PUNCT	O	O
in	ADP	O	O
per-protocol	NOUN	O	O
analysis,	NOUN	O	O
their	ADJ	O	O
eradication	NOUN	O	B-outcome
rates	NOUN	O	O
were	VERB	O	O
93.26%	NOUN	O	O
and	CCONJ	O	O
87.91%,	NUM	O	O
respectively	ADV	O	O
(P	NUM	O	O
=	SYM	O	O
.220).	NOUN	O	O

Journal-Name:Eye	NOUN	O	O
&	CCONJ	O	O
contact	NOUN	O	O
lens	NOUN	O	O

The	DET	O	O
exercise	NOUN	O	O
group	NOUN	O	O
performed	VERB	O	O
40	NUM	O	O
min	NOUN	O	O
of	ADP	O	O
resistance	NOUN	O	O
exercises	NOUN	O	O
on	ADP	O	O
machines	NOUN	O	O
followed	VERB	O	O
by	ADP	O	O
30	NUM	O	O
min	NOUN	O	O
of	ADP	O	O
aerobic	ADJ	O	O
training	VERB	O	O
on	ADP	O	O
a	DET	O	O
treadmill	ADV	O	O
3x/wk.	NOUN	O	O

PMID:	NOUN	O	O
31618328	NUM	O	O

Secondary	ADJ	O	O
endpoints	NOUN	O	O
in	ADP	O	O
rank	NOUN	O	O
order	NOUN	O	O
included:	NOUN	O	O
superiority	NOUN	O	O
of	ADP	O	O
HP	NOUN	O	O
relative	ADJ	O	O
to	PART	O	O
G	NOUN	O	O
+	SYM	O	O
T	NOUN	O	O
in	ADP	O	O
mean	NOUN	O	O
preparation	NOUN	O	B-outcome
time	NOUN	O	I-outcome
;	PUNCT	O	O
non-inferiority	NOUN	O	O
of	ADP	O	O
HP	NOUN	O	O
relative	ADJ	O	O
to	PART	O	O
G	NOUN	O	O
+	SYM	O	O
T	NOUN	O	O
for	ADP	O	O
achieving	VERB	O	O
hemostasis	NOUN	O	B-outcome
within	ADP	O	O
3	NUM	O	O
min;	NOUN	O	O
superiority	NOUN	O	O
of	ADP	O	O
HP	NOUN	O	O
relative	ADJ	O	O
to	PART	O	O
G	NOUN	O	O
+	SYM	O	O
T	NOUN	O	O
for	ADP	O	O
achieving	VERB	O	O
hemostasis	NOUN	O	B-outcome
within	ADP	O	O
6	NUM	O	O
min;	NOUN	O	O
and	CCONJ	O	O
superiority	NOUN	O	O
of	ADP	O	O
HP	NOUN	O	O
relative	ADJ	O	O
to	PART	O	O
G	NOUN	O	O
+	SYM	O	O
T	NOUN	O	O
for	ADP	O	O
success	NOUN	O	O
for	ADP	O	O
achieving	VERB	O	O
hemostasis	NOUN	O	B-outcome
within	ADP	O	O
3	NUM	O	O
min.	NOUN	O	O

The	DET	O	O
1st	ADJ	O	O
group	NOUN	O	O
contained	VERB	O	O
22	NUM	O	O
patients	NOUN	O	O
and	CCONJ	O	O
surgery	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
using	VERB	O	O
a	DET	O	O
fascia	NOUN	O	O
lata	NOUN	O	O
allograft.	NOUN	O	O

Title:	NOUN	O	O
Pegbelfermin	NOUN	O	O
(BMS-986036),	PUNCT	O	O
a	DET	O	O
PEGylated	VERB	O	O
fibroblast	NOUN	O	O
growth	NOUN	O	O
factor	NOUN	O	O
21	NUM	O	O
analogue,	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
non-alcoholic	ADJ	O	O
steatohepatitis:	NOUN	O	O
a	DET	O	O
randomised,	NOUN	O	O
double-blind,	NOUN	O	O
placebo-controlled,	NOUN	O	O
phase	NOUN	O	O
2a	NOUN	O	O
trial.	NOUN	O	O

Discussion:	NOUN	O	O
Short-term	NOUN	O	O
use	NOUN	O	O
of	ADP	O	O
IQOS(TM)	NOUN	O	O
has	VERB	O	O
a	DET	O	O
minimal	ADJ	O	O
impact	NOUN	O	O
on	ADP	O	O
exhaled	VERB	O	B-outcome
CO	NOUN	O	I-outcome
,	PUNCT	O	O
is	VERB	O	O
equally	ADV	O	O
effective	ADJ	O	O
in	ADP	O	O
reducing	VERB	O	O
cigarette	NOUN	O	B-outcome
craving	VERB	O	I-outcome
and	CCONJ	O	O
withdrawal	NOUN	O	B-outcome
symptoms	NOUN	O	I-outcome
as	ADP	O	O
an	DET	O	O
e-cigarette,	PUNCT	O	O
and	CCONJ	O	O
is	VERB	O	O
slightly	ADV	O	O
preferred	VERB	O	B-outcome
.	PUNCT	O	O

Achaogen,	VERB	O	O
South	NOUN	O	O
San	NOUN	O	O
Francisco,	ADV	O	O
CA.	NOUN	O	O

Subjects	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
take	NOUN	O	O
either	CCONJ	O	O
50,000	NUM	O	O
IU	NOUN	O	O
vitamin	NOUN	O	O
D	NOUN	O	O
every	DET	O	O
2	NUM	O	O
weeks	NOUN	O	O
plus	CCONJ	O	O
8	NUM	O	O
x	SYM	O	O
10(9)	NUM	O	O
CFU/day	NUM	O	O
probiotic	ADJ	O	O
(n	NOUN	O	O
=	SYM	O	O
30)	NOUN	O	O
or	CCONJ	O	O
placebo	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
30)	NOUN	O	O
for	ADP	O	O
12	NUM	O	O
weeks.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
100968547	NUM	O	O

CONCLUSIONS:	NOUN	O	O
Among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
TTP,	NOUN	O	O
treatment	NOUN	O	O
with	ADP	O	O
caplacizumab	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
faster	ADJ	O	O
normalization	NOUN	O	B-outcome
of	ADP	O	I-outcome
the	DET	O	Seperator
platelet	NOUN	O	I-outcome
count	NOUN	O	I-outcome
;	PUNCT	O	O
a	DET	O	O
lower	ADJ	O	O
incidence	NOUN	O	O
of	ADP	O	O
a	DET	O	O
composite	NOUN	O	O
of	ADP	O	O
TTP-related	VERB	O	B-outcome
death	NOUN	O	I-outcome
,	PUNCT	O	O
recurrence	NOUN	O	B-outcome
of	ADP	O	O
TTP,	NOUN	O	O
or	CCONJ	O	O
a	DET	O	O
thromboembolic	ADJ	O	B-outcome
event	NOUN	O	I-outcome
during	ADP	O	O
the	DET	O	O
trial	NOUN	O	O
treatment	NOUN	O	O
period;	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
lower	ADJ	O	O
rate	NOUN	O	O
of	ADP	O	O
recurrence	NOUN	O	B-outcome
of	ADP	O	O
TTP	NOUN	O	O
during	ADP	O	O
the	DET	O	O
trial	NOUN	O	O
than	ADP	O	O
placebo.	NOUN	O	O
(	PUNCT	O	O

The	DET	O	O
corresponding	VERB	O	O
rates	NOUN	O	O
between	ADP	O	O
weeks	NOUN	O	O
44	NUM	O	O
and	CCONJ	O	O
80	NUM	O	O
were	VERB	O	O
0.10+/-0.25	NUM	O	O
and	CCONJ	O	O
0.03+/-0.28	NUM	O	O
(difference,	ADV	O	O
0.07;	NOUN	O	O
two-sided	ADP	O	O
90%	VERB	O	O
CI,	NOUN	O	O
0.03	NUM	O	O
to	PART	O	O
0.10);	NUM	O	O
the	DET	O	O
difference	NOUN	O	O
in	ADP	O	O
the	DET	O	O
rate	NOUN	O	O
of	ADP	O	O
progression	NOUN	O	B-outcome
between	ADP	O	O
weeks	NOUN	O	O
44	NUM	O	O
and	CCONJ	O	O
80	NUM	O	O
did	VERB	O	O
not	ADV	O	O
meet	NOUN	O	O
the	DET	O	O
criterion	NOUN	O	O
for	ADP	O	O
noninferiority	NOUN	O	O
of	ADP	O	O
early	ADJ	O	O
receipt	NOUN	O	O
of	ADP	O	O
levodopa	NOUN	O	O
to	PART	O	O
delayed	VERB	O	O
receipt.	ADP	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Follow-up	NOUN	O	O
period	NOUN	O	O
was	VERB	O	O
2	NUM	O	O
years.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

RESULTS:	NOUN	O	O
At	ADP	O	O
T2,	NOUN	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
reported	VERB	O	O
significantly	ADV	O	O
higher	ADJ	O	O
self-efficacy	NOUN	O	B-outcome
to	PART	O	O
cope	NOUN	O	O
with	ADP	O	O
stress	NOUN	O	O
(effect	NOUN	O	O
size	NOUN	O	O
[Cohen's	NOUN	O	O
d	NOUN	O	O
=	SYM	O	O
0.53),	NUM	O	O
better	ADJ	O	O
emotional	ADJ	O	O
coping	VERB	O	B-outcome
response	NOUN	O	O
(d	NOUN	O	O
=	SYM	O	O
0.38),	NUM	O	O
less	ADV	O	O
stress	NOUN	O	B-outcome
(d	NOUN	O	O
=	SYM	O	O
0.34),	NUM	O	O
fewer	ADJ	O	O
depressive	ADJ	O	B-outcome
symptoms	NOUN	O	I-outcome
(d	NOUN	O	O
=	SYM	O	O
-	PUNCT	O	O
0.27),	NUM	O	O
and	CCONJ	O	O
more	ADV	O	O
positive	ADJ	O	B-outcome
affect	NOUN	O	I-outcome
(d	NOUN	O	O
=	SYM	O	O
0.31)	NUM	O	O
than	ADP	O	O
the	DET	O	O
comparison	NOUN	O	O
group.	VERB	O	O

Results:	NOUN	O	O
The	DET	O	O
self-assessment	ADJ	O	O
scores	NOUN	O	O
of	ADP	O	O
WDCs'	NOUN	O	O
capacity	NOUN	O	O
to	PART	O	O
fulfil	NOUN	O	O
their	ADJ	O	O
roles	NOUN	O	O
improved	VERB	O	O
more	ADV	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
comparison	NOUN	O	O
area	NOUN	O	O
for	ADP	O	O
all	DET	O	O
six	NUM	O	O
components,	NOUN	O	O
but	CCONJ	O	O
for	ADP	O	O
only	ADV	O	O
1	NUM	O	O
of	ADP	O	O
the	DET	O	O
6	NUM	O	O
was	VERB	O	O
the	DET	O	O
improvement	NOUN	O	O
statistically	ADV	O	O
significant	ADJ	O	O
(monthly	NUM	O	O
and	CCONJ	O	O
quarterly	ADV	O	O
meetings	NOUN	O	O
in	ADP	O	O
which	ADP	O	O
Peer	NOUN	O	O
Supervisor	NOUN	O	O
and/or	CCONJ	O	O
CHW	NOUN	O	O
supervision	NOUN	O	O
was	VERB	O	O
an	DET	O	O
agenda	NOUN	O	O
item).	NOUN	O	O

Data	NOUN	O	O
were	VERB	O	O
analysed	VERB	O	O
using	VERB	O	O
Systematic	ADJ	O	O
Text	VERB	O	O
Condensation.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/04	PUNCT	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Results:	NOUN	O	O
Twenty-four	NUM	O	O
children	NOUN	O	O
with	ADP	O	O
HIV	NOUN	O	O
and/or	CCONJ	O	O
PHE	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
one	NUM	O	O
of	ADP	O	O
the	DET	O	O
two	NUM	O	O
intervention	NOUN	O	O
groups.	NOUN	O	O

Journal-Name:JAMA	NOUN	O	O

Participants	NOUN	O	O
were	VERB	O	O
followed	VERB	O	O
for	ADP	O	O
1	NUM	O	O
year.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Ambulatory	ADJ	O	O
patients	NOUN	O	O
receiving	VERB	O	O
systemic	ADJ	O	O
cancer	NOUN	O	O
therapy	NOUN	O	O
are	VERB	O	O
at	ADP	O	O
varying	VERB	O	O
risk	NOUN	O	O
for	ADP	O	O
venous	ADJ	O	O
thromboembolism.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Dental	ADJ	O	B-outcome
,	PUNCT	O	O
skeletal	ADJ	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
soft	NOUN	O	B-outcome
tissue	NOUN	O	I-outcome
measurements	NOUN	O	O
were	VERB	O	O
performed	VERB	O	O
on	ADP	O	O
lateral	ADJ	O	O
cephalograms	NOUN	O	O
taken	VERB	O	O
just	ADV	O	O
before	ADP	O	O
and	CCONJ	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Herbst	NOUN	O	O
appliance	NOUN	O	O
therapy.	NOUN	O	O

Journal-Name:Indian	NOUN	O	O
heart	NOUN	O	O
journal	ADJ	O	O

RESULTS:	NOUN	O	O
Seventy-one	NUM	O	O
patients	NOUN	O	O
(45%	PUNCT	O	O
PAH,	NOUN	O	O
55%	NOUN	O	O
CTEPH;	NOUN	O	O
53.5%	NOUN	O	O
female;	NOUN	O	O
60	NUM	O	O
+/-	SYM	O	O
13	NUM	O	O
years,	NOUN	O	O
mean	NOUN	O	O
pulmonary	ADJ	O	O
arterial	ADJ	O	O
pressure	NOUN	O	O
46	NUM	O	O
+/-	SYM	O	O
10	NUM	O	O
mmHg,	NOUN	O	O
mean	NOUN	O	O
PVR	NOUN	O	O
700	NUM	O	O
+/-	SYM	O	O
282dynes.sec.cm-5)	NUM	O	O
were	VERB	O	O
included.	NOUN	O	O

Five	NUM	O	O
of	ADP	O	O
7	NUM	O	O
household	NOUN	O	O
behaviors	NOUN	O	O
judged	VERB	O	O
to	PART	O	O
be	VERB	O	O
amenable	ADJ	O	O
to	PART	O	O
promotion	NOUN	O	O
by	ADP	O	O
CHWs	NOUN	O	O
improved	VERB	O	O
more	ADV	O	O
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
area	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
comparison	NOUN	O	O
area,	NOUN	O	O
and	CCONJ	O	O
2	NUM	O	O
out	ADP	O	O
of	ADP	O	O
the	DET	O	O
5	NUM	O	O
were	VERB	O	O
statistically	ADV	O	O
significant	ADJ	O	O
(feeding	VERB	O	O
colostrum	NOUN	O	O
and	CCONJ	O	O
appropriate	ADJ	O	O
infant	NOUN	O	O
and	CCONJ	O	O
young	ADJ	O	O
child	NOUN	O	O
feeding).	NUM	O	O

We	PRON	O	O
measured	VERB	O	O
and	CCONJ	O	O
compare	NOUN	O	O
the	DET	O	O
knowledge	NOUN	O	B-outcome
of	ADP	O	I-outcome
and	CCONJ	O	Seperator
incidences	NOUN	O	X
of	NOUN	O	X
hand	NOUN	O	B-outcome
food	NOUN	O	I-outcome
mouth	NOUN	O	I-outcome
disease	NOUN	O	E4-outcome
between	ADP	O	O
2	NUM	O	O
groups.	NOUN	O	O

Outcomes	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
assessed	VERB	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
3,	NOUN	O	O
6,	NOUN	O	O
and	CCONJ	O	O
10	NUM	O	O
weeks	NOUN	O	O
after	ADP	O	O
screening.	NOUN	O	O

Trial	NOUN	O	O
Registration:	NOUN	O	O
ISRCTN53448131.	NOUN	O	O

Compared	VERB	O	O
with	ADP	O	O
SFC,	ADP	O	O
IND/GLY	NOUN	O	O
treatment	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
reductions	NOUN	O	O
in	ADP	O	O
the	DET	O	O
annualized	VERB	O	O
rates	NOUN	O	O
of	ADP	O	O
moderate/severe	ADV	O	O
exacerbations	NOUN	O	B-outcome
(rate	NOUN	O	O
ratio	NOUN	O	O
[95%	NOUN	O	O
CI]:	ADP	O	O
0.81	NUM	O	O
[0.73-0.91],	NUM	O	O
0.89	NUM	O	O
[0.74-1.07]	NOUN	O	O
in	ADP	O	O
men	NOUN	O	O
and	CCONJ	O	O
women,	NOUN	O	O
respectively).	NOUN	O	O

Electromyographic	ADJ	O	O
analysis	NOUN	O	O
of	ADP	O	O
the	DET	O	O
pectoralis	NOUN	O	O
major	ADJ	O	O
and	CCONJ	O	O
triceps	ADP	O	O
brachii	ADJ	O	O
were	VERB	O	O
monitored	VERB	O	O
during	ADP	O	O
3	NUM	O	O
maximal	ADJ	O	O
isometric	ADJ	O	O
contractions	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
fatiguing	VERB	O	O
endurance	NOUN	O	O
task.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
The	DET	O	O
objective	ADP	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
was	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
enhancement	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
aorta	NOUN	O	O
and	CCONJ	O	O
liver	NOUN	O	O
on	ADP	O	O
hepatic	ADJ	O	O
dynamic	ADJ	O	O
computed	VERB	O	O
tomography	NOUN	O	O
scans	NOUN	O	O
acquired	VERB	O	O
with	ADP	O	O
contrast	NOUN	O	O
material	ADJ	O	O
doses	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
the	DET	O	O
lean	ADJ	O	O
body	NOUN	O	O
weight	NOUN	O	O
(LBW)	NUM	O	O
or	CCONJ	O	O
the	DET	O	O
total	ADJ	O	O
body	NOUN	O	O
weight	NOUN	O	O
(TBW).	PUNCT	O	O

Does	VERB	O	O
the	DET	O	O
timing	VERB	O	O
of	ADP	O	O
hCG	NOUN	O	O
support	NOUN	O	O
make	VERB	O	O
a	DET	O	O
difference?	NOUN	O	O

Cumulative	ADJ	O	O
incidence	NOUN	O	O
and	CCONJ	O	O
relative	ADJ	O	O
risks	NOUN	O	O
with	ADP	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
intervals	NOUN	O	O
for	ADP	O	O
death	NOUN	O	B-outcome
from	ADP	O	I-outcome
any	DET	O	Seperator
cause	ADP	O	I-outcome
,	PUNCT	O	O
death	NOUN	O	B-outcome
from	ADP	O	I-outcome
prostate	NOUN	O	I-outcome
cancer	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
metastasis	NOUN	O	B-outcome
were	VERB	O	O
estimated	VERB	O	O
in	ADP	O	O
intention-to-treat	NOUN	O	O
and	CCONJ	O	O
per-protocol	NOUN	O	O
analyses,	NOUN	O	O
and	CCONJ	O	O
numbers	NOUN	O	O
of	ADP	O	O
years	NOUN	O	O
of	ADP	O	O
life	NOUN	O	O
gained	VERB	O	O
were	VERB	O	O
estimated.	NOUN	O	O

Title:	NOUN	O	O
Impact	NOUN	O	O
of	ADP	O	O
a	DET	O	O
Local	ADJ	O	O
Vision	NOUN	O	O
Care	NOUN	O	O
Center	NOUN	O	O
on	ADP	O	O
Glasses	NOUN	O	B-outcome
Ownership	NOUN	O	I-outcome
and	CCONJ	O	O
Wearing	VERB	O	B-outcome
Behavior	NOUN	O	I-outcome
in	ADP	O	O
Northwestern	ADJ	O	O
Rural	ADJ	O	O
China:	NOUN	O	O
A	DET	O	O
Cluster-Randomized	VERB	O	O
Controlled	VERB	O	O
Trial.	NOUN	O	O

CONCLUSION:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
does	VERB	O	O
not	ADV	O	O
support	NOUN	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
TENS	NOUN	O	O
in	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
LBP	NOUN	O	O
even	ADV	O	O
though	ADP	O	O
patients	NOUN	O	O
benefited	VERB	O	O
from	ADP	O	O
a	DET	O	O
therapeutic	ADJ	O	O
education	NOUN	O	O
program	NOUN	O	O
by	ADP	O	O
a	DET	O	O
pain	NOUN	O	O
resource	NOUN	O	O
nurse.	NOUN	O	O

Trial	NOUN	O	O
registered	VERB	O	O
with	ADP	O	O
Current	ADJ	O	O
Controlled	VERB	O	O
Trials,	NOUN	O	O
number	NOUN	O	O
ISRCTN17975376.	NOUN	O	O

Journal-Name:Zhonghua	NOUN	O	O
yi	ADP	O	O
xue	NOUN	O	O
za	ADP	O	O
zhi	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/31	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Contours	NOUN	O	O
were	VERB	O	O
analysed	VERB	O	O
with	ADP	O	O
Monaco	ADJ	O	O
ADMIRE	ADV	O	O
(research	NUM	O	O
v.	ADP	O	O
2.0)	NUM	O	O
to	PART	O	O
assess	NOUN	O	O
interobserver	ADV	O	O
variability	NOUN	O	O
and	CCONJ	O	O
accuracy	NOUN	O	O
by	ADP	O	O
comparison	NOUN	O	O
with	ADP	O	O
a	DET	O	O
gold	NOUN	O	O
standard	ADJ	O	O
clinician	NOUN	O	O
contour.	NOUN	O	O

The	DET	O	O
mean	NOUN	O	O
number	NOUN	O	O
of	ADP	O	O
accurate	ADJ	O	O
lifestyle	NOUN	O	B-outcome
factors	NOUN	O	I-outcome
(that	PUNCT	O	O
could	VERB	O	O
affect	NOUN	O	O
fertility)	ADV	O	O
mentioned	VERB	O	O
increased	VERB	O	O
from	ADP	O	O
3.6	NUM	O	O
to	PART	O	O
4.4	NUM	O	O
(P	NUM	O	O
<	SYM	O	O
0.001)	NUM	O	O
in	ADP	O	O
the	DET	O	O
IG.	NOUN	O	O

BACKGROUND/AIM:	NOUN	O	O
The	DET	O	O
analysis	NOUN	O	O
of	ADP	O	O
prognostic	ADJ	O	O
factors	NOUN	O	O
is	VERB	O	O
important	ADJ	O	O
to	PART	O	O
identify	NOUN	O	O
determinants	NOUN	O	O
of	ADP	O	O
disease-free	ADJ	O	O
survival	NOUN	O	O
(DFS)	NOUN	O	O
and	CCONJ	O	O
overall	ADJ	O	O
survival	NOUN	O	O
(OS)	NOUN	O	O
in	ADP	O	O
resected	VERB	O	O
non-small-cell	NOUN	O	O
lung	NOUN	O	O
cancer	NOUN	O	O
(NSCLC).	PUNCT	O	O

Funded	VERB	O	O
by	ADP	O	O
the	DET	O	O
British	NOUN	O	O
Heath	NOUN	O	O
Foundation	NOUN	O	O
and	CCONJ	O	O
others;	NOUN	O	O
Current	ADJ	O	O
Controlled	VERB	O	O
Trials	NOUN	O	O
number,	ADV	O	O
ISRCTN46552265	NOUN	O	O
.).	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
82	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
UIAS	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
2	NUM	O	O
groups	NOUN	O	O
that	ADP	O	O
received	VERB	O	O
NMES	NOUN	O	O
therapy	NOUN	O	O
(NMES	PUNCT	O	O
group)	ADJ	O	O
or	CCONJ	O	O
sham	NOUN	O	O
NMES	NOUN	O	O
(sham	PUNCT	O	O
group)	ADJ	O	O
for	ADP	O	O
10	NUM	O	O
weeks.	NOUN	O	O

POC	NOUN	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
group	NOUN	O	O
A	DET	O	O
(n=40)	NOUN	O	O
and	CCONJ	O	O
group	NOUN	O	O
B	NOUN	O	O
(n=39).	NOUN	O	O

Belatacept	NOUN	O	O
serum	NOUN	O	O
concentrations	NOUN	O	O
were	VERB	O	O
determined	VERB	O	O
at	ADP	O	O
several	ADJ	O	O
time	NOUN	O	O
points	NOUN	O	O
between	ADP	O	O
belatacept	ADV	O	O
infusions.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/12	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Participants	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
administered	VERB	O	O
loading	VERB	O	O
doses	NOUN	O	O
of	ADP	O	O
prasugrel	NOUN	O	O
60	NUM	O	O
mg	NOUN	O	O
(group	PUNCT	O	O
A,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
166)	NOUN	O	O
or	CCONJ	O	O
30	NUM	O	O
mg	NOUN	O	O
(group	PUNCT	O	O
B,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
166)	NOUN	O	O
before	ADP	O	O
undergoing	VERB	O	O
elective	ADJ	O	O
PCI	NOUN	O	O
in	ADP	O	O
a	DET	O	O
1:1	ADJ	O	O
manner.	NOUN	O	O

Conclusions:	NOUN	O	O
Tretinoin	NOUN	O	O
0.05%	NUM	O	O
lotion	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
more	ADV	O	O
effective	ADJ	O	O
than	ADP	O	O
its	ADJ	O	O
vehicle	NOUN	O	O
in	ADP	O	O
achieving	VERB	O	O
treatment	NOUN	O	B-outcome
success	NOUN	O	I-outcome
and	CCONJ	O	O
reducing	VERB	O	O
inflammatory	ADJ	O	O
and	CCONJ	O	O
noninflammatory	ADJ	O	O
acne	NOUN	O	O
lesions	NOUN	O	B-outcome
in	ADP	O	O
a	DET	O	O
Hispanic	ADJ	O	O
population.	ADV	O	O

A	DET	O	O
significance	NOUN	O	O
level	NOUN	O	O
of	ADP	O	O
p	NOUN	O	O
<	SYM	O	O
0.05	NUM	O	O
was	VERB	O	O
established.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8208604	NUM	O	O

Furthermore,	NOUN	O	O
we	PRON	O	O
identified	VERB	O	O
two	NUM	O	O
different	ADJ	O	O
pathways	NOUN	O	O
characterizing	VERB	O	O
ways	NOUN	O	O
to	PART	O	O
success	NOUN	O	O
(consistency:	NOUN	O	O
81%,	NUM	O	O
coverage:	NOUN	O	O
52%).	NOUN	O	O

lacrimal	ADJ	O	O
duct	NOUN	O	O
probing	VERB	O	O
is	VERB	O	O
the	DET	O	O
major	ADJ	O	O
treatment.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Both	CCONJ	O	O
techniques	NOUN	O	O
were	VERB	O	O
effective	ADJ	O	O
in	ADP	O	O
the	DET	O	O
short-term	NOUN	O	O
(18-30	NOUN	O	O
months)	NOUN	O	O
in	ADP	O	O
treatment	NOUN	O	O
of	ADP	O	O
recurrent	ADP	O	O
patellar	ADJ	O	O
dislocation.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Eligible	ADJ	O	O
patients	NOUN	O	O
were	VERB	O	O
stratified	VERB	O	O
by	ADP	O	O
type	NOUN	O	O
2	NUM	O	O
diabetes	NOUN	O	O
status	NOUN	O	O
and	CCONJ	O	O
they	PRON	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
(1:1:1)	NUM	O	O
by	ADP	O	O
a	DET	O	O
computer-based	VERB	O	O
system	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
subcutaneous	ADJ	O	O
injections	NOUN	O	O
of	ADP	O	O
placebo	NOUN	O	O
once	ADP	O	O
a	DET	O	O
day,	ADP	O	O
10	NUM	O	O
mg	NOUN	O	O
pegbelfermin	NOUN	O	O
once	ADP	O	O
a	DET	O	O
day,	ADP	O	O
or	CCONJ	O	O
20	NUM	O	O
mg	NOUN	O	O
pegbelfermin	NOUN	O	O
once	ADP	O	O
a	DET	O	O
week,	NOUN	O	O
all	DET	O	O
for	ADP	O	O
16	NUM	O	O
weeks.	NOUN	O	O

In	ADP	O	O
as-treated	VERB	O	O
analyses,	NOUN	O	O
participants	NOUN	O	O
in	ADP	O	O
the	DET	O	O
decolonization	NOUN	O	O
group	NOUN	O	O
who	ADP	O	O
adhered	VERB	O	O
fully	ADV	O	O
to	PART	O	O
the	DET	O	O
regimen	NOUN	O	O
had	VERB	O	O
44%	NOUN	O	O
fewer	ADJ	O	O
MRSA	NOUN	O	B-outcome
infections	NOUN	O	I-outcome
than	ADP	O	O
the	DET	O	O
education	NOUN	O	O
group	NOUN	O	O
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
0.56;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.36	NUM	O	O
to	PART	O	O
0.86)	NUM	O	O
and	CCONJ	O	O
had	VERB	O	O
40%	NUM	O	O
fewer	ADJ	O	O
infections	NOUN	O	B-outcome
from	ADP	O	O
any	DET	O	O
cause	ADP	O	O
(hazard	PUNCT	O	O
ratio,	NOUN	O	O
0.60;	NOUN	O	O
95%	NOUN	O	O
CI,	NOUN	O	O
0.46	NUM	O	O
to	PART	O	O
0.78).	NUM	O	O

30	NUM	O	O
individuals	NOUN	O	O
with	ADP	O	O
CD	NOUN	O	O
were	VERB	O	O
divided	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups:	NOUN	O	O
16	NUM	O	O
in	ADP	O	O
the	DET	O	O
experimental	ADJ	O	O
group	NOUN	O	O
(EG)	NOUN	O	O
and	CCONJ	O	O
14	NUM	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(CG).	NUM	O	O

The	DET	O	O
chi	NOUN	O	O
independent	ADJ	O	O
test	NOUN	O	O
or	CCONJ	O	O
2-tailed	VERB	O	O
paired	VERB	O	O
t	NOUN	O	O
test	NOUN	O	O
were	VERB	O	O
performed	VERB	O	O
for	ADP	O	O
statistical	ADJ	O	O
analysis.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

BACKGROUND:	NOUN	O	O
Medical	ADJ	O	O
researchers	NOUN	O	O
have	VERB	O	O
been	VERB	O	O
reluctant	NOUN	O	O
to	PART	O	O
use	NOUN	O	O
neuromuscular	ADJ	O	O
blocking	VERB	O	O
drugs	NOUN	O	O
(NMBD)	NUM	O	O
during	ADP	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
intraoperative	ADJ	O	O
motor	NOUN	O	O
evoked	VERB	O	O
potential	ADJ	O	O
(MEP)	PUNCT	O	O
monitoring	VERB	O	O
despite	ADP	O	O
the	DET	O	O
possibility	NOUN	O	O
of	ADP	O	O
patient	NOUN	O	O
movement.	NOUN	O	O

Additional	ADJ	O	O
analyses	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
changes	NOUN	O	O
in	ADP	O	O
active	ADJ	O	B-outcome
B12	NOUN	O	I-outcome
,	PUNCT	O	O
HcY	NOUN	O	B-outcome
and	CCONJ	O	O
folate	NOUN	O	B-outcome
measures	NOUN	O	O
during	ADP	O	O
WPI	NOUN	O	O
treatment	NOUN	O	O
correlated	VERB	O	O
with	ADP	O	O
improvements	NOUN	O	O
in	ADP	O	O
cognitive	ADJ	O	B-outcome
function	NOUN	O	I-outcome
(all	PUNCT	O	O
p	NOUN	O	O
<	SYM	O	O
0.05).	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Clinical	ADJ	O	O
assessments,	NOUN	O	O
including	VERB	O	O
neurological	ADJ	O	O
examination	NOUN	O	O
and	CCONJ	O	O
EDSS	NOUN	O	O
scoring,	NOUN	O	O
were	VERB	O	O
conducted	VERB	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
at	ADP	O	O
weeks	NOUN	O	O
12	NUM	O	O
and	CCONJ	O	O
24.	NUM	O	O

The	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
given	VERB	O	O
routine	ADJ	O	O
treatment	NOUN	O	O
and	CCONJ	O	O
respiratory	ADJ	O	O
function	NOUN	O	O
exercise,	NOUN	O	O
and	CCONJ	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
observation	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
given	VERB	O	O
nursing	VERB	O	O
intervention	NOUN	O	O
in	ADP	O	O
addition	NOUN	O	O
to	PART	O	O
the	DET	O	O
treatment	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

The	DET	O	O
original	ADJ	O	O
trial	NOUN	O	O
(number,	NOUN	O	O
NCT00678275)	NOUN	O	O
and	CCONJ	O	O
follow-up	NOUN	O	O
extension	NOUN	O	O
(number,	NOUN	O	O
NCT03042676)	NOUN	O	O
are	VERB	O	O
registered	VERB	O	O
at	ADP	O	O
ClinicalTrials.gov.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
dose-finding	VERB	O	O
randomized	VERB	O	O
Phase	NOUN	O	O
II	NUM	O	O
study	NOUN	O	O
of	ADP	O	O
oral	ADJ	O	O
netupitant	ADJ	O	O
in	ADP	O	O
combination	NOUN	O	O
with	ADP	O	O
palonosetron	NOUN	O	O
.75	NUM	O	O
mg	NOUN	O	O
intravenous	ADJ	O	O
for	ADP	O	O
the	DET	O	O
prevention	NOUN	O	O
of	ADP	O	O
chemotherapy-induced	VERB	O	O
nausea	NOUN	O	B-outcome
and	CCONJ	O	O
vomiting	VERB	O	B-outcome
in	ADP	O	O
Japanese	NOUN	O	O
patients	NOUN	O	O
receiving	VERB	O	O
highly	ADV	O	O
emetogenic	ADJ	O	O
chemotherapy.	NOUN	O	O

PE	NOUN	O	O
teachers	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
29)	NOUN	O	O
from	ADP	O	O
eleven	NUM	O	O
schools	NOUN	O	O
will	VERB	O	O
apply	NOUN	O	O
the	DET	O	O
intervention	NOUN	O	O
program	NOUN	O	O
to	PART	O	O
students	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
502)	NOUN	O	O
in	ADP	O	O
PE	NOUN	O	O
classes	NOUN	O	O
for	ADP	O	O
one	NUM	O	O
month.	NOUN	O	O

Title:	NOUN	O	O
Prognostic	ADJ	O	O
Factors	NOUN	O	O
in	ADP	O	O
Early-stage	NOUN	O	O
NSCLC:	NOUN	O	O
Analysis	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Placebo	NOUN	O	O
Group	NOUN	O	O
in	ADP	O	O
the	DET	O	O
MAGRIT	NOUN	O	O
Study.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Findings	NOUN	O	O
highlight	NOUN	O	O
the	DET	O	O
complexity	NOUN	O	O
of	ADP	O	O
implementing	VERB	O	O
a	DET	O	O
mhGAP-based	VERB	O	O
training	VERB	O	O
given	VERB	O	O
its	ADJ	O	O
interaction	NOUN	O	O
with	ADP	O	O
contextual	ADJ	O	O
factors	NOUN	O	O
to	PART	O	O
influence	NOUN	O	O
the	DET	O	O
attainment	NOUN	O	O
of	ADP	O	O
expected	VERB	O	O
outcomes.	ADJ	O	O

Conclusion:Compared	VERB	O	O
with	ADP	O	O
CHOP+IMRT	NOUN	O	O
regimen,	NOUN	O	O
the	DET	O	O
LOP+IMRT	NOUN	O	O
regimen	NOUN	O	O
for	ADP	O	O
nasal	ADJ	O	O
NK/T-cell	NOUN	O	O
lymphoma	NOUN	O	O
patients	NOUN	O	O
resulted	VERB	O	O
in	ADP	O	O
higher	ADJ	O	O
overall	ADJ	O	O
remission	NOUN	O	B-outcome
rate,	NOUN	O	O
survival	NOUN	O	B-outcome
rate	NOUN	O	O
and	CCONJ	O	O
lower	ADJ	O	O
adverse	ADJ	O	B-outcome
reactions	NOUN	O	I-outcome
,	PUNCT	O	O
so	ADV	O	O
it	PRON	O	O
is	VERB	O	O
worth	ADP	O	O
in	ADP	O	O
clinical	ADJ	O	O
promotion.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Multicenter	NOUN	O	O
Study	NOUN	O	O

Patient	NOUN	O	O
follow-up	NOUN	O	O
to	PART	O	O
3	NUM	O	O
months	NOUN	O	O
was	VERB	O	O
completed	VERB	O	O
on	ADP	O	O
April	NOUN	O	O
12,	NUM	O	O
2018.	NUM	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
foot	NOUN	O	O
and	CCONJ	O	O
ankle	NOUN	O	O
research	NOUN	O	O

Under	ADP	O	O
VCV	NOUN	O	O
mode,	NOUN	O	O
the	DET	O	O
levels	NOUN	O	O
of	ADP	O	O
peak	NOUN	O	B-outcome
airway	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
and	CCONJ	O	O
exhaled	VERB	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
were	VERB	O	O
increased	VERB	O	O
with	ADP	O	O
the	DET	O	O
increase	NOUN	O	O
in	ADP	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow,	NOUN	O	O
and	CCONJ	O	O
there	PRON	O	O
was	VERB	O	O
significant	ADJ	O	O
difference	NOUN	O	O
at	ADP	O	O
9	NUM	O	O
L/min	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
those	DET	O	O
before	ADP	O	O
atomization	NOUN	O	O
[	PUNCT	O	O
peak	NOUN	O	B-outcome
airway	NOUN	O	I-outcome
pressure	NOUN	O	I-outcome
(cmH2O):	PUNCT	O	O
29.44+/-4.58	NUM	O	O
vs.	CCONJ	O	O
24.39+/-4.64,	PUNCT	O	O
exhaled	VERB	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
(mL):	NOUN	O	O
896.26+/-24.91	NUM	O	O
vs.	CCONJ	O	O
497.61+/-8.67,	NOUN	O	O
both	CCONJ	O	O
P	NOUN	O	O
<	SYM	O	O
0.05].	NUM	O	O
There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
change	NOUN	O	O
in	ADP	O	O
inspiratory	ADJ	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
at	ADP	O	O
9	NUM	O	O
L/min	NOUN	O	O
of	ADP	O	O
atomized	VERB	O	O
oxygen	NOUN	O	O
flow	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
that	ADP	O	O
before	ADP	O	O
atomization	NOUN	O	O
(mL:	PUNCT	O	O
494.67+/-3.07	NOUN	O	O
vs.	CCONJ	O	O
492.61+/-6.05,	NOUN	O	O
P	NOUN	O	O
>	SYM	O	O
0.05).	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
no	DET	O	O
significant	ADJ	O	O
difference	NOUN	O	O
in	ADP	O	O
Pittsburgh	NOUN	O	O
Sleep	NOUN	O	B-outcome
Quality	NOUN	O	I-outcome
Index	NOUN	O	O
(PSQI)	NOUN	O	O
score	NOUN	O	O
and	CCONJ	O	O
Treatment	NOUN	O	O
Emergent	ADJ	O	O
Symptom	NOUN	O	O
Scale	NOUN	O	O
(TESS)	ADP	O	O
score	NOUN	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Systematic	ADJ	O	O
pelvic	ADJ	O	O
and	CCONJ	O	O
paraaortic	ADJ	O	O
lymphadenectomy	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
widely	ADV	O	O
used	VERB	O	O
in	ADP	O	O
the	DET	O	O
surgical	ADJ	O	O
treatment	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
advanced	VERB	O	O
ovarian	ADJ	O	O
cancer,	NOUN	O	O
although	ADP	O	O
supporting	VERB	O	O
evidence	NOUN	O	O
from	ADP	O	O
randomized	VERB	O	O
clinical	ADJ	O	O
trials	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
limited.	NOUN	O	O

One	NUM	O	O
hundred	NUM	O	O
and	CCONJ	O	O
thirty	NUM	O	O
adult	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
T2DM	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
discharged	VERB	O	O
to	PART	O	O
the	DET	O	O
community	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
either	CCONJ	O	O
the	DET	O	O
intervention	NOUN	O	O
or	CCONJ	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

STUDY	NOUN	O	O
IDENTIFICATION	NOUN	O	O
AND	CCONJ	O	O
TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Study	NOUN	O	O
Identification:	NOUN	O	O
EVOLVE-1	NOUN	O	O
(I5Q-MC-CGAG);	NUM	O	O
EVOLVE-2	NOUN	O	O
(I5Q-MC-CGAH);	NUM	O	O
REGAIN	NOUN	O	O
(I5Q-MC-CGAI)	NOUN	O	O
TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
ClinicalTrials.gov	NOUN	O	O
;	PUNCT	O	O
NCT02614183	NOUN	O	O
(EVOLVE-1);	NOUN	O	O
NCT02614196	NOUN	O	O
(EVOLVE-2);	PUNCT	O	O
NCT02614261	NOUN	O	O
(REGAIN).	NOUN	O	O

Before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
supplementation,	NOUN	O	O
we	PRON	O	O
determined	VERB	O	O
plasma	NOUN	O	O
fatty	ADJ	O	B-outcome
acid	NOUN	O	I-outcome
concentrations,	NOUN	O	O
latencies	NOUN	O	O
of	ADP	O	O
visually	ADV	O	B-outcome
evoked	VERB	O	I-outcome
potentials	NOUN	O	I-outcome
,	PUNCT	O	O
fine	ADV	O	B-outcome
and	CCONJ	O	Seperator
gross	ADJ	O	B-outcome
motor	NOUN	O	I-outcome
behaviour	NOUN	O	E2-outcome
,	PUNCT	O	O
and	CCONJ	O	O
IQ	NOUN	O	B-outcome
.	PUNCT	O	O
Fatty	ADJ	O	O
acid	NOUN	O	O
desaturase	NOUN	O	O
genotypes	NOUN	O	O
were	VERB	O	O
also	ADV	O	O
determined.	NOUN	O	O

We	PRON	O	O
also	ADV	O	O
examined	VERB	O	O
how	ADP	O	O
health	NOUN	O	O
warning	VERB	O	O
severity	NOUN	O	O
influences	NOUN	O	O
these	DET	O	O
reactions	NOUN	O	B-outcome
and	CCONJ	O	O
whether	ADP	O	O
there	PRON	O	O
is	VERB	O	O
an	DET	O	O
interaction	NOUN	O	O
between	ADP	O	O
self-affirmation	NOUN	O	O
and	CCONJ	O	O
severity.	DET	O	O

PARTICIPANTS:	NOUN	O	O
13	NUM	O	O
046	NUM	O	O
women	NOUN	O	O
aged	VERB	O	O
16	NUM	O	O
years	NOUN	O	O
or	CCONJ	O	O
older	ADJ	O	O
with	ADP	O	O
a	DET	O	O
low	ADJ	O	O
risk	NOUN	O	O
singleton	NOUN	O	O
pregnancy.	NOUN	O	O

After	ADP	O	O
baseline	NOUN	O	O
competency	NOUN	O	O
assessment,	NOUN	O	O
parents	NOUN	O	O
received	VERB	O	O
instruction	NOUN	O	O
according	ADJ	O	O
to	PART	O	O
their	ADJ	O	O
group.	VERB	O	O

METHODS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
98	NUM	O	O
dyslipidemic	ADJ	O	O
patients	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
and	CCONJ	O	O
divided	VERB	O	O
into	ADP	O	O
amla	NOUN	O	O
and	CCONJ	O	O
placebo	NOUN	O	O
groups.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8200894	NUM	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

However,	ADV	O	O
we	PRON	O	O
found	VERB	O	O
that	ADP	O	O
using	VERB	O	O
the	DET	O	O
motion	NOUN	O	O
tracking	VERB	O	O
device	NOUN	O	O
led	VERB	O	O
to	PART	O	O
transfer	NOUN	O	B-outcome
of	ADP	O	O
performance	NOUN	O	O
to	PART	O	O
the	DET	O	O
touchscreen.	NOUN	O	O

Journal-Name:Complementary	ADJ	O	O
therapies	NOUN	O	O
in	ADP	O	O
clinical	ADJ	O	O
practice	NOUN	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
of	ADP	O	O
sufentanil-midazolam	NOUN	O	O
and	CCONJ	O	O
sevoflurane	NOUN	O	O
for	ADP	O	O
anesthesia	NOUN	O	O
induction	NOUN	O	O
in	ADP	O	O
children	NOUN	O	O
undergoing	VERB	O	O
cardiac	ADJ	O	O
surgery	NOUN	O	O
by	ADP	O	O
real-time	NOUN	O	O
hemodynamic	ADJ	O	B-outcome
and	CCONJ	O	O
cardiac	ADJ	O	B-outcome
efficiency	NOUN	O	O
monitoring:	NOUN	O	O
A	DET	O	O
prospective	ADJ	O	O
randomized	VERB	O	O
study.	NOUN	O	O

In	ADP	O	O
addition,	NOUN	O	O
gene	NOUN	O	O
expression	NOUN	O	O
analysis	NOUN	O	O
in	ADP	O	O
PBMC	NOUN	O	O
showed	VERB	O	O
subtle	ADJ	O	O
changes	NOUN	O	O
in	ADP	O	O
superoxide	NOUN	O	B-outcome
metabolic	ADJ	O	I-outcome
processes.	NOUN	O	O

Compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
preoperative	ADJ	O	O
levels,	NOUN	O	O
serum	NOUN	O	O
cortisol	NOUN	O	B-outcome
level	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
the	DET	O	O
operation	NOUN	O	O
was	VERB	O	O
increased	VERB	O	O
in	ADP	O	O
the	DET	O	O
sedation	NOUN	O	O
group	NOUN	O	O
but	CCONJ	O	O
lowered	VERB	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
variations	NOUN	O	O
of	ADP	O	O
serum	NOUN	O	O
cortisol	NOUN	O	B-outcome
level	NOUN	O	O
differed	VERB	O	O
significantly	ADV	O	O
between	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
(t=4.75,	ADV	O	O
P	NOUN	O	O
&lt;	NOUN	O	O
0.01).	NOUN	O	O

The	DET	O	O
clinical	ADJ	O	O
examination	NOUN	O	O
included	VERB	O	O
hematology	NOUN	O	B-outcome
and	CCONJ	O	O
blood	NOUN	O	B-outcome
chemistry	NOUN	O	I-outcome
tests,	NOUN	O	O
urinalysis	ADV	O	B-outcome
,	PUNCT	O	O
vital	ADJ	O	B-outcome
signs	NOUN	O	I-outcome
,	PUNCT	O	O
body	NOUN	O	B-outcome
weight	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
electrocardiogram	NOUN	O	B-outcome
(ECG)	PUNCT	O	I-outcome
.	PUNCT	O	O
RESULTS:	NOUN	O	O
Eleven	NUM	O	O
adverse	ADJ	O	B-outcome
reactions	NOUN	O	I-outcome
were	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
ten	NUM	O	O
subjects	NOUN	O	O
receiving	VERB	O	O
BT-11	NOUN	O	O
while	ADP	O	O
seven	NUM	O	O
adverse	ADJ	O	B-outcome
reactions	NOUN	O	I-outcome
in	ADP	O	O
six	NUM	O	O
subjects	NOUN	O	O
receiving	VERB	O	O
placebo.	NOUN	O	O

The	DET	O	O
tendency	NOUN	O	O
to	PART	O	O
use	NOUN	O	O
different	ADJ	O	O
methods	NOUN	O	O
of	ADP	O	O
complementary	ADJ	O	O
medicine	NOUN	O	O
to	PART	O	O
control	NOUN	O	O
menopausal	ADJ	O	O
symptoms	NOUN	O	O
is	VERB	O	O
increasing.	NOUN	O	O

HR's	NOUN	O	O
for	ADP	O	O
erythromycin,	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
beta-lactam	NOUN	O	O
monotherapy,	ADJ	O	O
on	ADP	O	O
any	DET	O	O
cardiac	ADJ	O	B-outcome
event	NOUN	O	I-outcome
and	CCONJ	O	O
heart	NOUN	O	B-outcome
failure	NOUN	O	I-outcome
were	VERB	O	O
1.60	NUM	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
1.09;2.36)	NOUN	O	O
and	CCONJ	O	O
1.89	NUM	O	O
(95%	PUNCT	O	O
CI	NOUN	O	O
1.22;2.91),	NUM	O	O
respectively.	NOUN	O	O

Journal-Name:Medicine	NOUN	O	O

More	ADV	O	O
interestingly,	NOUN	O	O
preoperative	ADJ	O	O
analgesia	NOUN	O	O
group	NOUN	O	O
patients	NOUN	O	O
consumed	VERB	O	O
less	ADV	O	O
patient-controlled	VERB	O	O
analgesia	NOUN	O	B-outcome
compared	VERB	O	O
to	PART	O	O
postoperative	ADJ	O	O
analgesia	NOUN	O	O
group	NOUN	O	O
patients	NOUN	O	O
at	ADP	O	O
72	NUM	O	O
hours	NOUN	O	O
post	ADV	O	O
operation.	ADV	O	O

Results	NOUN	O	O
were	VERB	O	O
extrapolated	VERB	O	O
to	PART	O	O
two	NUM	O	O
years	NOUN	O	O
after	ADP	O	O
randomization.	NOUN	O	O

Whether	ADP	O	O
L-valine	NOUN	O	O
affects	NOUN	O	O
energy	NOUN	O	O
intake,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
gastrointestinal	ADJ	O	O
functions	NOUN	O	O
involved	VERB	O	O
in	ADP	O	O
the	DET	O	O
regulation	NOUN	O	O
of	ADP	O	O
energy	NOUN	O	O
intake,	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
blood	NOUN	O	O
glucose,	NOUN	O	O
in	ADP	O	O
humans,	NOUN	O	O
is	VERB	O	O
currently	ADV	O	O
unknown.	NOUN	O	O

However,	ADV	O	O
ED95	NOUN	O	O
is	VERB	O	O
more	ADV	O	O
meaningful	ADJ	O	O
to	PART	O	O
clinical	ADJ	O	O
practice	NOUN	O	O
than	ADP	O	O
ED50.	NOUN	O	O

PURPOSE:	NOUN	O	O
To	PART	O	O
determine	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
botulinum	NOUN	O	O
toxin	NOUN	O	O
type	NOUN	O	O
A	DET	O	O
(BTX-A)	PUNCT	O	O
injection	NOUN	O	O
on	ADP	O	O
dry	ADJ	O	B-outcome
eye	NOUN	O	I-outcome
signs	NOUN	O	I-outcome
,	PUNCT	O	Seperator
symptoms	NOUN	O	S2-outcome
,	PUNCT	O	O
and	CCONJ	O	O
tear	NUM	O	O
cytokine	NOUN	O	B-outcome
levels	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
intractable	ADJ	O	O
dry	ADJ	O	O
eye	NOUN	O	O
disease	NOUN	O	O
(DED).	NUM	O	O

Journal-Name:British	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
anaesthesia	NOUN	O	O

Journal-Name:Indian	NOUN	O	O
heart	NOUN	O	O
journal	ADJ	O	O

Journal-Name:Medicine	NOUN	O	O

Withdrawal	NOUN	O	B-outcome
symptoms	NOUN	O	I-outcome
declined	VERB	O	O
immediately	ADV	O	O
after	ADP	O	O
smoking	VERB	O	O
or	CCONJ	O	O
using	VERB	O	O
IQOS(TM),	NUM	O	O
and	CCONJ	O	O
with	ADP	O	O
some	DET	O	O
delay	NOUN	O	O
after	ADP	O	O
vaping.	NOUN	O	O

There	PRON	O	O
are	VERB	O	O
also	ADV	O	O
no	DET	O	O
studies	NOUN	O	O
that	ADP	O	O
establish	NOUN	O	O
a	DET	O	O
clear	ADJ	O	O
relationship	NOUN	O	O
between	ADP	O	O
EEN	NOUN	O	O
in	ADP	O	O
MAP	NOUN	O	O
and	CCONJ	O	O
levels	NOUN	O	O
of	ADP	O	O
albuminemia	NOUN	O	O
and	CCONJ	O	O
CRP.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
the	DET	O	O
International	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Sports	NOUN	O	O
Nutrition	NOUN	O	O

Patients	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
Ahmed	VERB	O	O
glaucoma	NOUN	O	O
valve	NOUN	O	O
implantation	NOUN	O	O
surgery	NOUN	O	O
from	ADP	O	O
August	NOUN	O	O
2015	NUM	O	O
to	PART	O	O
January	NOUN	O	O
2017	NUM	O	O
at	ADP	O	O
the	DET	O	O
Xiamen	NOUN	O	O
Eye	NOUN	O	O
Center	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
divided	VERB	O	O
into	ADP	O	O
2	NUM	O	O
groups.	NOUN	O	O

Adult	NOUN	O	O
mothers	NOUN	O	O
of	ADP	O	O
children	NOUN	O	O
born	VERB	O	O
in	ADP	O	O
participating	VERB	O	O
maternity	NOUN	O	O
wards	NOUN	O	O
were	VERB	O	O
recruited	VERB	O	O
between	ADP	O	O
March	NOUN	O	O
2014	NUM	O	O
and	CCONJ	O	O
February	ADJ	O	O
2015.	NUM	O	O

No	DET	O	O
statistical	ADJ	O	O
difference	NOUN	O	O
was	VERB	O	O
also	ADV	O	O
observed	VERB	O	O
in	ADP	O	O
safety	NOUN	O	O
laboratory	NOUN	O	O
tests,	NOUN	O	O
vital	ADJ	O	B-outcome
signs	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
electrocardiogram	NOUN	O	B-outcome
(ECG)	PUNCT	O	I-outcome
between	ADP	O	O
two	NUM	O	O
groups.	NOUN	O	O

Journal-Name:Radiation	NOUN	O	O
oncology	NOUN	O	O
(London,	PUNCT	O	O
England)	NOUN	O	O

Logistic	ADJ	O	O
regression	NOUN	O	O
analyses	NOUN	O	O
were	VERB	O	O
used	VERB	O	O
for	ADP	O	O
between	ADP	O	O
treatment	NOUN	O	O
comparisons.	NOUN	O	O

Statistically	ADV	O	O
significant	ADJ	O	O
differences	NOUN	O	O
in	ADP	O	O
cumulative	ADJ	O	O
QALYs	NOUN	O	O
and	CCONJ	O	O
costs	NOUN	O	B-outcome
were	VERB	O	O
found	VERB	O	O
at	ADP	O	O
six	NUM	O	O
and	CCONJ	O	O
12	NUM	O	O
months	NOUN	O	O
for	ADP	O	O
the	DET	O	O
decompression	NOUN	O	O
versus	CCONJ	O	O
no	DET	O	O
treatment	NOUN	O	O
comparison	NOUN	O	O
only.	NOUN	O	O

Refractory	ADJ	O	B-outcome
disease	NOUN	O	I-outcome
developed	VERB	O	O
in	ADP	O	O
no	DET	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
caplacizumab	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
three	NUM	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
placebo	NOUN	O	O
group.	VERB	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/04	ADP	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

BACKGROUND:	NOUN	O	O
Transcutaneous	ADJ	O	O
electrical	ADJ	O	O
nerve	NOUN	O	O
stimulation	NOUN	O	O
(TENS)	PUNCT	O	O
is	VERB	O	O
often	ADV	O	O
used	VERB	O	O
for	ADP	O	O
the	DET	O	O
treatment	NOUN	O	O
of	ADP	O	O
low-back	NOUN	O	O
pain	NOUN	O	O
(LBP).	NOUN	O	O

They	PRON	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
an	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
(410	NUM	O	O
participants)	NOUN	O	O
or	CCONJ	O	O
comparison	NOUN	O	O
group	NOUN	O	O
(202	NOUN	O	O
participants).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0414003	NUM	O	O

We	PRON	O	O
assessed	VERB	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
the	DET	O	O
interventions	NOUN	O	O
on	ADP	O	O
intensity	NOUN	O	B-outcome
of	ADP	O	I-outcome
low	ADJ	O	I-outcome
back	ADP	O	I-outcome
pain	NOUN	O	I-outcome
,	PUNCT	O	O
pain	NOUN	O	B-outcome
interfering	VERB	O	I-outcome
with	ADP	O	Seperator
work	NOUN	O	I-outcome
and	CCONJ	O	O
fear	ADJ	O	O
avoidance	NOUN	O	O
beliefs	NOUN	O	B-outcome
against	ADP	O	O
the	DET	O	O
Control,	NOUN	O	O
and	CCONJ	O	O
calculated	VERB	O	O
the	DET	O	O
incremental	ADJ	O	O
cost-effectiveness	NOUN	O	O
ratios	NOUN	O	O
for	ADP	O	O
sickness	NOUN	O	B-outcome
absence	NOUN	O	I-outcome
and	CCONJ	O	O
QALY.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0417355	NUM	O	O

CONCLUSIONS:	NOUN	O	O
Endometrial	ADJ	O	O
scratching	VERB	O	O
did	VERB	O	O
not	ADV	O	O
result	VERB	O	O
in	ADP	O	O
a	DET	O	O
higher	ADJ	O	O
rate	NOUN	O	O
of	ADP	O	O
live	ADJ	O	B-outcome
birth	NOUN	O	I-outcome
than	ADP	O	O
no	DET	O	O
intervention	NOUN	O	O
among	ADP	O	O
women	NOUN	O	O
undergoing	VERB	O	O
IVF.	NUM	O	O
(	PUNCT	O	O

Fatal	ADJ	O	B-outcome
adverse	ADJ	O	I-outcome
events	NOUN	O	I-outcome
occurred	VERB	O	O
in	ADP	O	O
seven	NUM	O	O
(3%)	ADV	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
A+CHP	ADV	O	O
group	NOUN	O	O
and	CCONJ	O	O
nine	NUM	O	O
(4%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
CHOP	VERB	O	O
group.	VERB	O	O

Each	DET	O	O
group	NOUN	O	O
was	VERB	O	O
subdivided	VERB	O	O
into	ADP	O	O
the	DET	O	O
3	NUM	O	O
classes	NOUN	O	O
based	VERB	O	O
on	ADP	O	O
the	DET	O	O
body	NOUN	O	O
mass	NOUN	O	O
index	NOUN	O	O
(BMI;	NUM	O	O
low,	PUNCT	O	O
normal,	ADJ	O	O
high).	NOUN	O	O

Twelve	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
treated	VERB	O	O
with	ADP	O	O
SuperPATH	NOUN	O	O
approach	NOUN	O	O
(SuperPATH	NOUN	O	O
group)	ADJ	O	O
and	CCONJ	O	O
12	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
posterolateral	ADJ	O	O
approach	NOUN	O	O
(control	PUNCT	O	O
group).	NOUN	O	O

Serum	NOUN	O	O
epinephrine	NOUN	O	B-outcome
in	ADP	O	O
group	NOUN	O	O
D	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
than	ADP	O	O
them	PRON	O	O
in	ADP	O	O
group	NOUN	O	O
C	NOUN	O	O
at	ADP	O	O
T(2),	NOUN	O	O
T(3),	NOUN	O	O
T(4),	NOUN	O	O
T(5)	ADJ	O	O
(t=6.153,	NOUN	O	O
8.774,	NOUN	O	O
9.127,	CCONJ	O	O
8.409,	NOUN	O	O
respectively;	NOUN	O	O
all	DET	O	O
P<0.05),	NOUN	O	O
but	CCONJ	O	O
there	PRON	O	O
were	VERB	O	O
no	DET	O	O
difference	NOUN	O	O
between	ADP	O	O
these	DET	O	O
two	NUM	O	O
groups	NOUN	O	O
at	ADP	O	O
T(0),	NOUN	O	O
T(1),	NOUN	O	O
T(6),	NOUN	O	O
T(7),	NOUN	O	O
T(8)(all	NOUN	O	O
P>0.05).	NOUN	O	O

During	ADP	O	O
the	DET	O	O
follow-up,	ADP	O	O
no	DET	O	O
loosening	VERB	O	B-outcome
or	CCONJ	O	O
migration	NOUN	O	B-outcome
was	VERB	O	O
observed.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
Randomized	VERB	O	O
Trial	NOUN	O	O
of	ADP	O	O
E-Cigarettes	NOUN	O	O
versus	CCONJ	O	O
Nicotine-Replacement	ADJ	O	O
Therapy.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7511141	NUM	O	O

Group	NOUN	O	O
A	DET	O	O
(n	NOUN	O	O
=	SYM	O	O
53)	NOUN	O	O
was	VERB	O	O
the	DET	O	O
single-shot	NOUN	O	O
group	NOUN	O	O
(16	NOUN	O	O
female	NOUN	O	O
patients	NOUN	O	O
and	CCONJ	O	O
37	NUM	O	O
male	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
a	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
of	ADP	O	O
63.9	NUM	O	O
years	NOUN	O	O
(sd	PUNCT	O	O
9.6)),	NOUN	O	O
group	NOUN	O	O
B	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
51)	NOUN	O	O
was	VERB	O	O
the	DET	O	O
24-hour	NOUN	O	O
infusion	NOUN	O	O
group	NOUN	O	O
(22	NOUN	O	O
female	NOUN	O	O
patients	NOUN	O	O
and	CCONJ	O	O
29	NUM	O	O
male	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
a	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
of	ADP	O	O
66.5	NUM	O	O
years	NOUN	O	O
(sd	PUNCT	O	O
8.5)),	NOUN	O	O
and	CCONJ	O	O
group	NOUN	O	O
C	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
52)	NOUN	O	O
was	VERB	O	O
the	DET	O	O
48-hour	NOUN	O	O
infusion	NOUN	O	O
group	NOUN	O	O
(18	NOUN	O	O
female	NOUN	O	O
patients	NOUN	O	O
and	CCONJ	O	O
34	NUM	O	O
male	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
a	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
of	ADP	O	O
62.2	NUM	O	O
years	NOUN	O	O
(sd	PUNCT	O	O
8.7)).	NOUN	O	O

The	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
short-	NOUN	O	O
and	CCONJ	O	O
long-TXA	NOUN	O	O
protocols	NOUN	O	O
in	ADP	O	O
the	DET	O	O
reduction	NOUN	O	O
of	ADP	O	O
perioperative	ADJ	O	O
real	ADJ	O	O
blood	NOUN	O	B-outcome
loss	NOUN	O	I-outcome
(RBL)	PUNCT	O	O
was	VERB	O	O
compared	VERB	O	O
with	ADP	O	O
a	DET	O	O
placebo	NOUN	O	O
group.	VERB	O	O

National	ADJ	O	O
and	CCONJ	O	O
Kapodistrian	ADJ	O	O
University	NOUN	O	O
of	ADP	O	O
Athens,	NOUN	O	O
Athens,	NOUN	O	O
Greece.	NOUN	O	O

Were	VERB	O	O
used	VERB	O	O
highly	ADV	O	B-outcome
sensitive	ADJ	O	I-outcome
troponin	NOUN	O	I-outcome
(HF-Tr)	PUNCT	O	I-outcome
and	CCONJ	O	O
creatine	NOUN	O	B-outcome
phosphokinase-MB	NOUN	O	I-outcome
as	ADP	O	O
an	DET	O	O
irreversible	ADJ	O	O
myocardial	ADJ	O	O
damage	NOUN	O	O
biomarkers.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

In	ADP	O	O
this	DET	O	O
study,	NOUN	O	O
we	PRON	O	O
investigated	VERB	O	O
mtDNA	ADJ	O	B-outcome
,	PUNCT	O	O
mitochondrial	ADJ	O	B-outcome
dynamics	NOUN	O	I-outcome
,	PUNCT	O	Seperator
function	NOUN	O	S1-outcome
and	CCONJ	O	O
metabolic	ADJ	O	O
pathways	NOUN	O	O
to	PART	O	O
determine	NOUN	O	O
if	ADP	O	O
mitochondrial	ADJ	O	O
damage	NOUN	O	O
plays	NOUN	O	O
a	DET	O	O
critical	ADJ	O	O
role	NOUN	O	O
in	ADP	O	O
the	DET	O	O
development	NOUN	O	O
of	ADP	O	O
tubular	ADJ	O	O
injury	NOUN	O	O
in	ADP	O	O
DKD	NOUN	O	O
patients.	NOUN	O	O

Title:	NOUN	O	O
[Effects	NOUN	O	O
of	ADP	O	O
early	ADJ	O	O
enteral	ADJ	O	O
nutrition	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
mild	ADJ	O	O
acute	ADJ	O	O
pancreatitis.	NOUN	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
of	ADP	O	O
prostate	NOUN	O	O
delineation	NOUN	O	O
on	ADP	O	O
multimodality	NOUN	O	O
imaging	VERB	O	O
for	ADP	O	O
MR-guided	VERB	O	O
radiotherapy.	NOUN	O	O

BACKGROUND:	NOUN	O	O
The	DET	O	O
onset	NOUN	O	O
of	ADP	O	O
puberty	NOUN	O	O
and	CCONJ	O	O
menarche	NOUN	O	O
is	VERB	O	O
a	DET	O	O
specifically	ADV	O	O
vulnerable	ADJ	O	O
time	NOUN	O	O
for	ADP	O	O
girls,	ADJ	O	O
during	ADP	O	O
which	ADP	O	O
they	PRON	O	O
begin	ADP	O	O
to	PART	O	O
show	VERB	O	O
interest	NOUN	O	O
in	ADP	O	O
the	DET	O	O
opposite	ADJ	O	O
sex,	NOUN	O	O
while	ADP	O	O
becoming	VERB	O	O
exposed	VERB	O	O
to	PART	O	O
a	DET	O	O
myriad	ADJ	O	O
of	ADP	O	O
external	ADJ	O	O
pressures,	ADP	O	O
including	VERB	O	O
sexual	ADJ	O	O
coercion	NOUN	O	O
or	CCONJ	O	O
harassment	ADV	O	O
from	ADP	O	O
boys	NOUN	O	O
and	CCONJ	O	O
men,	NOUN	O	O
expectations	NOUN	O	O
to	PART	O	O
marry	NOUN	O	O
from	ADP	O	O
their	ADJ	O	O
families,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
need	NOUN	O	O
to	PART	O	O
perform	NOUN	O	O
well	ADV	O	O
in	ADP	O	O
primary	ADJ	O	O
school	NOUN	O	O
in	ADP	O	O
order	NOUN	O	O
to	PART	O	O
qualify	NOUN	O	O
for	ADP	O	O
secondary	ADJ	O	O
school.	NOUN	O	O

All	DET	O	O
patients	NOUN	O	O
were	VERB	O	O
anaesthetized	VERB	O	O
(induced	NUM	O	O
and	CCONJ	O	O
maintained)	NOUN	O	O
with	ADP	O	O
intravenous	ADJ	O	O
target-controlled	VERB	O	O
infusion(TCl)	NOUN	O	O
of	ADP	O	O
propofol	NOUN	O	O
and	CCONJ	O	O
remifentanil,	ADV	O	O
and	CCONJ	O	O
intermittent	ADJ	O	O
intravenous	ADJ	O	O
injection	NOUN	O	O
of	ADP	O	O
cisatracuriumbesylate.	ADJ	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

BACKGROUND:	NOUN	O	O
Proprietary	ADJ	O	O
spearmint	NOUN	O	O
extract	NOUN	O	O
(PSE)	NOUN	O	O
containing	VERB	O	O
a	DET	O	O
minimum	NOUN	O	O
14.5%	NOUN	O	O
rosmarinic	ADJ	O	O
acid	NOUN	O	O
and	CCONJ	O	O
24%	NOUN	O	O
total	ADJ	O	O
phenolic	NOUN	O	O
content,	NOUN	O	O
has	VERB	O	O
evinced	VERB	O	O
positive	ADJ	O	O
effects	NOUN	O	O
on	ADP	O	O
cognition	NOUN	O	O
in	ADP	O	O
individuals	NOUN	O	O
aged	VERB	O	O
50-70	NUM	O	O
with	ADP	O	O
memory	NOUN	O	O
impairment	NOUN	O	O
after	ADP	O	O
chronic	ADJ	O	O
supplementation.	NOUN	O	O

A	DET	O	O
single	ADJ	O	O
agent	NOUN	O	O
to	PART	O	O
reduce	VERB	O	O
cholesterol	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
TG	NOUN	O	O
is	VERB	O	O
rare.	NOUN	O	O

All	DET	O	O
participants	NOUN	O	O
were	VERB	O	O
tested	VERB	O	O
(test-1)	PUNCT	O	O
following	VERB	O	O
an	DET	O	O
introductory	ADJ	O	O
course	NOUN	O	O
of	ADP	O	O
basic	ADJ	O	O
ultrasonography.	NOUN	O	O

The	DET	O	O
3-year	NOUN	O	O
survival	NOUN	O	B-outcome
rate	NOUN	O	O
of	ADP	O	O
group	NOUN	O	O
A	DET	O	O
was	VERB	O	O
higher	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
of	ADP	O	O
group	NOUN	O	O
BP<0.05.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

The	DET	O	O
forearm	NOUN	O	O
band	NOUN	O	O
showed	VERB	O	O
better	ADJ	O	O
scores	NOUN	O	O
on	ADP	O	O
joint	NOUN	O	B-outcome
position	NOUN	O	I-outcome
reproduction	NOUN	O	I-outcome
at	ADP	O	O
70	NUM	O	O
degrees	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
elbow	NOUN	O	O
sleeve	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.006),	PUNCT	O	O
whereas	ADP	O	O
the	DET	O	O
elbow	NOUN	O	O
sleeve	NOUN	O	O
showed	VERB	O	O
better	ADJ	O	O
scores	NOUN	O	O
at	ADP	O	O
110	NUM	O	O
degrees	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.001).	PUNCT	O	O

We	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
determine	NOUN	O	O
if	ADP	O	O
a	DET	O	O
program	NOUN	O	O
of	ADP	O	O
aerobic	ADJ	O	O
and	CCONJ	O	O
resistance	NOUN	O	O
exercise	NOUN	O	O
could	VERB	O	O
safely	ADV	O	O
achieve	NOUN	O	O
body	NOUN	O	B-outcome
composition	NOUN	O	I-outcome
changes	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
Inflammatory	ADJ	O	O
Bowel	NOUN	O	O
Disease.	NOUN	O	O

It	PRON	O	O
builds	NOUN	O	O
on	ADP	O	O
an	DET	O	O
existing	VERB	O	O
program	NOUN	O	O
of	ADP	O	O
mental	ADJ	O	O
health	NOUN	O	O
research	NOUN	O	O
with	ADP	O	O
demonstrated	VERB	O	O
efficacy	NOUN	O	O
-	PUNCT	O	O
the	DET	O	O
Aboriginal	ADJ	O	O
and	CCONJ	O	O
Islander	ADP	O	O
Mental	ADJ	O	O
Health	NOUN	O	O
Initiative	NOUN	O	O
(AIMhi)	NOUN	O	O
-	PUNCT	O	O
to	PART	O	O
test	NOUN	O	O
the	DET	O	O
newly	ADV	O	O
developed	VERB	O	O
electronic	ADJ	O	O
motivational	ADJ	O	O
care	NOUN	O	O
planning	VERB	O	O
(MCP)	NOUN	O	O
therapy	NOUN	O	O
-	PUNCT	O	O
the	DET	O	O
AIMhi	NOUN	O	O
Stay	NOUN	O	O
Strong	ADJ	O	O
App.	NOUN	O	O

It	PRON	O	O
was	VERB	O	O
found	VERB	O	O
that	ADP	O	O
exhausted	VERB	O	O
terminal	ADJ	O	O
programmed	VERB	O	O
cell	NOUN	O	O
death	NOUN	O	O
1	NUM	O	O
(PD1)+	PUNCT	O	O
CD8+	NOUN	O	O
T	NOUN	O	O
cells	NOUN	O	O
in	ADP	O	O
the	DET	O	O
peripheral	ADJ	O	O
blood	NOUN	O	O
are	VERB	O	O
independently	ADV	O	O
associated	VERB	O	O
with	ADP	O	O
worse	NOUN	O	O
progression	NOUN	O	B-outcome
free	ADJ	O	I-outcome
survival	NOUN	O	I-outcome
(PFS)	NOUN	O	I-outcome
and	CCONJ	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(OS)	NOUN	O	I-outcome
.	PUNCT	O	O
Notably,	NOUN	O	O
hydrogen	NOUN	O	O
gas	NOUN	O	O
decreased	VERB	O	O
the	DET	O	O
abundance	NOUN	O	O
of	ADP	O	O
exhausted	VERB	O	O
terminal	ADJ	O	O
PD1+	NOUN	O	B-outcome
CD8+	NOUN	O	I-outcome
T	NOUN	O	I-outcome
cells	NOUN	O	I-outcome
,	PUNCT	O	O
increased	VERB	O	O
that	ADP	O	O
of	ADP	O	O
active	ADJ	O	O
terminal	ADJ	O	O
PD1	NOUN	O	B-outcome
CD8+	NOUN	O	I-outcome
T	NOUN	O	I-outcome
cells	NOUN	O	I-outcome
,	PUNCT	O	O
and	CCONJ	O	O
improved	VERB	O	O
progression	NOUN	O	B-outcome
free	ADJ	O	I-outcome
survival	NOUN	O	I-outcome
(PFS)	NOUN	O	I-outcome
and	CCONJ	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
(OS)	NOUN	O	I-outcome
times,	NOUN	O	O
suggesting	VERB	O	O
that	ADP	O	O
the	DET	O	O
balance	NOUN	O	O
between	ADP	O	O
terminal	ADJ	O	O
PD1+	NOUN	O	B-outcome
and	CCONJ	O	Seperator
PD1	NOUN	O	B-outcome
CD8+	NOUN	O	I-outcome
cells	NOUN	O	E3-outcome
is	VERB	O	O
critical	ADJ	O	O
for	ADP	O	O
cancer	NOUN	O	O
prognosis.	NOUN	O	O

The	DET	O	O
OSTAP	NOUN	O	O
group	NOUN	O	O
showed	VERB	O	O
a	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
reduction	NOUN	O	O
at	ADP	O	O
the	DET	O	O
postoperative	ADJ	O	O
24th	ADJ	O	O
hour	NOUN	O	O
tramadol	NOUN	O	B-outcome
consumption	NOUN	O	O
(mean	NUM	O	O
difference	NOUN	O	O
22	NUM	O	O
mg,	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
-38.4	NUM	O	O
to	PART	O	O
-5.6	VERB	O	O
mL;	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.009).	ADP	O	O

Title:	NOUN	O	O
Wellbeing	VERB	O	O
intervention	NOUN	O	O
for	ADP	O	O
chronic	ADJ	O	O
kidney	NOUN	O	O
disease	NOUN	O	O
(WICKD):	NOUN	O	O
a	DET	O	O
randomised	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
study	NOUN	O	O
protocol.	NOUN	O	O

No	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
difference	NOUN	O	O
was	VERB	O	O
found	VERB	O	O
between	ADP	O	O
the	DET	O	O
orthoses'	NOUN	O	O
effects	NOUN	O	O
on	ADP	O	O
pain	NOUN	O	B-outcome
reduction	NOUN	O	O
and	CCONJ	O	O
grip	NOUN	O	B-outcome
strength	NOUN	O	I-outcome
(P	NUM	O	O
>	SYM	O	O
.05).	NUM	O	O

Journal-Name:American	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
orthodontics	NOUN	O	O
and	CCONJ	O	O
dentofacial	ADJ	O	O
orthopedics	NOUN	O	O
:	PUNCT	O	O
official	ADJ	O	O
publication	NOUN	O	O
of	ADP	O	O
the	DET	O	O
American	ADJ	O	O
Association	NOUN	O	O
of	ADP	O	O
Orthodontists,	NOUN	O	O
its	ADJ	O	O
constituent	ADP	O	O
societies,	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
American	ADJ	O	O
Board	NOUN	O	O
of	ADP	O	O
Orthodontics	NOUN	O	O

RESULTS:	NOUN	O	O
We	PRON	O	O
conducted	VERB	O	O
three	NUM	O	O
sub-studies	NOUN	O	O
in	ADP	O	O
consecutive	ADJ	O	O
years	NOUN	O	O
of	ADP	O	O
2011,	NUM	O	O
2012,	NUM	O	O
and	CCONJ	O	O
2013	NUM	O	O
to	PART	O	O
reach	NOUN	O	O
an	DET	O	O
adequate	ADJ	O	O
sample	NOUN	O	O
size.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/23	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Journal-Name:	NOUN	O	O
Revista	NOUN	O	O
latino-americana	NOUN	O	O
de	ADP	O	O
enfermagem	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/05	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

CONCLUSIONS:	NOUN	O	O
Once-monthly	ADV	O	O
injections	NOUN	O	O
of	ADP	O	O
givosiran	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
who	ADP	O	O
had	VERB	O	O
recurrent	ADP	O	O
porphyria	NOUN	O	B-outcome
attacks	NOUN	O	O
resulted	VERB	O	O
in	ADP	O	O
mainly	ADV	O	O
low-grade	NOUN	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
,	PUNCT	O	O
reductions	NOUN	O	O
in	ADP	O	O
induced	VERB	O	O
ALAS1	NOUN	O	B-outcome
mRNA	NOUN	O	I-outcome
levels,	NOUN	O	O
nearly	ADV	O	O
normalized	VERB	O	O
levels	NOUN	O	O
of	ADP	O	O
the	DET	O	O
neurotoxic	ADJ	O	O
intermediates	NOUN	O	O
delta	NOUN	O	B-outcome
aminolevulinic	ADJ	O	I-outcome
acid	NOUN	O	I-outcome
and	CCONJ	O	O
porphobilinogen	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
a	DET	O	O
lower	ADJ	O	O
attack	NOUN	O	B-outcome
rate	NOUN	O	O
than	ADP	O	O
that	ADP	O	O
observed	VERB	O	O
with	ADP	O	O
placebo.	NOUN	O	O
(	PUNCT	O	O

In	ADP	O	O
addition,	NOUN	O	O
22	NUM	O	O
patients	NOUN	O	O
treated	VERB	O	O
by	ADP	O	O
monthly	ADV	O	O
regimen	NOUN	O	O
were	VERB	O	O
evaluated	VERB	O	O
after	ADP	O	O
18	NUM	O	O
months	NOUN	O	O
of	ADP	O	O
treatment.	NOUN	O	O

Participants	NOUN	O	O
were	VERB	O	O
randomly-assigned	VERB	O	O
to	PART	O	O
receive	VERB	O	O
either	CCONJ	O	O
CM	NOUN	O	O
or	CCONJ	O	O
CHO	NOUN	O	O
immediately	ADV	O	O
post-exercise.	NOUN	O	O

Conclusion:	NOUN	O	O
High-fidelity	NOUN	O	O
simulation	NOUN	O	O
training	VERB	O	O
is	VERB	O	O
superior	ADJ	O	O
to	PART	O	O
low-fidelity	NOUN	O	O
CPR	NOUN	O	O
manikin	NOUN	O	O
training	VERB	O	O
for	ADP	O	O
teaching	VERB	O	O
fourth-year	NOUN	O	O
medical	ADJ	O	O
students	NOUN	O	O
implementation	NOUN	O	O
of	ADP	O	O
high-quality	NOUN	O	O
CPR	NOUN	O	O
for	ADP	O	O
chest	NOUN	O	B-outcome
compression	NOUN	O	I-outcome
depth	NOUN	O	I-outcome
and	CCONJ	O	O
compression	NOUN	O	B-outcome
fraction	NOUN	O	I-outcome
.	PUNCT	O	O

Follow	VERB	O	O
up	ADP	O	O
of	ADP	O	O
the	DET	O	O
participants'	NOUN	O	O
outcomes	NOUN	O	O
was	VERB	O	O
conducted	VERB	O	O
via	ADP	O	O
electronic	ADJ	O	O
medical	ADJ	O	O
records.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/17	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
8912748	NUM	O	O

BACKGROUPD:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
investigated	VERB	O	O
the	DET	O	O
plasma	NOUN	O	O
fentanyl	NOUN	O	O
concentration	NOUN	O	O
and	CCONJ	O	O
efficacy	NOUN	O	O
of	ADP	O	O
transdermal	ADJ	O	O
fentanyl	NOUN	O	O
patch	NOUN	O	O
(TFP)	NUM	O	O
(25	NOUN	O	O
mug/h)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
management	NOUN	O	O
of	ADP	O	O
acute	ADJ	O	O
postoperative	ADJ	O	O
pain	NOUN	O	B-outcome
.	PUNCT	O	O
METHODS:	NOUN	O	O
Patients	NOUN	O	O
undergoing	VERB	O	O
laparoscopic	ADJ	O	O
cholecystectomy	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
2	NUM	O	O
groups.	NOUN	O	O

In	ADP	O	O
multivariate	ADJ	O	O
analysis	NOUN	O	O
of	ADP	O	O
disease-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
,	PUNCT	O	O
SPC-prognosis	NOUN	O	O
[hazard	PUNCT	O	O
ratio	NOUN	O	O
(HR):	NOUN	O	O
1.879	NUM	O	O
(1.101-3.205),	NOUN	O	O
2.399	NUM	O	O
(1.415-4.067),	NOUN	O	O
p=0.003	NOUN	O	O
and	CCONJ	O	O
MSI	NOUN	O	O
status	NOUN	O	O
(HR:	NOUN	O	O
0.363,	NUM	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval:	NOUN	O	O
0.161-0.820,	NUM	O	O
p=0.015)	NOUN	O	O
were	VERB	O	O
independent	ADJ	O	O
prognostic	ADJ	O	O
factors	NOUN	O	O
along	ADV	O	O
with	ADP	O	O
age,	NOUN	O	O
Lauren	NOUN	O	O
classification,	NOUN	O	O
TNM	NOUN	O	O
stage,	VERB	O	O
and	CCONJ	O	O
chemotherapy.	NOUN	O	O

Haematology	NOUN	O	O

Knee	NOUN	O	B-outcome
function	NOUN	O	I-outcome
was	VERB	O	O
assessed	VERB	O	O
using	VERB	O	O
HSS,	ADJ	O	O
KSS,	ADJ	O	O
NASS,	ADJ	O	O
and	CCONJ	O	O
ROM.	NOUN	O	O

At	ADP	O	O
3	NUM	O	O
years,	NOUN	O	O
overall	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
was	VERB	O	O
67%	ADJ	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
57	NUM	O	O
to	PART	O	O
75)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
hybrid-procedure	NOUN	O	O
group,	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
with	ADP	O	O
55%	NOUN	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
45	NUM	O	O
to	PART	O	O
64)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
open-procedure	NOUN	O	O
group;	ADJ	O	O
disease-free	ADJ	O	B-outcome
Survival	NOUN	O	I-outcome
was	VERB	O	O
57%	NUM	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
47	NUM	O	O
to	PART	O	O
66)	NOUN	O	O
and	CCONJ	O	O
48%	ADP	O	O
(95%	PUNCT	O	O
CI,	NOUN	O	O
38	NUM	O	O
to	PART	O	O
57),	NOUN	O	O
respectively.	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Clinical	ADJ	O	O
trials,	NOUN	O	O
NCT01949558	NOUN	O	O
,	PUNCT	O	O
2013-09-24.	NUM	O	O

PMID:	NOUN	O	O
31613945	NUM	O	O

CLINICAL	ADJ	O	O
TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
NCT00788398.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

DESIGN:	NOUN	O	O
Open	ADJ	O	O
randomized	VERB	O	O
monocentric	ADP	O	O
study.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
['2019/10/15	NOUN	O	O
06:00'	NUM	O	O

After	ADP	O	O
144	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
treatment,	NOUN	O	O
HBV	NOUN	O	B-outcome
DNA	NOUN	O	I-outcome
levels	NOUN	O	O
were	VERB	O	O
similarly	ADV	O	O
suppressed	VERB	O	O
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
(ETV	NUM	O	O
vs	CCONJ	O	O
TDF;	ADJ	O	O
-6.6485	SYM	O	O
vs	CCONJ	O	O
-6.692	NOUN	O	O
log10IU/mL,	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.807).	PUNCT	O	O

Conclusion:	NOUN	O	O
The	DET	O	O
results	NOUN	O	O
suggest	VERB	O	O
that	ADP	O	O
it	PRON	O	O
is	VERB	O	O
feasible	ADJ	O	O
to	PART	O	O
use	NOUN	O	O
the	DET	O	O
Borg	ADJ	O	O
rating	VERB	O	O
of	ADP	O	O
perceived	VERB	O	B-outcome
exertion	NOUN	O	I-outcome
scale	NOUN	O	O
to	PART	O	O
adjust	NOUN	O	O
FT	NOUN	O	O
intensity.	NOUN	O	O

Parents	NOUN	O	O
were	VERB	O	O
taught	NOUN	O	O
the	DET	O	O
same	ADJ	O	O
3	NUM	O	O
infant-handling	VERB	O	O
techniques	NOUN	O	O
after	ADP	O	O
random	NOUN	O	O
assignment	NOUN	O	O
to	PART	O	O
the	DET	O	O
(1)	PUNCT	O	O
direct,	NOUN	O	O
(2)	PUNCT	O	O
video,	ADV	O	O
or	CCONJ	O	O
(3)	PUNCT	O	O
written-pictorial	ADJ	O	O
instructional	ADJ	O	O
groups.	NOUN	O	O

The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
hand	NOUN	O	B-outcome
food	NOUN	O	I-outcome
mouth	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
(2.1%)	PUNCT	O	O
in	ADP	O	O
intervention	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
(4.2%)	PUNCT	O	O
at	ADP	O	O
year	NOUN	O	O
2	NUM	O	O
(chi	PUNCT	O	O
=	SYM	O	O
22.138,	NUM	O	O
P	NOUN	O	O
<.001).	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7501160	NUM	O	O

On	ADP	O	O
the	DET	O	O
basis	NOUN	O	O
of	ADP	O	O
traditional	ADJ	O	O
treatment,	NOUN	O	O
the	DET	O	O
children	NOUN	O	O
in	ADP	O	O
the	DET	O	O
SBH	NOUN	O	O
treatment	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
given	VERB	O	O
SBH	NOUN	O	O
treatment	NOUN	O	O
within	ADP	O	O
6	NUM	O	O
hours	NOUN	O	O
after	ADP	O	O
birth.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

A	DET	O	O
net	ADJ	O	O
cost	NOUN	O	B-outcome
analysis	NOUN	O	O
from	ADP	O	O
an	DET	O	O
employer	NOUN	O	O
perspective	ADJ	O	O
demonstrated	VERB	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
mean	NOUN	O	O
of	ADP	O	O
2.97	NUM	O	O
h	NOUN	O	O
less	ADV	O	O
absenteeism	NOUN	O	B-outcome
over	ADP	O	O
a	DET	O	O
4	NUM	O	O
week	NOUN	O	O
period	NOUN	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.62),	NUM	O	O
which	ADP	O	O
could	VERB	O	O
result	VERB	O	O
in	ADP	O	O
net	ADJ	O	O
savings	NOUN	O	O
ranging	VERB	O	O
from	ADP	O	O
pound66	ADJ	O	O
to	PART	O	O
pound735	NOUN	O	O
depending	VERB	O	O
on	ADP	O	O
the	DET	O	O
wage	NOUN	O	O
rate	NOUN	O	O
employed.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
efficacy	NOUN	O	O
endpoint	NOUN	O	O
was	VERB	O	O
non-inferiority	NOUN	O	O
of	ADP	O	O
HP	NOUN	O	O
relative	ADJ	O	O
to	PART	O	O
G	NOUN	O	O
+	SYM	O	O
T	NOUN	O	O
for	ADP	O	O
success	NOUN	O	O
at	ADP	O	O
achieving	VERB	O	O
hemostasis	NOUN	O	B-outcome
within	ADP	O	O
6	NUM	O	O
minutes.	ADJ	O	O

Full-mouth	NOUN	O	O
scaling	VERB	O	O
and	CCONJ	O	O
root	NOUN	O	O
planing	VERB	O	O
(SRP)	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
followed	VERB	O	O
by	ADP	O	O
the	DET	O	O
application	NOUN	O	O
of	ADP	O	O
curcumin	NOUN	O	O
gel	NOUN	O	O
on	ADP	O	O
a	DET	O	O
single	ADJ	O	O
side.	NOUN	O	O

There	PRON	O	O
was	VERB	O	O
a	DET	O	O
minor	ADJ	O	O
change	NOUN	O	O
(0.0	PUNCT	O	O
to	PART	O	O
0.3	NUM	O	O
mm)	NOUN	O	O
in	ADP	O	O
peri-implant	ADJ	O	B-outcome
mucosal	ADJ	O	I-outcome
zenith	ADP	O	I-outcome
positions	NOUN	O	I-outcome
over	ADP	O	O
time	NOUN	O	O
and	CCONJ	O	O
between	ADP	O	O
groups.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/01	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Introduction:	NOUN	O	O
Videoconferencing	VERB	O	O
has	VERB	O	O
been	VERB	O	O
employed	VERB	O	O
in	ADP	O	O
numerous	ADJ	O	O
medical	ADJ	O	O
education	NOUN	O	O
settings	NOUN	O	O
ranging	VERB	O	O
from	ADP	O	O
remote	ADV	O	O
supervision	NOUN	O	O
of	ADP	O	O
medical	ADJ	O	O
trainees	NOUN	O	O
to	PART	O	O
conducting	VERB	O	O
residency	NOUN	O	O
interviews.	NOUN	O	O

METHODS:	NOUN	O	O
The	DET	O	O
study	NOUN	O	O
included	VERB	O	O
20	NUM	O	O
men	NOUN	O	O
(20-31	PUNCT	O	O
yrs.,	ADP	O	O

BACKGROUND:	NOUN	O	O
Based	VERB	O	O
on	ADP	O	O
epidemiological	ADJ	O	O
and	CCONJ	O	O
clinical	ADJ	O	O
data	NOUN	O	O
acute	ADJ	O	O
appendicitis	NOUN	O	O
can	VERB	O	O
present	ADJ	O	O
either	CCONJ	O	O
as	ADP	O	O
uncomplicated	VERB	O	O
(70-80%)	PUNCT	O	O
or	CCONJ	O	O
complicated	VERB	O	O
(20-30%)	NOUN	O	O
disease.	NOUN	O	O

METHODS:	NOUN	O	O
50	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
chronic	ADJ	O	O
low	ADJ	O	O
back	ADP	O	O
pain	NOUN	O	O
(78%	PUNCT	O	O
female,	NOUN	O	O
49.7+/-10.0	NOUN	O	O
years)	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
to	PART	O	O
two	NUM	O	O
Gua	NOUN	O	O
Sha	NOUN	O	O
treatments	NOUN	O	O
(n=25)	PUNCT	O	O
or	CCONJ	O	O
waitlist	ADJ	O	O
control	NOUN	O	O
(n=25).	NOUN	O	O

The	DET	O	O
OR	CCONJ	O	O
Study	NOUN	O	O
intervention	NOUN	O	O
was	VERB	O	O
delayed	VERB	O	O
because	ADP	O	O
of	ADP	O	O
interruptions	NOUN	O	O
in	ADP	O	O
finalizing	VERB	O	O
the	DET	O	O
national	ADJ	O	O
CHW	NOUN	O	O
policy,	NOUN	O	O
two	NUM	O	O
separate	ADJ	O	O
cholera	NOUN	O	O
epidemics,	ADJ	O	O
and	CCONJ	O	O
the	DET	O	O
Ebola	NOUN	O	O
epidemic	ADJ	O	O
lasting	VERB	O	O
more	ADV	O	O
than	ADP	O	O
2	NUM	O	O
years.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

BACKGROUND:	NOUN	O	O
Tafenoquine,	NOUN	O	O
a	DET	O	O
single-dose	NOUN	O	O
therapy	NOUN	O	O
for	ADP	O	O
Plasmodium	NOUN	O	O
vivax	NOUN	O	O
malaria,	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
associated	VERB	O	O
with	ADP	O	O
relapse	NOUN	O	O
prevention	NOUN	O	O
through	ADP	O	O
the	DET	O	O
clearance	NOUN	O	O
of	ADP	O	O
P.	NOUN	O	O
vivax	NOUN	O	O
parasitemia	NOUN	O	O
and	CCONJ	O	O
hypnozoites,	NOUN	O	O
termed	VERB	O	O
"radical	ADJ	O	O
cure."	NOUN	O	O

Protrusion	NOUN	O	B-outcome
and	CCONJ	O	Seperator
proclination	NOUN	O	B-outcome
of	ADP	O	I-outcome
mandibular	ADJ	O	I-outcome
incisors	NOUN	O	E3-outcome
were	VERB	O	O
greater	ADJ	O	O
in	ADP	O	O
the	DET	O	O
IA	NOUN	O	O
group	NOUN	O	O
(95.90	ADV	O	O
degrees	NOUN	O	O
+/-	SYM	O	O
5.34	NUM	O	O
degrees	NOUN	O	O
)	PUNCT	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
MA	NOUN	O	O
group	NOUN	O	O
(92.04	PUNCT	O	O
degrees	NOUN	O	O
+/-	SYM	O	O
7.92	NUM	O	O
degrees	NOUN	O	O
).	NOUN	O	O

BACKGROUND:	NOUN	O	O
Many	ADJ	O	O
surgical	ADJ	O	O
procedures	NOUN	O	O
have	VERB	O	O
been	VERB	O	O
described	VERB	O	O
to	PART	O	O
treat	NOUN	O	O
recurrent	ADP	O	O
patellar	ADJ	O	O
dislocation,	NOUN	O	O
but	CCONJ	O	O
none	NUM	O	O
of	ADP	O	O
these	DET	O	O
techniques	NOUN	O	O
has	VERB	O	O
been	VERB	O	O
successful	ADJ	O	O
in	ADP	O	O
all	DET	O	O
patients.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
of	ADP	O	O
ultrasound-guided	VERB	O	O
pulsed	VERB	O	O
radiofrequency	NOUN	O	O
for	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
frozen	NOUN	O	O
shoulder.	NOUN	O	O

After	ADP	O	O
further	ADV	O	O
exclusions,	NOUN	O	O
75	NUM	O	O
(94%)	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
randomly	ADV	O	O
assigned	VERB	O	O
to	PART	O	O
groups,	NOUN	O	O
received	VERB	O	O
at	ADP	O	O
least	ADV	O	O
one	NUM	O	O
dose	NOUN	O	O
of	ADP	O	O
treatment	NOUN	O	O
(25	NOUN	O	O
patients	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
10	NUM	O	O
mg	NOUN	O	O
pegbelfermin	NOUN	O	O
once	ADP	O	O
a	DET	O	O
day;	NOUN	O	O
24	NUM	O	O
patients	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
20	NUM	O	O
mg	NOUN	O	O
pegbelfermin	NOUN	O	O
once	ADP	O	O
a	DET	O	O
week,	NOUN	O	O
and	CCONJ	O	O
26	NUM	O	O
patients	NOUN	O	O
to	PART	O	O
receive	VERB	O	O
placebo),	NOUN	O	O
and	CCONJ	O	O
were	VERB	O	O
included	VERB	O	O
in	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
analysis.	NOUN	O	O

At	ADP	O	O
day	NOUN	O	O
5,	ADJ	O	O
composite	NOUN	O	O
cure	NOUN	O	B-outcome
was	VERB	O	O
observed	VERB	O	O
in	ADP	O	O
88.0%	NUM	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
(168	NUM	O	O
of	ADP	O	O
191	NUM	O	O
patients)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
plazomicin	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
91.4%	NOUN	O	O
(180	PUNCT	O	O
of	ADP	O	O
197	NUM	O	O
patients)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
meropenem	NOUN	O	O
group	NOUN	O	O
(difference,	ADV	O	O
-3.4	NUM	O	O
percentage	NOUN	O	O
points;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval	NOUN	O	O
[CI],	VERB	O	O
-10.0	NUM	O	O
to	PART	O	O
3.1).	NOUN	O	O

RESULTS:	NOUN	O	O
After	ADP	O	O
followed	VERB	O	O
up	ADP	O	O
for	ADP	O	O
6	NUM	O	O
to	PART	O	O
20	NUM	O	O
months,	NOUN	O	O
a	DET	O	O
thinner	NOUN	O	O
appearance	NOUN	O	B-outcome
was	VERB	O	O
seen	VERB	O	O
in	ADP	O	O
3	NUM	O	O
eyes	NOUN	O	O
(2.2%)	PUNCT	O	O
in	ADP	O	O
the	DET	O	O
corneal	ADJ	O	O
graft	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
7	NUM	O	O
eyes	NOUN	O	O
(5.5%)	NOUN	O	O
in	ADP	O	O
the	DET	O	O
scleral	ADJ	O	O
group.	VERB	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
reduce	VERB	O	O
the	DET	O	O
inappropriate	ADJ	O	O
identification	NOUN	O	O
of	ADP	O	O
eye	NOUN	O	O
drops,	NOUN	O	O
through	ADP	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
different	ADJ	O	O
colors.	NOUN	O	O

A	DET	O	O
prespecified	VERB	O	O
interim	ADJ	O	O
analysis	NOUN	O	O
at	ADP	O	O
week	NOUN	O	O
8	NUM	O	O
showed	VERB	O	O
a	DET	O	O
greater	ADJ	O	O
than	ADP	O	O
expected	VERB	O	O
change	NOUN	O	O
in	ADP	O	O
the	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
and	CCONJ	O	O
supported	VERB	O	O
early	ADJ	O	O
closing	VERB	O	O
of	ADP	O	O
patient	NOUN	O	O
enrolment,	NOUN	O	O
since	ADP	O	O
this	DET	O	O
analysis	NOUN	O	O
indicated	VERB	O	O
that	ADP	O	O
the	DET	O	O
full	ADJ	O	O
planned	VERB	O	O
sample	NOUN	O	O
size	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
needed.	NOUN	O	O

A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
55	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
histologically	ADV	O	O
and	CCONJ	O	O
clinically	ADV	O	O
diagnosed	VERB	O	O
stage	NOUN	O	O
IV	NUM	O	O
colorectal	ADJ	O	O
carcinoma	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
between	ADP	O	O
July	NOUN	O	O
2014	NUM	O	O
and	CCONJ	O	O
July	NOUN	O	O
2017.	NUM	O	O

The	DET	O	O
study	NOUN	O	O
consisted	VERB	O	O
of	ADP	O	O
a	DET	O	O
pre-screening,	NOUN	O	O
screening,	NOUN	O	O
day	NOUN	O	O
0	NUM	O	O
baseline	NOUN	O	O
(randomization	NOUN	O	O
visit)	NOUN	O	O
and	CCONJ	O	O
three	NUM	O	O
follow-up	NOUN	O	O
visits	NOUN	O	O
on	ADP	O	O
days	NOUN	O	O
14,	NUM	O	O
28	NUM	O	O
and	CCONJ	O	O
56.	PART	O	O

RESULTS:	NOUN	O	O
Of	ADP	O	O
131	NUM	O	O
subjects	NOUN	O	O
who	ADP	O	O
underwent	VERB	O	O
routine	ADJ	O	O
phacoemulsification,	NOUN	O	O
analyzable	ADJ	O	O
endothelial	ADJ	O	O
images	NOUN	O	O
at	ADP	O	O
24	NUM	O	O
months	NOUN	O	O
were	VERB	O	O
available	ADJ	O	O
for	ADP	O	O
126	NUM	O	O
subjects	NOUN	O	O
(96.2%).	PUNCT	O	O

AIMS	NOUN	O	O
OF	ADP	O	O
THE	DET	O	O
STUDY:	NOUN	O	O
The	DET	O	O
safety	NOUN	O	O
and	CCONJ	O	O
efficacy	NOUN	O	O
of	ADP	O	O
a	DET	O	O
hemostatic	ADJ	O	O
powder	NOUN	O	O
(HP)	NOUN	O	O
versus	CCONJ	O	O
a	DET	O	O
control	NOUN	O	O
agent,	NOUN	O	O
absorbable	ADJ	O	O
gelatin	NOUN	O	O
sponge	NOUN	O	O
and	CCONJ	O	O
thrombin	NOUN	O	O
(G	NUM	O	O
+	SYM	O	O
T),	NOUN	O	O
were	VERB	O	O
assessed,	NOUN	O	O
using	VERB	O	O
a	DET	O	O
validated,	NOUN	O	O
quantitative	ADJ	O	O
bleeding	VERB	O	B-outcome
severity	NOUN	O	I-outcome
scale.	ADJ	O	O

PROTOCOL:	NOUN	O	O
The	DET	O	O
protocol	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
published	VERB	O	O
before	ADP	O	O
trial	NOUN	O	O
commencement.	NOUN	O	O

METHODS:	NOUN	O	O
The	DET	O	O
study	NOUN	O	O
was	VERB	O	O
a	DET	O	O
randomised,	NOUN	O	O
double-blinded,	NOUN	O	O
placebo-controlled	VERB	O	O
intervention	NOUN	O	O
study	NOUN	O	O
with	ADP	O	O
35	NUM	O	O
overweight	NUM	O	O
subjects	NOUN	O	O
with	ADP	O	O
mildly	ADV	O	O
or	CCONJ	O	O
moderately	ADV	O	O
elevated	VERB	O	O
blood	NOUN	O	O
pressure,	NOUN	O	O
who	ADP	O	O
took	VERB	O	O
4	NUM	O	O
g	NOUN	O	O
krill	NOUN	O	O
oil	NOUN	O	O
powder	NOUN	O	O
or	CCONJ	O	O
4	NUM	O	O
g	NOUN	O	O
of	ADP	O	O
placebo	NOUN	O	O
during	ADP	O	O
an	DET	O	O
8-week	NOUN	O	O
follow-up	NOUN	O	O
period.	NOUN	O	O

Title:	NOUN	O	O
Effectiveness	NOUN	O	O
of	ADP	O	O
routine	ADJ	O	O
third	ADJ	O	O
trimester	NOUN	O	O
ultrasonography	NOUN	O	O
to	PART	O	O
reduce	VERB	O	O
adverse	ADJ	O	B-outcome
perinatal	ADJ	O	I-outcome
outcomes	NOUN	O	I-outcome
in	ADP	O	O
low	ADJ	O	O
risk	NOUN	O	O
pregnancy	NOUN	O	O
(the	NOUN	O	O
IRIS	NOUN	O	O
study):	NUM	O	O
nationwide,	NOUN	O	O
pragmatic,	NOUN	O	O
multicentre,	NOUN	O	O
stepped	VERB	O	O
wedge	NOUN	O	O
cluster	NOUN	O	O
randomised	VERB	O	O
trial.	NOUN	O	O

Results	NOUN	O	O
The	DET	O	O
TC	NOUN	O	O
had	VERB	O	O
produced	VERB	O	O
significant	ADJ	O	O
positive	ADJ	O	O
chances	NOUN	O	O
in	ADP	O	O
depression	NOUN	O	B-outcome
and	CCONJ	O	O
some	DET	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
variability	NOUN	O	I-outcome
parameters	NOUN	O	O
(mean	NUM	O	O
heart	NOUN	O	B-outcome
rate	NOUN	O	I-outcome
,	PUNCT	O	O
RMSSD	NOUN	O	B-outcome
,	PUNCT	O	O
HF	NOUN	O	B-outcome
,	PUNCT	O	O
LFnorm	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
HFnorm	NOUN	O	B-outcome
)	PUNCT	O	O
(p	PUNCT	O	O
<	SYM	O	O
0.05),	NUM	O	O
whereas	ADP	O	O
these	DET	O	O
positive	ADJ	O	O
results	NOUN	O	O
were	VERB	O	O
not	ADV	O	O
observed	VERB	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group.	VERB	O	O

Twelve	NUM	O	O
deaths	NOUN	O	B-outcome
(8	NOUN	O	O
in	ADP	O	O
the	DET	O	O
omadacycline	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
4	NUM	O	O
in	ADP	O	O
the	DET	O	O
moxifloxacin	NOUN	O	O
group)	ADJ	O	O
occurred	VERB	O	O
during	ADP	O	O
the	DET	O	O
trial.	NOUN	O	O

Title:	NOUN	O	O
Does	VERB	O	O
L-Methylfolate	NOUN	O	O
Supplement	NOUN	O	O
Methylphenidate	NOUN	O	O
Pharmacotherapy	NOUN	O	O
in	ADP	O	O
Attention-Deficit/Hyperactivity	NOUN	O	O
Disorder?:	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/05/09	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

BACKGROUND:	NOUN	O	O
Maintenance	NOUN	O	O
of	ADP	O	O
effect	NOUN	O	O
following	VERB	O	O
treatment	NOUN	O	O
with	ADP	O	O
galcanezumab	NOUN	O	O
compared	VERB	O	O
to	PART	O	O
placebo	NOUN	O	O
in	ADP	O	O
adult	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
episodic	NOUN	O	O
or	CCONJ	O	O
chronic	ADJ	O	O
migraine	NOUN	O	O
was	VERB	O	O
evaluated.	NOUN	O	O

min(-1);	NOUN	O	O
CON	NOUN	O	O
=	SYM	O	O
0.19	NUM	O	O
+/-	SYM	O	O
0.05	NUM	O	O
degrees	NOUN	O	O
C	NOUN	O	O
.	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/15	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

We	PRON	O	O
aimed	VERB	O	O
to	PART	O	O
compare	NOUN	O	O
the	DET	O	O
immunogenicity	NOUN	O	B-outcome
and	CCONJ	O	O
safety	NOUN	O	O
of	ADP	O	O
the	DET	O	O
most	DET	O	O
commonly	ADV	O	O
used	VERB	O	O
HA	NOUN	O	O
vaccines	NOUN	O	O
in	ADP	O	O
ethnic	ADJ	O	O
Korean	NOUN	O	O
children	NOUN	O	O
aged	VERB	O	O
12	NUM	O	O
to	PART	O	O
18	NUM	O	O
months.	NOUN	O	O

Journal-Name:BMC	NOUN	O	O
public	ADJ	O	O
health	NOUN	O	O

The	DET	O	O
initial	ADJ	O	O
3	NUM	O	O
mg	NOUN	O	O
dose	NOUN	O	O
was	VERB	O	O
increased	VERB	O	O
to	PART	O	O
4	NUM	O	O
mg	NOUN	O	O
from	ADP	O	O
cycle	NOUN	O	O
5	NUM	O	O
if	ADP	O	O
tolerated	VERB	O	O
during	ADP	O	O
cycles	NOUN	O	O
1-4.	ADP	O	O

It	PRON	O	O
may	VERB	O	O
be	VERB	O	O
used	VERB	O	O
as	ADP	O	O
an	DET	O	O
alternative	ADJ	O	O
drug	NOUN	O	O
for	ADP	O	O
fentanyl	NOUN	O	O
in	ADP	O	O
pain	NOUN	O	O
control	NOUN	O	O
after	ADP	O	O
orthopedic	ADJ	O	O
surgery.	VERB	O	O

Our	ADJ	O	O
purpose	NOUN	O	O
was	VERB	O	O
to	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
effectiveness	NOUN	O	O
and	CCONJ	O	O
cost-effectiveness	NOUN	O	O
of	ADP	O	O
three	NUM	O	O
intervention-arms	NOUN	O	O
(combined	PUNCT	O	O
neuromuscular	ADJ	O	O
exercise	NOUN	O	O
and	CCONJ	O	O
back	ADP	O	O
care	NOUN	O	O
counselling	VERB	O	O
or	CCONJ	O	O
either	CCONJ	O	O
alone)	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
non-treatment.	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial,	NOUN	O	O
we	PRON	O	O
compared	VERB	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
DR	NOUN	O	O
versus	CCONJ	O	O
EODR	NOUN	O	O
by	ADP	O	O
measuring	VERB	O	O
lipid	NOUN	O	B-outcome
indices	NOUN	O	O
and	CCONJ	O	O
serum	NOUN	O	O
HMGCR	ADV	O	B-outcome
levels	NOUN	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
12	NUM	O	O
weeks	NOUN	O	O
of	ADP	O	O
10mg	NUM	O	O
atorvastatin	NOUN	O	O
therapy.	NOUN	O	O

A	DET	O	O
sequential	ADJ	O	O
design	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
with	ADP	O	O
a	DET	O	O
triangular	ADJ	O	O
continuation	NOUN	O	O
region.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

L(-	NOUN	O	O
1);	NOUN	O	O
PL:	NOUN	O	O
8.7	NUM	O	O
+/-	SYM	O	O
0.9	NUM	O	O
mmol.	NOUN	O	O

They	PRON	O	O
were	VERB	O	O
randomly	ADV	O	O
treated	VERB	O	O
by	ADP	O	O
endoscopic	ADJ	O	O
sclerotherapy	NOUN	O	O
or	CCONJ	O	O
cyanoacrylate	VERB	O	O
injection	NOUN	O	O
as	ADP	O	O
banding	VERB	O	O
was	VERB	O	O
not	ADV	O	O
suitable	ADJ	O	O
for	ADP	O	O
those	DET	O	O
patients	NOUN	O	O
due	ADJ	O	O
to	PART	O	O
profuse	NOUN	O	O
bleeding	VERB	O	O
making	VERB	O	O
unclear	ADJ	O	O
endoscopic	ADJ	O	O
visual	ADJ	O	O
field.	NOUN	O	O

Aim:	NOUN	O	O
To	PART	O	O
clinically	ADV	O	O
assess	NOUN	O	O
the	DET	O	O
efficacy	NOUN	O	O
of	ADP	O	O
resin	NOUN	O	O
infiltration	NOUN	O	O
versus	CCONJ	O	O
fluoride	NOUN	O	O
varnish	NOUN	O	O
for	ADP	O	O
arresting	VERB	O	O
white	ADP	O	B-outcome
spot	NOUN	O	I-outcome
lesions	NOUN	O	I-outcome
(WSLs)	NOUN	O	I-outcome
on	ADP	O	O
permanent	ADJ	O	O
teeth	NOUN	O	O
in	ADP	O	O
children.	NOUN	O	O

METHODS:	NOUN	O	O
A	DET	O	O
cross-sectional	ADJ	O	O
study	NOUN	O	O
was	VERB	O	O
carried	VERB	O	O
out	ADP	O	O
among	ADP	O	O
healthy	ADJ	O	O
controls	NOUN	O	O
(HCs,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
65),	NUM	O	O
diabetes	NOUN	O	O
patients	NOUN	O	O
without	ADP	O	O
kidney	NOUN	O	O
disease	NOUN	O	O
(DCs,	NOUN	O	O
n	NOUN	O	O
=	SYM	O	O
48)	NOUN	O	O
and	CCONJ	O	O
DKD	NOUN	O	O
patients	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
60).	NOUN	O	O

PATIENTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
288	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
clinically	ADV	O	O
confirmed	VERB	O	O
uncontrolled	VERB	O	O
chronic	ADJ	O	O
rhinosinusitis	NOUN	O	O
were	VERB	O	O
subjected	VERB	O	O
to	PART	O	O
randomization	NOUN	O	O
(1:1	NUM	O	O
ratio).	ADP	O	O

METHODS:	NOUN	O	O
This	DET	O	O
prospective	ADJ	O	O
study	NOUN	O	O
included	VERB	O	O
113	NUM	O	O
cirrhotic	ADJ	O	O
patients	NOUN	O	O
with	ADP	O	O
actively	ADV	O	O
bleeding	VERB	O	O
esophageal	ADJ	O	O
varices.	NOUN	O	O

Children	NOUN	O	O
with	ADP	O	O
phenylketonuria	NOUN	O	O
(PKU)	PUNCT	O	O
follow	VERB	O	O
a	DET	O	O
protein	NOUN	O	O
restricted	VERB	O	O
diet	NOUN	O	O
with	ADP	O	O
negligible	ADJ	O	O
amounts	NOUN	O	O
of	ADP	O	O
docosahexaenoic	VERB	O	O
acid	NOUN	O	O
(DHA).	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/31	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
7511141	NUM	O	O

Belatacept	NOUN	O	O
concentrations	NOUN	O	O
were	VERB	O	O
determined	VERB	O	O
in	ADP	O	O
a	DET	O	O
total	ADJ	O	O
of	ADP	O	O
203	NUM	O	O
serum	NOUN	O	O
samples	NOUN	O	O
collected	VERB	O	O
during	ADP	O	O
26	NUM	O	O
infusion	NOUN	O	O
intervals	NOUN	O	O
from	ADP	O	O
5	NUM	O	O
renal	ADJ	O	O
transplant	NOUN	O	O
recipients.	NOUN	O	O

The	DET	O	O
selection	NOUN	O	O
of	ADP	O	O
proper	ADJ	O	O
respirators	NOUN	O	O
and	CCONJ	O	O
training	VERB	O	O
would	VERB	O	O
be	VERB	O	O
beneficial	ADJ	O	O
to	PART	O	O
the	DET	O	O
safety	NOUN	O	O
of	ADP	O	O
healthcare	NOUN	O	O
providers.	ADP	O	O

Undoubtedly,	NOUN	O	O
further	ADV	O	O
in	ADP	O	O
vitro	ADV	O	O
and	CCONJ	O	O
in	ADP	O	O
vivo	ADV	O	O
studies	NOUN	O	O
need	NOUN	O	O
to	PART	O	O
be	VERB	O	O
performed	VERB	O	O
in	ADP	O	O
order	NOUN	O	O
to	PART	O	O
elucidate	NOUN	O	O
possible	ADJ	O	O
mechanisms	NOUN	O	O
of	ADP	O	O
action	NOUN	O	O
and	CCONJ	O	O
corroborate	VERB	O	O
our	ADJ	O	O
preliminary	ADJ	O	O
results.	NOUN	O	O

Obesity	NOUN	O	O
prevention	NOUN	O	O
campaign	ADV	O	O
sponsorship	NOUN	O	O
promoted	VERB	O	O
higher	ADJ	O	O
campaign	ADV	O	O
awareness	ADV	O	B-outcome
and	CCONJ	O	O
perceived	VERB	O	B-outcome
event-sponsor	NOUN	O	I-outcome
fit	NOUN	O	I-outcome
,	PUNCT	O	O
but	CCONJ	O	O
did	VERB	O	O
not	ADV	O	O
impact	NOUN	O	O
food	NOUN	O	O
attitudes	NOUN	O	B-outcome
or	CCONJ	O	O
preference	NOUN	O	B-outcome
for	ADP	O	O
unhealthy	NOUN	O	O
versus	CCONJ	O	O
healthier	ADJ	O	O
foods.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/08	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

The	DET	O	O
BRPE	NOUN	O	O
could	VERB	O	O
be	VERB	O	O
a	DET	O	O
valuable	ADJ	O	O
tool	NOUN	O	O
for	ADP	O	O
clinicians	NOUN	O	O
to	PART	O	O
dose	NOUN	O	O
FT	NOUN	O	O
intensity	NOUN	O	O
after	ADP	O	O
a	DET	O	O
stroke,	NOUN	O	O
but	CCONJ	O	O
this	DET	O	O
remains	NOUN	O	O
to	PART	O	O
be	VERB	O	O
tested.	NOUN	O	O

Journal-Name:The	ADJ	O	O
New	ADJ	O	O
England	NOUN	O	O
journal	ADJ	O	O
of	ADP	O	O
medicine	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101234168	NUM	O	O

Four-hundred	VERB	O	O
twenty-four	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
septic	ADJ	O	O
shock	NOUN	O	O
were	VERB	O	O
included	VERB	O	O
between	ADP	O	O
March	NOUN	O	O
2017	NUM	O	O
and	CCONJ	O	O
March	NOUN	O	O
2018.	NUM	O	O

Title:	NOUN	O	O
Does	VERB	O	O
all	DET	O	O
single	ADJ	O	O
infarction	NOUN	O	O
have	VERB	O	O
lower	ADJ	O	O
risk	NOUN	O	O
of	ADP	O	O
stroke	NOUN	O	B-outcome
recurrence	NOUN	O	O
than	ADP	O	O
multiple	ADJ	O	O
infarctions	NOUN	O	O
in	ADP	O	O
minor	ADJ	O	O
stroke?	NOUN	O	O

However,	ADV	O	O
this	DET	O	O
needs	NOUN	O	O
reconfirmation	NOUN	O	O
in	ADP	O	O
a	DET	O	O
larger	ADJ	O	O
study.	NOUN	O	O

Journal-Name:Nutrients	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
This	DET	O	O
trial	NOUN	O	O
was	VERB	O	O
registered	VERB	O	O
prior	ADJ	O	O
to	PART	O	O
enrollment	NOUN	O	O
at	ADP	O	O
the	DET	O	O
Registry	NOUN	O	O
for	ADP	O	O
International	ADJ	O	O
Impact	NOUN	O	O
Evaluations	NOUN	O	O
(RIDIE	PUNCT	O	O
STUDY	NOUN	O	O
ID:	NOUN	O	O
582a2462ae2ab):	NOUN	O	O
http://ridie.3ieimpact.org/index.php?r=search/detailView&id=492	NOUN	O	O
.	PUNCT	O	O

RESULTS:	NOUN	O	O
Despite	ADP	O	O
similar	ADJ	O	O
fluoroscopy	NOUN	O	O
times	NOUN	O	O
(20.4+/-9.4min	NOUN	O	O
with	ADP	O	O
RADPAD	NOUN	O	O
vs.	CCONJ	O	O
19.4+/-9.2min	NOUN	O	O
without	ADP	O	O
RADPAD,	NOUN	O	O
P=0.871)	NOUN	O	O
and	CCONJ	O	O
total	ADJ	O	O
radiation	NOUN	O	O
dose	NOUN	O	O
(3.4+/-4.3	PUNCT	O	O
Gy	NOUN	O	O
with	ADP	O	O
RADPAD	NOUN	O	O
vs.	CCONJ	O	O
2.3+/-1.4	NOUN	O	O
Gy,	NOUN	O	O
P=0.198),	NOUN	O	O
the	DET	O	O
relative	ADJ	O	B-outcome
operator	NOUN	O	I-outcome
exposure	NOUN	O	I-outcome
was	VERB	O	O
significantly	ADV	O	O
less	ADV	O	O
with	ADP	O	O
RADPAD	NOUN	O	O
(1.39+/-0.95)	PUNCT	O	O
as	ADP	O	O
compared	VERB	O	O
to	PART	O	O
no	DET	O	O
RADPAD	NOUN	O	O
group	NOUN	O	O
(2.27+/-1.4)	NUM	O	O
(p=0.004)	ADV	O	O
amounting	VERB	O	O
to	PART	O	O
a	DET	O	O
39%	NUM	O	O
reduction.	NOUN	O	O

Results:	NOUN	O	O
After	ADP	O	O
the	DET	O	O
treatment,	NOUN	O	O
the	DET	O	O
improvement	NOUN	O	O
of	ADP	O	O
glycosylated	VERB	O	B-outcome
hemoglobin	NOUN	O	I-outcome
(HbA1c)	NOUN	O	I-outcome
,	PUNCT	O	O
blood	NOUN	O	B-outcome
urea	NOUN	O	I-outcome
nitrogen	NOUN	O	I-outcome
(BUN)	PUNCT	O	I-outcome
,	PUNCT	O	O
systolic	ADJ	O	B-outcome
pressure	NOUN	O	I-outcome
(SP),	PUNCT	O	O
high	ADJ	O	B-outcome
sensitive	ADJ	O	I-outcome
C-reactive	ADJ	O	I-outcome
protein	NOUN	O	I-outcome
(hs-CRP)	NOUN	O	I-outcome
,	PUNCT	O	O
erythrocyte	NOUN	O	B-outcome
sedimentation	NOUN	O	I-outcome
rate	NOUN	O	I-outcome
(ESR)	NOUN	O	I-outcome
,	PUNCT	O	O
estimated	VERB	O	B-outcome
glomerular	ADJ	O	I-outcome
filtration	NOUN	O	I-outcome
rate	NOUN	O	I-outcome
(eGFR)	NOUN	O	I-outcome
in	ADP	O	O
the	DET	O	O
intervention	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
better	ADJ	O	O
than	ADP	O	O
those	DET	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(all	PUNCT	O	O
P<0.05),	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
the	DET	O	O
urine	NOUN	O	O
albumin/creatine	NOUN	O	B-outcome
ratio	NOUN	O	I-outcome
[47(26,	VERB	O	O
120)	NOUN	O	O
mg/g	ADV	O	O
vs	CCONJ	O	O
103(42,	NOUN	O	O
267)	NOUN	O	O
mg/g,	VERB	O	O
P<0.001]and	NOUN	O	O
serum	NOUN	O	O
cystatin	NOUN	O	B-outcome
C	NOUN	O	I-outcome
[(0.83+/-0.30)	NOUN	O	O
mg/L	NOUN	O	O
vs	CCONJ	O	O
(0.98+/-0.25)	PUNCT	O	O
mg/L,	NOUN	O	O
P=0.031].	NOUN	O	O
However,	ADV	O	O
there	PRON	O	O
was	VERB	O	O
no	DET	O	O
statistically	ADV	O	O
significant	ADJ	O	O
difference	NOUN	O	O
of	ADP	O	O
urine	NOUN	O	O
albumin/creatine	NOUN	O	B-outcome
ratio	NOUN	O	I-outcome
and	CCONJ	O	O
cystatin	NOUN	O	B-outcome
C	NOUN	O	I-outcome
between	ADP	O	O
before	ADP	O	O
and	CCONJ	O	O
after	ADP	O	O
treatment	NOUN	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(all	PUNCT	O	O
P>0.05).	NOUN	O	O

Training	VERB	O	O
was	VERB	O	O
performed	VERB	O	O
by	ADP	O	O
lecture,	NOUN	O	O
real-time	NOUN	O	O
feedback,	NUM	O	O
and	CCONJ	O	O
fit	NOUN	O	O
check.	NOUN	O	O

Freedom	NOUN	O	O
from	ADP	O	O
recurrence	NOUN	O	B-outcome
of	ADP	O	O
P.	NOUN	O	O
vivax	NOUN	O	O
parasitemia	NOUN	O	O
at	ADP	O	O
6	NUM	O	O
months	NOUN	O	O
was	VERB	O	O
the	DET	O	O
primary	ADJ	O	O
efficacy	NOUN	O	O
outcome	NOUN	O	O
in	ADP	O	O
a	DET	O	O
planned	VERB	O	O
patient-level	NOUN	O	O
meta-analysis	NOUN	O	O
of	ADP	O	O
the	DET	O	O
current	ADJ	O	O
trial	NOUN	O	O
and	CCONJ	O	O
another	DET	O	O
phase	NOUN	O	O
3	NUM	O	O
trial	NOUN	O	O
of	ADP	O	O
tafenoquine	NOUN	O	O
and	CCONJ	O	O
primaquine	NOUN	O	O
(per-protocol	NOUN	O	O
populations),	NOUN	O	O
and	CCONJ	O	O
an	DET	O	O
odds	NOUN	O	O
ratio	NOUN	O	O
for	ADP	O	O
recurrence	NOUN	O	B-outcome
of	ADP	O	O
1.45	NUM	O	O
(tafenoquine	NUM	O	O
vs.	CCONJ	O	O
primaquine)	NOUN	O	O
was	VERB	O	O
used	VERB	O	O
as	ADP	O	O
a	DET	O	O
noninferiority	NOUN	O	O
margin.	NOUN	O	O

RESULTS:	NOUN	O	O
A	DET	O	O
total	ADJ	O	O
of	ADP	O	O
366	NUM	O	O
patients	NOUN	O	O
(mean	NUM	O	O
age,	NOUN	O	O
48.5	NUM	O	O
years;	NOUN	O	O
280	NUM	O	O
men)	NOUN	O	O
were	VERB	O	O
enrolled.	NOUN	O	O

Exploratory	ADJ	O	O
analyses	NOUN	O	O
suggested	VERB	O	O
that	ADP	O	O
variation	NOUN	O	O
in	ADP	O	O
a	DET	O	O
guanosine	NOUN	O	O
triphosphate	NOUN	O	O
cyclohydrolase	NOUN	O	O
gene	NOUN	O	O
predicted	VERB	O	O
association	NOUN	O	O
with	ADP	O	O
higher	ADJ	O	O
doses	NOUN	O	B-outcome
of	ADP	O	I-outcome
methylphenidate	NOUN	O	I-outcome
(P	NUM	O	O
<	SYM	O	O
0.001).	NUM	O	O

Title:	NOUN	O	O
Comparison	NOUN	O	O
of	ADP	O	O
analgesic	ADP	O	B-outcome
efficacy	NOUN	O	O
of	ADP	O	O
oxycodone	NOUN	O	O
and	CCONJ	O	O
fentanyl	NOUN	O	O
after	ADP	O	O
total	ADJ	O	O
hip	NOUN	O	O
replacement	NOUN	O	O
surgery:	NOUN	O	O
A	DET	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial.	NOUN	O	O

BACKGROUND:	NOUN	O	O
Postoperative	ADJ	O	O
complications	NOUN	O	B-outcome
,	PUNCT	O	O
especially	ADV	O	O
pulmonary	ADJ	O	B-outcome
complications	NOUN	O	I-outcome
,	PUNCT	O	O
affect	NOUN	O	O
more	ADV	O	O
than	ADP	O	O
half	NOUN	O	O
the	DET	O	O
patients	NOUN	O	O
who	ADP	O	O
undergo	NOUN	O	O
open	ADJ	O	O
esophagectomy	NOUN	O	O
for	ADP	O	O
esophageal	ADJ	O	O
cancer.	NOUN	O	O

Cry	NOUN	O	B-outcome
and	CCONJ	O	Seperator
fuss	NOUN	O	B-outcome
time	NOUN	O	E1-outcome
were	VERB	O	O
measured	VERB	O	O
with	ADP	O	O
validated	VERB	O	O
Baby's	NOUN	O	O
Day	NOUN	O	O
Diary	NOUN	O	O
on	ADP	O	O
days	NOUN	O	O
0	NUM	O	O
and	CCONJ	O	O
28.	NUM	O	O

The	DET	O	O
primary	ADJ	O	O
outcome	NOUN	O	O
included	VERB	O	O
bacteriological	ADJ	O	B-outcome
cure	NOUN	O	I-outcome
.	PUNCT	O	O
It	PRON	O	O
was	VERB	O	O
assessed	VERB	O	O
by	ADP	O	O
the	DET	O	O
eradication	NOUN	O	O
of	ADP	O	O
urogenital	ADJ	O	O
gonorrhea	ADJ	O	O
at	ADP	O	O
any	DET	O	O
site	NOUN	O	O
cultured	VERB	O	O
after	ADP	O	O
taken	VERB	O	O
the	DET	O	O
study	NOUN	O	O
medications.	NOUN	O	O

Journal-Name:Occupational	ADJ	O	O
therapy	NOUN	O	O
international	ADJ	O	O

Furthermore,	NOUN	O	O
the	DET	O	O
100-mm	NOUN	O	O
VAS	NOUN	O	O
for	ADP	O	O
radiating	VERB	O	B-outcome
pain	NOUN	O	I-outcome
,	PUNCT	O	O
Oswestry	NOUN	O	O
disability	NOUN	O	B-outcome
index	NOUN	O	O
(ODI)],	NOUN	O	O
Roland-Morris	NOUN	O	O
disability	NOUN	O	B-outcome
questionnaire	NOUN	O	O
(RMDQ)],	NOUN	O	O
EuroQol	NOUN	O	O
5	NUM	O	O
Dimensions	NOUN	O	O
5	NUM	O	O
Levels	NOUN	O	O
(EQ-5D-5L)],	NOUN	O	O
global	ADJ	O	B-outcome
perceived	VERB	O	I-outcome
effect	NOUN	O	O
(GPE),	NUM	O	O
and	CCONJ	O	O
deficiency	NOUN	O	B-outcome
syndrome	NOUN	O	I-outcome
of	ADP	O	I-outcome
kidney	NOUN	O	I-outcome
index	NOUN	O	O
(DSKI)	NOUN	O	O
will	VERB	O	O
be	VERB	O	O
used	VERB	O	O
to	PART	O	O
evaluate	VERB	O	O
secondary	ADJ	O	O
outcomes.	ADJ	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/06/12	ADJ	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

There	PRON	O	O
were	VERB	O	O
significant	ADJ	O	O
differences	NOUN	O	O
favoring	VERB	O	O
acetaminophen	ADV	O	O
vs	CCONJ	O	O
placebo	NOUN	O	O
for	ADP	O	O
3	NUM	O	O
prespecified	VERB	O	O
secondary	ADJ	O	O
outcomes:	NOUN	O	O
delirium	NOUN	O	B-outcome
duration	NOUN	O	I-outcome
(median,	NOUN	O	O
1	NUM	O	O
vs	CCONJ	O	O
2	NUM	O	O
days;	NOUN	O	O
difference,	NOUN	O	O
-1	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-2	NUM	O	O
to	PART	O	O
0]),	NOUN	O	O
ICU	NOUN	O	B-outcome
length	NOUN	O	I-outcome
of	ADP	O	I-outcome
stay	NOUN	O	I-outcome
(median,	NOUN	O	O
29.5	NUM	O	O
vs	CCONJ	O	O
46.7	NUM	O	O
hours;	ADV	O	O
difference,	NOUN	O	O
-16.7	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-20.3	NUM	O	O
to	PART	O	O
-0.8]),	NUM	O	O
and	CCONJ	O	O
breakthrough	NOUN	O	O
analgesia	NOUN	O	B-outcome
(median,	NOUN	O	O
322.5	NUM	O	O
vs	CCONJ	O	O
405.3	NUM	O	O
microg	NOUN	O	O
morphine	NOUN	O	O
equivalents;	ADJ	O	O
difference,	NOUN	O	O
-83	NUM	O	O
[95%	NOUN	O	O
CI,	NOUN	O	O
-154	NUM	O	O
to	PART	O	O
-14]).	NOUN	O	O

Respiratory	ADJ	O	O
muscle	NOUN	O	O
training	VERB	O	O
of	ADP	O	O
the	DET	O	O
experiment	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
performed	VERB	O	O
using	VERB	O	O
the	DET	O	O
respiratory	ADJ	O	O
endurance	NOUN	O	O
training	VERB	O	O
device	NOUN	O	O
combined	VERB	O	O
with	ADP	O	O
traditional	ADJ	O	O
techniques.	NUM	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/12/19	NOUN	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

The	DET	O	O
administration	NOUN	O	O
of	ADP	O	O
gonadotrophin-releasing	VERB	O	O
hormone	NOUN	O	O
(GnRH)	NUM	O	O
agonists	NOUN	O	O
prior	ADJ	O	O
to	PART	O	O
IVF/ICSI	NOUN	O	O
can	VERB	O	O
improve	VERB	O	O
the	DET	O	O
successful	ADJ	O	O
pregnancy	NOUN	O	O
rate.	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Journal	ADJ	O	O
Article	NOUN	O	O

Pain	NOUN	O	B-outcome
is	VERB	O	O
an	DET	O	O
important	ADJ	O	O
factor	NOUN	O	O
that	ADP	O	O
inversely	ADV	O	O
correlates	NOUN	O	O
with	ADP	O	O
the	DET	O	O
improvements	NOUN	O	O
in	ADP	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
.	PUNCT	O	O

BACKGROUND:	NOUN	O	O
This	DET	O	O
study	NOUN	O	O
assessed	VERB	O	O
the	DET	O	O
feasibility	NOUN	O	B-outcome
and	CCONJ	O	O
acceptability	NOUN	O	B-outcome
of	ADP	O	O
two	NUM	O	O
common	ADJ	O	O
types	NOUN	O	O
of	ADP	O	O
exercise	NOUN	O	O
training-high-intensity	NOUN	O	O
interval	NOUN	O	O
training	VERB	O	O
(HIIT)	NOUN	O	O
and	CCONJ	O	O
moderate-intensity	NOUN	O	O
continuous	ADJ	O	O
training	VERB	O	O
(MICT)-in	NOUN	O	O
adults	NOUN	O	O
with	ADP	O	O
Crohn's	NOUN	O	O
disease	NOUN	O	O
(CD).	NUM	O	O

Further	ADV	O	O
investigation	NOUN	O	O
would	VERB	O	O
be	VERB	O	O
required	VERB	O	O
to	PART	O	O
confirm	NOUN	O	O
this	DET	O	O
effect	NOUN	O	O
and	CCONJ	O	O
its	ADJ	O	O
mechanism	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
genotype	NOUN	O	O
prediction	NOUN	O	O
of	ADP	O	O
effects	NOUN	O	O
on	ADP	O	O
dosing.	NOUN	O	O

RESULTS:	NOUN	O	O
After	ADP	O	O
4-week	NOUN	O	O
treatment,	NOUN	O	O
the	DET	O	O
patients	NOUN	O	O
undergoing	VERB	O	O
verum	NOUN	O	O
TENS	NOUN	O	O
showed	VERB	O	O
statistically	ADV	O	O
efficacy	NOUN	O	O
of	ADP	O	O
symptoms	NOUN	O	B-outcome
relief,	NOUN	O	O
as	ADP	O	O
measured	VERB	O	O
by	ADP	O	O
the	DET	O	O
scales	NOUN	O	O
of	ADP	O	O
Tinnitus	NOUN	O	B-outcome
Severity	NOUN	O	I-outcome
Scale	NOUN	O	O
(TSS)	PUNCT	O	O
(P	NUM	O	O
<	SYM	O	O
.01),	PUNCT	O	O
Tinnitus	NOUN	O	B-outcome
Questionnaire	PROPN	O	O
(TQ)	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.01),	PUNCT	O	O
and	CCONJ	O	O
Tinnitus	NOUN	O	B-outcome
Handicap	NOUN	O	I-outcome
Inventory	ADJ	O	O
(THI)],	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.01),	PUNCT	O	O
and	CCONJ	O	O
improvement	NOUN	O	O
of	ADP	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
life	NOUN	O	I-outcome
,	PUNCT	O	O
as	ADP	O	O
assessed	VERB	O	O
by	ADP	O	O
the	DET	O	O
SF-12	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.01),	PUNCT	O	O
compared	VERB	O	O
with	ADP	O	O
patients	NOUN	O	O
receiving	VERB	O	O
sham	NOUN	O	O
TENS.	NOUN	O	O

In	ADP	O	O
the	DET	O	O
conventional	ADJ	O	O
group,	NOUN	O	O
the	DET	O	O
treatment	NOUN	O	O
goal	NOUN	O	O
was	VERB	O	O
clinical	ADJ	O	B-outcome
remission	NOUN	O	I-outcome
.	PUNCT	O	O
Main	ADJ	O	O
Outcomes	NOUN	O	O
and	CCONJ	O	O
Measures:	NOUN	O	O
Co-primary	ADJ	O	O
outcomes	NOUN	O	O
were	VERB	O	O
proportions	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
achieving	VERB	O	O
DAS28-CRP	NOUN	O	B-outcome
remission	NOUN	O	I-outcome
(DAS28-CRP	NUM	O	O
<2.6)	NOUN	O	O
and	CCONJ	O	O
with	ADP	O	O
no	DET	O	O
radiographic	ADJ	O	B-outcome
progression	NOUN	O	I-outcome
(no	PUNCT	O	O
increase	NOUN	O	O
in	ADP	O	O
total	ADJ	O	O
van	NOUN	O	O
der	NOUN	O	O
Heijde-modified	VERB	O	O
Sharp	NOUN	O	O
score)	NOUN	O	O
at	ADP	O	O
24	NUM	O	O
months.	NOUN	O	O

The	DET	O	O
primary	ADJ	O	O
end	NOUN	O	O
point	NOUN	O	O
was	VERB	O	O
investigator-assessed	VERB	O	O
progression-free	ADJ	O	B-outcome
survival	NOUN	O	I-outcome
;	PUNCT	O	O
rates	NOUN	O	O
of	ADP	O	O
objective	ADP	O	B-outcome
response	NOUN	O	I-outcome
and	CCONJ	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
were	VERB	O	O
also	ADV	O	O
evaluated.	NOUN	O	O

Title:	NOUN	O	O
[Randomized	VERB	O	O
controlled	VERB	O	O
trial	NOUN	O	O
of	ADP	O	O
comparison	NOUN	O	O
between	ADP	O	O
the	DET	O	O
SuperPATH	NOUN	O	O
and	CCONJ	O	O
posterolateral	ADJ	O	O
approaches	NOUN	O	O
in	ADP	O	O
total	ADJ	O	O
hip	NOUN	O	O
arthroplasty].	NOUN	O	O

Functional	ADJ	O	B-outcome
outcomes	NOUN	O	O
were	VERB	O	O
similar	ADJ	O	O
in	ADP	O	O
all	DET	O	O
three	NUM	O	O
groups	NOUN	O	O
in	ADP	O	O
POD	NOUN	O	O
1	NUM	O	O
and	CCONJ	O	O
POD	NOUN	O	O
2.	NUM	O	O

Methods:	NOUN	O	O
Seventy-five	NUM	O	O
patients	NOUN	O	O
were	VERB	O	O
randomized	VERB	O	O
into	ADP	O	O
either	CCONJ	O	O
CBT-i	NOUN	O	O
group	NOUN	O	O
(n=37)	NOUN	O	O
or	CCONJ	O	O
combination	NOUN	O	O
group	NOUN	O	O
(n=38).	NUM	O	O

RESULTS:	NOUN	O	O
In	ADP	O	O
the	DET	O	O
dry	ADJ	O	O
needling	VERB	O	O
group,	NOUN	O	O
intensity	NOUN	O	B-outcome
of,	NOUN	O	I-outcome
frequency	NOUN	O	X
and	NOUN	O	X
duration	NOUN	O	B-outcome
of	ADP	O	I-outcome
headache	NOUN	O	B-outcome
,	PUNCT	O	O
and	CCONJ	O	O
the	DET	O	O
scores	NOUN	O	O
of	ADP	O	O
Short	NOUN	O	O
Form-36	NOUN	O	O
subscales	NOUN	O	O
were	VERB	O	O
significantly	ADV	O	O
improved	VERB	O	O
after	ADP	O	O
treatment	NOUN	O	O
(P	NUM	O	O
<	SYM	O	O
.05).	NUM	O	O

RESULTS:	NOUN	O	O
After	ADP	O	O
6	NUM	O	O
weeks	NOUN	O	O
treatment,	NOUN	O	O
lactulose	ADV	O	O
showed	VERB	O	O
better	ADJ	O	O
outcomes	NOUN	O	O
in	ADP	O	O
daily	ADJ	O	O
stool	NOUN	O	B-outcome
frequency	NOUN	O	I-outcome
(P	NUM	O	O
<	SYM	O	O
.01),	PUNCT	O	O
and	CCONJ	O	O
stool	NOUN	O	B-outcome
consistency	NOUN	O	I-outcome
(P	NUM	O	O
<	SYM	O	O
.01),	PUNCT	O	O
except	ADP	O	O
the	DET	O	O
abdominal	ADJ	O	B-outcome
pain	NOUN	O	I-outcome
(P	NUM	O	O
=	SYM	O	O
.24),	PUNCT	O	O
and	CCONJ	O	O
flatulence	NOUN	O	B-outcome
(P	NUM	O	O
=	SYM	O	O
.44),	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
the	DET	O	O
placebo.	NOUN	O	O

At	ADP	O	O
the	DET	O	O
test-of-cure	NOUN	O	O
visit,	NOUN	O	O
a	DET	O	O
higher	ADJ	O	O
percentage	NOUN	O	O
of	ADP	O	O
patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
plazomicin	NOUN	O	O
group	NOUN	O	O
than	ADP	O	O
in	ADP	O	O
the	DET	O	O
meropenem	NOUN	O	O
group	NOUN	O	O
were	VERB	O	O
found	VERB	O	O
to	PART	O	O
have	VERB	O	O
microbiologic	ADJ	O	B-outcome
eradication	NOUN	O	I-outcome
,	PUNCT	O	O
including	VERB	O	O
eradication	NOUN	O	O
of	ADP	O	O
Enterobacteriaceae	NOUN	O	O
that	ADP	O	O
were	VERB	O	O
not	ADV	O	O
susceptible	ADJ	O	O
to	PART	O	O
aminoglycosides	NOUN	O	O
(78.8%	PUNCT	O	O
vs.	CCONJ	O	O
68.6%)	ADP	O	O
and	CCONJ	O	O
Enterobacteriaceae	NOUN	O	O
that	ADP	O	O
produce	VERB	O	O
extended-spectrum	NOUN	O	O
beta-lactamases	NOUN	O	O
(82.4%	NUM	O	O
vs.	CCONJ	O	O
75.0%).	NUM	O	O

BACKGROUND:	NOUN	O	O
Endometrial	ADJ	O	O
scratching	VERB	O	O
(with	PUNCT	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
a	DET	O	O
pipelle	ADJ	O	O
biopsy)	NOUN	O	O
is	VERB	O	O
a	DET	O	O
technique	NOUN	O	O
proposed	VERB	O	O
to	PART	O	O
facilitate	VERB	O	O
embryo	NOUN	O	B-outcome
implantation	NOUN	O	I-outcome
and	CCONJ	O	O
increase	NOUN	O	O
the	DET	O	O
probability	NOUN	O	O
of	ADP	O	O
pregnancy	NOUN	O	B-outcome
in	ADP	O	O
women	NOUN	O	O
undergoing	VERB	O	O
in	ADP	O	O
vitro	ADV	O	O
fertilization	NOUN	O	O
(IVF).	NOUN	O	O

Conclusions	NOUN	O	O
and	CCONJ	O	O
Relevance:	NOUN	O	O
Among	ADP	O	O
older	ADJ	O	O
adults	NOUN	O	O
undergoing	VERB	O	O
major	ADJ	O	O
surgery,	NOUN	O	O
EEG-guided	VERB	O	O
anesthetic	ADJ	O	O
administration,	NOUN	O	O
compared	VERB	O	O
with	ADP	O	O
usual	ADJ	O	O
care,	NOUN	O	O
did	VERB	O	O
not	ADV	O	O
decrease	NOUN	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
postoperative	ADJ	O	O
delirium	NOUN	O	B-outcome
.	PUNCT	O	O
This	DET	O	O
finding	VERB	O	O
does	VERB	O	O
not	ADV	O	O
support	NOUN	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
EEG-guided	VERB	O	O
anesthetic	ADJ	O	O
administration	NOUN	O	O
for	ADP	O	O
this	DET	O	O
indication.	ADV	O	O

Significant	ADJ	O	O
survival	NOUN	O	O
benefit	NUM	O	O
from	ADP	O	O
adjuvant	NOUN	O	O
chemotherapy	NOUN	O	O
was	VERB	O	O
observed	VERB	O	O
by	ADP	O	O
SPC-Prediction	NOUN	O	O
in	ADP	O	O
MSS	NOUN	O	O
and	CCONJ	O	O
EBV-negative	ADJ	O	O
gastric	ADJ	O	O
cancer.	NOUN	O	O

There	PRON	O	O
is	VERB	O	O
evidence	NOUN	O	O
that	ADP	O	O
supplementation	NOUN	O	O
with	ADP	O	O
L-methylfolate	NOUN	O	O
augments	NOUN	O	O
antidepressant	NOUN	O	O
agent	NOUN	O	O
effects	NOUN	O	O
and	CCONJ	O	O
thus	ADV	O	O
might	VERB	O	O
also	ADV	O	O
augment	ADP	O	O
ADHD	NOUN	O	O
treatment	NOUN	O	O
effects	NOUN	O	O
by	ADP	O	O
a	DET	O	O
common	ADJ	O	O
catecholaminergic	ADJ	O	O
mechanism.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

Funded	VERB	O	O
by	ADP	O	O
the	DET	O	O
University	NOUN	O	O
of	ADP	O	O
Auckland	CCONJ	O	O
and	CCONJ	O	O
others;	NOUN	O	O
PIP	NOUN	O	O
Australian	ADJ	O	O
New	ADJ	O	O
Zealand	NOUN	O	O
Clinical	ADJ	O	O
Trials	NOUN	O	O
Registry	NOUN	O	O
number,	ADV	O	O
ACTRN12614000626662	NOUN	O	O
.).	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
0255562	NUM	O	O

The	DET	O	O
ratio	NOUN	O	B-outcome
of	ADP	O	I-outcome
Apo	NOUN	O	I-outcome
B	NOUN	O	I-outcome
to	PART	O	I-outcome
Apo	NOUN	O	I-outcome
A1	NOUN	O	I-outcome
was	VERB	O	O
reduced	VERB	O	O
more	ADV	O	O
(p	PUNCT	O	O
=	SYM	O	O
0.0866)	NUM	O	O
in	ADP	O	O
the	DET	O	O
amla	NOUN	O	O
group	NOUN	O	O
as	ADP	O	O
compared	VERB	O	O
to	PART	O	O
the	DET	O	O
placebo.	NOUN	O	O

None	NUM	O	O
of	ADP	O	O
the	DET	O	O
intervention-arms	NOUN	O	O
was	VERB	O	O
cost-effective	ADJ	O	O
for	ADP	O	O
sickness	NOUN	O	B-outcome
absence	NOUN	O	I-outcome
.	PUNCT	O	O
There	PRON	O	O
was	VERB	O	O
85%	NOUN	O	O
probability	NOUN	O	O
of	ADP	O	O
exercise-arm	NOUN	O	O
being	VERB	O	O
cost-effective	ADJ	O	O
if	ADP	O	O
willing	VERB	O	O
to	PART	O	O
pay	NOUN	O	O
euro3550	NOUN	O	O
for	ADP	O	O
QALY	NOUN	O	O
gained.	NOUN	O	O

The	DET	O	O
preventive,	ADJ	O	O
complex	NOUN	O	O
psychological	ADJ	O	O
intervention	NOUN	O	O
comprised	VERB	O	O
promotion	NOUN	O	O
of	ADP	O	O
a	DET	O	O
therapeutic	ADJ	O	O
ICU	NOUN	O	O
environment	NOUN	O	O
plus	CCONJ	O	O
3	NUM	O	O
stress	NOUN	O	O
support	NOUN	O	O
sessions	NOUN	O	O
and	CCONJ	O	O
a	DET	O	O
relaxation	NOUN	O	O
and	CCONJ	O	O
recovery	NOUN	O	O
program	NOUN	O	O
delivered	VERB	O	O
by	ADP	O	O
trained	VERB	O	O
ICU	NOUN	O	O
nurses	NOUN	O	O
to	PART	O	O
high-risk	NOUN	O	O
(acutely	ADV	O	O
stressed)	NOUN	O	O
patients.	NOUN	O	O

We	PRON	O	O
measured	VERB	O	O
the	DET	O	O
correct	ADJ	O	O
index	NOUN	O	O
in	ADP	O	O
the	DET	O	O
identification	NOUN	O	B-outcome
of	ADP	O	O
the	DET	O	O
eye	NOUN	O	O
drops	NOUN	O	O
of	ADP	O	O
the	DET	O	O
two	NUM	O	O
groups.	NOUN	O	O

Journal-Name:Revista	NOUN	O	O
medica	NOUN	O	O
de	ADP	O	O
Chile	NOUN	O	O

All	DET	O	O
other	ADJ	O	O
adverse	ADJ	O	B-outcome
reactions	NOUN	O	I-outcome
observed	VERB	O	O
during	ADP	O	O
the	DET	O	O
test	NOUN	O	O
period	NOUN	O	O
were	VERB	O	O
resolved	VERB	O	O
completely	ADV	O	O
without	ADP	O	O
special	ADJ	O	O
treatment.	NOUN	O	O

During	ADP	O	O
clinically	ADV	O	O
apparent	ADJ	O	O
infection,	NOUN	O	O
a	DET	O	O
reduction	NOUN	O	O
in	ADP	O	O
the	DET	O	O
diversity	NOUN	O	O
of	ADP	O	O
micro-organisms	NOUN	O	O
in	ADP	O	O
a	DET	O	O
DFU	NOUN	O	O
was	VERB	O	O
often	ADV	O	O
observed	VERB	O	O
due	ADJ	O	O
to	PART	O	O
expansion	NOUN	O	O
of	ADP	O	O
one	NUM	O	O
or	CCONJ	O	O
two	NUM	O	O
taxa,	NOUN	O	O
with	ADP	O	O
recovery	NOUN	O	O
in	ADP	O	O
diversity	NOUN	O	O
at	ADP	O	O
resolution.	NOUN	O	O

Trimethylamine	NOUN	O	O
N-oxide	NOUN	O	O
(TMAO)	NOUN	O	O
is	VERB	O	O
considered	VERB	O	O
a	DET	O	O
novel	ADJ	O	O
risk	NOUN	O	O
factor	NOUN	O	O
for	ADP	O	O
cardiovascular	ADJ	O	O
diseases.	NOUN	O	O

Side	NOUN	O	B-outcome
effects	NOUN	O	I-outcome
(all	PUNCT	O	O
mild)	NOUN	O	O
occurred	VERB	O	O
in	ADP	O	O
4.2%	NOUN	O	O
of	ADP	O	O
the	DET	O	O
participants.	NOUN	O	O

Periprosthetic	ADJ	O	B-outcome
fracture	NOUN	O	I-outcome
occurred	VERB	O	O
in	ADP	O	O
1	NUM	O	O
case	NOUN	O	O
of	ADP	O	O
the	DET	O	O
SuperPATH	NOUN	O	O
group.	VERB	O	O

Pain	NOUN	O	B-outcome
scores,	NOUN	O	O
opioid	NOUN	O	B-outcome
requirements	NOUN	O	I-outcome
,	PUNCT	O	O
PT	NOUN	O	O
test	NOUN	O	O
results,	NOUN	O	O
and	CCONJ	O	O
patient-reported	VERB	O	O
outcome	NOUN	O	O
instruments	NOUN	O	O
were	VERB	O	O
compared	VERB	O	O
between	ADP	O	O
the	DET	O	O
three	NUM	O	O
groups.	NOUN	O	O

2019;	NOUN	O	O
90(1):12-17.	NOUN	O	O

Journal-Name:Graefe's	NOUN	O	O
archive	ADJ	O	O
for	ADP	O	O
clinical	ADJ	O	O
and	CCONJ	O	O
experimental	ADJ	O	O
ophthalmology	NOUN	O	O
=	SYM	O	O
Albrecht	NOUN	O	O
von	ADP	O	O
Graefes	NOUN	O	O
Archiv	NOUN	O	O
fur	NUM	O	O
klinische	NOUN	O	O
und	NOUN	O	O
experimentelle	NOUN	O	O
Ophthalmologie	NOUN	O	O

Publication	NOUN	O	O
Type:	NOUN	O	O
Randomized	VERB	O	O
Controlled	VERB	O	O
Trial	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101160941	NUM	O	O

The	DET	O	O
combination	NOUN	O	O
of	ADP	O	O
an	DET	O	O
unsatisfying	VERB	O	O
quality	NOUN	O	B-outcome
of	ADP	O	I-outcome
implementing	VERB	O	I-outcome
the	DET	O	Seperator
intervention	NOUN	O	I-outcome
and	CCONJ	O	O
a	DET	O	O
low	ADJ	O	O
previous	ADJ	O	O
knowledge	NOUN	O	B-outcome
about	ADV	O	O
the	DET	O	O
intervention	NOUN	O	O
showed	VERB	O	O
the	DET	O	O
highest	ADP	O	O
empirical	ADJ	O	O
relevance.	NOUN	O	O

Title:	NOUN	O	O
A	DET	O	O
High	ADJ	O	O
Adherence	NOUN	O	O
to	PART	O	O
Six	NUM	O	O
Food	NOUN	O	O
Targets	NOUN	O	O
of	ADP	O	O
the	DET	O	O
Mediterranean	NOUN	O	O
Diet	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Late	ADJ	O	O
First	ADV	O	O
Trimester	NOUN	O	O
is	VERB	O	O
Associated	VERB	O	O
with	ADP	O	O
a	DET	O	O
Reduction	NOUN	O	O
in	ADP	O	O
the	DET	O	O
Risk	NOUN	O	O
of	ADP	O	O
Materno-Foetal	ADJ	O	O
Outcomes:	NOUN	O	O
The	DET	O	O
St.	NOUN	O	O
Carlos	NOUN	O	O
Gestational	ADJ	O	O
Diabetes	NOUN	O	O
Mellitus	NOUN	O	O
Prevention	NOUN	O	O
Study.	NOUN	O	O

RESULTS:	NOUN	O	O
Twenty-two	NUM	O	O
patients	NOUN	O	O
(44%)	PUNCT	O	O
were	VERB	O	O
still	ADV	O	O
assessable	ADJ	O	O
at	ADP	O	O
the	DET	O	O
end-of-study	NOUN	O	O
visit,	NOUN	O	O
whereas	ADP	O	O
33	NUM	O	O
(70%)	NOUN	O	O
were	VERB	O	O
assessable	ADJ	O	O
at	ADP	O	O
the	DET	O	O
same	ADJ	O	O
time	NOUN	O	O
point	NOUN	O	O
in	ADP	O	O
the	DET	O	O
TENS-TEP	ADV	O	O
group	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.013).	PUNCT	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101521595	NUM	O	O

Group	NOUN	O	O
A	DET	O	O
consisted	VERB	O	O
of	ADP	O	O
66	NUM	O	O
patients	NOUN	O	O
who	ADP	O	O
received	VERB	O	O
dexmedetomidine,	ADP	O	O
and	CCONJ	O	O
Group	NOUN	O	O
B	NOUN	O	O
included	VERB	O	O
66	NUM	O	O
patients	NOUN	O	O
with	ADP	O	O
paracetamol	NOUN	O	O
administration.	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

RESULTS:	NOUN	O	O
At	ADP	O	O
3	NUM	O	O
and	CCONJ	O	O
6	NUM	O	O
month	NOUN	O	O
follow	VERB	O	O
up,	NOUN	O	O
Atorvastatin	ADP	O	O
40mg	NOUN	O	O
leads	NOUN	O	O
to	PART	O	O
mean	NOUN	O	O
LDL	NOUN	O	B-outcome
cholesterol	NOUN	O	I-outcome
reduction	NOUN	O	O
of	ADP	O	O
47.18+/-20.81	NUM	O	O
&	CCONJ	O	O
50.03+/-18.06	NUM	O	O
respectively.	NOUN	O	O

Thirty	NUM	O	O
minutes	NOUN	O	O
before	ADP	O	O
operation,	NOUN	O	O
control	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
intranasal	ADJ	O	O
placebo	NOUN	O	O
(0.9%	NOUN	O	O
saline)	NOUN	O	O
0.02	NUM	O	O
mL/kg,	NOUN	O	O
and	CCONJ	O	O
DEX	NOUN	O	O
group	NOUN	O	O
received	VERB	O	O
intranasal	ADJ	O	O
DEX	NOUN	O	O
2	NUM	O	O
mug/kg.	NOUN	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
2985248R	NOUN	O	O

Twelve	NUM	O	O
(9.5%)	NOUN	O	O
and	CCONJ	O	O
10	NUM	O	O
(7.9%)	PUNCT	O	O
subjects	NOUN	O	O
experienced	VERB	O	O
>30%	NOUN	O	O
endothelial	ADJ	O	B-outcome
cell	NOUN	O	I-outcome
loss	NOUN	O	O
(ECL)	ADV	O	O
at	ADP	O	O
12	NUM	O	O
and	CCONJ	O	O
24	NUM	O	O
months,	NOUN	O	O
respectively.	NOUN	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
use	NOUN	O	O
of	ADP	O	O
Bilevel	NOUN	O	O
Positive	ADJ	O	O
Airway	NOUN	O	O
Pressure	NOUN	O	O
(BiPAP)	NOUN	O	O
in	ADP	O	O
morbidly	ADV	O	O
obese	NOUN	O	O
individuals	NOUN	O	O
in	ADP	O	O
two	NUM	O	O
moments	NOUN	O	O
following	VERB	O	O
bariatric	ADJ	O	O
surgery	NOUN	O	O
(Roux-en-Y	NUM	O	O
gastric	ADJ	O	O
bypass):	NOUN	O	O
post-anesthetic	ADJ	O	O
recovery	NOUN	O	O
(PAR)	NOUN	O	O
and	CCONJ	O	O
first	ADV	O	O
postoperative	ADJ	O	O
day	NOUN	O	O
(1PO).	NUM	O	O

Title:	NOUN	O	O
[Effects	NOUN	O	O
of	ADP	O	O
intranasal	ADJ	O	O
dexmedetomidine	NOUN	O	O
for	ADP	O	O
children	NOUN	O	O
undergoing	VERB	O	O
dental	ADJ	O	O
rehabilitation	NOUN	O	O
under	ADP	O	O
general	ADJ	O	O
anesthesia:	NOUN	O	O
a	DET	O	O
double-blinded	VERB	O	O
randomized	VERB	O	O
controlled	VERB	O	O
trial].	ADV	O	O

Only	ADV	O	O
one	NUM	O	O
tooth	NOUN	O	O
of	ADP	O	O
G1	NOUN	O	O
was	VERB	O	O
unsuccessful	ADJ	O	B-outcome
;	PUNCT	O	O
hence,	NOUN	O	O
pulpectomy	NOUN	O	B-outcome
performance	NOUN	O	I-outcome
in	ADP	O	O
both	CCONJ	O	O
groups	NOUN	O	O
was	VERB	O	O
not	ADV	O	O
influenced	VERB	O	O
by	ADP	O	O
the	DET	O	O
filling	VERB	O	O
material,	NOUN	O	O
nor	CCONJ	O	O
by	ADP	O	O
any	DET	O	O
other	ADJ	O	O
analyzed	VERB	O	O
variable.	NOUN	O	O

C-group	NOUN	O	O
received	VERB	O	O
a	DET	O	O
brochure.	NOUN	O	O

The	DET	O	O
frequency	NOUN	O	O
of	ADP	O	O
live	ADJ	O	B-outcome
birth	NOUN	O	I-outcome
was	VERB	O	O
180	NUM	O	O
of	ADP	O	O
690	NUM	O	O
women	NOUN	O	O
(26.1%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
endometrial-scratch	NOUN	O	O
group	NOUN	O	O
and	CCONJ	O	O
176	NUM	O	O
of	ADP	O	O
674	NUM	O	O
women	NOUN	O	O
(26.1%)	NUM	O	O
in	ADP	O	O
the	DET	O	O
control	NOUN	O	O
group	NOUN	O	O
(adjusted	PUNCT	O	O
odds	NOUN	O	O
ratio,	NOUN	O	O
1.00;	NOUN	O	O
95%	NOUN	O	O
confidence	NOUN	O	O
interval,	ADP	O	O
0.78	NUM	O	O
to	PART	O	O
1.27).	NOUN	O	O

FUNDING:	NOUN	O	O
National	ADJ	O	O
Institute	NOUN	O	O
for	ADP	O	O
Health	NOUN	O	O
Research	NOUN	O	O
Efficacy	NOUN	O	O
and	CCONJ	O	O
Mechanism	NOUN	O	O
Evaluation	NOUN	O	O
Programme.	NOUN	O	O

The	DET	O	O
results	NOUN	O	O
of	ADP	O	O
nine-gene	NOUN	O	O
based	VERB	O	O
SPC	NOUN	O	O
assay	NOUN	O	O
were	VERB	O	O
classified	VERB	O	O
as	ADP	O	O
prognostication	NOUN	O	O
(SPC-prognosis)	PUNCT	O	O
and	CCONJ	O	O
prediction	NOUN	O	O
of	ADP	O	O
chemotherapy	NOUN	O	O
benefit	NUM	O	O
(SPC-prediction).	PUNCT	O	O

Title:	NOUN	O	O
Chocolate	NOUN	O	O
Milk	NOUN	O	O
versus	CCONJ	O	O
carbohydrate	NOUN	O	O
supplements	NOUN	O	O
in	ADP	O	O
adolescent	NOUN	O	O
athletes:	ADJ	O	O
a	DET	O	O
field	NOUN	O	O
based	VERB	O	O
study.	NOUN	O	O

Results	NOUN	O	O
were	VERB	O	O
similar	ADJ	O	O
for	ADP	O	O
all	DET	O	O
(mild/moderate/severe)	PUNCT	O	O
exacerbations	NOUN	O	B-outcome
.	PUNCT	O	O
Improvements	NOUN	O	O
in	ADP	O	O
lung	NOUN	O	B-outcome
function	NOUN	O	I-outcome
,	PUNCT	O	O
health	NOUN	O	B-outcome
status	NOUN	O	O
and	CCONJ	O	O
rescue	NOUN	O	B-outcome
medication	NOUN	O	I-outcome
use	NOUN	O	I-outcome
with	ADP	O	O
IND/GLY	NOUN	O	O
vs	CCONJ	O	O
SFC	NOUN	O	O
were	VERB	O	O
comparable	ADJ	O	O
between	ADP	O	O
men	NOUN	O	O
and	CCONJ	O	O
women.	NOUN	O	O

Participants	NOUN	O	O
are	VERB	O	O
randomised	VERB	O	O
to	PART	O	O
receive	VERB	O	O
MCP	NOUN	O	O
either	CCONJ	O	O
at	ADP	O	O
baseline	NOUN	O	O
(early	ADV	O	O
treatment)	NOUN	O	O
or	CCONJ	O	O
after	ADP	O	O
3	NUM	O	O
months	NOUN	O	O
(delayed	PUNCT	O	O
treatment).	NOUN	O	O

The	DET	O	O
positive	ADJ	O	O
percent	NOUN	O	O
of	ADP	O	O
coli-form	NOUN	O	B-outcome
on	ADP	O	O
the	DET	O	O
hand	NOUN	O	O
swabs	NOUN	O	O
in	ADP	O	O
intervention	NOUN	O	O
group	NOUN	O	O
(2.00%)	NUM	O	O
were	VERB	O	O
significantly	ADV	O	O
lower	ADJ	O	O
than	ADP	O	O
that	ADP	O	O
in	ADP	O	O
control	NOUN	O	O
group	NOUN	O	O
(9.45%)	NOUN	O	O
at	ADP	O	O
the	DET	O	O
end	NOUN	O	O
of	ADP	O	O
year	NOUN	O	O
2.The	NUM	O	O
intervention	NOUN	O	O
of	ADP	O	O
intensive	ADJ	O	O
education	NOUN	O	O
on	ADP	O	O
hand	NOUN	O	O
hygiene	NOUN	O	O
effectively	ADV	O	O
improved	VERB	O	O
the	DET	O	O
personal	ADJ	O	B-outcome
hygiene	NOUN	O	I-outcome
both	CCONJ	O	O
of	ADP	O	O
children	NOUN	O	O
and	CCONJ	O	O
parents,	NOUN	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
reduced	VERB	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
hand	NOUN	O	B-outcome
food	NOUN	O	I-outcome
mouth	NOUN	O	I-outcome
disease	NOUN	O	I-outcome
.	PUNCT	O	O
We	PRON	O	O
suggested	VERB	O	O
expanding	VERB	O	O
the	DET	O	O
intervention	NOUN	O	O
measures	NOUN	O	O
in	ADP	O	O
community	NOUN	O	O
to	PART	O	O
prevent	NOUN	O	O
HFMD.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/02/12	ADJ	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

The	DET	O	O
data	NOUN	O	O
were	VERB	O	O
analyzed	VERB	O	O
using	VERB	O	O
repeated	VERB	O	O
measures	NOUN	O	O
MANOVA.	NOUN	O	O

Whey	NOUN	O	O
protein	NOUN	O	O
isolate	VERB	O	O
(WPI)	ADV	O	O
is	VERB	O	O
high	ADJ	O	O
in	ADP	O	O
vitamin	NOUN	O	O
B12	NOUN	O	O
and	CCONJ	O	O
folate.	NOUN	O	O

Such	ADJ	O	O
guidelines	NOUN	O	O
are	VERB	O	O
made	VERB	O	O
available	ADJ	O	O
for	ADP	O	O
strength	NOUN	O	O
training	VERB	O	O
(ST)	NOUN	O	O
using	VERB	O	O
the	DET	O	O
1	NUM	O	O
repetition	NOUN	O	O
maximum	NOUN	O	O
(1RM),	NOUN	O	O
which	ADP	O	O
has	VERB	O	O
been	VERB	O	O
linked	VERB	O	O
to	PART	O	O
individuals'	NOUN	O	O
self-rated	VERB	O	O
level	NOUN	O	O
of	ADP	O	O
exertion	NOUN	O	O
using	VERB	O	O
the	DET	O	O
Borg	ADJ	O	O
rating	VERB	O	O
of	ADP	O	O
perceived	VERB	O	O
exertion	NOUN	O	O
(BRPE)	ADV	O	O
scale.	ADJ	O	O

Patients	NOUN	O	O
in	ADP	O	O
the	DET	O	O
routine	ADJ	O	O
chemotherapy	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
30,	NUM	O	O
RC	NOUN	O	O
group)	ADJ	O	O
received	VERB	O	O
cisplatin	NOUN	O	O
infusion	NOUN	O	O
within	ADP	O	O
1	NUM	O	O
h	NOUN	O	O
and	CCONJ	O	O
5-FU	NOUN	O	O
infusion	NOUN	O	O
for	ADP	O	O
about	ADV	O	O
24	NUM	O	O
h.	NOUN	O	O
The	DET	O	O
dose	NOUN	O	O
in	ADP	O	O
the	DET	O	O
RC	NOUN	O	O
group	NOUN	O	O
was	VERB	O	O
the	DET	O	O
same	ADJ	O	O
as	ADP	O	O
that	ADP	O	O
in	ADP	O	O
the	DET	O	O
CC	NOUN	O	O
group.	VERB	O	O

METHODS:	NOUN	O	O
A	DET	O	O
sample	NOUN	O	O
of	ADP	O	O
37	NUM	O	O
patients	NOUN	O	O
poststroke	NOUN	O	O
(29	NOUN	O	O
males)	NOUN	O	O
was	VERB	O	O
randomly	ADV	O	O
allocated	VERB	O	O
to	PART	O	O
either	CCONJ	O	O
SPT	NOUN	O	O
control	NOUN	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
18)	NOUN	O	O
or	CCONJ	O	O
SPT	NOUN	O	O
and	CCONJ	O	O
SMV	NOUN	O	O
(SPT-SMV)	NOUN	O	O
experimental	ADJ	O	O
group	NOUN	O	O
(n	NOUN	O	O
=	SYM	O	O
19).	ADJ	O	O

RESULTS:	NOUN	O	O
Participants	NOUN	O	O
identified	VERB	O	O
more	ADV	O	O
barriers	NOUN	O	O
than	ADP	O	O
facilitators	NOUN	O	O
when	ADP	O	O
describing	VERB	O	O
contextual	ADJ	O	O
factors	NOUN	O	O
influencing	VERB	O	O
the	DET	O	O
mhGAP-based	VERB	O	O
training's	NOUN	O	O
expected	VERB	O	O
outcomes.	ADJ	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/01/10	ADV	O	O
06:00	ADP	O	O
[entrez]	ADP	O	O

min(-1)).	NOUN	O	O

TRIAL	NOUN	O	O
REGISTRATION:	NOUN	O	O
Registered	VERB	O	O
with	ADP	O	O
Clinical	ADJ	O	O
Trials	NOUN	O	O
Registry-	NOUN	O	O
India	PROPN	O	O
at	ADP	O	O
www.ctri.nic.in	NOUN	O	O
(Registration	NOUN	O	O
number:	NOUN	O	O
CTRI/2015/04/005682	NOUN	O	O
)	PUNCT	O	O
on	ADP	O	O
8	NUM	O	O
April	NOUN	O	O
2015	NUM	O	O
(retrospectively	ADV	O	O
registered).	ADP	O	O

Whether	ADP	O	O
a	DET	O	O
briefer	VERB	O	O
treatment	NOUN	O	O
interval	NOUN	O	O
would	VERB	O	O
be	VERB	O	O
efficacious	ADJ	O	O
has	VERB	O	O
not	ADV	O	O
been	VERB	O	O
studied.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
the	DET	O	O
International	ADJ	O	O
Society	NOUN	O	O
of	ADP	O	O
Sports	NOUN	O	O
Nutrition	NOUN	O	O

Serum	NOUN	O	O
levels	NOUN	O	O
of	ADP	O	O
AdipoR1	VERB	O	O
were	VERB	O	O
positively	ADV	O	O
correlated	VERB	O	O
with	ADP	O	O
APN	NOUN	O	O
(r	NUM	O	O
=	SYM	O	O
0.726,	PUNCT	O	O
P<0.01),	NOUN	O	O
and	CCONJ	O	O
negatively	ADV	O	O
correlated	VERB	O	O
with	ADP	O	O
BMI,	NUM	O	O
SBP,	NOUN	O	O
DBP,	NOUN	O	O
FBG,	NOUN	O	O
TC	NOUN	O	O
and	CCONJ	O	O
LDL-C	NOUN	O	O
(r	NUM	O	O
=	SYM	O	O
-0.440,	NOUN	O	O
-0.446,	NUM	O	O
-0.374,	NUM	O	O
-0.444,	NOUN	O	O
-0.344,	NOUN	O	O
-0.709,	NOUN	O	O
respectively;	NOUN	O	O
all	DET	O	O
P<0.01).	NOUN	O	O

Statistical	ADJ	O	O
significance	NOUN	O	O
was	VERB	O	O
set	NOUN	O	O
at	ADP	O	O
P	NOUN	O	O
</=	NOUN	O	O
0.05.	PUNCT	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2019/03/12	NOUN	O	O
06:00	ADP	O	O
[medline]	NOUN	O	O

Single-arm	NUM	O	O
studies	NOUN	O	O
have	VERB	O	O
suggested	VERB	O	O
that	ADP	O	O
a	DET	O	O
10-day	NOUN	O	O
schedule	NOUN	O	O
of	ADP	O	O
decitabine	NOUN	O	O
cycles	NOUN	O	O
leads	NOUN	O	O
to	PART	O	O
better	ADJ	O	O
outcomes	NOUN	O	O
than	ADP	O	O
the	DET	O	O
usual	ADJ	O	O
5-day	NOUN	O	O
schedule.	NOUN	O	O

The	DET	O	O
interruption	NOUN	O	O
of	ADP	O	O
the	DET	O	O
blood	NOUN	O	O
supply	NOUN	O	O
to	PART	O	O
the	DET	O	O
donor	NOUN	O	O
liver	NOUN	O	O
during	ADP	O	O
cold	NOUN	O	O
storage	NOUN	O	O
damages	NOUN	O	O
the	DET	O	O
liver,	NOUN	O	O
affecting	VERB	O	O
how	ADP	O	O
well	ADV	O	O
the	DET	O	O
liver	NOUN	O	O
will	VERB	O	O
function	NOUN	O	O
after	ADP	O	O
transplant.	NOUN	O	O

METHODS:	NOUN	O	O
In	ADP	O	O
this	DET	O	O
randomised	VERB	O	O
placebo-controlled	VERB	O	O
trial,	NOUN	O	O
we	PRON	O	O
recruited	VERB	O	O
very	ADV	O	O
preterm	NOUN	O	O
infants	NOUN	O	O
born	VERB	O	O
before	ADP	O	O
32	NUM	O	O
weeks'	ADP	O	O
gestation	NOUN	O	O
in	ADP	O	O
37	NUM	O	O
UK	PROPN	O	O
hospitals	NOUN	O	O
and	CCONJ	O	O
younger	ADJ	O	O
than	ADP	O	O
72	NUM	O	O
h	NOUN	O	O
at	ADP	O	O
randomisation.	ADV	O	O

Journal	ADJ	O	O
ID:	NOUN	O	O
101224380	NUM	O	O

CONCLUSION:	NOUN	O	O
The	DET	O	O
findings	NOUN	O	O
of	ADP	O	O
this	DET	O	O
study	NOUN	O	O
showed	VERB	O	O
that	ADP	O	O
BZSF	NOUN	O	O
as	ADP	O	O
an	DET	O	O
adjunctive	ADJ	O	O
therapy	NOUN	O	O
to	PART	O	O
ceftriaxone	NOUN	O	O
may	VERB	O	O
be	VERB	O	O
not	ADV	O	O
superior	ADJ	O	O
to	PART	O	O
the	DET	O	O
ceftriaxone	NOUN	O	O
alone	ADJ	O	O
for	ADP	O	O
Chinese	NOUN	O	O
female	NOUN	O	O
patients	NOUN	O	O
with	ADP	O	O
uncomplicated	VERB	O	O
gonorrhea	ADJ	O	O
after	ADP	O	O
10	NUM	O	O
days	NOUN	O	O
treatment.	NOUN	O	O

Publication	NOUN	O	O
date:	NOUN	O	O
2018/11/30	NOUN	O	O
00:00	NOUN	O	O
[accepted]	ADV	O	O

Based	VERB	O	O
on	ADP	O	O
the	DET	O	O
benefit	NUM	O	O
of	ADP	O	O
polyphenolic	ADJ	O	O
compounds	NOUN	O	O
on	ADP	O	O
osteoporosis,	PRON	O	O
we	PRON	O	O
hypothesized	VERB	O	O
that	ADP	O	O
the	DET	O	O
polyphenol-rich	ADJ	O	O
herbal	ADJ	O	O
congee	ADP	O	O
containing	VERB	O	O
the	DET	O	O
combined	VERB	O	O
extract	NOUN	O	O
of	ADP	O	O
Morus	NOUN	O	O
alba	NOUN	O	O
and	CCONJ	O	O
Polygonum	NOUN	O	O
odoratum	NOUN	O	O
leaves	NOUN	O	O
should	VERB	O	O
improve	VERB	O	O
bone	NOUN	O	B-outcome
turnover	ADV	O	I-outcome
markers	NOUN	O	O
in	ADP	O	O
menopausal	ADJ	O	O
women.	NOUN	O	O

The	DET	O	O
secondary	ADJ	O	O
outcome	NOUN	O	O
was	VERB	O	O
the	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
severe	ADJ	O	B-outcome
hypoxemia	NOUN	O	I-outcome
,	PUNCT	O	O
defined	VERB	O	O
as	ADP	O	O
an	DET	O	O
oxygen	NOUN	O	O
saturation	NOUN	O	O
of	ADP	O	O
less	ADV	O	O
than	ADP	O	O
80%.	NUM	O	O

After	ADP	O	O
the	DET	O	O
exercise,	NOUN	O	O
improvement	NOUN	O	O
was	VERB	O	O
noted	VERB	O	O
in	ADP	O	O
Ober	NOUN	O	O
test	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.005;	PUNCT	O	O
d	NOUN	O	O
=	SYM	O	O
0.75	NUM	O	O
on	ADP	O	O
the	DET	O	O
right	ADJ	O	O
side,	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.005;	PUNCT	O	O
d	NOUN	O	O
=	SYM	O	O
0.78	NUM	O	O
on	ADP	O	O
the	DET	O	O
left	ADV	O	O
side)	NOUN	O	O
and	CCONJ	O	O
in	ADP	O	O
the	DET	O	O
Thomas	NOUN	O	O
test	NOUN	O	O
(P	NUM	O	O
=	SYM	O	O
.005;	PUNCT	O	O
d	NOUN	O	O
=	SYM	O	O
0.66	NUM	O	O
on	ADP	O	O
the	DET	O	O
right	ADJ	O	O
side,	NOUN	O	O
P	NOUN	O	O
=	SYM	O	O
.005;	PUNCT	O	O
d	NOUN	O	O
=	SYM	O	O
0.67	NUM	O	O
on	ADP	O	O
the	DET	O	O
left	ADV	O	O
side).	ADJ	O	O

Title:	NOUN	O	O
Bilevel	NOUN	O	O
positive	ADJ	O	O
airway	NOUN	O	O
pressure	NOUN	O	O
in	ADP	O	O
two	NUM	O	O
moments	NOUN	O	O
after	ADP	O	O
bariatric	ADJ	O	O
surgery.	VERB	O	O

Title:	NOUN	O	O
A	DET	O	O
Phase	NOUN	O	O
II	NUM	O	O
Study	NOUN	O	O
Alternating	VERB	O	O
Erlotinib	NOUN	O	O
With	ADP	O	O
Second-line	NOUN	O	O
mFOLFOX6	NOUN	O	O
or	CCONJ	O	O
FOLFIRI	NOUN	O	O
for	ADP	O	O
Metastatic	ADJ	O	O
Colorectal	ADJ	O	O
Cancer.	ADV	O	O

Both	CCONJ	O	O
inspiratory	ADJ	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
and	CCONJ	O	O
exhaled	VERB	O	B-outcome
tidal	DET	O	I-outcome
volume	NOUN	O	I-outcome
monitored	VERB	O	O
by	ADP	O	O
ventilator	NOUN	O	O
could	VERB	O	O
not	ADV	O	O
reflect	NOUN	O	O
the	DET	O	O
patient's	NOUN	O	O
tidal	DET	O	B-outcome
volume	NOUN	O	I-outcome
under	ADP	O	O
either	CCONJ	O	O
VCV	NOUN	O	O
or	CCONJ	O	O
PCV	NOUN	O	O
mode.	VERB	O	O

AIM:	NOUN	O	O
To	PART	O	O
assess	NOUN	O	O
the	DET	O	O
effectiveness	NOUN	O	O
of	ADP	O	O
a	DET	O	O
self-administered	VERB	O	O
rehabilitation	NOUN	O	O
program	NOUN	O	O
in	ADP	O	O
adults	NOUN	O	O
with	ADP	O	O
shoulder	NOUN	O	O
pain	NOUN	O	O
syndrome	NOUN	O	O
in	ADP	O	O
primary	ADJ	O	O
care.	NOUN	O	O

The	DET	O	O
preoperative	ADJ	O	O
sedation	NOUN	O	B-outcome
score,	NOUN	O	O
the	DET	O	O
status	NOUN	O	B-outcome
of	ADP	O	I-outcome
separation	NOUN	O	I-outcome
from	ADP	O	I-outcome
parents	NOUN	O	I-outcome
,	PUNCT	O	O
compliance	NOUN	O	B-outcome
with	ADP	O	O
the	DET	O	O
mask	NOUN	O	O
and	CCONJ	O	O
hemodynamic	ADJ	O	B-outcome
parameters	NOUN	O	O
were	VERB	O	O
recorded	VERB	O	O
by	ADP	O	O
an	DET	O	O
anesthesiologists	NOUN	O	O
until	ADP	O	O
anesthesia	NOUN	O	O
induction.	NOUN	O	O

Journal-Name:Journal	ADJ	O	O
of	ADP	O	O
drugs	NOUN	O	O
in	ADP	O	O
dermatology	NOUN	O	O
:	PUNCT	O	O
JDD	NOUN	O	O

RESULTS:	NOUN	O	O
The	DET	O	O
incidence	NOUN	O	O
of	ADP	O	O
involuntary	ADJ	O	B-outcome
movement	NOUN	O	I-outcome
and	CCONJ	O	O
spontaneous	ADJ	O	B-outcome
movement	NOUN	O	I-outcome
were	VERB	O	O
measured	VERB	O	O
as	ADP	O	O
significantly	ADV	O	O
lower	ADJ	O	O
in	ADP	O	O
group	NOUN	O	O
I	NUM	O	O
(P	NUM	O	O
<	SYM	O	O
.05).	NUM	O	O

RESULTS:	NOUN	O	O
Among	ADP	O	O
42	NUM	O	O
HIE	NOUN	O	O
children,	NOUN	O	O
1	NUM	O	O
child	NOUN	O	O
of	ADP	O	O
severe	ADJ	O	O
congenital	ADJ	O	O
malformation	NOUN	O	O
and	CCONJ	O	O
1	NUM	O	O
child	NOUN	O	O
of	ADP	O	O
platelet	NOUN	O	O
count	NOUN	O	O
(PLT)	PUNCT	O	O
<	SYM	O	O
50x10(9)/L	NOUN	O	O
were	VERB	O	O
excluded,	VERB	O	O
and	CCONJ	O	O
40	NUM	O	O
children	NOUN	O	O
were	VERB	O	O
enrolled	VERB	O	O
in	ADP	O	O
the	DET	O	O
study	NOUN	O	O
group.	VERB	O	O

Overall,	NOUN	O	O
the	DET	O	O
study	NOUN	O	O
demonstrated	VERB	O	O
the	DET	O	O
acceptability	NOUN	O	B-outcome
of	ADP	O	O
an	DET	O	O
adapted	VERB	O	O
version	NOUN	O	O
of	ADP	O	O
the	DET	O	O
WHO	NOUN	O	O
Moments	NOUN	O	O
for	ADP	O	O
Hand	NOUN	O	O
Hygiene	NOUN	O	O
poster	NOUN	O	O
in	ADP	O	O
the	DET	O	O
introduction	NOUN	O	O
of	ADP	O	O
an	DET	O	O
intervention	NOUN	O	O
in	ADP	O	O
the	DET	O	O
community.	ADJ	O	O

OBJECTIVE:	NOUN	O	O
To	PART	O	O
investigate	NOUN	O	O
the	DET	O	O
effects	NOUN	O	O
of	ADP	O	O
aerosol	NOUN	O	O
inhalation	NOUN	O	O
on	ADP	O	O
respiratory	ADJ	O	B-outcome
mechanical	ADJ	O	I-outcome
parameters	NOUN	O	O
under	ADP	O	O
different	ADJ	O	O
ventilation	NOUN	O	O
patterns	NOUN	O	O
and	CCONJ	O	O
ventilator	NOUN	O	O
parameters	NOUN	O	O
in	ADP	O	O
patients	NOUN	O	O
on	ADP	O	O
mechanical	ADJ	O	O
ventilation	NOUN	O	O
and	CCONJ	O	O
simulated	VERB	O	O
model	NOUN	O	O
of	ADP	O	O
aqualung	NOUN	O	O
in	ADP	O	O
vitro.	NOUN	O	O

The	DET	O	O
secondary	ADJ	O	O
outcomes	NOUN	O	O
consisted	VERB	O	O
of	ADP	O	O
stool	NOUN	O	B-outcome
consistency	NOUN	O	I-outcome
,	PUNCT	O	O
measured	VERB	O	O
by	ADP	O	O
the	DET	O	O
Bristol	NOUN	O	O
Stool	NOUN	O	O
Form	NOUN	O	O
Scale,	NOUN	O	O
abdominal	ADJ	O	B-outcome
pain	NOUN	O	I-outcome
,	PUNCT	O	O
flatulence	NOUN	O	B-outcome
,	PUNCT	O	O
as	ADP	O	O
well	ADV	O	O
as	ADP	O	O
the	DET	O	O
adverse	ADJ	O	B-outcome
events	NOUN	O	I-outcome
.	PUNCT	O	O
All	DET	O	O
outcomes	NOUN	O	O
were	VERB	O	O
measured	VERB	O	O
at	ADP	O	O
baseline	NOUN	O	O
and	CCONJ	O	O
after	ADP	O	O
6-weeks	NOUN	O	O
treatment.	NOUN	O	O

CONCLUSIONS:	NOUN	O	O
Among	ADP	O	O
patients	NOUN	O	O
with	ADP	O	O
early	ADJ	O	O
Parkinson's	NOUN	O	O
disease	NOUN	O	O
who	ADP	O	O
were	VERB	O	O
evaluated	VERB	O	O
over	ADP	O	O
the	DET	O	O
course	NOUN	O	O
of	ADP	O	O
80	NUM	O	O
weeks,	NOUN	O	O
treatment	NOUN	O	O
with	ADP	O	O
levodopa	NOUN	O	O
in	ADP	O	O
combination	NOUN	O	O
with	ADP	O	O
carbidopa	NOUN	O	O
had	VERB	O	O
no	DET	O	O
disease-modifying	VERB	O	O
effect.	NOUN	O	O
(	PUNCT	O	O

The	DET	O	O
mean	NOUN	O	O
age	NOUN	O	O
of	ADP	O	O
the	DET	O	O
patients	NOUN	O	O
was	VERB	O	O
14.9	NUM	O	O
years	NOUN	O	O
and	CCONJ	O	O
the	DET	O	O
mean	NOUN	O	O
follow-up	NOUN	O	O
was	VERB	O	O
24	NUM	O	O
months.	NOUN	O	O

Background	NOUN	O	O
Intravenous	ADJ	O	O
sufentanil-midazolam	NOUN	O	O
and	CCONJ	O	O
inhalational	ADJ	O	O
sevoflurane	NOUN	O	O
are	VERB	O	O
widely	ADV	O	O
used	VERB	O	O
for	ADP	O	O
anesthetic	ADJ	O	O
induction	NOUN	O	O
in	ADP	O	O
children	NOUN	O	O
undergoing	VERB	O	O
cardiac	ADJ	O	O
surgery.	VERB	O	O

